data_1shp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1shp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.3 pt . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 112.295 0.479 . . . . 2.8700000000000001 112.295 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 89.0 m -34.55 -42.58 0.15 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.827 1.251 . . . . 1.5700000000000001 111.441 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.95 -17.39 62.08 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.909 1.077 . . . . 1.8700000000000001 113.909 -170.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -73.39 143.29 82.59 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 119.889 1.222 . . . . 3.0299999999999998 110.819 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.22 -179.18 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.215 2.61 . . . . 1.45 109.936 166.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.51 134.64 55.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.663 0.744 . . . . 3.29 110.591 170.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -139.34 128.25 23.55 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.461 1.904 . . . . 6.54 106.076 170.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.6 t -75.45 -85.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.122 -1.436 . . . . 1.9199999999999999 107.122 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.96 179.24 30.0 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 107.861 -2.096 . . . . 1.9199999999999999 107.861 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -72.1 -48.73 41.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.725 -1.213 . . . . 6.25 107.725 174.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.1 m -71.08 150.31 45.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.105 -1.072 . . . . 2.29 108.105 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.45 20.21 13.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.703 0.801 . . . . 8.0600000000000005 110.363 -170.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.25 147.9 50.91 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.9 -0.88 . . . . 1.6399999999999999 110.9 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -81.7 73.3 8.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.728 0.775 . . . . 2.0699999999999998 108.912 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -99.35 93.13 2.05 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 106.895 -1.52 . . . . 1.3200000000000001 106.895 166.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.6 125.19 13.93 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 N-CA-C 108.064 -1.552 . . . . 0.63 108.064 171.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -132.78 176.47 8.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.345 1.458 . . . . 4.9699999999999998 107.279 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -118.25 139.37 51.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.847 1.659 . . . . 0.84999999999999998 108.394 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -118.26 148.89 41.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.903 -1.888 . . . . 1.1699999999999999 105.903 168.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -70.78 100.02 1.82 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.47 -2.419 . . . . 1.8999999999999999 104.47 160.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -71.88 77.96 0.89 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 105.602 -1.999 . . . . 2.3700000000000001 105.602 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.0 t -61.71 -18.87 61.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.419 1.088 . . . . 1.48 110.342 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -62.06 -44.37 96.82 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 105.459 -2.052 . . . . 4.3899999999999997 105.459 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.7 p -94.58 -24.55 17.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.52 1.528 . . . . 2.1600000000000001 114.04 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.43 19.37 64.38 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.766 1.174 . . . . 0.91000000000000003 112.418 -165.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -103.4 163.28 12.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.644 1.178 . . . . 6.5199999999999996 109.99 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.5 m -90.28 138.95 31.12 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 105.55 -2.018 . . . . 1.05 105.55 148.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.1 m -156.13 145.73 15.39 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 118.377 -0.82 . . . . 1.95 109.212 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.33 153.27 61.49 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.074 2.516 . . . . 0.52000000000000002 112.11 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -154.68 166.1 34.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.543 1.937 . . . . 0.56000000000000005 105.93 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.99 127.76 50.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 106.67 -1.604 . . . . 1.96 106.67 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -85.93 -77.42 0.3 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.177 0.991 . . . . 2.5499999999999998 110.957 -172.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.67 98.17 0.51 Allowed Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.861 -1.296 . . . . 3.1099999999999999 109.861 -168.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -32.41 -63.45 0.28 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 127.219 2.343 . . . . 2.48 114.071 -171.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.254 0.8 OUTLIER -74.47 121.66 21.83 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.534 0.938 . . . . 2.96 113.534 -176.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.48 18.97 26.66 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.043 1.783 . . . . 2.5 113.357 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.24 162.93 39.35 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.309 1.055 . . . . 1.6699999999999999 113.691 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -118.79 -169.25 1.69 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.111 1.365 . . . . 1.47 110.513 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.44 -44.1 6.68 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.446 -1.062 . . . . 1.04 110.446 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -72.75 73.95 1.1 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.432 0.634 . . . . 1.6100000000000001 110.549 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -159.33 96.37 1.29 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.833 1.253 . . . . 2.3100000000000001 108.555 -166.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -125.19 141.4 52.12 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 124.821 1.248 . . . . 0.93000000000000005 111.343 -165.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -55.47 -34.6 64.67 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.511 0.724 . . . . 3.1000000000000001 111.547 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.7 p -141.12 160.05 40.92 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.794 0.838 . . . . 1.6200000000000001 112.061 -169.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -51.37 -48.12 62.63 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-O 117.941 -1.028 . . . . 1.8 108.839 158.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -39.41 -56.5 1.58 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.063 0.847 . . . . 3.3100000000000001 110.766 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -70.11 -50.28 42.35 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 121.164 -0.214 . . . . 4.5099999999999998 110.812 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.8 t -52.9 -32.78 47.13 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 122.064 0.935 . . . . 0.93999999999999995 112.143 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -73.83 -72.68 0.26 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 124.677 1.191 . . . . 5.0 107.952 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -41.76 -45.15 3.46 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.798 1.639 . . . . 1.6299999999999999 112.439 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.8 mm -73.18 -33.5 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 119.344 -0.36 . . . . 2.7200000000000002 111.852 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 113.33 0.863 . . . . 1.3100000000000001 113.33 -171.713 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 C--O 1.224 -0.25 0 N-CA-C 112.938 0.718 . . . . 3.3500000000000001 112.938 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.65 -32.44 19.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.31 1.044 . . . . 1.78 111.955 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -30.31 64.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.058 0.543 . . . . 1.8400000000000001 112.409 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -77.14 131.04 73.42 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.599 -0.889 . . . . 4.0999999999999996 108.599 -170.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.81 -176.48 3.06 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.071 1.847 . . . . 1.71 113.602 -164.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -61.61 153.29 28.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.245 1.018 . . . . 3.52 109.301 157.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.501 ' CD ' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -155.95 173.83 16.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.918 -2.253 . . . . 6.5999999999999996 104.918 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.0 -87.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 106.236 -1.764 . . . . 2.5499999999999998 106.236 160.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.93 -171.01 43.21 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.84 -1.704 . . . . 2.2799999999999998 108.84 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -120.24 24.81 10.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.292 1.037 . . . . 7.75 110.62 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.3 m -138.83 159.73 41.43 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.55 -1.648 . . . . 2.2799999999999998 106.55 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -79.75 55.97 2.17 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.883 0.473 . . . . 5.1900000000000004 110.594 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.8 159.57 29.3 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.331 -0.707 . . . . 1.6299999999999999 111.331 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -140.41 73.05 1.41 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.781 -1.563 . . . . 1.9399999999999999 106.781 171.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.89 97.03 22.25 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 108.632 -0.877 . . . . 1.01 108.632 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.0 118.27 5.12 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 120.462 1.201 . . . . 1.1200000000000001 109.153 172.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -120.88 179.3 4.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 127.571 2.349 . . . . 4.6200000000000001 108.429 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -117.83 148.39 42.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.584 2.354 . . . . 1.22 107.729 167.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -134.32 156.02 49.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.498 -1.667 . . . . 1.6399999999999999 106.498 166.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -66.77 112.28 4.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.558 -1.645 . . . . 2.21 106.558 159.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -93.08 122.3 35.31 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 123.898 0.749 . . . . 1.76 110.49 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -89.2 -5.25 57.84 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 117.82 -1.086 . . . . 2.3199999999999998 111.938 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -71.19 -48.86 49.06 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.624 -1.621 . . . . 4.6900000000000004 106.624 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.8 p -88.16 -30.81 19.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.695 1.198 . . . . 2.96 112.73 174.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.33 26.75 29.7 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.1 0.857 . . . . 1.27 111.952 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -142.49 154.32 44.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.189 1.396 . . . . 5.4900000000000002 110.819 -167.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.7 m -68.99 121.27 16.29 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 108.224 -1.028 . . . . 0.64000000000000001 108.224 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.2 m -144.65 145.07 26.93 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 123.512 0.725 . . . . 1.8600000000000001 109.183 -160.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.48 154.44 68.83 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.913 2.409 . . . . 0.72999999999999998 111.723 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -155.66 158.07 37.7 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.652 -1.24 . . . . 0.72999999999999998 107.652 166.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -94.92 118.33 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 N-CA-C 107.48 -1.304 . . . . 2.4199999999999999 107.48 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -91.49 145.17 24.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.881 1.272 . . . . 2.0899999999999999 109.82 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.26 22.61 37.69 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.786 1.184 . . . . 2.0800000000000001 112.734 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.92 -46.34 3.64 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.629 1.214 . . . . 1.4099999999999999 111.99 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.0 155.45 49.96 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.564 1.146 . . . . 2.71 110.325 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.07 47.79 35.97 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.285 -0.726 . . . . 2.7799999999999998 111.285 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.96 -153.42 29.31 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.736 0.684 . . . . 1.6399999999999999 111.907 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.501 ' ND2' ' CD ' ' A' ' 8' ' ' LYS . 17.5 p30 -149.36 -171.52 3.91 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.93 -1.878 . . . . 1.8400000000000001 105.93 165.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.51 -35.01 85.94 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.907 0.776 . . . . 0.81999999999999995 112.175 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -76.65 70.76 3.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.572 1.149 . . . . 1.8200000000000001 109.731 -176.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.92 63.48 0.65 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.071 -0.714 . . . . 2.1000000000000001 109.071 -161.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -104.41 146.89 28.2 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.722 1.209 . . . . 1.01 109.519 -162.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -64.54 -40.01 94.82 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.873 1.669 . . . . 2.8300000000000001 110.58 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -126.03 153.73 43.99 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.998 1.111 . . . . 1.8700000000000001 113.998 -167.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.85 -47.22 42.84 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.557 1.143 . . . . 1.72 110.273 159.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -44.16 -53.77 6.2 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.416 0.686 . . . . 3.3100000000000001 110.408 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -64.92 -52.37 56.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 119.534 -0.269 . . . . 2.4500000000000002 110.44 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.0 t -48.25 -52.68 20.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.533 0.682 . . . . 0.70999999999999996 111.436 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.9 ttm-85 -57.0 -62.05 2.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.726 1.211 . . . . 3.6299999999999999 109.927 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.97 -38.06 64.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.513 0.725 . . . . 1.73 111.993 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.4 mt -75.41 -53.53 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 122.91 0.484 . . . . 2.7599999999999998 110.75 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.9 t . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 113.584 0.957 . . . . 1.6799999999999999 113.584 -171.157 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 112.157 0.429 . . . . 2.7999999999999998 112.157 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.02 -13.32 1.86 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.89 1.676 . . . . 2.3399999999999999 114.324 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.03 -33.97 70.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.198 -1.038 . . . . 3.0099999999999998 108.198 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -77.98 137.98 61.41 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.44 -0.948 . . . . 3.5099999999999998 108.44 167.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -80.13 -179.68 5.46 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.064 1.842 . . . . 1.75 110.072 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -39.87 139.13 0.68 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 115.496 1.665 . . . . 4.0199999999999996 115.496 149.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -157.36 151.53 24.77 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 129.128 2.971 . . . . 5.79 104.853 168.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.3 t -136.7 -60.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.09 0.471 . . . . 2.9199999999999999 111.961 -160.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.67 65.96 3.09 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 114.679 0.632 . . . . 5.4299999999999997 114.679 -155.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.78 -18.51 5.57 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.49 0.716 . . . . 7.5899999999999999 112.245 164.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.5 m -130.88 160.81 33.35 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 106.845 -1.539 . . . . 1.9099999999999999 106.845 161.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -120.69 52.94 1.14 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.503 1.121 . . . . 5.6399999999999997 109.727 -170.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.16 139.61 15.49 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.316 -1.113 . . . . 1.76 110.316 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -82.64 74.48 9.6 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.078 -0.712 . . . . 1.98 109.078 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -101.7 92.44 2.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 118.204 -0.903 . . . . 1.3100000000000001 109.998 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.21 111.36 2.24 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.977 1.784 . . . . 0.72999999999999998 109.586 174.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -120.66 -179.08 3.88 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.897 1.679 . . . . 4.3499999999999996 108.891 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -120.0 146.48 45.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.735 1.614 . . . . 0.46999999999999997 108.538 172.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.473 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 6.0 p90 -127.76 152.22 48.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.451 -1.315 . . . . 1.8999999999999999 107.451 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -68.04 101.9 1.21 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.071 -1.825 . . . . 1.9399999999999999 106.071 158.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -73.44 138.06 44.95 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.412 -0.588 . . . . 2.2200000000000002 109.412 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.7 t -108.2 -8.37 15.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.692 1.197 . . . . 2.0 111.068 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.64 -50.25 45.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.363 -1.347 . . . . 4.2199999999999998 107.363 168.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.9 p -89.14 -28.23 20.19 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.798 0.839 . . . . 2.5099999999999998 112.231 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.06 39.7 18.97 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.317 -0.713 . . . . 1.04 111.352 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -148.69 148.09 29.64 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.614 1.207 . . . . 5.1900000000000004 110.414 -166.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.8 m -68.7 118.4 11.64 Favored 'General case' 0 CA--C 1.526 0.049 0 N-CA-C 108.572 -0.899 . . . . 0.52000000000000002 108.572 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.2 m -136.71 142.02 37.43 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 124.928 1.291 . . . . 1.49 108.718 -164.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.52 154.45 50.15 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.016 2.478 . . . . 0.46000000000000002 111.453 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -159.64 158.24 31.16 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.577 1.151 . . . . 1.1399999999999999 109.176 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.1 mm -86.3 119.87 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 106.64 -1.615 . . . . 2.7400000000000002 106.64 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -80.09 -19.78 46.64 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.018 0.747 . . . . 4.8099999999999996 113.018 -168.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.29 -46.46 3.41 Favored Glycine 0 CA--C 1.527 0.821 0 O-C-N 120.979 -1.076 . . . . 2.21 110.45 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.8 -30.94 3.85 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.21 0.909 . . . . 1.79 112.953 165.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.69 159.42 39.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.736 0.814 . . . . 2.7400000000000002 111.607 -169.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.0 5.03 51.32 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.192 0.901 . . . . 3.1499999999999999 112.414 -166.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.17 -149.71 3.5 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.395 0.998 . . . . 2.4199999999999999 110.943 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -151.56 -176.24 5.52 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.709 1.204 . . . . 1.3 108.629 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.38 -5.14 90.22 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.549 -1.14 . . . . 1.5600000000000001 113.152 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -78.15 65.58 3.56 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.961 1.88 . . . . 1.5900000000000001 107.073 170.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -159.0 112.68 2.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.929 -1.137 . . . . 3.3799999999999999 107.929 -165.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -136.24 148.5 48.08 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.549 1.14 . . . . 0.83999999999999997 108.206 -165.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.46 -38.59 84.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.337 0.517 . . . . 2.6000000000000001 109.779 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.5 p -135.66 160.14 39.43 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.873 0.869 . . . . 1.6899999999999999 111.707 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.66 -46.81 58.73 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 123.393 0.677 . . . . 1.72 109.803 161.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -49.32 -49.59 43.29 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.099 -0.334 . . . . 3.8999999999999999 110.099 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -67.22 -50.61 60.11 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.024 -0.362 . . . . 2.4399999999999999 110.024 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.8 t -50.63 -46.15 58.08 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.507 0.67 . . . . 0.60999999999999999 111.184 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -59.15 -59.8 4.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.806 1.242 . . . . 3.6200000000000001 109.727 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.54 -41.93 54.52 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.359 0.664 . . . . 1.75 111.824 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.92 -50.39 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 122.962 0.505 . . . . 2.73 111.236 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 114.783 1.401 . . . . 2.0 114.783 -156.699 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.222 -0.36 0 CA-C-O 120.835 0.35 . . . . 3.2999999999999998 111.234 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 66.4 m -45.13 -32.95 1.99 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.488 1.515 . . . . 1.4299999999999999 112.093 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.55 7.14 47.25 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.617 0.599 . . . . 2.98 112.617 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.16 127.5 92.03 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.56 1.073 . . . . 3.29 109.165 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.11 145.61 49.83 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.797 2.331 . . . . 2.3700000000000001 107.337 170.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 132.58 40.18 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 117.932 -1.507 . . . . 9.4199999999999999 112.087 -164.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.86 148.1 39.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.789 2.036 . . . . 6.5300000000000002 107.251 168.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -80.87 -87.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.746 -1.575 . . . . 2.27 106.746 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.57 55.09 0.03 OUTLIER Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.357 0.503 . . . . 3.48 112.657 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.25 47.55 0.69 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.63 1.972 . . . . 5.9400000000000004 113.679 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.8 m -96.53 164.25 12.69 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.237 0.615 . . . . 3.7200000000000002 111.343 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -140.33 58.86 1.57 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.425 -1.324 . . . . 7.4800000000000004 107.425 170.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.49 171.97 31.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 108.35 -1.9 . . . . 1.53 108.35 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -125.71 102.36 7.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.78 1.232 . . . . 1.52 108.43 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -131.9 105.15 13.96 Favored Pre-proline 0 C--O 1.233 0.207 0 N-CA-C 106.364 -1.717 . . . . 1.47 106.364 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.67 132.04 21.1 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.92 1.747 . . . . 0.75 108.773 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -136.97 178.91 6.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.678 1.591 . . . . 4.79 107.356 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -122.27 145.46 48.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.508 1.523 . . . . 0.56999999999999995 109.3 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -130.97 150.56 52.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.063 -1.088 . . . . 1.1499999999999999 108.063 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -72.34 101.42 2.88 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.63 -1.618 . . . . 1.72 106.63 166.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.79 109.57 6.48 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.541 -1.281 . . . . 2.04 107.541 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -85.62 -7.07 59.05 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.017 0.927 . . . . 2.1499999999999999 111.971 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -71.01 -55.64 7.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.828 -1.545 . . . . 7.4000000000000004 106.828 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 p -85.37 -19.03 32.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.774 -1.103 . . . . 2.1299999999999999 111.986 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.22 41.47 69.05 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.129 -1.188 . . . . 1.1799999999999999 110.129 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.08 131.81 45.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.072 0.949 . . . . 6.2699999999999996 109.893 -170.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.0 m -67.44 113.01 4.96 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.041 -1.466 . . . . 0.68000000000000005 107.041 159.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.2 m -126.93 137.25 30.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 126.767 2.027 . . . . 1.5900000000000001 107.825 -165.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.55 156.21 58.26 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.633 2.222 . . . . 0.45000000000000001 111.022 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -161.63 165.8 27.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.47 1.508 . . . . 1.02 107.588 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.28 118.72 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 107.62 -1.252 . . . . 2.0299999999999998 107.62 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -77.45 -42.68 35.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.67 0.788 . . . . 2.3500000000000001 110.834 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.7 -16.92 43.15 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.978 -0.901 . . . . 2.8599999999999999 112.895 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.75 25.17 21.24 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 118.171 0.986 . . . . 1.8999999999999999 113.24 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.86 159.98 9.97 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.323 1.062 . . . . 2.9399999999999999 109.939 -171.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.85 32.9 59.48 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.221 1.391 . . . . 2.3100000000000001 114.575 169.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.43 -163.28 9.76 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 122.263 0.924 . . . . 1.6299999999999999 115.276 -168.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -156.7 -179.75 8.49 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 127.686 2.394 . . . . 1.3799999999999999 106.377 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.99 -40.03 95.09 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 118.237 0.472 . . . . 0.98999999999999999 113.411 -169.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -77.34 57.57 1.52 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.466 1.106 . . . . 1.73 111.25 -167.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.75 76.75 1.02 Allowed 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.251 -0.905 . . . . 2.4199999999999999 110.725 -148.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -122.04 145.24 48.34 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.11 1.364 . . . . 1.02 111.802 -152.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -57.12 -39.06 74.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.487 1.115 . . . . 2.77 111.533 -173.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -144.94 161.15 40.06 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.139 0.576 . . . . 1.6100000000000001 110.109 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 tp -52.12 -48.46 64.82 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 118.514 -0.755 . . . . 1.97 109.012 164.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -43.63 -53.9 5.38 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.477 -0.564 . . . . 3.6899999999999999 109.477 176.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -69.72 -46.51 65.8 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.835 -0.432 . . . . 2.29 109.835 -171.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.4 t -51.97 -49.35 63.39 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 121.078 0.466 . . . . 0.58999999999999997 110.726 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -60.98 -61.19 2.76 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.223 -1.028 . . . . 6.4299999999999997 108.223 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -43.8 -48.44 8.18 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.473 1.509 . . . . 1.8 111.55 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -67.4 -50.85 58.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.655 0.382 . . . . 2.8700000000000001 111.048 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 32.1 m . . . . . 0 CA--C 1.529 0.139 0 O-C-N 122.071 -0.393 . . . . 2.27 112.054 -172.112 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.2 pt . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 113.321 0.86 . . . . 2.9500000000000002 113.321 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.6 m -56.38 -41.3 76.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.643 -0.661 . . . . 1.5700000000000001 110.172 160.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.4 -27.47 41.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.592 1.157 . . . . 1.8400000000000001 111.99 -173.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -58.32 139.38 84.47 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 106.974 -1.491 . . . . 3.1800000000000002 106.974 166.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -102.56 -175.77 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.836 2.357 . . . . 1.49 110.821 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.0 132.3 37.5 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.114 -0.699 . . . . 3.54 109.114 167.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.25 136.6 15.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.487 -2.042 . . . . 5.7699999999999996 105.487 172.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t -74.11 -71.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.131 0.878 . . . . 2.0099999999999998 108.971 -174.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.69 178.34 17.74 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.232 -1.547 . . . . 2.02 109.232 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -79.01 37.28 0.3 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 117.842 0.821 . . . . 6.2800000000000002 110.688 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.8 m -166.34 158.86 14.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 105.513 -2.032 . . . . 1.78 105.513 -166.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -139.6 41.53 2.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.399 0.68 . . . . 7.0700000000000003 110.543 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.81 152.1 49.99 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 109.981 -1.247 . . . . 1.3600000000000001 109.981 173.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -82.4 74.15 9.39 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.721 -0.87 . . . . 1.3700000000000001 109.032 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.58 91.0 3.05 Favored Pre-proline 0 CA--C 1.529 0.169 0 N-CA-C 108.77 -0.826 . . . . 0.98999999999999999 108.77 171.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -62.81 122.63 11.01 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 N-CA-C 108.702 -1.307 . . . . 0.93000000000000005 108.702 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -130.65 176.39 8.22 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.059 1.744 . . . . 4.8099999999999996 107.984 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -109.01 148.95 29.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.837 1.255 . . . . 0.59999999999999998 108.488 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -131.51 153.58 49.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.323 -1.362 . . . . 0.98999999999999999 107.323 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -82.71 107.01 15.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.171 -1.789 . . . . 1.6699999999999999 106.171 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.16 112.88 15.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.275 -1.009 . . . . 2.1000000000000001 108.275 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 t -88.5 -0.56 57.35 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 117.966 -1.016 . . . . 1.5900000000000001 113.106 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -82.63 -48.98 10.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.498 -1.668 . . . . 5.21 106.498 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.4 p -79.63 -30.71 41.47 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.769 1.228 . . . . 2.23 110.062 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.39 57.06 5.77 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.056 -1.618 . . . . 0.88 109.056 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.28 160.89 37.55 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.18 0.992 . . . . 5.5599999999999996 110.039 -177.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.0 m -85.99 128.72 34.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.652 0.781 . . . . 0.57999999999999996 109.075 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -144.06 144.91 27.99 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.52 1.128 . . . . 1.5900000000000001 108.306 -161.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.43 155.2 45.79 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.969 2.446 . . . . 0.53000000000000003 112.265 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.25 169.5 23.09 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.526 1.53 . . . . 0.82999999999999996 108.114 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.18 119.13 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.307 -0.998 . . . . 2.1600000000000001 108.307 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -89.39 143.57 26.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.32 1.848 . . . . 1.97 109.963 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.3 -36.59 91.3 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.412 -0.66 . . . . 2.1899999999999999 113.381 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.86 18.9 28.32 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.125 0.869 . . . . 2.21 112.894 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.4 m -141.95 -159.18 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.559 1.144 . . . . 3.1899999999999999 108.162 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -15.55 -60.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 C-N-CA 128.27 2.843 . . . . 4.4299999999999997 115.664 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.42 -133.79 12.14 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 119.336 -0.702 . . . . 1.6499999999999999 111.545 168.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 168.66 -173.42 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 128.904 2.881 . . . . 1.98 106.851 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.17 -44.94 10.69 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.767 -0.933 . . . . 1.0900000000000001 110.767 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -73.65 67.94 1.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.72 1.208 . . . . 2.9399999999999999 110.057 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -163.15 88.12 0.58 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.736 1.214 . . . . 3.2400000000000002 109.791 -168.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -121.21 148.76 43.81 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.432 1.093 . . . . 1.5800000000000001 111.537 -162.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.45 -38.26 80.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.853 0.461 . . . . 2.9399999999999999 111.022 -174.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.3 p -142.28 165.83 26.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.516 0.726 . . . . 2.0600000000000001 110.561 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -47.76 79.01 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.814 0.846 . . . . 1.6799999999999999 110.675 166.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -48.82 -53.61 18.59 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.316 -0.624 . . . . 3.6400000000000001 109.316 175.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -65.44 -49.98 67.11 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.541 -0.54 . . . . 2.3700000000000001 109.541 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.5 t -50.3 -51.95 40.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.549 0.69 . . . . 0.97999999999999998 110.933 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -65.27 -49.18 70.56 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.466 -0.788 . . . . 4.6100000000000003 109.815 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.87 -44.42 82.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.388 0.675 . . . . 1.9199999999999999 111.624 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.3 mt -69.95 -51.78 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 122.579 0.352 . . . . 3.3399999999999999 110.667 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.528 0.126 0 N-CA-C 112.504 0.557 . . . . 2.4100000000000001 112.504 -174.066 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.3 pt . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 111.774 0.287 . . . . 2.7000000000000002 111.774 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.7 m -77.36 -27.88 52.79 Favored 'General case' 0 C--O 1.222 -0.359 0 O-C-N 121.87 -0.519 . . . . 1.51 110.655 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.92 -30.77 19.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.494 -0.928 . . . . 1.98 108.494 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -52.99 139.04 44.51 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 108.006 -1.109 . . . . 2.79 108.006 165.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -98.79 175.74 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.747 2.298 . . . . 1.6299999999999999 111.064 172.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -53.28 138.88 31.24 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.853 -1.067 . . . . 4.0099999999999998 110.1 160.221 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 132.4 8.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 128.242 2.617 . . . . 5.21 106.378 176.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.1 t -75.51 -86.02 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.103 -1.073 . . . . 2.8799999999999999 108.103 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.74 147.57 0.6 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 123.606 0.622 . . . . 3.1699999999999999 113.005 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 65.16 -55.47 0.31 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.871 2.868 . . . . 9.3200000000000003 115.808 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.7 m -140.06 166.57 24.29 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.299 1.04 . . . . 1.8799999999999999 109.73 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -133.28 33.0 3.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.087 0.955 . . . . 6.9900000000000002 110.787 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.75 146.72 42.27 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.071 -1.212 . . . . 1.45 110.071 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -81.79 72.4 8.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.883 0.849 . . . . 1.5800000000000001 108.718 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -101.57 95.95 5.78 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 107.761 -1.2 . . . . 1.02 107.761 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.1 131.02 29.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 N-CA-C 108.511 -1.38 . . . . 0.71999999999999997 108.511 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -135.11 174.89 10.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.46 -1.311 . . . . 4.3499999999999996 107.46 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -111.08 146.65 36.39 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.703 1.201 . . . . 0.53000000000000003 108.311 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 16.9 p90 -129.75 152.13 49.59 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.634 -1.247 . . . . 0.98999999999999999 107.634 173.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.47 102.42 5.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 103.892 -2.633 . . . . 2.3100000000000001 103.892 160.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -72.08 109.98 6.24 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.82 -1.918 . . . . 2.2400000000000002 105.82 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 t -86.27 -14.75 42.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.508 -0.553 . . . . 1.3500000000000001 109.508 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -63.09 -44.43 95.72 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.846 -1.909 . . . . 4.3499999999999996 105.846 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.7 p -91.95 -40.83 10.91 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.952 2.501 . . . . 1.8799999999999999 111.465 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.03 21.89 24.32 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.926 1.727 . . . . 1.04 112.398 -169.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -120.93 151.16 40.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.936 1.694 . . . . 5.4000000000000004 109.195 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -73.15 136.68 44.82 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 120.664 -1.273 . . . . 0.57999999999999996 108.093 168.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.8 m -155.11 147.24 17.4 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.431 -0.795 . . . . 1.73 108.947 -169.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.44 152.18 29.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.285 2.657 . . . . 0.64000000000000001 111.774 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -150.72 158.41 44.12 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 124.831 1.252 . . . . 0.68999999999999995 108.867 172.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.07 118.79 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 105.726 -1.953 . . . . 1.98 105.726 168.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.79 -54.06 9.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.408 0.683 . . . . 2.8399999999999999 110.569 -173.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.29 -27.81 7.52 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.208 -0.757 . . . . 2.3100000000000001 111.208 -173.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.64 -45.36 1.4 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.419 1.009 . . . . 1.5 111.364 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 m -106.4 157.73 17.41 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.577 1.151 . . . . 2.6400000000000001 108.745 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 30.83 60.95 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.499 -0.612 . . . . 2.1699999999999999 113.459 166.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.18 157.96 46.12 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 118.442 1.121 . . . . 2.04 111.75 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -117.17 -163.1 0.9 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.557 1.543 . . . . 1.1599999999999999 108.495 170.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.98 69.39 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.17 -1.172 . . . . 1.1000000000000001 110.17 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -75.17 58.8 0.94 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.678 1.591 . . . . 2.6899999999999999 111.522 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.29 78.57 1.02 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.935 -0.478 . . . . 2.0499999999999998 110.202 -161.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -109.77 154.57 22.76 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.247 1.019 . . . . 0.89000000000000001 110.983 -164.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -67.01 -44.54 80.05 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.833 -0.542 . . . . 2.4500000000000002 109.564 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 78.3 p -131.28 154.29 48.66 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.958 0.725 . . . . 1.72 112.958 -169.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.02 -47.01 22.38 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.5 1.12 . . . . 1.96 110.037 159.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.3 -50.72 15.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.241 0.616 . . . . 3.46 110.598 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -65.89 -53.62 37.17 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 119.038 -0.506 . . . . 2.6800000000000002 110.842 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 t -47.39 -44.29 24.2 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.555 0.693 . . . . 0.59999999999999998 111.656 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.1 ttm-85 -62.14 -70.41 0.2 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.499 1.12 . . . . 3.7999999999999998 109.576 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.02 -40.81 45.81 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.204 1.402 . . . . 1.6899999999999999 112.939 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mm -63.68 -39.3 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 123.99 0.916 . . . . 2.4100000000000001 110.638 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 17.5 t . . . . . 0 C--N 1.339 0.115 0 N-CA-C 113.005 0.742 . . . . 1.73 113.005 -165.9 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.1 pt . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 113.098 0.777 . . . . 2.7599999999999998 113.098 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.9 m -73.37 -32.65 64.63 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.811 0.444 . . . . 1.6299999999999999 111.096 166.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.2 -35.51 31.26 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.908 -0.495 . . . . 2.3700000000000001 110.134 -177.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -60.01 135.43 90.42 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 117.853 -1.07 . . . . 4.0599999999999996 109.125 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -104.58 177.2 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.994 2.463 . . . . 1.9099999999999999 111.757 170.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -36.54 134.07 0.49 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 126.958 2.103 . . . . 3.4300000000000002 112.911 166.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.07 135.81 9.45 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 113.282 -1.781 . . . . 5.6699999999999999 109.132 166.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.61 -49.87 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.063 -0.717 . . . . 2.1800000000000002 109.063 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.95 85.42 0.97 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.705 0.669 . . . . 3.6899999999999999 112.815 165.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 87.9 mtm-85 65.66 -52.52 0.37 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 128.89 2.876 . . . . 10.029999999999999 115.027 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 m -71.87 169.44 15.8 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.114 0.566 . . . . 2.3999999999999999 109.984 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -129.42 31.03 4.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.012 1.325 . . . . 8.4700000000000006 109.493 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.83 177.67 48.21 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.808 -1.317 . . . . 1.4299999999999999 109.808 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -124.96 87.61 2.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.091 0.956 . . . . 2.9300000000000002 108.73 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -111.57 103.13 54.76 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 108.096 -1.076 . . . . 1.0700000000000001 108.096 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.6 125.17 14.99 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 N-CA-C 108.874 -1.241 . . . . 0.98999999999999999 108.874 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -134.2 175.71 9.25 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.468 1.507 . . . . 3.3500000000000001 107.886 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -103.64 149.28 25.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.942 1.297 . . . . 0.95999999999999996 108.06 167.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -128.32 157.45 40.93 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.726 -1.583 . . . . 0.98999999999999999 106.726 166.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -78.84 103.0 8.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.056 -1.831 . . . . 1.98 106.056 163.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -77.4 111.38 13.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.619 -0.882 . . . . 1.8300000000000001 108.619 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 t -89.3 9.83 24.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.531 0.733 . . . . 1.6699999999999999 111.892 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -86.68 -45.29 11.13 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.16 -1.792 . . . . 4.4900000000000002 106.16 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.1 p -93.76 -31.71 14.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 130.263 3.425 . . . . 2.2799999999999998 111.684 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.35 30.93 12.47 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.436 1.493 . . . . 0.94999999999999996 112.765 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -143.61 148.11 35.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.19 1.396 . . . . 5.3499999999999996 111.502 -161.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 78.8 m -71.31 128.23 35.21 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 120.18 -1.575 . . . . 0.5 109.663 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.1 m -149.4 147.33 22.98 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 117.965 -1.016 . . . . 2.0 109.253 -161.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.78 150.0 34.34 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.319 2.679 . . . . 0.53000000000000003 112.219 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -153.42 171.83 18.05 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.17 1.388 . . . . 0.78000000000000003 109.014 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.58 107.86 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.765 -0.828 . . . . 2.5800000000000001 108.765 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -78.47 139.68 38.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.21 1.004 . . . . 2.1699999999999999 108.706 170.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.12 -43.03 49.39 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-O 119.365 -0.686 . . . . 1.9399999999999999 112.385 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.62 -9.03 13.02 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.149 0.88 . . . . 1.6299999999999999 113.448 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.0 m -113.34 -131.11 0.32 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.155 -1.424 . . . . 2.8500000000000001 107.155 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.04 -62.78 0.04 OUTLIER Glycine 0 C--N 1.338 0.694 0 C-N-CA 127.881 2.657 . . . . 3.0 115.193 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.26 -134.16 8.04 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.506 -1.038 . . . . 2.0899999999999999 110.506 -166.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -170.0 177.0 4.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 128.21 2.604 . . . . 1.27 106.139 171.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.17 -25.12 73.49 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.193 -0.763 . . . . 0.85999999999999999 111.193 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -73.7 55.61 0.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.649 1.58 . . . . 2.71 109.908 174.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -147.53 120.57 8.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.521 -1.289 . . . . 2.3999999999999999 107.521 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -138.6 147.72 43.3 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.49 1.116 . . . . 0.81999999999999995 108.898 -165.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -78.68 -25.13 44.77 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.884 -0.51 . . . . 3.1000000000000001 110.92 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -142.42 155.42 45.1 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.512 0.725 . . . . 1.6899999999999999 111.021 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.13 -45.59 53.12 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 109.297 -0.631 . . . . 1.98 109.297 160.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -44.77 -53.77 7.03 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.939 0.496 . . . . 3.3900000000000001 110.543 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -63.97 -54.12 39.47 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 110.161 -0.311 . . . . 2.0099999999999998 110.161 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -48.58 -49.74 35.4 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.31 0.576 . . . . 0.54000000000000004 111.503 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -59.93 -64.43 0.95 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.613 1.165 . . . . 3.2999999999999998 109.165 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -44.55 -45.64 9.49 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.508 1.123 . . . . 1.8999999999999999 111.699 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.8 mm -71.29 -56.71 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.888 0.875 . . . . 2.6299999999999999 110.739 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 113.225 0.824 . . . . 1.51 113.225 -168.051 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.9 pt . . . . . 0 C--O 1.225 -0.229 0 N-CA-C 112.025 0.38 . . . . 3.21 112.025 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.8 t -32.23 -41.44 0.05 Allowed 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 126.88 2.072 . . . . 2.0600000000000001 114.708 169.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.72 -22.82 61.57 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.138 -1.392 . . . . 1.8 111.186 -169.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.43 149.76 94.45 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 118.879 0.763 . . . . 3.0600000000000001 109.395 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.68 173.16 13.32 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.137 1.891 . . . . 1.29 110.259 170.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -54.32 141.88 28.51 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.782 0.801 . . . . 3.3599999999999999 109.471 160.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -143.94 133.05 22.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.602 -1.629 . . . . 6.8099999999999996 106.602 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.84 -55.19 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.295 0.498 . . . . 2.5299999999999998 110.144 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.64 -157.83 22.53 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 108.39 -1.884 . . . . 2.2999999999999998 108.39 -175.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -24.13 4.59 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.886 0.875 . . . . 6.71 112.22 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 64.9 m -79.12 158.26 27.79 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.539 -0.911 . . . . 2.7000000000000002 108.539 166.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -106.28 45.84 0.96 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.836 0.855 . . . . 5.8799999999999999 110.15 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.98 176.15 54.11 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.167 -0.773 . . . . 1.26 111.167 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -124.44 81.07 1.9 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.15 1.38 . . . . 1.24 107.287 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -105.99 104.67 50.46 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 108.027 -1.101 . . . . 1.5600000000000001 108.027 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -65.07 112.96 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 N-CA-C 108.544 -1.368 . . . . 0.62 108.544 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -121.69 178.34 4.89 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.934 2.094 . . . . 4.3600000000000003 109.211 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -127.32 146.15 50.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.131 1.772 . . . . 0.60999999999999999 108.313 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -135.25 153.29 51.96 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.167 -1.42 . . . . 0.89000000000000001 107.167 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -65.57 103.16 0.81 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.482 -1.673 . . . . 2.0499999999999998 106.482 161.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -78.54 114.91 17.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.376 -1.713 . . . . 1.95 106.376 169.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 t -86.28 -16.64 36.95 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.404 0.281 . . . . 2.0899999999999999 110.275 -175.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -67.2 -45.52 76.61 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 126.673 1.989 . . . . 3.6699999999999999 106.139 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.7 p -88.16 -35.6 17.31 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.246 1.818 . . . . 2.4399999999999999 110.981 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.48 44.18 8.82 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.845 -1.302 . . . . 0.91000000000000003 109.845 -171.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.54 141.93 43.4 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.842 1.657 . . . . 6.9699999999999998 110.162 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.5 m -65.61 113.47 4.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.099 -1.074 . . . . 0.81000000000000005 108.099 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.7 m -132.94 144.13 51.54 Favored Pre-proline 0 C--N 1.332 -0.185 0 C-N-CA 125.65 1.58 . . . . 1.54 108.613 -163.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.31 156.3 62.21 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.732 2.288 . . . . 0.47999999999999998 111.697 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -155.21 161.76 41.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.839 1.255 . . . . 0.83999999999999997 108.051 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.9 mm -93.67 112.39 26.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 108.136 -1.061 . . . . 2.3799999999999999 108.136 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -90.19 147.14 23.75 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.691 1.196 . . . . 2.2599999999999998 109.366 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.48 -6.68 89.16 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.252 1.406 . . . . 1.8799999999999999 113.536 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.78 -49.87 1.41 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.915 1.358 . . . . 1.72 111.581 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -127.23 144.74 50.98 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.127 0.971 . . . . 3.3399999999999999 110.379 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.51 12.47 41.28 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.669 1.604 . . . . 2.1899999999999999 112.745 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.03 148.88 47.87 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 118.313 1.056 . . . . 2.1699999999999999 113.094 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -91.01 -161.18 0.79 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.411 1.484 . . . . 1.6899999999999999 109.732 171.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.27 -45.67 6.13 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.914 -1.275 . . . . 1.1100000000000001 109.914 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -73.76 72.68 1.52 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.624 0.712 . . . . 1.53 110.158 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -159.95 93.79 1.09 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.745 1.218 . . . . 3.0499999999999998 108.704 -163.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -131.66 141.63 49.64 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 123.208 0.603 . . . . 1.4099999999999999 111.056 -160.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -54.52 -43.68 72.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.747 0.819 . . . . 2.7000000000000002 110.833 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.7 p -137.01 158.28 44.83 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.172 0.511 . . . . 1.6299999999999999 112.363 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.24 -46.93 62.47 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.167 -0.679 . . . . 1.97 109.167 159.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -46.59 -50.67 17.07 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.223 0.465 . . . . 3.2000000000000002 110.437 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -65.08 -53.9 38.38 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.764 0.426 . . . . 3.5499999999999998 110.215 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.0 t -51.83 -45.06 63.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.868 0.842 . . . . 0.54000000000000004 111.246 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -64.56 -53.76 42.76 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.153 1.381 . . . . 3.8700000000000001 109.349 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.6 -43.11 56.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.768 0.427 . . . . 1.8200000000000001 111.167 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.4 mt -69.26 -57.05 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.045 0.538 . . . . 2.98 111.719 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 114.022 1.119 . . . . 1.5900000000000001 114.022 -166.858 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 pt . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 114.37 1.248 . . . . 2.9399999999999999 114.37 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.3 m -55.61 -35.91 66.36 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.896 -0.502 . . . . 1.55 112.226 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.05 -19.37 20.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.947 0.499 . . . . 1.8799999999999999 111.088 -162.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -72.56 146.21 88.38 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 118.208 0.458 . . . . 4.25 110.323 -161.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.36 166.49 29.14 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.499 2.132 . . . . 2.2599999999999998 113.092 -169.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -57.68 147.27 28.1 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 107.702 -1.221 . . . . 3.4199999999999999 107.702 169.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -154.92 69.74 0.74 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.966 0.888 . . . . 7.1699999999999999 110.791 -156.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.3 t -60.35 -44.67 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.392 -0.596 . . . . 2.6299999999999999 109.392 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.7 -146.26 18.16 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 107.972 -2.051 . . . . 2.96 107.972 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -154.15 55.11 0.71 Allowed 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.086 -0.709 . . . . 8.4900000000000002 109.086 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.0 m -150.16 150.56 31.81 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.29 1.036 . . . . 2.8500000000000001 108.247 -165.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -77.81 63.87 2.95 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.975 0.51 . . . . 8.0800000000000001 110.351 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -116.2 153.42 17.47 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.733 -1.747 . . . . 2.0299999999999998 108.733 168.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -144.56 81.2 1.65 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.537 -0.912 . . . . 2.0099999999999998 108.537 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.33 100.13 45.21 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 108.148 -1.056 . . . . 2.1800000000000002 108.148 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.71 126.0 17.27 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.32 1.346 . . . . 0.66000000000000003 109.418 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -137.64 176.24 8.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.493 1.517 . . . . 4.6699999999999999 108.305 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -121.2 142.44 49.9 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.556 1.543 . . . . 0.67000000000000004 108.52 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -128.36 152.15 48.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.965 -1.494 . . . . 1.3500000000000001 106.965 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -73.03 104.14 4.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.637 -1.616 . . . . 2.0499999999999998 106.637 168.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.16 105.96 4.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.084 -1.45 . . . . 2.04 107.084 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.2 t -81.17 -6.9 59.36 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.154 -0.927 . . . . 1.49 112.831 -173.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -76.09 -49.95 16.03 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.211 -1.403 . . . . 5.2400000000000002 107.211 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.4 p -88.97 -12.64 40.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.708 0.803 . . . . 2.5499999999999998 111.752 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.7 37.17 76.36 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.924 1.249 . . . . 0.87 111.119 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -137.96 135.49 36.07 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.316 1.046 . . . . 5.2699999999999996 110.747 -163.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 90.6 m -66.04 124.45 22.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.347 -0.983 . . . . 0.59999999999999998 108.347 170.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.5 m -141.37 138.99 18.15 Favored Pre-proline 0 N--CA 1.451 -0.401 0 C-N-CA 124.701 1.2 . . . . 1.8600000000000001 107.862 -164.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.03 156.89 61.55 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.456 2.104 . . . . 0.72999999999999998 111.06 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.1 157.86 36.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.215 -1.402 . . . . 1.1100000000000001 107.215 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.63 116.24 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 105.293 -2.114 . . . . 1.74 105.293 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -86.28 131.2 34.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.53 -1.285 . . . . 2.3300000000000001 107.53 173.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.52 18.38 56.33 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.851 -0.416 . . . . 1.8600000000000001 112.408 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.62 -53.83 4.73 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.854 -1.698 . . . . 2.75 108.854 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.6 m -64.3 168.97 5.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.391 1.076 . . . . 4.2699999999999996 108.73 162.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.15 39.77 62.32 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 109.816 -1.314 . . . . 4.2599999999999998 109.816 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.95 57.55 5.04 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.655 -1.497 . . . . 2.6699999999999999 112.686 -171.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -81.68 173.54 12.23 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.146 0.973 . . . . 1.99 108.912 161.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.62 -23.45 72.85 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.519 0.581 . . . . 0.83999999999999997 114.051 -166.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -77.15 74.76 3.72 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.972 0.886 . . . . 1.74 109.724 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -152.17 96.52 2.2 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.071 0.548 . . . . 2.54 109.96 -160.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -124.35 148.46 47.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.137 0.575 . . . . 1.5900000000000001 109.492 -170.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -77.06 -27.55 54.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.971 -0.381 . . . . 4.7300000000000004 109.971 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.9 p -137.0 162.43 33.31 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.819 0.848 . . . . 2.0699999999999998 112.208 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.77 -49.26 39.38 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.254 1.021 . . . . 2.0499999999999998 110.101 159.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -46.8 -50.5 18.22 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.701 0.4 . . . . 3.3599999999999999 110.085 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -66.42 -52.57 45.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 119.235 -0.412 . . . . 5.0199999999999996 111.2 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 t -47.9 -49.74 28.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.606 0.639 . . . . 0.5 111.212 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -56.71 -65.44 0.61 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.49 1.116 . . . . 4.3399999999999999 109.538 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.62 -40.0 71.55 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.05 0.94 . . . . 2.3799999999999999 112.949 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mp -74.19 -52.1 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 119.258 -0.401 . . . . 3.5800000000000001 110.094 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.0 t . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 119.097 0.862 . . . . 1.55 112.546 -170.01 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.224 -0.264 0 N-CA-C 113.166 0.802 . . . . 4.5700000000000003 113.166 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -18.46 60.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.286 0.565 . . . . 1.8899999999999999 111.692 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.81 -44.2 12.67 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.388 1.075 . . . . 1.9299999999999999 110.741 168.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.2 116.15 20.46 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.787 -0.625 . . . . 4.1600000000000001 110.221 -174.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.93 153.53 42.2 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.502 1.468 . . . . 1.5800000000000001 110.791 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.88 143.93 9.3 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 122.123 0.963 . . . . 3.3799999999999999 112.52 163.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.99 128.78 10.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.257 1.823 . . . . 6.3200000000000003 106.274 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.0 t -72.86 -51.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.11 -0.7 . . . . 2.04 109.11 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.9 143.87 15.6 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.119 1.342 . . . . 2.46 109.838 -172.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -76.81 67.11 2.82 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.857 -0.79 . . . . 10.6 108.893 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 m -107.05 178.57 4.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.414 1.086 . . . . 3.3599999999999999 109.919 -171.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -122.28 68.05 0.94 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.404 -1.332 . . . . 9.1199999999999992 107.404 167.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.14 165.97 35.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.325 -1.51 . . . . 1.51 109.325 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -146.37 99.36 3.21 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.099 1.759 . . . . 1.5 106.283 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -123.64 100.86 37.4 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 107.66 -1.237 . . . . 1.1299999999999999 107.66 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.2 125.73 17.7 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 108.484 -1.391 . . . . 0.62 108.484 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.6 mmt-85 -135.66 174.47 10.58 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.388 1.475 . . . . 4.4199999999999999 108.347 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -115.85 140.98 48.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.241 1.417 . . . . 0.46999999999999997 108.154 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 7.4 p90 -123.6 152.65 41.68 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.331 -1.359 . . . . 0.82999999999999996 107.331 169.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -66.64 105.66 1.6 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.24 -1.763 . . . . 1.47 106.24 155.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.427 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 6.5 t70 -72.05 116.87 12.96 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.767 -1.938 . . . . 1.8300000000000001 105.767 168.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.65 -25.11 28.71 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.745 -0.835 . . . . 2.71 108.745 -169.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -63.73 -45.9 87.85 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 128.208 2.603 . . . . 3.8999999999999999 106.636 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.8 p -84.9 -34.24 22.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.101 1.36 . . . . 2.0800000000000001 110.783 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.9 37.01 23.73 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.146 1.355 . . . . 1.22 110.494 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.93 156.75 43.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.779 1.232 . . . . 7.6399999999999997 110.384 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.2 m -67.34 139.03 57.2 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.398 -0.814 . . . . 0.75 109.435 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -156.65 146.15 15.3 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.874 -1.158 . . . . 1.8100000000000001 107.874 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.66 156.49 49.11 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.091 2.528 . . . . 0.39000000000000001 111.695 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -153.69 162.95 40.79 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.414 1.486 . . . . 0.56999999999999995 107.359 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -96.05 113.67 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.862 -1.903 . . . . 1.9399999999999999 105.862 170.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -81.57 139.77 34.87 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.639 -1.245 . . . . 2.1200000000000001 107.639 169.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.26 -11.24 85.53 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 121.725 -0.609 . . . . 1.98 112.653 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.27 -43.88 1.7 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.206 -1.158 . . . . 1.51 110.206 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.9 159.03 15.19 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.131 1.773 . . . . 2.3999999999999999 111.374 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.09 37.59 93.05 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 114.759 0.664 . . . . 2.6899999999999999 114.759 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.61 -153.6 15.81 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.887 0.844 . . . . 1.6299999999999999 112.815 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -160.38 -163.32 1.08 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.381 2.272 . . . . 1.4399999999999999 105.675 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.21 -20.84 68.83 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.566 1.076 . . . . 1.0 112.239 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -81.5 63.97 6.02 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 118.502 1.151 . . . . 1.6200000000000001 110.069 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -159.09 78.24 0.74 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.914 -0.584 . . . . 2.7400000000000002 109.544 -155.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -112.99 154.5 26.36 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.465 0.706 . . . . 0.96999999999999997 110.916 -167.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.24 -39.73 94.56 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.803 -0.814 . . . . 3.04 108.803 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.8 p -130.66 150.59 51.78 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.142 1.164 . . . . 1.52 114.142 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.9 -46.11 42.33 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.224 1.41 . . . . 1.8600000000000001 110.242 159.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.42 -49.96 23.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.704 0.802 . . . . 3.27 110.488 175.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -64.46 -54.96 24.39 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 119.186 -0.435 . . . . 2.2999999999999998 110.358 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.25 -43.54 42.91 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.294 1.045 . . . . 0.65000000000000002 111.509 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -60.61 -58.77 7.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.864 1.266 . . . . 6.2000000000000002 111.516 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.32 -43.55 67.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.621 0.769 . . . . 1.6799999999999999 112.298 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.5 -44.17 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.899 0.88 . . . . 2.7999999999999998 110.331 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 113.058 0.762 . . . . 2.3399999999999999 113.058 -171.802 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.8 pt . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 111.927 0.343 . . . . 2.6800000000000002 111.927 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.2 m -49.1 -27.35 3.33 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.343 1.057 . . . . 1.6799999999999999 112.704 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -33.26 66.13 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.912 -0.492 . . . . 1.8799999999999999 111.038 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.44 119.21 44.6 Favored Pre-proline 0 C--O 1.225 -0.2 0 CA-C-O 118.11 -0.947 . . . . 4.9000000000000004 109.072 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.08 173.51 12.03 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 120.802 1.322 . . . . 1.6399999999999999 111.626 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -45.21 131.56 7.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.115 -1.402 . . . . 3.5800000000000001 110.52 157.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -159.17 137.01 10.25 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.711 2.004 . . . . 6.0099999999999998 106.722 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.52 -66.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.799 0.727 . . . . 1.97 109.782 -172.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.77 -178.82 19.1 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.241 -1.543 . . . . 1.8400000000000001 109.241 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -68.06 -43.36 78.81 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.915 -0.772 . . . . 7.2300000000000004 108.915 172.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.2 m -71.52 151.97 43.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.269 -1.752 . . . . 2.4500000000000002 106.269 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -138.09 46.95 2.03 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.448 0.699 . . . . 7.1900000000000004 109.134 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.94 153.91 34.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.269 -1.532 . . . . 1.4199999999999999 109.269 170.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -83.1 77.8 9.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.981 -0.717 . . . . 1.4099999999999999 109.523 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -101.31 94.35 3.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.071 -0.715 . . . . 0.94999999999999996 109.071 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.67 122.33 10.39 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 CA-C-N 120.548 1.232 . . . . 0.56000000000000005 108.935 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -130.7 177.99 6.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 125.578 1.551 . . . . 4.7699999999999996 107.268 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -117.53 142.49 47.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.794 1.638 . . . . 0.46000000000000002 108.144 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -124.84 150.43 46.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.567 -1.642 . . . . 0.98999999999999999 106.567 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.9 102.34 0.77 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 104.559 -2.386 . . . . 2.1699999999999999 104.559 157.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.39 103.22 3.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.243 -1.762 . . . . 2.0800000000000001 106.243 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 t -74.9 -15.33 60.71 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.258 0.623 . . . . 2.1899999999999999 110.66 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -62.4 -41.66 98.84 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.446 1.098 . . . . 4.3399999999999999 108.107 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.5 p -105.33 -25.66 12.31 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.783 2.833 . . . . 1.74 112.911 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.1 30.39 22.97 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.867 2.175 . . . . 0.97999999999999998 113.233 -173.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -136.65 138.2 40.87 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.152 1.476 . . . . 5.4900000000000002 110.96 -161.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 m -70.48 120.17 15.73 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 120.491 -1.38 . . . . 0.56999999999999995 108.952 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.9 m -140.72 145.65 40.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.637 1.175 . . . . 1.5800000000000001 108.868 -163.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.65 151.25 41.16 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.218 2.612 . . . . 0.51000000000000001 111.899 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -154.64 162.99 40.88 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.349 1.46 . . . . 0.67000000000000004 108.27 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.39 113.15 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.02 -1.474 . . . . 1.8500000000000001 107.02 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -80.83 145.19 31.53 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.526 1.13 . . . . 1.98 108.004 168.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.31 -31.3 47.16 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.992 0.806 . . . . 2.1600000000000001 114.012 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.42 17.35 24.51 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.391 0.996 . . . . 1.75 113.115 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -125.57 -156.93 0.76 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.125 1.37 . . . . 3.2599999999999998 109.403 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.48 67.61 0.26 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.868 1.699 . . . . 2.98 110.254 163.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.33 -83.92 0.09 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.135 -1.586 . . . . 2.6099999999999999 109.135 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -177.85 -174.13 0.43 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 127.431 2.292 . . . . 1.21 108.061 167.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.55 -20.51 61.81 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.463 0.554 . . . . 1.24 112.69 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -80.24 64.89 5.21 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.372 1.086 . . . . 1.7 108.577 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.9 69.39 0.73 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.824 -0.806 . . . . 2.0600000000000001 108.824 -151.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -106.77 163.41 12.95 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.438 1.495 . . . . 0.81999999999999995 111.309 -162.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -30.43 35.29 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.671 -0.643 . . . . 3.3700000000000001 110.59 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.8 p -146.97 162.38 38.88 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.244 0.618 . . . . 1.8300000000000001 110.852 -173.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -46.11 70.31 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 123.432 0.693 . . . . 1.8400000000000001 109.855 163.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -47.82 -51.95 20.8 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.91 -0.404 . . . . 3.6899999999999999 109.91 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -68.96 -49.98 53.17 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.361 -0.237 . . . . 2.0099999999999998 110.361 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -50.49 -47.65 57.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.509 0.671 . . . . 0.57999999999999996 110.699 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -61.89 -58.86 6.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 123.921 0.889 . . . . 5.5999999999999996 110.097 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.64 -45.61 63.38 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.502 0.721 . . . . 1.7 111.584 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.5 mm -65.63 -54.58 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 122.661 0.385 . . . . 2.4500000000000002 110.014 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.5 t . . . . . 0 CA--C 1.528 0.127 0 N-CA-C 112.781 0.66 . . . . 1.75 112.781 -168.145 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.4 pt . . . . . 0 C--O 1.226 -0.166 0 CA-C-O 120.708 0.29 . . . . 2.7799999999999998 110.756 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.4 m -47.76 -28.5 2.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.644 0.778 . . . . 1.77 112.302 176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.34 -17.03 55.34 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.025 -0.988 . . . . 2.29 112.419 -172.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.77 148.91 81.58 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 120.511 1.505 . . . . 3.21 111.518 -173.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.2 170.15 20.84 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.665 2.243 . . . . 1.8799999999999999 110.29 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HE2' ' CE1' ' A' ' 20' ' ' TYR . 26.7 ttmt -67.99 140.84 56.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.255 -0.646 . . . . 5.2599999999999998 109.255 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.53 149.92 30.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.505 -1.665 . . . . 6.2599999999999998 106.505 176.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.6 t -90.73 -72.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 108.915 -0.772 . . . . 2.04 108.915 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.96 173.48 34.46 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 108.838 -1.705 . . . . 2.3700000000000001 108.838 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -74.23 -43.17 58.14 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.289 -1.374 . . . . 9.8000000000000007 107.289 168.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.24 144.21 50.14 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.059 -1.83 . . . . 2.8199999999999998 106.059 166.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -59.61 2.64 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 119.041 -0.504 . . . . 7.2599999999999998 109.963 -173.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.19 -178.28 0.62 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.314 1.435 . . . . 2.0 115.839 166.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -147.99 95.26 2.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.402 1.081 . . . . 1.48 108.986 170.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.2 107.17 13.54 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 109.121 -0.696 . . . . 1.04 109.121 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.81 117.81 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.628 1.552 . . . . 0.82999999999999996 110.208 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -120.22 176.94 5.21 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 126.921 2.088 . . . . 3.9700000000000002 109.238 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -123.63 140.69 52.74 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.779 2.031 . . . . 0.56999999999999995 107.559 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.436 ' CE1' ' HE2' ' A' ' 7' ' ' LYS . 1.3 p90 -122.55 150.65 42.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.852 -1.906 . . . . 1.05 105.852 169.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -68.57 107.74 3.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.381 -2.081 . . . . 2.2200000000000002 105.381 159.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.07 111.98 7.77 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.884 -1.525 . . . . 2.23 106.884 170.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 t -88.06 1.53 54.04 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.004 -0.998 . . . . 1.3200000000000001 112.945 -171.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -85.0 -50.07 7.77 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.862 -1.533 . . . . 5.7199999999999998 106.862 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.3 p -83.43 -26.07 30.68 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.862 0.865 . . . . 2.6400000000000001 111.357 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.08 31.27 53.39 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.867 1.222 . . . . 1.0600000000000001 111.126 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.2 131.61 53.55 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 118.751 1.275 . . . . 5.4199999999999999 110.548 -169.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.8 m -62.31 129.02 38.83 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 107.439 -1.319 . . . . 0.47999999999999998 107.439 168.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.0 m -156.28 149.62 18.78 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.899 -1.148 . . . . 1.6899999999999999 107.899 -165.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.97 157.88 46.62 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.101 2.534 . . . . 0.54000000000000004 114.528 -174.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -154.07 164.3 38.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.257 1.423 . . . . 0.95999999999999996 108.869 167.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.9 mm -98.93 104.87 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.575 -1.268 . . . . 2.1699999999999999 107.575 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -73.4 152.75 40.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.498 -0.927 . . . . 2.25 108.498 168.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.53 13.27 47.18 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 114.365 0.506 . . . . 1.8899999999999999 114.365 -172.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.76 -48.86 2.8 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 118.645 1.223 . . . . 1.49 110.943 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.52 128.04 38.5 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.712 0.805 . . . . 3.1400000000000001 111.834 174.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.14 52.5 0.24 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.522 2.01 . . . . 2.46 108.548 -170.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.15 164.73 54.35 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.065 -0.814 . . . . 2.48 111.065 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -156.8 -173.2 4.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.206 -1.775 . . . . 1.55 106.206 171.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.09 -47.29 9.37 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.023 -1.231 . . . . 1.0900000000000001 110.023 -172.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.11 65.92 2.19 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.929 0.492 . . . . 1.5600000000000001 110.926 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.0 66.12 0.91 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.343 1.057 . . . . 2.1000000000000001 109.859 -159.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -108.65 140.93 41.35 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.726 0.81 . . . . 0.89000000000000001 110.994 -160.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.15 -42.29 80.76 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.252 0.933 . . . . 2.52 110.722 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.9 p -138.98 163.5 32.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.615 0.766 . . . . 1.6599999999999999 111.507 -169.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.79 -47.7 67.37 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.207 0.603 . . . . 1.6399999999999999 109.548 162.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -48.69 -48.68 39.94 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.998 -0.371 . . . . 3.46 109.998 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -68.58 -51.54 41.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.517 0.327 . . . . 2.25 110.641 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.5 t -51.13 -48.53 61.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.548 0.69 . . . . 0.54000000000000004 111.092 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -57.49 -60.34 3.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.224 1.01 . . . . 3.5699999999999998 109.129 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.75 -43.6 27.36 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.479 0.712 . . . . 1.8899999999999999 112.204 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.38 -59.35 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.945 0.339 . . . . 2.5 110.151 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.532 0.277 0 C-N-CA 119.95 -0.7 . . . . 1.6200000000000001 112.522 -164.696 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 119.343 -0.36 . . . . 3.52 111.774 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.3 m -33.12 -45.84 0.15 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.069 1.347 . . . . 1.6799999999999999 111.165 166.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.44 -22.25 61.12 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.589 0.959 . . . . 1.8500000000000001 113.589 -169.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -65.71 146.16 99.0 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 119.787 1.176 . . . . 3.0899999999999999 111.027 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.32 169.91 21.45 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.949 1.766 . . . . 1.3799999999999999 110.735 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -56.68 143.03 37.82 Favored 'General case' 0 N--CA 1.46 0.051 0 C-N-CA 125.506 1.523 . . . . 3.2000000000000002 111.327 161.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -146.75 99.01 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.038 1.735 . . . . 6.21 110.196 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.3 -42.09 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.442 -0.577 . . . . 1.8799999999999999 109.442 174.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.62 -178.33 42.52 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.67 -0.972 . . . . 2.0800000000000001 110.67 -172.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.06 55.56 2.53 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.985 -0.715 . . . . 8.9199999999999999 112.105 -170.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.9 m -147.58 165.44 30.36 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.917 1.287 . . . . 2.0699999999999998 107.573 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -139.42 20.55 2.56 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.236 0.615 . . . . 6.5099999999999998 112.103 -177.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.71 145.19 38.14 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.255 -1.138 . . . . 1.5600000000000001 110.255 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -81.95 73.32 9.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.69 0.757 . . . . 1.76 109.097 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -102.42 90.75 2.28 Favored Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 108.03 -1.1 . . . . 1.1399999999999999 108.03 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.56 136.45 46.41 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.207 1.271 . . . . 0.93999999999999995 109.549 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -140.43 179.35 6.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.051 2.141 . . . . 3.3700000000000001 107.62 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -122.95 147.23 46.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.892 2.077 . . . . 0.60999999999999999 108.391 169.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -128.61 155.81 44.37 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.955 -1.869 . . . . 1.21 105.955 166.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -75.99 101.93 5.43 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.341 -1.355 . . . . 2.0499999999999998 107.341 164.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -72.35 98.66 2.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.28 -1.378 . . . . 1.8 107.28 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -72.26 -14.69 61.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.245 -0.883 . . . . 1.6100000000000001 112.817 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -69.27 -49.05 59.64 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.413 -1.328 . . . . 4.9800000000000004 107.413 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 64.1 p -83.77 -19.54 34.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.937 0.495 . . . . 2.0800000000000001 111.596 174.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.96 34.36 58.92 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.51 1.052 . . . . 0.78000000000000003 110.831 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.73 136.52 52.54 Favored 'General case' 0 CA--C 1.523 -0.059 0 C-N-CA 124.631 1.172 . . . . 6.3600000000000003 110.527 -169.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.8 m -61.99 124.68 21.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.905 -1.146 . . . . 0.63 107.905 156.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.5 m -141.54 137.69 16.67 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 107.299 -1.371 . . . . 1.8799999999999999 107.299 -166.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.03 155.17 65.67 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.405 2.07 . . . . 0.73999999999999999 110.84 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -153.46 157.84 40.47 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.147 -1.057 . . . . 0.81999999999999995 108.147 167.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.6 120.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 105.961 -1.866 . . . . 1.72 105.961 172.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -84.84 -7.53 59.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.071 1.348 . . . . 2.6299999999999999 111.707 -172.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.09 -33.12 1.5 Allowed Glycine 0 CA--C 1.533 1.203 0 O-C-N 119.991 -1.693 . . . . 2.4100000000000001 113.221 172.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.96 25.73 18.9 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 126.059 1.79 . . . . 2.2599999999999998 110.478 -171.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.87 -160.71 0.72 Allowed 'General case' 0 C--N 1.34 0.195 0 N-CA-C 114.926 1.454 . . . . 4.1799999999999997 114.926 -164.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -31.02 -58.51 0.26 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 127.343 2.401 . . . . 3.3799999999999999 113.42 173.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.04 -161.88 46.89 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.995 -0.442 . . . . 1.8700000000000001 111.995 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -172.23 -169.8 0.67 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.976 1.71 . . . . 1.3700000000000001 109.776 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.73 -41.9 18.39 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.584 -1.407 . . . . 1.0700000000000001 109.584 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -73.89 67.06 1.2 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.879 0.371 . . . . 1.78 111.179 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -149.58 117.92 6.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.097 1.359 . . . . 2.1400000000000001 108.492 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -138.77 139.84 38.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.766 0.827 . . . . 1.1699999999999999 108.83 -166.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -63.44 -35.98 82.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.878 0.763 . . . . 3.1299999999999999 110.936 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.5 p -131.11 155.05 47.62 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.592 0.757 . . . . 1.51 111.314 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.92 -45.57 60.5 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.137 -0.69 . . . . 1.79 109.137 161.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.14 -53.72 7.72 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.821 0.449 . . . . 3.3900000000000001 110.498 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -64.71 -54.2 35.21 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.038 -0.356 . . . . 2.1200000000000001 110.038 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 t -49.64 -50.22 44.05 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.01 0.433 . . . . 0.46000000000000002 110.93 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -57.81 -60.89 3.01 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.743 1.217 . . . . 3.8700000000000001 109.111 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.05 -32.55 61.99 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.103 0.961 . . . . 2.0 112.851 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.5 mm -88.29 -50.4 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.29 0.636 . . . . 2.9100000000000001 110.82 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.8 t . . . . . 0 CA--C 1.532 0.253 0 O-C-N 121.705 -0.622 . . . . 1.55 111.484 -175.84 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.569 0.224 . . . . 3.8799999999999999 110.976 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m -40.73 -36.8 0.66 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.462 1.505 . . . . 1.6799999999999999 111.694 170.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -23.89 60.77 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.594 0.961 . . . . 2.6099999999999999 113.594 -176.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -72.29 144.66 87.21 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.695 0.68 . . . . 4.0999999999999996 109.893 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -83.54 169.27 12.37 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.252 1.968 . . . . 2.6099999999999999 112.193 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -60.3 140.42 57.1 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.906 1.283 . . . . 3.8100000000000001 107.914 153.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.49 ' CD ' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -158.24 134.47 9.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.529 0.732 . . . . 5.9400000000000004 109.763 176.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.56 -27.27 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.692 0.758 . . . . 2.1600000000000001 110.445 -173.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.4 179.07 9.69 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 121.932 0.74 . . . . 2.1200000000000001 111.77 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -81.25 53.2 1.98 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.605 -0.939 . . . . 8.5500000000000007 109.266 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.6 m -143.47 147.34 34.39 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.299 -1.371 . . . . 1.8700000000000001 107.299 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.71 39.11 3.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.411 0.685 . . . . 5.7300000000000004 111.953 -171.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.09 141.56 15.66 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.501 -1.04 . . . . 1.55 110.501 174.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -82.05 74.93 9.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.743 -0.836 . . . . 1.73 108.743 -176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -102.0 88.55 1.31 Allowed Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.114 0.966 . . . . 1.0 109.059 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.34 119.88 6.99 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.57 1.514 . . . . 0.62 109.322 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -116.7 178.05 4.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.823 2.049 . . . . 4.1100000000000003 108.919 169.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -116.62 139.69 50.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.989 1.716 . . . . 0.47999999999999998 108.373 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -120.79 148.01 44.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.931 -1.507 . . . . 0.85999999999999999 106.931 165.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -67.47 105.44 1.82 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.546 -1.65 . . . . 1.4399999999999999 106.546 158.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.57 103.57 3.59 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.149 -1.426 . . . . 1.9399999999999999 107.149 168.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 t -76.91 -9.46 58.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.215 -0.898 . . . . 1.49 112.593 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.85 -48.85 34.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.522 -1.288 . . . . 4.1900000000000004 107.522 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.8 p -92.0 -13.72 30.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.904 0.882 . . . . 2.27 112.589 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.03 33.67 84.4 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.134 0.873 . . . . 0.98999999999999999 111.108 -174.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 133.69 55.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 125.049 1.34 . . . . 6.1399999999999997 109.844 -170.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.3 m -64.55 124.01 20.74 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.063 -1.088 . . . . 0.51000000000000001 108.063 158.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.8 m -142.71 141.83 21.26 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.724 1.61 . . . . 1.6000000000000001 107.36 -165.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.45 153.9 50.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.45 2.1 . . . . 0.56999999999999995 111.693 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -153.87 159.25 41.72 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.884 1.273 . . . . 0.68000000000000005 108.054 169.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.55 120.5 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 106.734 -1.58 . . . . 1.8600000000000001 106.734 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.0 -23.81 59.49 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.162 0.585 . . . . 2.7400000000000002 112.392 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.14 -49.73 4.17 Favored Glycine 0 CA--C 1.522 0.489 0 O-C-N 121.08 -1.013 . . . . 2.3300000000000001 110.749 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.68 -31.18 2.03 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.396 -0.669 . . . . 1.78 113.062 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.05 176.23 7.17 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.371 1.085 . . . . 2.8999999999999999 108.38 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.23 43.62 25.21 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.922 -1.271 . . . . 2.75 109.922 -172.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.85 147.47 48.43 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.091 -1.203 . . . . 2.71 110.091 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.49 ' ND2' ' CD ' ' A' ' 8' ' ' LYS . 51.8 p30 -153.65 -174.45 4.96 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 105.758 -1.942 . . . . 1.8600000000000001 105.758 170.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.79 -43.7 65.66 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.906 -1.278 . . . . 1.51 109.906 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -75.17 67.11 1.77 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.471 0.708 . . . . 1.72 111.705 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.05 60.69 0.46 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.726 0.81 . . . . 2.0600000000000001 110.061 -160.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -104.07 142.1 35.05 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 123.622 0.769 . . . . 1.1299999999999999 110.822 -161.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -63.6 -41.91 98.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.549 1.068 . . . . 2.6499999999999999 110.542 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.1 p -118.21 152.24 36.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.751 0.82 . . . . 1.55 112.571 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.23 -46.68 54.92 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.55 0.74 . . . . 1.7 109.578 160.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.56 -51.8 11.41 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.246 0.618 . . . . 3.2400000000000002 110.586 176.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -65.25 -54.68 25.74 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 110.078 -0.341 . . . . 2.3799999999999999 110.078 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 t -48.28 -48.02 35.92 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.293 0.568 . . . . 0.52000000000000002 111.47 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -57.46 -62.65 1.63 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.908 1.283 . . . . 4.1299999999999999 108.794 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.04 -46.23 43.9 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.873 0.869 . . . . 1.74 112.64 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mp -75.64 -57.46 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 118.061 0.392 . . . . 3.02 110.272 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 16.0 t . . . . . 0 C--N 1.34 0.173 0 CA-C-N 118.782 0.719 . . . . 1.6299999999999999 111.257 -170.373 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 114.07 1.137 . . . . 3.7999999999999998 114.07 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.2 m -96.89 -12.61 23.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.792 0.437 . . . . 1.49 111.466 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.22 -37.47 8.9 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.087 0.955 . . . . 2.1099999999999999 108.754 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -59.2 132.24 87.58 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.54 -1.652 . . . . 4.1100000000000003 106.54 172.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -99.44 175.68 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.597 2.198 . . . . 1.6399999999999999 111.398 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -48.95 140.88 8.33 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.673 1.702 . . . . 3.6400000000000001 112.693 153.442 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.86 -176.61 5.27 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 102.709 -3.071 . . . . 5.8799999999999999 102.709 165.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 t -120.89 -84.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.82 -1.548 . . . . 2.2200000000000002 106.82 158.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.2 170.6 15.6 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 107.185 -2.366 . . . . 2.7599999999999998 107.185 -173.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -80.38 60.58 3.85 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.287 -1.005 . . . . 7.29 108.287 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.5 m -151.68 157.13 41.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.053 -1.091 . . . . 3.0899999999999999 108.053 -161.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.14 81.13 1.84 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.175 0.99 . . . . 6.9199999999999999 108.659 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.86 131.67 6.55 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.61 -1.396 . . . . 1.73 109.61 169.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -83.12 74.35 10.0 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.766 0.827 . . . . 2.1699999999999999 109.398 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -102.83 87.31 1.17 Allowed Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 107.879 -1.156 . . . . 1.5800000000000001 107.879 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.7 120.93 8.32 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 N-CA-C 108.038 -1.562 . . . . 0.78000000000000003 108.038 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -128.91 177.28 7.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.2 1.4 . . . . 4.9900000000000002 107.774 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -112.63 156.52 22.58 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.276 1.83 . . . . 0.59999999999999998 107.946 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.445 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 6.3 p90 -148.26 152.09 36.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.924 -1.139 . . . . 1.3500000000000001 107.924 175.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -76.07 100.08 4.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.987 -1.857 . . . . 1.3600000000000001 105.987 169.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -72.3 109.68 6.2 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.638 -1.245 . . . . 2.48 107.638 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.6 t -87.21 6.76 31.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.593 -0.718 . . . . 1.8100000000000001 111.631 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.5 -45.63 10.31 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 105.987 -1.857 . . . . 4.5 105.987 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.9 p -94.25 -25.98 16.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.581 2.752 . . . . 2.4199999999999999 111.602 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.53 59.9 3.95 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.015 -1.234 . . . . 1.3100000000000001 110.015 -173.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.5 144.96 17.24 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.826 1.313 . . . . 4.8200000000000003 112.938 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.5 m -73.84 119.21 17.75 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.352 -0.842 . . . . 0.52000000000000002 108.75 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.3 m -141.93 147.54 45.23 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 117.956 -1.021 . . . . 1.6799999999999999 109.205 -161.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.38 145.22 21.02 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.333 2.689 . . . . 0.63 112.702 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -147.7 161.07 41.95 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.602 1.561 . . . . 0.95999999999999996 108.268 173.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.87 118.57 37.57 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 105.57 -2.011 . . . . 1.79 105.57 170.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -72.77 -41.43 65.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.73 0.412 . . . . 2.9700000000000002 111.52 -171.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.15 -15.33 61.59 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 118.37 0.532 . . . . 2.1600000000000001 112.206 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.87 -51.72 4.61 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.626 1.213 . . . . 1.6200000000000001 110.145 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -178.9 4.77 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.036 1.334 . . . . 2.9900000000000002 109.928 170.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.99 49.74 65.42 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.604 -0.598 . . . . 2.5099999999999998 111.604 164.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.61 148.91 44.28 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.584 -0.95 . . . . 2.54 112.6 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -143.62 178.99 7.41 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 104.782 -2.303 . . . . 1.3200000000000001 104.782 157.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.05 -25.66 68.46 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.253 -0.739 . . . . 1.0 111.253 -175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -72.91 65.84 0.75 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.138 1.375 . . . . 2.52 110.471 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -162.07 97.16 1.02 Allowed 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.873 -0.517 . . . . 2.3300000000000001 110.466 -169.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.46 140.75 52.66 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.415 1.486 . . . . 1.0 110.282 -165.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.68 -32.39 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.603 1.092 . . . . 2.8700000000000001 111.501 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.9 p -143.76 156.6 44.56 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.277 0.631 . . . . 1.4399999999999999 111.809 -169.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -45.08 64.71 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 108.869 -0.789 . . . . 1.5800000000000001 108.869 160.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -43.9 -53.44 6.1 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.476 0.31 . . . . 3.3799999999999999 110.757 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -63.66 -57.04 11.29 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 117.951 0.341 . . . . 2.5699999999999998 110.136 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.9 t -49.12 -42.1 38.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.086 0.469 . . . . 0.64000000000000001 111.963 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -66.82 -54.78 19.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.161 1.384 . . . . 4.0199999999999996 109.684 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.73 -40.94 30.4 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.932 0.493 . . . . 1.7 111.955 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.18 -63.78 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.003 0.521 . . . . 3.0800000000000001 110.961 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 123.971 0.908 . . . . 2.1899999999999999 113.355 -166.939 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.2 pt . . . . . 0 C--O 1.224 -0.275 0 N-CA-C 110.451 -0.203 . . . . 2.6400000000000001 110.451 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.0 m -51.05 -24.93 4.25 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.27 0.628 . . . . 1.7 112.685 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.59 -35.66 67.97 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.216 0.462 . . . . 1.78 110.336 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 110.02 3.58 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.206 1.003 . . . . 4.2699999999999996 111.873 -164.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.95 146.0 69.94 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 CA-C-N 120.912 1.361 . . . . 1.8600000000000001 110.83 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -34.05 133.67 0.21 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 128.589 2.755 . . . . 4.7800000000000002 112.62 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -138.73 149.01 44.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.162 2.585 . . . . 6.2999999999999998 108.118 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.5 t -117.82 -22.63 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.365 1.066 . . . . 2.1400000000000001 111.759 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.17 150.64 0.77 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-O 122.391 0.995 . . . . 2.1600000000000001 112.612 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.29 50.23 0.9 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.587 -0.949 . . . . 8.9900000000000002 111.721 -178.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.1 m -126.3 142.71 51.42 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.37 0.668 . . . . 2.0099999999999998 111.098 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 78.33 8.71 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.27 -1.011 . . . . 8.8499999999999996 108.27 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.97 -179.77 22.43 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.02 -1.232 . . . . 1.51 110.02 168.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -146.53 117.86 7.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.899 1.28 . . . . 1.6699999999999999 107.793 -176.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -145.1 119.03 5.55 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 106.847 -1.538 . . . . 1.0900000000000001 106.847 175.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.9 134.37 23.5 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.643 1.562 . . . . 1.3500000000000001 109.055 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.2 mmt-85 -140.82 176.26 8.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.506 1.122 . . . . 4.0300000000000002 108.519 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -125.28 136.97 54.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.068 1.747 . . . . 0.60999999999999999 107.634 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -118.93 150.97 39.01 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.338 -1.356 . . . . 1.1299999999999999 107.338 171.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.24 100.33 2.08 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.215 -2.142 . . . . 2.4300000000000002 105.215 161.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.39 104.02 3.63 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.844 -1.539 . . . . 2.0600000000000001 106.844 171.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 t -82.62 -0.14 45.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.394 -0.812 . . . . 1.47 112.564 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.98 -47.55 12.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.947 -1.501 . . . . 3.7000000000000002 106.947 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.5 p -79.48 -30.15 41.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.719 1.208 . . . . 1.99 111.167 170.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.23 29.78 44.17 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.83 1.205 . . . . 0.80000000000000004 111.309 -172.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -129.19 147.35 51.03 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 118.858 1.329 . . . . 5.46 110.131 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 57.8 m -69.86 135.09 49.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.152 -1.425 . . . . 0.73999999999999999 107.152 166.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 m -151.72 139.42 12.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.06 -1.089 . . . . 1.55 108.06 -169.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.17 159.1 53.12 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.842 2.361 . . . . 0.5 111.101 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -158.47 163.53 37.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.952 1.301 . . . . 0.84999999999999998 108.158 171.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.7 mm -93.11 115.35 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.545 -1.65 . . . . 2.5899999999999999 106.545 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.03 -19.34 61.21 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.789 0.836 . . . . 2.6099999999999999 111.678 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.47 -45.78 3.31 Favored Glycine 0 CA--C 1.525 0.681 0 O-C-N 121.303 -0.873 . . . . 2.4700000000000002 110.951 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.32 -24.43 3.38 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 124.074 0.845 . . . . 1.28 111.86 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -145.04 176.55 9.42 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.545 1.138 . . . . 2.25 109.426 -172.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 41.52 44.61 4.19 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.262 1.411 . . . . 3.3999999999999999 114.245 171.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.95 -133.66 7.31 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.602 -1.399 . . . . 2.4100000000000001 109.602 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -152.94 -168.51 3.06 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.337 1.855 . . . . 1.46 107.028 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.27 -12.07 65.94 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.928 0.775 . . . . 1.1499999999999999 113.035 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -79.15 63.76 3.88 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 118.5 1.15 . . . . 1.8999999999999999 107.913 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -159.44 87.91 0.84 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.818 -0.808 . . . . 2.98 108.818 -146.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -126.41 150.64 48.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.751 0.82 . . . . 0.78000000000000003 110.497 -159.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.86 -42.81 98.62 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.474 0.709 . . . . 2.6699999999999999 109.917 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.6 p -135.37 159.35 41.86 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.26 0.624 . . . . 1.5600000000000001 112.091 -170.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.01 -47.4 61.62 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.67 0.788 . . . . 2.0899999999999999 110.041 160.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -48.15 -49.96 30.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.485 0.314 . . . . 3.9300000000000002 110.179 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -67.67 -52.47 37.6 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 110.198 -0.297 . . . . 2.71 110.198 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.0 t -49.88 -46.28 51.52 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.387 0.675 . . . . 0.47999999999999998 111.207 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -59.52 -73.24 0.09 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.752 -1.203 . . . . 3.5899999999999999 107.752 172.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -42.3 -43.55 3.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.589 1.156 . . . . 2.1299999999999999 113.577 -172.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.26 -40.74 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 122.855 0.462 . . . . 2.48 111.875 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.532 0.272 0 N-CA-C 113.979 1.103 . . . . 1.6599999999999999 113.979 -170.134 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.8 pt . . . . . 0 N--CA 1.467 0.377 0 N-CA-C 113.702 1.001 . . . . 3.4700000000000002 113.702 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 t -31.85 -45.3 0.1 Allowed 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.279 1.832 . . . . 2.4900000000000002 113.738 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.16 -21.0 61.51 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 125.32 1.638 . . . . 2.3900000000000001 111.723 -164.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -62.84 157.85 56.88 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.361 0.982 . . . . 3.2200000000000002 109.489 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -88.33 166.65 6.58 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.588 2.192 . . . . 1.3700000000000001 111.132 173.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -44.63 132.02 6.51 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.013 0.925 . . . . 3.2599999999999998 108.67 157.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.0 tttm -158.57 99.03 1.56 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 104.807 -2.294 . . . . 5.9800000000000004 104.807 -169.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.78 -43.04 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.521 0.728 . . . . 1.8799999999999999 111.809 -168.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.84 151.11 27.76 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.682 -1.367 . . . . 2.0 109.682 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -80.75 50.66 1.38 Allowed 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.967 -0.725 . . . . 6.4500000000000002 112.872 -166.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.47 142.01 39.43 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 107.578 -1.267 . . . . 1.6899999999999999 107.578 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -85.32 54.72 3.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.208 0.603 . . . . 6.54 109.617 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.53 173.15 25.74 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.618 -0.593 . . . . 1.6699999999999999 111.618 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -137.65 79.58 1.75 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.992 1.317 . . . . 1.4399999999999999 107.814 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -116.1 107.25 48.05 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 106.96 -1.496 . . . . 1.1599999999999999 106.96 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.21 133.99 40.37 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 CA-C-N 120.637 1.263 . . . . 0.78000000000000003 109.097 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -131.55 172.3 12.39 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.836 -1.172 . . . . 4.0300000000000002 107.836 170.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.06 144.67 36.77 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.682 1.593 . . . . 0.62 107.501 170.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.437 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 1.8 p90 -131.22 161.19 32.79 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.568 -0.901 . . . . 0.97999999999999998 108.568 169.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -73.16 105.39 4.57 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.64 -1.985 . . . . 1.8 105.64 156.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 6.4 t70 -73.45 118.52 16.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.895 -1.52 . . . . 2.29 106.895 169.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 t -86.26 -25.44 25.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.186 0.994 . . . . 2.1400000000000001 108.799 -174.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -61.94 -43.79 98.11 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 127.178 2.191 . . . . 4.2400000000000002 107.082 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.1 p -96.24 -36.57 10.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.825 2.05 . . . . 2.1200000000000001 110.759 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.64 48.82 4.83 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.208 1.385 . . . . 0.92000000000000004 110.506 -173.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.04 147.04 31.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 128.29 2.636 . . . . 4.8200000000000003 111.92 -172.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.9 m -69.75 123.14 20.64 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.802 -0.814 . . . . 0.64000000000000001 108.802 171.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.4 m -147.33 148.86 32.95 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 124.353 1.061 . . . . 1.7 108.457 -161.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.75 151.58 36.4 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.969 2.446 . . . . 0.5 112.148 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -149.91 163.2 38.69 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.537 1.535 . . . . 0.64000000000000001 107.743 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.56 120.24 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 107.958 -1.127 . . . . 2.0800000000000001 107.958 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -95.79 143.96 26.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.535 1.934 . . . . 2.2200000000000002 107.427 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.33 0.77 88.67 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.509 -0.606 . . . . 1.8999999999999999 113.068 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.94 6.16 77.82 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.796 1.298 . . . . 1.72 112.125 -172.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.98 -156.06 0.31 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.291 1.037 . . . . 3.4300000000000002 111.393 -174.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -38.81 -41.96 1.37 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.429 1.49 . . . . 3.79 114.173 169.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.95 -141.01 46.11 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.698 -1.361 . . . . 1.6299999999999999 109.698 -177.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -179.95 -160.53 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.786 2.034 . . . . 1.27 108.634 174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.62 -44.14 16.77 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 118.685 0.675 . . . . 1.0600000000000001 111.447 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -73.87 64.94 1.01 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.92 1.288 . . . . 3.0499999999999998 109.314 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -159.14 74.31 0.63 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.082 0.953 . . . . 2.0699999999999998 109.375 -168.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -103.34 153.59 20.28 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 124.049 0.939 . . . . 0.93000000000000005 110.371 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.25 -48.63 79.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.325 -0.62 . . . . 2.6600000000000001 109.325 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.1 p -130.87 161.06 32.67 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.243 0.831 . . . . 1.96 113.243 -164.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.45 -49.46 61.69 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.713 -0.847 . . . . 1.95 108.713 159.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -42.54 -51.88 4.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.427 0.558 . . . . 3.3199999999999998 110.504 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -61.31 -56.54 19.37 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.07 -0.49 . . . . 2.1499999999999999 111.044 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.9 t -52.75 -41.15 63.77 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.924 0.868 . . . . 0.93999999999999995 112.368 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -60.74 3.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.973 2.109 . . . . 3.6800000000000002 109.165 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.72 -44.29 93.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.77 0.828 . . . . 2.04 111.347 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.49 -40.75 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.259 1.023 . . . . 2.7599999999999998 110.991 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.9 t . . . . . 0 CA--C 1.522 -0.109 0 N-CA-C 112.551 0.574 . . . . 1.8799999999999999 112.551 -166.644 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.225 -0.227 0 N-CA-C 116.934 2.198 . . . . 3.8100000000000001 116.934 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.9 m -72.55 -12.77 61.21 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.674 -0.641 . . . . 1.8600000000000001 111.835 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -52.5 10.75 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.192 -1.04 . . . . 2.48 108.192 165.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.14 108.08 1.46 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.347 1.459 . . . . 4.5300000000000002 111.544 -174.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.06 175.43 10.91 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 CA-C-N 120.698 1.285 . . . . 2.2400000000000002 112.031 -173.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -40.96 133.65 2.12 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 126.189 1.795 . . . . 3.8599999999999999 111.206 167.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -156.6 130.92 8.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.842 2.057 . . . . 5.9000000000000004 105.922 170.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.68 -52.37 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 N-CA-C 109.547 -0.538 . . . . 2.0299999999999998 109.547 -170.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.0 28.86 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.465 -1.854 . . . . 2.2000000000000002 108.465 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -94.59 14.38 21.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.007 0.523 . . . . 6.6299999999999999 111.128 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.0 m -145.36 160.07 42.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 105.877 -1.897 . . . . 2.1699999999999999 105.877 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -74.09 -73.11 0.24 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.918 0.326 . . . . 6.0800000000000001 110.273 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.51 -179.91 0.53 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.56 1.076 . . . . 1.8899999999999999 113.571 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -148.12 76.0 1.36 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.7 0.8 . . . . 2.23 109.73 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -114.64 100.36 53.09 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.851 -0.796 . . . . 1.28 108.851 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.59 118.5 5.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.49 1.46 . . . . 0.69999999999999996 109.771 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -125.19 -179.61 4.66 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 127.24 2.216 . . . . 4.1100000000000003 109.292 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -123.29 143.86 49.8 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.288 2.235 . . . . 0.54000000000000004 107.661 171.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -126.28 154.15 43.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.133 -1.432 . . . . 0.80000000000000004 107.133 170.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.14 104.45 5.72 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.726 -1.583 . . . . 1.51 106.726 160.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.03 117.01 17.3 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.118 1.367 . . . . 1.97 107.769 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 t -86.47 -20.79 27.59 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 122.191 -0.318 . . . . 1.3799999999999999 110.37 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -65.56 -46.4 79.62 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 126.859 2.064 . . . . 4.1600000000000001 106.75 -173.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.4 p -88.71 -29.85 19.54 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.374 1.869 . . . . 1.9099999999999999 110.413 170.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.73 54.45 7.36 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.348 -1.501 . . . . 0.84999999999999998 109.348 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -146.1 157.21 43.84 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 126.813 2.045 . . . . 5.6699999999999999 108.129 -172.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 95.7 m -80.48 142.43 34.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.321 -1.362 . . . . 0.72999999999999998 107.321 161.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.9 m -154.32 141.39 13.42 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.327 -0.99 . . . . 1.55 108.327 -169.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.76 154.83 59.01 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.954 2.436 . . . . 0.44 111.177 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -158.03 160.89 37.93 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.083 0.953 . . . . 0.58999999999999997 109.179 172.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -89.65 115.01 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 107.309 -1.367 . . . . 1.8899999999999999 107.309 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -85.37 149.77 25.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.612 1.565 . . . . 2.27 107.581 167.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.81 13.64 34.91 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.601 1.096 . . . . 1.8600000000000001 113.273 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.4 -52.29 4.71 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.891 1.234 . . . . 1.6599999999999999 110.237 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.42 122.37 40.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.093 0.949 . . . . 2.6299999999999999 111.268 -165.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.94 -66.25 3.8 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.613 1.101 . . . . 2.73 110.836 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 36.58 -118.38 0.47 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.03 1.3 . . . . 2.29 112.366 -172.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -172.46 179.9 2.38 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 127.984 2.513 . . . . 1.3200000000000001 107.272 165.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.09 -32.24 72.78 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 112.176 -0.37 . . . . 1.3200000000000001 112.176 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -75.45 70.56 2.33 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.889 0.875 . . . . 1.6799999999999999 109.831 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -158.62 78.61 0.79 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.897 1.279 . . . . 2.2200000000000002 108.069 -157.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -115.71 144.45 43.93 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.316 1.446 . . . . 0.93000000000000005 110.433 -162.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.89 -38.3 90.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.294 0.952 . . . . 3.1699999999999999 111.579 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -133.49 161.69 33.9 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.277 0.631 . . . . 1.51 111.987 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 tp -51.8 -49.69 62.24 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.638 -0.875 . . . . 2.3300000000000001 108.638 159.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -45.93 -48.58 16.24 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.183 0.901 . . . . 3.6800000000000002 110.38 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -66.03 -54.42 26.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.375 -0.232 . . . . 2.6899999999999999 110.375 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.3 t -53.62 -48.41 69.34 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.437 0.637 . . . . 0.5 111.895 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -54.19 -55.18 30.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.876 2.47 . . . . 3.3599999999999999 110.055 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.23 -43.46 78.64 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.666 0.386 . . . . 1.6499999999999999 110.957 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.4 mm -68.25 -45.13 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 118.916 -0.564 . . . . 2.8799999999999999 111.126 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.7 m . . . . . 0 C--N 1.34 0.19 0 CA-C-N 118.833 0.742 . . . . 2.5099999999999998 110.991 -175.64 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 pt . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 120.825 0.345 . . . . 2.9300000000000002 110.8 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.9 m -57.71 -18.35 20.42 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.536 0.734 . . . . 1.9299999999999999 112.617 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.01 -25.23 32.4 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.256 0.935 . . . . 1.5800000000000001 110.792 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -64.41 144.36 98.53 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 118.787 0.721 . . . . 4.5899999999999999 110.699 -174.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.81 -173.63 1.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.038 2.492 . . . . 1.47 110.702 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -77.83 141.73 38.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.08 1.352 . . . . 4.2800000000000002 111.411 161.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HD2' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -159.16 139.9 12.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.116 -2.55 . . . . 5.9100000000000001 104.116 -176.666 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.7 t -63.15 -44.89 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 120.144 1.338 . . . . 2.4399999999999999 109.506 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.52 144.69 15.74 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.823 -1.711 . . . . 2.4399999999999999 108.823 -171.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -80.66 59.32 3.57 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.13 -0.629 . . . . 6.5499999999999998 112.682 -165.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.4 m -143.35 144.03 31.91 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 108.837 -0.801 . . . . 2.3700000000000001 108.837 167.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -90.08 72.04 7.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.682 0.793 . . . . 5.7400000000000002 109.457 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.07 -174.96 13.79 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.636 -0.985 . . . . 1.27 110.636 172.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -142.05 93.89 2.6 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.323 1.449 . . . . 1.48 107.354 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -124.75 105.74 29.73 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 108.486 -0.931 . . . . 1.1499999999999999 108.486 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.4 100.18 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.572 1.514 . . . . 1.22 109.477 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.6 mmt85 -106.81 179.84 4.15 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.512 1.525 . . . . 4.5899999999999999 108.345 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -119.53 145.09 46.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.253 1.421 . . . . 0.5 108.333 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -124.02 150.42 44.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.144 -1.428 . . . . 0.93000000000000005 107.144 167.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -75.56 102.0 5.11 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.307 -1.738 . . . . 1.9299999999999999 106.307 162.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.44 104.95 4.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.619 -1.252 . . . . 2.21 107.619 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.2 t -84.0 -1.63 55.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.048 -0.977 . . . . 1.8400000000000001 112.824 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.29 -48.12 10.77 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.936 -1.505 . . . . 5.25 106.936 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 64.7 p -82.32 -32.14 29.58 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.431 1.092 . . . . 2.1299999999999999 110.603 175.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.92 4.84 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.008 -1.237 . . . . 0.95999999999999996 110.008 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.51 135.61 22.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.904 0.882 . . . . 6.8099999999999996 111.809 -169.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.3 m -69.5 126.45 29.79 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.215 -1.402 . . . . 0.45000000000000001 107.215 163.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.2 m -147.68 138.41 12.99 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.321 -0.992 . . . . 1.6200000000000001 108.321 -163.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 157.47 57.66 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.516 2.144 . . . . 0.38 111.015 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -158.17 155.65 29.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.343 1.057 . . . . 0.78000000000000003 109.401 170.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.4 mm -84.51 109.2 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.871 -1.159 . . . . 2.3500000000000001 107.871 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -87.12 146.15 26.16 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.693 1.197 . . . . 2.2999999999999998 109.616 174.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.08 -28.78 53.2 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.585 1.564 . . . . 1.8100000000000001 112.488 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.59 -40.89 1.71 Allowed Glycine 0 C--N 1.339 0.706 0 CA-C-N 117.738 0.769 . . . . 1.9099999999999999 111.294 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -154.29 165.2 37.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.6 -0.889 . . . . 3.9199999999999999 108.6 -174.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.24 49.14 81.75 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.962 0.791 . . . . 2.98 111.9 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.0 -121.37 4.16 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.115 -1.194 . . . . 2.4700000000000002 110.115 174.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.468 ' ND2' ' HD2' ' A' ' 8' ' ' LYS . 29.4 p30 -157.03 -179.73 8.49 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.965 1.306 . . . . 1.27 107.559 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.58 -21.67 74.73 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.347 -0.696 . . . . 1.1100000000000001 113.821 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -78.26 70.65 4.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.092 1.446 . . . . 1.53 108.065 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -158.84 85.35 0.82 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.017 1.727 . . . . 3.4399999999999999 108.046 -169.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -114.29 147.15 39.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.502 1.121 . . . . 0.93999999999999995 109.587 -164.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.14 -39.2 93.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.937 0.399 . . . . 2.6200000000000001 110.475 -174.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.6 p -141.33 163.04 34.02 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.689 0.795 . . . . 1.6200000000000001 110.735 -169.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.61 -45.97 66.82 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 109.402 -0.592 . . . . 1.8 109.402 162.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -47.56 -51.11 22.06 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.973 0.352 . . . . 3.3399999999999999 110.509 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -69.56 -49.4 54.6 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.264 -0.273 . . . . 2.21 110.264 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 t -50.66 -44.02 57.51 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.381 0.61 . . . . 0.55000000000000004 111.143 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -62.94 -58.39 7.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.46 1.104 . . . . 4.9199999999999999 109.603 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.11 -41.38 17.2 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.782 0.676 . . . . 2.1200000000000001 111.429 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.03 -53.3 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.767 0.427 . . . . 2.77 112.028 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 78.7 m . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 114.392 1.256 . . . . 2.8399999999999999 114.392 -163.98 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.8 pt . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.008 0.432 . . . . 2.6099999999999999 111.905 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.5 m -49.87 -26.29 3.93 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.493 1.117 . . . . 1.8 112.743 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.27 -26.51 62.02 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.289 0.495 . . . . 1.8100000000000001 110.433 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -61.06 137.87 94.14 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 108.597 -0.89 . . . . 3.52 108.597 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.16 170.2 20.52 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.864 1.709 . . . . 1.54 111.769 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -51.76 140.69 18.6 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.164 0.983 . . . . 3.3700000000000001 110.697 156.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 132.54 8.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 113.756 -1.565 . . . . 6.4500000000000002 106.943 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -67.48 -39.95 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.479 -0.934 . . . . 2.0800000000000001 108.479 172.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.48 33.38 8.63 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.836 0.732 . . . . 3.2400000000000002 111.655 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 48.71 60.55 3.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.254 1.821 . . . . 9.1099999999999994 113.391 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -153.89 152.15 30.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.774 -0.825 . . . . 1.98 108.774 168.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -82.82 70.36 9.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.853 -1.166 . . . . 5.5 107.853 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.23 149.85 16.97 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 109.39 -1.484 . . . . 1.4299999999999999 109.39 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -120.14 72.6 0.94 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.923 -1.51 . . . . 1.3400000000000001 106.923 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -102.73 96.01 7.05 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 107.092 -1.447 . . . . 0.93999999999999995 107.092 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -60.97 127.15 21.45 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 N-CA-C 108.879 -1.239 . . . . 0.64000000000000001 108.879 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -135.49 179.98 6.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.71 1.604 . . . . 3.3900000000000001 107.642 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -119.8 149.17 42.48 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.101 1.76 . . . . 0.63 107.949 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.475 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 2.2 p90 -134.03 157.26 46.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.866 -1.902 . . . . 0.88 105.866 170.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -71.34 105.89 3.67 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.377 -1.712 . . . . 1.3899999999999999 106.377 159.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.475 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 7.5 t0 -71.65 115.31 10.69 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.855 -1.535 . . . . 2.25 106.855 172.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 t -94.46 -9.25 36.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 123.8 0.688 . . . . 1.6200000000000001 109.674 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.45 -43.68 72.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.451 -2.055 . . . . 4.2999999999999998 105.451 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.8 p -98.89 -40.08 8.27 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.564 2.346 . . . . 1.6899999999999999 112.846 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 60.9 1.26 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.94 -1.264 . . . . 1.05 109.94 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -157.63 138.36 13.1 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 124.16 0.984 . . . . 6.0099999999999998 109.556 -163.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.6 m -72.85 122.38 21.5 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 120.617 -1.302 . . . . 0.56000000000000005 107.594 165.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.4 m -143.06 145.34 32.51 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 108.507 -0.923 . . . . 1.5700000000000001 108.507 -162.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.51 153.21 65.64 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.789 2.326 . . . . 0.51000000000000001 111.188 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -155.76 163.21 40.14 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.195 -1.409 . . . . 1.1299999999999999 107.195 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.11 126.47 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 N-CA-C 108.01 -1.107 . . . . 2.0 108.01 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -105.91 148.66 27.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.515 1.126 . . . . 2.2999999999999998 108.384 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.83 -9.57 62.42 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.711 1.148 . . . . 1.8300000000000001 113.028 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 14.05 80.65 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.155 0.977 . . . . 1.6399999999999999 112.395 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.5 m -145.96 178.48 8.16 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 107.016 -1.476 . . . . 2.4399999999999999 107.016 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.64 -69.17 2.1 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.383 1.944 . . . . 3.0699999999999998 110.674 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.67 -163.98 3.52 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.326 1.917 . . . . 1.98 113.578 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.5 p30 170.46 -160.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.256 3.822 . . . . 1.9099999999999999 104.759 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.38 -44.52 7.93 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.76 1.164 . . . . 1.24 110.287 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -74.88 78.26 2.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.105 0.955 . . . . 1.5600000000000001 112.134 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -156.55 115.38 3.39 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.763 1.625 . . . . 2.23 108.002 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -133.95 155.65 49.56 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 124.762 1.225 . . . . 0.77000000000000002 108.73 -168.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -80.2 -31.22 38.75 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.463 -0.773 . . . . 2.9700000000000002 111.633 -174.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.1 p -145.73 165.01 30.03 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.761 0.824 . . . . 1.9099999999999999 110.08 -173.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.57 -46.55 70.32 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 109.558 -0.534 . . . . 1.9099999999999999 109.558 163.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -47.03 -52.19 15.53 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 110.039 -0.356 . . . . 3.4500000000000002 110.039 175.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 tp-100 -66.94 -51.73 51.72 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.283 -0.265 . . . . 4.0700000000000003 110.283 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -51.84 -48.59 63.89 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 122.911 0.484 . . . . 0.58999999999999997 110.882 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.4 -58.13 9.82 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.943 0.897 . . . . 3.2200000000000002 109.273 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.19 -41.64 62.82 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.514 0.725 . . . . 1.76 111.763 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.3 mm -70.43 -51.66 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.39 0.276 . . . . 2.3999999999999999 110.522 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.7 t . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 113.044 0.757 . . . . 1.49 113.044 -164.879 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 107.314 -1.365 . . . . 3.73 107.314 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.3 pt -53.05 -22.58 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.717 0.807 . . . . 2.8700000000000001 112.295 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 89.0 m -34.55 -42.58 0.15 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.827 1.251 . . . . 1.5700000000000001 111.441 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.95 -17.39 62.08 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.909 1.077 . . . . 1.8700000000000001 113.909 -170.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -73.39 143.29 82.59 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 119.889 1.222 . . . . 3.0299999999999998 110.819 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.22 -179.18 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.215 2.61 . . . . 1.45 109.936 166.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.51 134.64 55.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.663 0.744 . . . . 3.29 110.591 170.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -139.34 128.25 23.55 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.461 1.904 . . . . 6.54 106.076 170.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.6 t -75.45 -85.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.122 -1.436 . . . . 1.9199999999999999 107.122 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.96 179.24 30.0 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 107.861 -2.096 . . . . 1.9199999999999999 107.861 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -72.1 -48.73 41.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.725 -1.213 . . . . 6.25 107.725 174.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.1 m -71.08 150.31 45.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.105 -1.072 . . . . 2.29 108.105 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.45 20.21 13.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.703 0.801 . . . . 8.0600000000000005 110.363 -170.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.25 147.9 50.91 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.9 -0.88 . . . . 1.6399999999999999 110.9 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -81.7 73.3 8.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.728 0.775 . . . . 2.0699999999999998 108.912 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -99.35 93.13 2.05 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 106.895 -1.52 . . . . 1.3200000000000001 106.895 166.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.6 125.19 13.93 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 N-CA-C 108.064 -1.552 . . . . 0.63 108.064 171.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -132.78 176.47 8.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.345 1.458 . . . . 4.9699999999999998 107.279 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -118.25 139.37 51.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.847 1.659 . . . . 0.84999999999999998 108.394 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -118.26 148.89 41.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.903 -1.888 . . . . 1.1699999999999999 105.903 168.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -70.78 100.02 1.82 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.47 -2.419 . . . . 1.8999999999999999 104.47 160.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -71.88 77.96 0.89 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 105.602 -1.999 . . . . 2.3700000000000001 105.602 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.0 t -61.71 -18.87 61.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.419 1.088 . . . . 1.48 110.342 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -62.06 -44.37 96.82 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 105.459 -2.052 . . . . 4.3899999999999997 105.459 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.7 p -94.58 -24.55 17.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.52 1.528 . . . . 2.1600000000000001 114.04 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.43 19.37 64.38 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.766 1.174 . . . . 0.91000000000000003 112.418 -165.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -103.4 163.28 12.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.644 1.178 . . . . 6.5199999999999996 109.99 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.5 m -90.28 138.95 31.12 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 105.55 -2.018 . . . . 1.05 105.55 148.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.1 m -156.13 145.73 15.39 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 118.377 -0.82 . . . . 1.95 109.212 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.33 153.27 61.49 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.074 2.516 . . . . 0.52000000000000002 112.11 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -154.68 166.1 34.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.543 1.937 . . . . 0.56000000000000005 105.93 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.99 127.76 50.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 106.67 -1.604 . . . . 1.96 106.67 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -85.93 -77.42 0.3 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.177 0.991 . . . . 2.5499999999999998 110.957 -172.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.67 98.17 0.51 Allowed Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.861 -1.296 . . . . 3.1099999999999999 109.861 -168.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -32.41 -63.45 0.28 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 127.219 2.343 . . . . 2.48 114.071 -171.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.254 0.8 OUTLIER -74.47 121.66 21.83 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.534 0.938 . . . . 2.96 113.534 -176.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.48 18.97 26.66 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.043 1.783 . . . . 2.5 113.357 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.24 162.93 39.35 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.309 1.055 . . . . 1.6699999999999999 113.691 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -118.79 -169.25 1.69 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.111 1.365 . . . . 1.47 110.513 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.44 -44.1 6.68 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.446 -1.062 . . . . 1.04 110.446 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -72.75 73.95 1.1 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.432 0.634 . . . . 1.6100000000000001 110.549 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -159.33 96.37 1.29 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.833 1.253 . . . . 2.3100000000000001 108.555 -166.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -125.19 141.4 52.12 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 124.821 1.248 . . . . 0.93000000000000005 111.343 -165.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -55.47 -34.6 64.67 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.511 0.724 . . . . 3.1000000000000001 111.547 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.7 p -141.12 160.05 40.92 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.794 0.838 . . . . 1.6200000000000001 112.061 -169.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -51.37 -48.12 62.63 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-O 117.941 -1.028 . . . . 1.8 108.839 158.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -39.41 -56.5 1.58 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.063 0.847 . . . . 3.3100000000000001 110.766 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -70.11 -50.28 42.35 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 121.164 -0.214 . . . . 4.5099999999999998 110.812 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.8 t -52.9 -32.78 47.13 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 122.064 0.935 . . . . 0.93999999999999995 112.143 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.425 HH12 ' C ' ' A' ' 55' ' ' ALA . 7.8 tpt85 -73.83 -72.68 0.26 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 124.677 1.191 . . . . 5.0 107.952 176.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -41.76 -45.15 3.46 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.798 1.639 . . . . 1.6299999999999999 112.439 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.8 mm -73.18 -33.5 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 119.344 -0.36 . . . . 2.7200000000000002 111.852 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -106.68 -52.52 2.76 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.33 0.863 . . . . 1.3100000000000001 113.33 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mtm-85 -130.43 120.7 24.62 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.468 1.907 . . . . 7.1299999999999999 111.211 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.425 ' C ' HH12 ' A' ' 50' ' ' ARG . . . . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 117.549 -1.215 . . . . 5.5199999999999996 110.0 161.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 118.267 -0.873 . . . . 3.54 109.416 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.2 pp -53.97 -31.57 21.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 O-C-N 124.13 0.894 . . . . 3.3500000000000001 112.938 -168.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.65 -32.44 19.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.31 1.044 . . . . 1.78 111.955 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -30.31 64.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.058 0.543 . . . . 1.8400000000000001 112.409 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -77.14 131.04 73.42 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.599 -0.889 . . . . 4.0999999999999996 108.599 -170.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.81 -176.48 3.06 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.071 1.847 . . . . 1.71 113.602 -164.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -61.61 153.29 28.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.245 1.018 . . . . 3.52 109.301 157.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.501 ' CD ' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -155.95 173.83 16.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.918 -2.253 . . . . 6.5999999999999996 104.918 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.0 -87.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 106.236 -1.764 . . . . 2.5499999999999998 106.236 160.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.93 -171.01 43.21 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.84 -1.704 . . . . 2.2799999999999998 108.84 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -120.24 24.81 10.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.292 1.037 . . . . 7.75 110.62 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.3 m -138.83 159.73 41.43 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.55 -1.648 . . . . 2.2799999999999998 106.55 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -79.75 55.97 2.17 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.883 0.473 . . . . 5.1900000000000004 110.594 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.8 159.57 29.3 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.331 -0.707 . . . . 1.6299999999999999 111.331 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -140.41 73.05 1.41 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.781 -1.563 . . . . 1.9399999999999999 106.781 171.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.89 97.03 22.25 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 108.632 -0.877 . . . . 1.01 108.632 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.0 118.27 5.12 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 120.462 1.201 . . . . 1.1200000000000001 109.153 172.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -120.88 179.3 4.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 127.571 2.349 . . . . 4.6200000000000001 108.429 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -117.83 148.39 42.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.584 2.354 . . . . 1.22 107.729 167.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -134.32 156.02 49.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.498 -1.667 . . . . 1.6399999999999999 106.498 166.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -66.77 112.28 4.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.558 -1.645 . . . . 2.21 106.558 159.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -93.08 122.3 35.31 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 123.898 0.749 . . . . 1.76 110.49 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -89.2 -5.25 57.84 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 117.82 -1.086 . . . . 2.3199999999999998 111.938 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -71.19 -48.86 49.06 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.624 -1.621 . . . . 4.6900000000000004 106.624 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.8 p -88.16 -30.81 19.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.695 1.198 . . . . 2.96 112.73 174.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.33 26.75 29.7 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.1 0.857 . . . . 1.27 111.952 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -142.49 154.32 44.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.189 1.396 . . . . 5.4900000000000002 110.819 -167.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.7 m -68.99 121.27 16.29 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 108.224 -1.028 . . . . 0.64000000000000001 108.224 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.2 m -144.65 145.07 26.93 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 123.512 0.725 . . . . 1.8600000000000001 109.183 -160.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.48 154.44 68.83 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.913 2.409 . . . . 0.72999999999999998 111.723 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -155.66 158.07 37.7 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.652 -1.24 . . . . 0.72999999999999998 107.652 166.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -94.92 118.33 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 N-CA-C 107.48 -1.304 . . . . 2.4199999999999999 107.48 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -91.49 145.17 24.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.881 1.272 . . . . 2.0899999999999999 109.82 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.26 22.61 37.69 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.786 1.184 . . . . 2.0800000000000001 112.734 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.92 -46.34 3.64 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.629 1.214 . . . . 1.4099999999999999 111.99 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.0 155.45 49.96 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.564 1.146 . . . . 2.71 110.325 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.07 47.79 35.97 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.285 -0.726 . . . . 2.7799999999999998 111.285 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.96 -153.42 29.31 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.736 0.684 . . . . 1.6399999999999999 111.907 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.501 ' ND2' ' CD ' ' A' ' 8' ' ' LYS . 17.5 p30 -149.36 -171.52 3.91 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.93 -1.878 . . . . 1.8400000000000001 105.93 165.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.51 -35.01 85.94 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.907 0.776 . . . . 0.81999999999999995 112.175 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -76.65 70.76 3.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.572 1.149 . . . . 1.8200000000000001 109.731 -176.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.92 63.48 0.65 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.071 -0.714 . . . . 2.1000000000000001 109.071 -161.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -104.41 146.89 28.2 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.722 1.209 . . . . 1.01 109.519 -162.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -64.54 -40.01 94.82 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.873 1.669 . . . . 2.8300000000000001 110.58 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -126.03 153.73 43.99 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.998 1.111 . . . . 1.8700000000000001 113.998 -167.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.85 -47.22 42.84 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.557 1.143 . . . . 1.72 110.273 159.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -44.16 -53.77 6.2 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.416 0.686 . . . . 3.3100000000000001 110.408 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -64.92 -52.37 56.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 119.534 -0.269 . . . . 2.4500000000000002 110.44 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.0 t -48.25 -52.68 20.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.533 0.682 . . . . 0.70999999999999996 111.436 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.9 ttm-85 -57.0 -62.05 2.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.726 1.211 . . . . 3.6299999999999999 109.927 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.97 -38.06 64.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.513 0.725 . . . . 1.73 111.993 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.4 mt -75.41 -53.53 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 122.91 0.484 . . . . 2.7599999999999998 110.75 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.9 t -99.47 -37.74 9.07 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.584 0.957 . . . . 1.6799999999999999 113.584 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -111.49 -152.45 0.5 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.551 1.54 . . . . 5.2800000000000002 109.856 -169.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 104.478 -2.416 . . . . 5.5899999999999999 104.478 161.011 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 117.789 -1.1 . . . . 3.3199999999999998 109.221 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -44.61 -38.17 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.632 1.173 . . . . 2.7999999999999998 112.157 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.02 -13.32 1.86 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.89 1.676 . . . . 2.3399999999999999 114.324 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.03 -33.97 70.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.198 -1.038 . . . . 3.0099999999999998 108.198 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -77.98 137.98 61.41 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.44 -0.948 . . . . 3.5099999999999998 108.44 167.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -80.13 -179.68 5.46 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.064 1.842 . . . . 1.75 110.072 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -39.87 139.13 0.68 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 115.496 1.665 . . . . 4.0199999999999996 115.496 149.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -157.36 151.53 24.77 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 129.128 2.971 . . . . 5.79 104.853 168.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.3 t -136.7 -60.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.09 0.471 . . . . 2.9199999999999999 111.961 -160.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.67 65.96 3.09 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 114.679 0.632 . . . . 5.4299999999999997 114.679 -155.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.78 -18.51 5.57 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.49 0.716 . . . . 7.5899999999999999 112.245 164.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.5 m -130.88 160.81 33.35 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 106.845 -1.539 . . . . 1.9099999999999999 106.845 161.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -120.69 52.94 1.14 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.503 1.121 . . . . 5.6399999999999997 109.727 -170.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.16 139.61 15.49 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.316 -1.113 . . . . 1.76 110.316 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -82.64 74.48 9.6 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.078 -0.712 . . . . 1.98 109.078 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -101.7 92.44 2.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 118.204 -0.903 . . . . 1.3100000000000001 109.998 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.21 111.36 2.24 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.977 1.784 . . . . 0.72999999999999998 109.586 174.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -120.66 -179.08 3.88 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.897 1.679 . . . . 4.3499999999999996 108.891 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -120.0 146.48 45.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.735 1.614 . . . . 0.46999999999999997 108.538 172.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.473 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 6.0 p90 -127.76 152.22 48.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.451 -1.315 . . . . 1.8999999999999999 107.451 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -68.04 101.9 1.21 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.071 -1.825 . . . . 1.9399999999999999 106.071 158.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -73.44 138.06 44.95 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.412 -0.588 . . . . 2.2200000000000002 109.412 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.7 t -108.2 -8.37 15.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.692 1.197 . . . . 2.0 111.068 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.64 -50.25 45.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.363 -1.347 . . . . 4.2199999999999998 107.363 168.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.9 p -89.14 -28.23 20.19 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.798 0.839 . . . . 2.5099999999999998 112.231 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.06 39.7 18.97 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.317 -0.713 . . . . 1.04 111.352 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -148.69 148.09 29.64 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.614 1.207 . . . . 5.1900000000000004 110.414 -166.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.8 m -68.7 118.4 11.64 Favored 'General case' 0 CA--C 1.526 0.049 0 N-CA-C 108.572 -0.899 . . . . 0.52000000000000002 108.572 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.2 m -136.71 142.02 37.43 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 124.928 1.291 . . . . 1.49 108.718 -164.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.52 154.45 50.15 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.016 2.478 . . . . 0.46000000000000002 111.453 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -159.64 158.24 31.16 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.577 1.151 . . . . 1.1399999999999999 109.176 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.1 mm -86.3 119.87 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 106.64 -1.615 . . . . 2.7400000000000002 106.64 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -80.09 -19.78 46.64 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.018 0.747 . . . . 4.8099999999999996 113.018 -168.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.29 -46.46 3.41 Favored Glycine 0 CA--C 1.527 0.821 0 O-C-N 120.979 -1.076 . . . . 2.21 110.45 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.8 -30.94 3.85 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.21 0.909 . . . . 1.79 112.953 165.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.69 159.42 39.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.736 0.814 . . . . 2.7400000000000002 111.607 -169.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.0 5.03 51.32 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.192 0.901 . . . . 3.1499999999999999 112.414 -166.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.17 -149.71 3.5 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.395 0.998 . . . . 2.4199999999999999 110.943 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -151.56 -176.24 5.52 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.709 1.204 . . . . 1.3 108.629 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.38 -5.14 90.22 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.549 -1.14 . . . . 1.5600000000000001 113.152 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -78.15 65.58 3.56 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.961 1.88 . . . . 1.5900000000000001 107.073 170.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -159.0 112.68 2.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.929 -1.137 . . . . 3.3799999999999999 107.929 -165.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -136.24 148.5 48.08 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.549 1.14 . . . . 0.83999999999999997 108.206 -165.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.46 -38.59 84.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.337 0.517 . . . . 2.6000000000000001 109.779 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.5 p -135.66 160.14 39.43 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.873 0.869 . . . . 1.6899999999999999 111.707 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.66 -46.81 58.73 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 123.393 0.677 . . . . 1.72 109.803 161.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -49.32 -49.59 43.29 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.099 -0.334 . . . . 3.8999999999999999 110.099 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -67.22 -50.61 60.11 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.024 -0.362 . . . . 2.4399999999999999 110.024 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.8 t -50.63 -46.15 58.08 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.507 0.67 . . . . 0.60999999999999999 111.184 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -59.15 -59.8 4.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.806 1.242 . . . . 3.6200000000000001 109.727 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.54 -41.93 54.52 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.359 0.664 . . . . 1.75 111.824 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.92 -50.39 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 122.962 0.505 . . . . 2.73 111.236 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.0 t -129.24 -5.63 4.87 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.783 1.401 . . . . 2.0 114.783 -156.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -117.75 -156.82 0.65 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.609 1.564 . . . . 6.5 108.591 167.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 104.075 -2.565 . . . . 5.4500000000000002 104.075 148.005 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 107.347 -1.353 . . . . 3.77 107.347 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -50.56 -29.51 6.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 O-C-N 123.888 0.743 . . . . 3.2999999999999998 111.234 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 66.4 m -45.13 -32.95 1.99 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.488 1.515 . . . . 1.4299999999999999 112.093 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.55 7.14 47.25 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.617 0.599 . . . . 2.98 112.617 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.16 127.5 92.03 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.56 1.073 . . . . 3.29 109.165 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.11 145.61 49.83 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.797 2.331 . . . . 2.3700000000000001 107.337 170.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 132.58 40.18 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 117.932 -1.507 . . . . 9.4199999999999999 112.087 -164.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.86 148.1 39.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.789 2.036 . . . . 6.5300000000000002 107.251 168.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -80.87 -87.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.746 -1.575 . . . . 2.27 106.746 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.57 55.09 0.03 OUTLIER Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.357 0.503 . . . . 3.48 112.657 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.25 47.55 0.69 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.63 1.972 . . . . 5.9400000000000004 113.679 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.8 m -96.53 164.25 12.69 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.237 0.615 . . . . 3.7200000000000002 111.343 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -140.33 58.86 1.57 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.425 -1.324 . . . . 7.4800000000000004 107.425 170.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.49 171.97 31.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 108.35 -1.9 . . . . 1.53 108.35 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -125.71 102.36 7.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.78 1.232 . . . . 1.52 108.43 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -131.9 105.15 13.96 Favored Pre-proline 0 C--O 1.233 0.207 0 N-CA-C 106.364 -1.717 . . . . 1.47 106.364 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.67 132.04 21.1 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.92 1.747 . . . . 0.75 108.773 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -136.97 178.91 6.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.678 1.591 . . . . 4.79 107.356 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -122.27 145.46 48.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.508 1.523 . . . . 0.56999999999999995 109.3 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -130.97 150.56 52.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.063 -1.088 . . . . 1.1499999999999999 108.063 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -72.34 101.42 2.88 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.63 -1.618 . . . . 1.72 106.63 166.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.79 109.57 6.48 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.541 -1.281 . . . . 2.04 107.541 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -85.62 -7.07 59.05 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.017 0.927 . . . . 2.1499999999999999 111.971 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -71.01 -55.64 7.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.828 -1.545 . . . . 7.4000000000000004 106.828 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 p -85.37 -19.03 32.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.774 -1.103 . . . . 2.1299999999999999 111.986 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.22 41.47 69.05 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.129 -1.188 . . . . 1.1799999999999999 110.129 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.08 131.81 45.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.072 0.949 . . . . 6.2699999999999996 109.893 -170.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.0 m -67.44 113.01 4.96 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.041 -1.466 . . . . 0.68000000000000005 107.041 159.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.2 m -126.93 137.25 30.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 126.767 2.027 . . . . 1.5900000000000001 107.825 -165.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.55 156.21 58.26 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.633 2.222 . . . . 0.45000000000000001 111.022 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -161.63 165.8 27.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.47 1.508 . . . . 1.02 107.588 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.28 118.72 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 107.62 -1.252 . . . . 2.0299999999999998 107.62 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -77.45 -42.68 35.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.67 0.788 . . . . 2.3500000000000001 110.834 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.7 -16.92 43.15 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.978 -0.901 . . . . 2.8599999999999999 112.895 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.75 25.17 21.24 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 118.171 0.986 . . . . 1.8999999999999999 113.24 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.86 159.98 9.97 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.323 1.062 . . . . 2.9399999999999999 109.939 -171.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.85 32.9 59.48 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.221 1.391 . . . . 2.3100000000000001 114.575 169.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.43 -163.28 9.76 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 122.263 0.924 . . . . 1.6299999999999999 115.276 -168.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -156.7 -179.75 8.49 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 127.686 2.394 . . . . 1.3799999999999999 106.377 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.99 -40.03 95.09 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 118.237 0.472 . . . . 0.98999999999999999 113.411 -169.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -77.34 57.57 1.52 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.466 1.106 . . . . 1.73 111.25 -167.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.75 76.75 1.02 Allowed 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.251 -0.905 . . . . 2.4199999999999999 110.725 -148.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -122.04 145.24 48.34 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.11 1.364 . . . . 1.02 111.802 -152.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -57.12 -39.06 74.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.487 1.115 . . . . 2.77 111.533 -173.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -144.94 161.15 40.06 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.139 0.576 . . . . 1.6100000000000001 110.109 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 tp -52.12 -48.46 64.82 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 118.514 -0.755 . . . . 1.97 109.012 164.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -43.63 -53.9 5.38 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.477 -0.564 . . . . 3.6899999999999999 109.477 176.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -69.72 -46.51 65.8 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.835 -0.432 . . . . 2.29 109.835 -171.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.4 t -51.97 -49.35 63.39 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 121.078 0.466 . . . . 0.58999999999999997 110.726 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -60.98 -61.19 2.76 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.223 -1.028 . . . . 6.4299999999999997 108.223 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -43.8 -48.44 8.18 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.473 1.509 . . . . 1.8 111.55 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -67.4 -50.85 58.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.655 0.382 . . . . 2.8700000000000001 111.048 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 32.1 m -76.85 -52.81 8.81 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.071 -0.393 . . . . 2.27 112.054 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.48 HH21 ' C ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -138.07 107.87 6.29 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 125.583 1.553 . . . . 9.6999999999999993 109.654 171.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.48 ' C ' HH21 ' A' ' 54' ' ' ARG . . . . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 118.858 -0.591 . . . . 6.6600000000000001 109.975 162.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 118.144 -0.932 . . . . 3.2999999999999998 109.201 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.2 pt -71.73 -5.53 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.082 0.953 . . . . 2.9500000000000002 113.321 -171.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.6 m -56.38 -41.3 76.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.643 -0.661 . . . . 1.5700000000000001 110.172 160.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.4 -27.47 41.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.592 1.157 . . . . 1.8400000000000001 111.99 -173.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -58.32 139.38 84.47 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 106.974 -1.491 . . . . 3.1800000000000002 106.974 166.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -102.56 -175.77 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.836 2.357 . . . . 1.49 110.821 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.0 132.3 37.5 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.114 -0.699 . . . . 3.54 109.114 167.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.25 136.6 15.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.487 -2.042 . . . . 5.7699999999999996 105.487 172.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t -74.11 -71.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.131 0.878 . . . . 2.0099999999999998 108.971 -174.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.69 178.34 17.74 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.232 -1.547 . . . . 2.02 109.232 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -79.01 37.28 0.3 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 117.842 0.821 . . . . 6.2800000000000002 110.688 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.8 m -166.34 158.86 14.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 105.513 -2.032 . . . . 1.78 105.513 -166.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -139.6 41.53 2.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.399 0.68 . . . . 7.0700000000000003 110.543 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.81 152.1 49.99 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 109.981 -1.247 . . . . 1.3600000000000001 109.981 173.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -82.4 74.15 9.39 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.721 -0.87 . . . . 1.3700000000000001 109.032 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.58 91.0 3.05 Favored Pre-proline 0 CA--C 1.529 0.169 0 N-CA-C 108.77 -0.826 . . . . 0.98999999999999999 108.77 171.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -62.81 122.63 11.01 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 N-CA-C 108.702 -1.307 . . . . 0.93000000000000005 108.702 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -130.65 176.39 8.22 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.059 1.744 . . . . 4.8099999999999996 107.984 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -109.01 148.95 29.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.837 1.255 . . . . 0.59999999999999998 108.488 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -131.51 153.58 49.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.323 -1.362 . . . . 0.98999999999999999 107.323 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -82.71 107.01 15.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.171 -1.789 . . . . 1.6699999999999999 106.171 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.16 112.88 15.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.275 -1.009 . . . . 2.1000000000000001 108.275 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 t -88.5 -0.56 57.35 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 117.966 -1.016 . . . . 1.5900000000000001 113.106 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -82.63 -48.98 10.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.498 -1.668 . . . . 5.21 106.498 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.4 p -79.63 -30.71 41.47 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.769 1.228 . . . . 2.23 110.062 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.39 57.06 5.77 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.056 -1.618 . . . . 0.88 109.056 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.28 160.89 37.55 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.18 0.992 . . . . 5.5599999999999996 110.039 -177.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.0 m -85.99 128.72 34.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.652 0.781 . . . . 0.57999999999999996 109.075 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -144.06 144.91 27.99 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.52 1.128 . . . . 1.5900000000000001 108.306 -161.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.43 155.2 45.79 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.969 2.446 . . . . 0.53000000000000003 112.265 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.25 169.5 23.09 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.526 1.53 . . . . 0.82999999999999996 108.114 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.18 119.13 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.307 -0.998 . . . . 2.1600000000000001 108.307 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -89.39 143.57 26.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.32 1.848 . . . . 1.97 109.963 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.3 -36.59 91.3 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.412 -0.66 . . . . 2.1899999999999999 113.381 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.86 18.9 28.32 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.125 0.869 . . . . 2.21 112.894 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.4 m -141.95 -159.18 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.559 1.144 . . . . 3.1899999999999999 108.162 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -15.55 -60.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 C-N-CA 128.27 2.843 . . . . 4.4299999999999997 115.664 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.42 -133.79 12.14 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 119.336 -0.702 . . . . 1.6499999999999999 111.545 168.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 168.66 -173.42 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 128.904 2.881 . . . . 1.98 106.851 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.17 -44.94 10.69 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.767 -0.933 . . . . 1.0900000000000001 110.767 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -73.65 67.94 1.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.72 1.208 . . . . 2.9399999999999999 110.057 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -163.15 88.12 0.58 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.736 1.214 . . . . 3.2400000000000002 109.791 -168.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -121.21 148.76 43.81 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.432 1.093 . . . . 1.5800000000000001 111.537 -162.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.45 -38.26 80.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.853 0.461 . . . . 2.9399999999999999 111.022 -174.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.3 p -142.28 165.83 26.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.516 0.726 . . . . 2.0600000000000001 110.561 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -47.76 79.01 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.814 0.846 . . . . 1.6799999999999999 110.675 166.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -48.82 -53.61 18.59 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.316 -0.624 . . . . 3.6400000000000001 109.316 175.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -65.44 -49.98 67.11 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.541 -0.54 . . . . 2.3700000000000001 109.541 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.5 t -50.3 -51.95 40.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.549 0.69 . . . . 0.97999999999999998 110.933 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -65.27 -49.18 70.56 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.466 -0.788 . . . . 4.6100000000000003 109.815 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.87 -44.42 82.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.388 0.675 . . . . 1.9199999999999999 111.624 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.3 mt -69.95 -51.78 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 122.579 0.352 . . . . 3.3399999999999999 110.667 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.6 t -73.26 -53.59 10.49 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.504 0.557 . . . . 2.4100000000000001 112.504 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 54' ' ' ARG . 7.8 mtp-105 -83.65 166.42 18.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 114.608 1.336 . . . . 7.1600000000000001 114.608 -167.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 104.468 -2.419 . . . . 7.1900000000000004 104.468 139.398 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 108.704 -0.851 . . . . 3.4100000000000001 108.704 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.3 pt -64.31 -15.54 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.393 0.677 . . . . 2.7000000000000002 111.774 171.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.7 m -77.36 -27.88 52.79 Favored 'General case' 0 C--O 1.222 -0.359 0 O-C-N 121.87 -0.519 . . . . 1.51 110.655 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.92 -30.77 19.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.494 -0.928 . . . . 1.98 108.494 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -52.99 139.04 44.51 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 108.006 -1.109 . . . . 2.79 108.006 165.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -98.79 175.74 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.747 2.298 . . . . 1.6299999999999999 111.064 172.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -53.28 138.88 31.24 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.853 -1.067 . . . . 4.0099999999999998 110.1 160.221 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 132.4 8.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 128.242 2.617 . . . . 5.21 106.378 176.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.1 t -75.51 -86.02 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.103 -1.073 . . . . 2.8799999999999999 108.103 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.74 147.57 0.6 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 123.606 0.622 . . . . 3.1699999999999999 113.005 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 65.16 -55.47 0.31 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.871 2.868 . . . . 9.3200000000000003 115.808 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.7 m -140.06 166.57 24.29 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.299 1.04 . . . . 1.8799999999999999 109.73 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -133.28 33.0 3.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.087 0.955 . . . . 6.9900000000000002 110.787 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.75 146.72 42.27 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.071 -1.212 . . . . 1.45 110.071 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -81.79 72.4 8.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.883 0.849 . . . . 1.5800000000000001 108.718 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -101.57 95.95 5.78 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 107.761 -1.2 . . . . 1.02 107.761 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.1 131.02 29.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 N-CA-C 108.511 -1.38 . . . . 0.71999999999999997 108.511 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -135.11 174.89 10.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.46 -1.311 . . . . 4.3499999999999996 107.46 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -111.08 146.65 36.39 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.703 1.201 . . . . 0.53000000000000003 108.311 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 16.9 p90 -129.75 152.13 49.59 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.634 -1.247 . . . . 0.98999999999999999 107.634 173.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.47 102.42 5.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 103.892 -2.633 . . . . 2.3100000000000001 103.892 160.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -72.08 109.98 6.24 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.82 -1.918 . . . . 2.2400000000000002 105.82 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 t -86.27 -14.75 42.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.508 -0.553 . . . . 1.3500000000000001 109.508 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -63.09 -44.43 95.72 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.846 -1.909 . . . . 4.3499999999999996 105.846 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.7 p -91.95 -40.83 10.91 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.952 2.501 . . . . 1.8799999999999999 111.465 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.03 21.89 24.32 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.926 1.727 . . . . 1.04 112.398 -169.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -120.93 151.16 40.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.936 1.694 . . . . 5.4000000000000004 109.195 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -73.15 136.68 44.82 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 120.664 -1.273 . . . . 0.57999999999999996 108.093 168.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.8 m -155.11 147.24 17.4 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.431 -0.795 . . . . 1.73 108.947 -169.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.44 152.18 29.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.285 2.657 . . . . 0.64000000000000001 111.774 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -150.72 158.41 44.12 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 124.831 1.252 . . . . 0.68999999999999995 108.867 172.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.07 118.79 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 105.726 -1.953 . . . . 1.98 105.726 168.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.79 -54.06 9.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.408 0.683 . . . . 2.8399999999999999 110.569 -173.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.29 -27.81 7.52 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.208 -0.757 . . . . 2.3100000000000001 111.208 -173.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.64 -45.36 1.4 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.419 1.009 . . . . 1.5 111.364 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 m -106.4 157.73 17.41 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.577 1.151 . . . . 2.6400000000000001 108.745 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 30.83 60.95 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.499 -0.612 . . . . 2.1699999999999999 113.459 166.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.18 157.96 46.12 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 118.442 1.121 . . . . 2.04 111.75 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -117.17 -163.1 0.9 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.557 1.543 . . . . 1.1599999999999999 108.495 170.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.98 69.39 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.17 -1.172 . . . . 1.1000000000000001 110.17 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -75.17 58.8 0.94 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.678 1.591 . . . . 2.6899999999999999 111.522 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.29 78.57 1.02 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.935 -0.478 . . . . 2.0499999999999998 110.202 -161.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -109.77 154.57 22.76 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.247 1.019 . . . . 0.89000000000000001 110.983 -164.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -67.01 -44.54 80.05 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.833 -0.542 . . . . 2.4500000000000002 109.564 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 78.3 p -131.28 154.29 48.66 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.958 0.725 . . . . 1.72 112.958 -169.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.02 -47.01 22.38 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.5 1.12 . . . . 1.96 110.037 159.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.3 -50.72 15.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.241 0.616 . . . . 3.46 110.598 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -65.89 -53.62 37.17 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 119.038 -0.506 . . . . 2.6800000000000002 110.842 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 t -47.39 -44.29 24.2 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.555 0.693 . . . . 0.59999999999999998 111.656 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.1 ttm-85 -62.14 -70.41 0.2 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.499 1.12 . . . . 3.7999999999999998 109.576 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.02 -40.81 45.81 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.204 1.402 . . . . 1.6899999999999999 112.939 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mm -63.68 -39.3 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 123.99 0.916 . . . . 2.4100000000000001 110.638 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 17.5 t -107.84 -52.2 2.8 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 113.005 0.742 . . . . 1.73 113.005 -165.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -129.09 -154.83 0.66 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.626 1.57 . . . . 5.25 110.18 -160.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 105.919 -1.882 . . . . 5.9199999999999999 105.919 170.502 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 118.44 -0.791 . . . . 4.79 109.384 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.1 pt -71.19 -14.31 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 113.098 0.777 . . . . 2.7599999999999998 113.098 -168.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.9 m -73.37 -32.65 64.63 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.811 0.444 . . . . 1.6299999999999999 111.096 166.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.2 -35.51 31.26 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.908 -0.495 . . . . 2.3700000000000001 110.134 -177.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -60.01 135.43 90.42 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 117.853 -1.07 . . . . 4.0599999999999996 109.125 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -104.58 177.2 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.994 2.463 . . . . 1.9099999999999999 111.757 170.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -36.54 134.07 0.49 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 126.958 2.103 . . . . 3.4300000000000002 112.911 166.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.07 135.81 9.45 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 113.282 -1.781 . . . . 5.6699999999999999 109.132 166.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.61 -49.87 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.063 -0.717 . . . . 2.1800000000000002 109.063 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.95 85.42 0.97 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.705 0.669 . . . . 3.6899999999999999 112.815 165.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 87.9 mtm-85 65.66 -52.52 0.37 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 128.89 2.876 . . . . 10.029999999999999 115.027 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 m -71.87 169.44 15.8 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.114 0.566 . . . . 2.3999999999999999 109.984 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -129.42 31.03 4.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.012 1.325 . . . . 8.4700000000000006 109.493 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.83 177.67 48.21 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.808 -1.317 . . . . 1.4299999999999999 109.808 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -124.96 87.61 2.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.091 0.956 . . . . 2.9300000000000002 108.73 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -111.57 103.13 54.76 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 108.096 -1.076 . . . . 1.0700000000000001 108.096 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.6 125.17 14.99 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 N-CA-C 108.874 -1.241 . . . . 0.98999999999999999 108.874 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -134.2 175.71 9.25 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.468 1.507 . . . . 3.3500000000000001 107.886 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -103.64 149.28 25.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.942 1.297 . . . . 0.95999999999999996 108.06 167.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -128.32 157.45 40.93 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.726 -1.583 . . . . 0.98999999999999999 106.726 166.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -78.84 103.0 8.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.056 -1.831 . . . . 1.98 106.056 163.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -77.4 111.38 13.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.619 -0.882 . . . . 1.8300000000000001 108.619 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 t -89.3 9.83 24.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.531 0.733 . . . . 1.6699999999999999 111.892 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -86.68 -45.29 11.13 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.16 -1.792 . . . . 4.4900000000000002 106.16 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.1 p -93.76 -31.71 14.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 130.263 3.425 . . . . 2.2799999999999998 111.684 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.35 30.93 12.47 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.436 1.493 . . . . 0.94999999999999996 112.765 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -143.61 148.11 35.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.19 1.396 . . . . 5.3499999999999996 111.502 -161.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 78.8 m -71.31 128.23 35.21 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 120.18 -1.575 . . . . 0.5 109.663 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.1 m -149.4 147.33 22.98 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 117.965 -1.016 . . . . 2.0 109.253 -161.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.78 150.0 34.34 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.319 2.679 . . . . 0.53000000000000003 112.219 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -153.42 171.83 18.05 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.17 1.388 . . . . 0.78000000000000003 109.014 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.58 107.86 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.765 -0.828 . . . . 2.5800000000000001 108.765 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -78.47 139.68 38.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.21 1.004 . . . . 2.1699999999999999 108.706 170.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.12 -43.03 49.39 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-O 119.365 -0.686 . . . . 1.9399999999999999 112.385 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.62 -9.03 13.02 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.149 0.88 . . . . 1.6299999999999999 113.448 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.0 m -113.34 -131.11 0.32 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.155 -1.424 . . . . 2.8500000000000001 107.155 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.04 -62.78 0.04 OUTLIER Glycine 0 C--N 1.338 0.694 0 C-N-CA 127.881 2.657 . . . . 3.0 115.193 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.26 -134.16 8.04 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.506 -1.038 . . . . 2.0899999999999999 110.506 -166.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -170.0 177.0 4.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 128.21 2.604 . . . . 1.27 106.139 171.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.17 -25.12 73.49 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.193 -0.763 . . . . 0.85999999999999999 111.193 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -73.7 55.61 0.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.649 1.58 . . . . 2.71 109.908 174.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -147.53 120.57 8.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.521 -1.289 . . . . 2.3999999999999999 107.521 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -138.6 147.72 43.3 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.49 1.116 . . . . 0.81999999999999995 108.898 -165.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -78.68 -25.13 44.77 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.884 -0.51 . . . . 3.1000000000000001 110.92 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -142.42 155.42 45.1 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.512 0.725 . . . . 1.6899999999999999 111.021 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.13 -45.59 53.12 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 109.297 -0.631 . . . . 1.98 109.297 160.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -44.77 -53.77 7.03 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.939 0.496 . . . . 3.3900000000000001 110.543 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -63.97 -54.12 39.47 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 110.161 -0.311 . . . . 2.0099999999999998 110.161 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -48.58 -49.74 35.4 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.31 0.576 . . . . 0.54000000000000004 111.503 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -59.93 -64.43 0.95 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.613 1.165 . . . . 3.2999999999999998 109.165 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -44.55 -45.64 9.49 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.508 1.123 . . . . 1.8999999999999999 111.699 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.8 mm -71.29 -56.71 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.888 0.875 . . . . 2.6299999999999999 110.739 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 46.5 t -88.09 -44.9 10.6 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.225 0.824 . . . . 1.51 113.225 -168.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.85 82.98 1.63 Allowed 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.633 1.573 . . . . 6.04 111.006 176.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 118.275 -0.869 . . . . 6.0 112.335 -176.794 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 107.383 -1.34 . . . . 4.4800000000000004 107.383 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.9 pt -47.11 -32.58 2.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 124.574 1.15 . . . . 3.21 112.025 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.8 t -32.23 -41.44 0.05 Allowed 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 126.88 2.072 . . . . 2.0600000000000001 114.708 169.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.72 -22.82 61.57 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.138 -1.392 . . . . 1.8 111.186 -169.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.43 149.76 94.45 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 118.879 0.763 . . . . 3.0600000000000001 109.395 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.68 173.16 13.32 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.137 1.891 . . . . 1.29 110.259 170.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -54.32 141.88 28.51 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.782 0.801 . . . . 3.3599999999999999 109.471 160.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -143.94 133.05 22.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.602 -1.629 . . . . 6.8099999999999996 106.602 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.84 -55.19 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.295 0.498 . . . . 2.5299999999999998 110.144 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.64 -157.83 22.53 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 108.39 -1.884 . . . . 2.2999999999999998 108.39 -175.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -24.13 4.59 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.886 0.875 . . . . 6.71 112.22 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 64.9 m -79.12 158.26 27.79 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.539 -0.911 . . . . 2.7000000000000002 108.539 166.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -106.28 45.84 0.96 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.836 0.855 . . . . 5.8799999999999999 110.15 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.98 176.15 54.11 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.167 -0.773 . . . . 1.26 111.167 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -124.44 81.07 1.9 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.15 1.38 . . . . 1.24 107.287 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -105.99 104.67 50.46 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 108.027 -1.101 . . . . 1.5600000000000001 108.027 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -65.07 112.96 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 N-CA-C 108.544 -1.368 . . . . 0.62 108.544 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -121.69 178.34 4.89 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.934 2.094 . . . . 4.3600000000000003 109.211 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -127.32 146.15 50.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.131 1.772 . . . . 0.60999999999999999 108.313 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -135.25 153.29 51.96 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.167 -1.42 . . . . 0.89000000000000001 107.167 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -65.57 103.16 0.81 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.482 -1.673 . . . . 2.0499999999999998 106.482 161.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -78.54 114.91 17.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.376 -1.713 . . . . 1.95 106.376 169.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 t -86.28 -16.64 36.95 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.404 0.281 . . . . 2.0899999999999999 110.275 -175.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -67.2 -45.52 76.61 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 126.673 1.989 . . . . 3.6699999999999999 106.139 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.7 p -88.16 -35.6 17.31 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.246 1.818 . . . . 2.4399999999999999 110.981 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.48 44.18 8.82 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.845 -1.302 . . . . 0.91000000000000003 109.845 -171.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.54 141.93 43.4 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.842 1.657 . . . . 6.9699999999999998 110.162 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.5 m -65.61 113.47 4.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.099 -1.074 . . . . 0.81000000000000005 108.099 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.7 m -132.94 144.13 51.54 Favored Pre-proline 0 C--N 1.332 -0.185 0 C-N-CA 125.65 1.58 . . . . 1.54 108.613 -163.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.31 156.3 62.21 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.732 2.288 . . . . 0.47999999999999998 111.697 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -155.21 161.76 41.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.839 1.255 . . . . 0.83999999999999997 108.051 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.9 mm -93.67 112.39 26.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 108.136 -1.061 . . . . 2.3799999999999999 108.136 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -90.19 147.14 23.75 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.691 1.196 . . . . 2.2599999999999998 109.366 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.48 -6.68 89.16 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.252 1.406 . . . . 1.8799999999999999 113.536 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.78 -49.87 1.41 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.915 1.358 . . . . 1.72 111.581 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -127.23 144.74 50.98 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.127 0.971 . . . . 3.3399999999999999 110.379 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.51 12.47 41.28 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.669 1.604 . . . . 2.1899999999999999 112.745 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.03 148.88 47.87 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 118.313 1.056 . . . . 2.1699999999999999 113.094 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -91.01 -161.18 0.79 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.411 1.484 . . . . 1.6899999999999999 109.732 171.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.27 -45.67 6.13 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.914 -1.275 . . . . 1.1100000000000001 109.914 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -73.76 72.68 1.52 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.624 0.712 . . . . 1.53 110.158 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -159.95 93.79 1.09 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.745 1.218 . . . . 3.0499999999999998 108.704 -163.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -131.66 141.63 49.64 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 123.208 0.603 . . . . 1.4099999999999999 111.056 -160.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -54.52 -43.68 72.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.747 0.819 . . . . 2.7000000000000002 110.833 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.7 p -137.01 158.28 44.83 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.172 0.511 . . . . 1.6299999999999999 112.363 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.24 -46.93 62.47 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.167 -0.679 . . . . 1.97 109.167 159.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -46.59 -50.67 17.07 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.223 0.465 . . . . 3.2000000000000002 110.437 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -65.08 -53.9 38.38 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.764 0.426 . . . . 3.5499999999999998 110.215 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.0 t -51.83 -45.06 63.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.868 0.842 . . . . 0.54000000000000004 111.246 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.44 HH21 ' C ' ' A' ' 55' ' ' ALA . 30.9 ttm180 -64.56 -53.76 42.76 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.153 1.381 . . . . 3.8700000000000001 109.349 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.6 -43.11 56.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.768 0.427 . . . . 1.8200000000000001 111.167 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.4 mt -69.26 -57.05 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.045 0.538 . . . . 2.98 111.719 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -120.97 -24.4 5.61 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.022 1.119 . . . . 1.5900000000000001 114.022 -166.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.275 0.3 OUTLIER 67.56 118.25 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 130.929 3.692 . . . . 7.8099999999999996 110.719 -177.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.44 ' C ' HH21 ' A' ' 50' ' ' ARG . . . . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 127.473 2.309 . . . . 10.17 106.448 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 118.68 -0.676 . . . . 5.21 110.051 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 pt -55.8 -28.65 24.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 114.37 1.248 . . . . 2.9399999999999999 114.37 -162.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.3 m -55.61 -35.91 66.36 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.896 -0.502 . . . . 1.55 112.226 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.05 -19.37 20.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.947 0.499 . . . . 1.8799999999999999 111.088 -162.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -72.56 146.21 88.38 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 118.208 0.458 . . . . 4.25 110.323 -161.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.36 166.49 29.14 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.499 2.132 . . . . 2.2599999999999998 113.092 -169.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -57.68 147.27 28.1 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 107.702 -1.221 . . . . 3.4199999999999999 107.702 169.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -154.92 69.74 0.74 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.966 0.888 . . . . 7.1699999999999999 110.791 -156.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.3 t -60.35 -44.67 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.392 -0.596 . . . . 2.6299999999999999 109.392 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.7 -146.26 18.16 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 107.972 -2.051 . . . . 2.96 107.972 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -154.15 55.11 0.71 Allowed 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.086 -0.709 . . . . 8.4900000000000002 109.086 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.0 m -150.16 150.56 31.81 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.29 1.036 . . . . 2.8500000000000001 108.247 -165.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -77.81 63.87 2.95 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.975 0.51 . . . . 8.0800000000000001 110.351 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -116.2 153.42 17.47 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.733 -1.747 . . . . 2.0299999999999998 108.733 168.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -144.56 81.2 1.65 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.537 -0.912 . . . . 2.0099999999999998 108.537 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.33 100.13 45.21 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 108.148 -1.056 . . . . 2.1800000000000002 108.148 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.71 126.0 17.27 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.32 1.346 . . . . 0.66000000000000003 109.418 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -137.64 176.24 8.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.493 1.517 . . . . 4.6699999999999999 108.305 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -121.2 142.44 49.9 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.556 1.543 . . . . 0.67000000000000004 108.52 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -128.36 152.15 48.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.965 -1.494 . . . . 1.3500000000000001 106.965 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -73.03 104.14 4.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.637 -1.616 . . . . 2.0499999999999998 106.637 168.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.16 105.96 4.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.084 -1.45 . . . . 2.04 107.084 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.2 t -81.17 -6.9 59.36 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.154 -0.927 . . . . 1.49 112.831 -173.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -76.09 -49.95 16.03 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.211 -1.403 . . . . 5.2400000000000002 107.211 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.4 p -88.97 -12.64 40.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.708 0.803 . . . . 2.5499999999999998 111.752 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.7 37.17 76.36 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.924 1.249 . . . . 0.87 111.119 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -137.96 135.49 36.07 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.316 1.046 . . . . 5.2699999999999996 110.747 -163.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 90.6 m -66.04 124.45 22.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.347 -0.983 . . . . 0.59999999999999998 108.347 170.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.5 m -141.37 138.99 18.15 Favored Pre-proline 0 N--CA 1.451 -0.401 0 C-N-CA 124.701 1.2 . . . . 1.8600000000000001 107.862 -164.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.03 156.89 61.55 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.456 2.104 . . . . 0.72999999999999998 111.06 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.1 157.86 36.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.215 -1.402 . . . . 1.1100000000000001 107.215 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.63 116.24 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 105.293 -2.114 . . . . 1.74 105.293 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -86.28 131.2 34.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.53 -1.285 . . . . 2.3300000000000001 107.53 173.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.52 18.38 56.33 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.851 -0.416 . . . . 1.8600000000000001 112.408 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.62 -53.83 4.73 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.854 -1.698 . . . . 2.75 108.854 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.6 m -64.3 168.97 5.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.391 1.076 . . . . 4.2699999999999996 108.73 162.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.15 39.77 62.32 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 109.816 -1.314 . . . . 4.2599999999999998 109.816 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.95 57.55 5.04 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.655 -1.497 . . . . 2.6699999999999999 112.686 -171.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -81.68 173.54 12.23 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.146 0.973 . . . . 1.99 108.912 161.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.62 -23.45 72.85 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.519 0.581 . . . . 0.83999999999999997 114.051 -166.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -77.15 74.76 3.72 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.972 0.886 . . . . 1.74 109.724 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -152.17 96.52 2.2 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.071 0.548 . . . . 2.54 109.96 -160.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -124.35 148.46 47.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.137 0.575 . . . . 1.5900000000000001 109.492 -170.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -77.06 -27.55 54.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.971 -0.381 . . . . 4.7300000000000004 109.971 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.9 p -137.0 162.43 33.31 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.819 0.848 . . . . 2.0699999999999998 112.208 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.77 -49.26 39.38 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.254 1.021 . . . . 2.0499999999999998 110.101 159.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -46.8 -50.5 18.22 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.701 0.4 . . . . 3.3599999999999999 110.085 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -66.42 -52.57 45.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 119.235 -0.412 . . . . 5.0199999999999996 111.2 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 t -47.9 -49.74 28.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.606 0.639 . . . . 0.5 111.212 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -56.71 -65.44 0.61 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.49 1.116 . . . . 4.3399999999999999 109.538 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.62 -40.0 71.55 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.05 0.94 . . . . 2.3799999999999999 112.949 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mp -74.19 -52.1 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 119.258 -0.401 . . . . 3.5800000000000001 110.094 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.0 t -79.56 -47.87 14.79 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.097 0.862 . . . . 1.55 112.546 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -125.97 -151.68 0.49 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.6 1.96 . . . . 5.1699999999999999 109.155 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 105.423 -2.066 . . . . 5.3700000000000001 105.423 163.142 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.529 -0.545 . . . . 4.9500000000000002 109.529 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pp -63.76 -29.39 47.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 113.166 0.802 . . . . 4.5700000000000003 113.166 -156.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -18.46 60.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.286 0.565 . . . . 1.8899999999999999 111.692 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.81 -44.2 12.67 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.388 1.075 . . . . 1.9299999999999999 110.741 168.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.2 116.15 20.46 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.787 -0.625 . . . . 4.1600000000000001 110.221 -174.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.93 153.53 42.2 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.502 1.468 . . . . 1.5800000000000001 110.791 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.88 143.93 9.3 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 122.123 0.963 . . . . 3.3799999999999999 112.52 163.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.99 128.78 10.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.257 1.823 . . . . 6.3200000000000003 106.274 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.0 t -72.86 -51.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.11 -0.7 . . . . 2.04 109.11 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.9 143.87 15.6 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.119 1.342 . . . . 2.46 109.838 -172.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -76.81 67.11 2.82 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.857 -0.79 . . . . 10.6 108.893 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 m -107.05 178.57 4.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.414 1.086 . . . . 3.3599999999999999 109.919 -171.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -122.28 68.05 0.94 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.404 -1.332 . . . . 9.1199999999999992 107.404 167.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.14 165.97 35.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.325 -1.51 . . . . 1.51 109.325 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -146.37 99.36 3.21 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.099 1.759 . . . . 1.5 106.283 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -123.64 100.86 37.4 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 107.66 -1.237 . . . . 1.1299999999999999 107.66 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.2 125.73 17.7 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 108.484 -1.391 . . . . 0.62 108.484 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.6 mmt-85 -135.66 174.47 10.58 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.388 1.475 . . . . 4.4199999999999999 108.347 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -115.85 140.98 48.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.241 1.417 . . . . 0.46999999999999997 108.154 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 7.4 p90 -123.6 152.65 41.68 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.331 -1.359 . . . . 0.82999999999999996 107.331 169.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -66.64 105.66 1.6 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.24 -1.763 . . . . 1.47 106.24 155.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.427 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 6.5 t70 -72.05 116.87 12.96 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.767 -1.938 . . . . 1.8300000000000001 105.767 168.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.65 -25.11 28.71 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.745 -0.835 . . . . 2.71 108.745 -169.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -63.73 -45.9 87.85 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 128.208 2.603 . . . . 3.8999999999999999 106.636 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.8 p -84.9 -34.24 22.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.101 1.36 . . . . 2.0800000000000001 110.783 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.9 37.01 23.73 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.146 1.355 . . . . 1.22 110.494 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.93 156.75 43.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.779 1.232 . . . . 7.6399999999999997 110.384 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.2 m -67.34 139.03 57.2 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.398 -0.814 . . . . 0.75 109.435 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -156.65 146.15 15.3 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.874 -1.158 . . . . 1.8100000000000001 107.874 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.66 156.49 49.11 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.091 2.528 . . . . 0.39000000000000001 111.695 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -153.69 162.95 40.79 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.414 1.486 . . . . 0.56999999999999995 107.359 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -96.05 113.67 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.862 -1.903 . . . . 1.9399999999999999 105.862 170.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -81.57 139.77 34.87 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.639 -1.245 . . . . 2.1200000000000001 107.639 169.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.26 -11.24 85.53 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 121.725 -0.609 . . . . 1.98 112.653 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.27 -43.88 1.7 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.206 -1.158 . . . . 1.51 110.206 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.9 159.03 15.19 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.131 1.773 . . . . 2.3999999999999999 111.374 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.09 37.59 93.05 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 114.759 0.664 . . . . 2.6899999999999999 114.759 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.61 -153.6 15.81 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.887 0.844 . . . . 1.6299999999999999 112.815 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -160.38 -163.32 1.08 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.381 2.272 . . . . 1.4399999999999999 105.675 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.21 -20.84 68.83 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.566 1.076 . . . . 1.0 112.239 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -81.5 63.97 6.02 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 118.502 1.151 . . . . 1.6200000000000001 110.069 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -159.09 78.24 0.74 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.914 -0.584 . . . . 2.7400000000000002 109.544 -155.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -112.99 154.5 26.36 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.465 0.706 . . . . 0.96999999999999997 110.916 -167.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.24 -39.73 94.56 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.803 -0.814 . . . . 3.04 108.803 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.8 p -130.66 150.59 51.78 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.142 1.164 . . . . 1.52 114.142 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.9 -46.11 42.33 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.224 1.41 . . . . 1.8600000000000001 110.242 159.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.42 -49.96 23.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.704 0.802 . . . . 3.27 110.488 175.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -64.46 -54.96 24.39 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 119.186 -0.435 . . . . 2.2999999999999998 110.358 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.25 -43.54 42.91 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.294 1.045 . . . . 0.65000000000000002 111.509 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -60.61 -58.77 7.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.864 1.266 . . . . 6.2000000000000002 111.516 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.32 -43.55 67.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.621 0.769 . . . . 1.6799999999999999 112.298 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.5 -44.17 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.899 0.88 . . . . 2.7999999999999998 110.331 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 10.7 t -147.94 -54.51 0.21 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.058 0.762 . . . . 2.3399999999999999 113.058 -171.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.15 136.38 52.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.301 1.223 . . . . 8.6199999999999992 114.301 -153.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.298 0 C-N-CA 125.587 1.555 . . . . 7.3799999999999999 107.685 163.679 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 117.94 -1.028 . . . . 3.2400000000000002 109.3 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.8 pt -45.24 -34.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.168 0.987 . . . . 2.6800000000000002 111.927 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.2 m -49.1 -27.35 3.33 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.343 1.057 . . . . 1.6799999999999999 112.704 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -33.26 66.13 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.912 -0.492 . . . . 1.8799999999999999 111.038 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.44 119.21 44.6 Favored Pre-proline 0 C--O 1.225 -0.2 0 CA-C-O 118.11 -0.947 . . . . 4.9000000000000004 109.072 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.08 173.51 12.03 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 120.802 1.322 . . . . 1.6399999999999999 111.626 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -45.21 131.56 7.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.115 -1.402 . . . . 3.5800000000000001 110.52 157.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -159.17 137.01 10.25 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.711 2.004 . . . . 6.0099999999999998 106.722 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.52 -66.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.799 0.727 . . . . 1.97 109.782 -172.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.77 -178.82 19.1 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.241 -1.543 . . . . 1.8400000000000001 109.241 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -68.06 -43.36 78.81 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.915 -0.772 . . . . 7.2300000000000004 108.915 172.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.2 m -71.52 151.97 43.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.269 -1.752 . . . . 2.4500000000000002 106.269 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -138.09 46.95 2.03 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.448 0.699 . . . . 7.1900000000000004 109.134 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.94 153.91 34.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.269 -1.532 . . . . 1.4199999999999999 109.269 170.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -83.1 77.8 9.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.981 -0.717 . . . . 1.4099999999999999 109.523 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -101.31 94.35 3.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.071 -0.715 . . . . 0.94999999999999996 109.071 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.67 122.33 10.39 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 CA-C-N 120.548 1.232 . . . . 0.56000000000000005 108.935 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -130.7 177.99 6.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 125.578 1.551 . . . . 4.7699999999999996 107.268 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -117.53 142.49 47.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.794 1.638 . . . . 0.46000000000000002 108.144 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -124.84 150.43 46.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.567 -1.642 . . . . 0.98999999999999999 106.567 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.9 102.34 0.77 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 104.559 -2.386 . . . . 2.1699999999999999 104.559 157.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.39 103.22 3.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.243 -1.762 . . . . 2.0800000000000001 106.243 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 t -74.9 -15.33 60.71 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.258 0.623 . . . . 2.1899999999999999 110.66 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -62.4 -41.66 98.84 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.446 1.098 . . . . 4.3399999999999999 108.107 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.5 p -105.33 -25.66 12.31 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.783 2.833 . . . . 1.74 112.911 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.1 30.39 22.97 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.867 2.175 . . . . 0.97999999999999998 113.233 -173.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -136.65 138.2 40.87 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.152 1.476 . . . . 5.4900000000000002 110.96 -161.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 m -70.48 120.17 15.73 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 120.491 -1.38 . . . . 0.56999999999999995 108.952 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.9 m -140.72 145.65 40.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.637 1.175 . . . . 1.5800000000000001 108.868 -163.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.65 151.25 41.16 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.218 2.612 . . . . 0.51000000000000001 111.899 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -154.64 162.99 40.88 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.349 1.46 . . . . 0.67000000000000004 108.27 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.39 113.15 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.02 -1.474 . . . . 1.8500000000000001 107.02 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -80.83 145.19 31.53 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.526 1.13 . . . . 1.98 108.004 168.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.31 -31.3 47.16 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.992 0.806 . . . . 2.1600000000000001 114.012 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.42 17.35 24.51 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.391 0.996 . . . . 1.75 113.115 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -125.57 -156.93 0.76 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.125 1.37 . . . . 3.2599999999999998 109.403 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.48 67.61 0.26 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.868 1.699 . . . . 2.98 110.254 163.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.33 -83.92 0.09 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.135 -1.586 . . . . 2.6099999999999999 109.135 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -177.85 -174.13 0.43 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 127.431 2.292 . . . . 1.21 108.061 167.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.55 -20.51 61.81 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.463 0.554 . . . . 1.24 112.69 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -80.24 64.89 5.21 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.372 1.086 . . . . 1.7 108.577 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.9 69.39 0.73 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.824 -0.806 . . . . 2.0600000000000001 108.824 -151.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -106.77 163.41 12.95 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.438 1.495 . . . . 0.81999999999999995 111.309 -162.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -30.43 35.29 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.671 -0.643 . . . . 3.3700000000000001 110.59 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.8 p -146.97 162.38 38.88 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.244 0.618 . . . . 1.8300000000000001 110.852 -173.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -46.11 70.31 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 123.432 0.693 . . . . 1.8400000000000001 109.855 163.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -47.82 -51.95 20.8 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.91 -0.404 . . . . 3.6899999999999999 109.91 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -68.96 -49.98 53.17 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.361 -0.237 . . . . 2.0099999999999998 110.361 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -50.49 -47.65 57.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.509 0.671 . . . . 0.57999999999999996 110.699 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -61.89 -58.86 6.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 123.921 0.889 . . . . 5.5999999999999996 110.097 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.64 -45.61 63.38 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.502 0.721 . . . . 1.7 111.584 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.5 mm -65.63 -54.58 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 122.661 0.385 . . . . 2.4500000000000002 110.014 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.5 t -81.26 -57.03 3.68 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.781 0.66 . . . . 1.75 112.781 -168.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -125.84 67.06 1.18 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.706 2.002 . . . . 5.1399999999999997 108.695 -166.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 118.14 -0.933 . . . . 6.4100000000000001 110.035 174.579 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 108.151 -1.055 . . . . 3.7999999999999998 108.151 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.4 pt -51.58 -30.93 11.9 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 C-N-CA 123.304 0.642 . . . . 2.7799999999999998 110.756 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.4 m -47.76 -28.5 2.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.644 0.778 . . . . 1.77 112.302 176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.34 -17.03 55.34 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.025 -0.988 . . . . 2.29 112.419 -172.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.77 148.91 81.58 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 120.511 1.505 . . . . 3.21 111.518 -173.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.2 170.15 20.84 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.665 2.243 . . . . 1.8799999999999999 110.29 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HE2' ' CE1' ' A' ' 20' ' ' TYR . 26.7 ttmt -67.99 140.84 56.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.255 -0.646 . . . . 5.2599999999999998 109.255 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.53 149.92 30.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.505 -1.665 . . . . 6.2599999999999998 106.505 176.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.6 t -90.73 -72.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 108.915 -0.772 . . . . 2.04 108.915 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.96 173.48 34.46 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 108.838 -1.705 . . . . 2.3700000000000001 108.838 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -74.23 -43.17 58.14 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.289 -1.374 . . . . 9.8000000000000007 107.289 168.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.24 144.21 50.14 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.059 -1.83 . . . . 2.8199999999999998 106.059 166.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -59.61 2.64 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 119.041 -0.504 . . . . 7.2599999999999998 109.963 -173.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.19 -178.28 0.62 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.314 1.435 . . . . 2.0 115.839 166.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -147.99 95.26 2.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.402 1.081 . . . . 1.48 108.986 170.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.2 107.17 13.54 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 109.121 -0.696 . . . . 1.04 109.121 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.81 117.81 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.628 1.552 . . . . 0.82999999999999996 110.208 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -120.22 176.94 5.21 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 126.921 2.088 . . . . 3.9700000000000002 109.238 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -123.63 140.69 52.74 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.779 2.031 . . . . 0.56999999999999995 107.559 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.436 ' CE1' ' HE2' ' A' ' 7' ' ' LYS . 1.3 p90 -122.55 150.65 42.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.852 -1.906 . . . . 1.05 105.852 169.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -68.57 107.74 3.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.381 -2.081 . . . . 2.2200000000000002 105.381 159.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.07 111.98 7.77 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.884 -1.525 . . . . 2.23 106.884 170.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 t -88.06 1.53 54.04 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.004 -0.998 . . . . 1.3200000000000001 112.945 -171.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -85.0 -50.07 7.77 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.862 -1.533 . . . . 5.7199999999999998 106.862 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.3 p -83.43 -26.07 30.68 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.862 0.865 . . . . 2.6400000000000001 111.357 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.08 31.27 53.39 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.867 1.222 . . . . 1.0600000000000001 111.126 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.2 131.61 53.55 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 118.751 1.275 . . . . 5.4199999999999999 110.548 -169.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.8 m -62.31 129.02 38.83 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 107.439 -1.319 . . . . 0.47999999999999998 107.439 168.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.0 m -156.28 149.62 18.78 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.899 -1.148 . . . . 1.6899999999999999 107.899 -165.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.97 157.88 46.62 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.101 2.534 . . . . 0.54000000000000004 114.528 -174.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -154.07 164.3 38.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.257 1.423 . . . . 0.95999999999999996 108.869 167.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.9 mm -98.93 104.87 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.575 -1.268 . . . . 2.1699999999999999 107.575 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -73.4 152.75 40.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.498 -0.927 . . . . 2.25 108.498 168.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.53 13.27 47.18 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 114.365 0.506 . . . . 1.8899999999999999 114.365 -172.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.76 -48.86 2.8 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 118.645 1.223 . . . . 1.49 110.943 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.52 128.04 38.5 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.712 0.805 . . . . 3.1400000000000001 111.834 174.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.14 52.5 0.24 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.522 2.01 . . . . 2.46 108.548 -170.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.15 164.73 54.35 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.065 -0.814 . . . . 2.48 111.065 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -156.8 -173.2 4.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.206 -1.775 . . . . 1.55 106.206 171.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.09 -47.29 9.37 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.023 -1.231 . . . . 1.0900000000000001 110.023 -172.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.11 65.92 2.19 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.929 0.492 . . . . 1.5600000000000001 110.926 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.0 66.12 0.91 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.343 1.057 . . . . 2.1000000000000001 109.859 -159.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -108.65 140.93 41.35 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.726 0.81 . . . . 0.89000000000000001 110.994 -160.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.15 -42.29 80.76 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.252 0.933 . . . . 2.52 110.722 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.9 p -138.98 163.5 32.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.615 0.766 . . . . 1.6599999999999999 111.507 -169.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.79 -47.7 67.37 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.207 0.603 . . . . 1.6399999999999999 109.548 162.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -48.69 -48.68 39.94 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.998 -0.371 . . . . 3.46 109.998 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -68.58 -51.54 41.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.517 0.327 . . . . 2.25 110.641 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.5 t -51.13 -48.53 61.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.548 0.69 . . . . 0.54000000000000004 111.092 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -57.49 -60.34 3.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.224 1.01 . . . . 3.5699999999999998 109.129 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.75 -43.6 27.36 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.479 0.712 . . . . 1.8899999999999999 112.204 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.38 -59.35 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.945 0.339 . . . . 2.5 110.151 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.3 t -81.38 -47.11 13.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 119.95 -0.7 . . . . 1.6200000000000001 112.522 -164.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -126.26 77.99 1.73 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.299 3.039 . . . . 5.8099999999999996 110.222 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 118.202 -0.904 . . . . 7.0899999999999999 109.786 169.158 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 107.942 -1.132 . . . . 3.9500000000000002 107.942 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.35 -24.84 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.618 0.767 . . . . 3.52 111.774 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.3 m -33.12 -45.84 0.15 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.069 1.347 . . . . 1.6799999999999999 111.165 166.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.44 -22.25 61.12 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.589 0.959 . . . . 1.8500000000000001 113.589 -169.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -65.71 146.16 99.0 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 119.787 1.176 . . . . 3.0899999999999999 111.027 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.32 169.91 21.45 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.949 1.766 . . . . 1.3799999999999999 110.735 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -56.68 143.03 37.82 Favored 'General case' 0 N--CA 1.46 0.051 0 C-N-CA 125.506 1.523 . . . . 3.2000000000000002 111.327 161.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -146.75 99.01 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.038 1.735 . . . . 6.21 110.196 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.3 -42.09 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.442 -0.577 . . . . 1.8799999999999999 109.442 174.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.62 -178.33 42.52 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.67 -0.972 . . . . 2.0800000000000001 110.67 -172.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.06 55.56 2.53 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.985 -0.715 . . . . 8.9199999999999999 112.105 -170.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.9 m -147.58 165.44 30.36 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.917 1.287 . . . . 2.0699999999999998 107.573 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -139.42 20.55 2.56 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.236 0.615 . . . . 6.5099999999999998 112.103 -177.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.71 145.19 38.14 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.255 -1.138 . . . . 1.5600000000000001 110.255 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -81.95 73.32 9.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.69 0.757 . . . . 1.76 109.097 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -102.42 90.75 2.28 Favored Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 108.03 -1.1 . . . . 1.1399999999999999 108.03 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.56 136.45 46.41 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.207 1.271 . . . . 0.93999999999999995 109.549 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -140.43 179.35 6.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.051 2.141 . . . . 3.3700000000000001 107.62 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -122.95 147.23 46.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.892 2.077 . . . . 0.60999999999999999 108.391 169.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -128.61 155.81 44.37 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.955 -1.869 . . . . 1.21 105.955 166.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -75.99 101.93 5.43 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.341 -1.355 . . . . 2.0499999999999998 107.341 164.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -72.35 98.66 2.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.28 -1.378 . . . . 1.8 107.28 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -72.26 -14.69 61.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.245 -0.883 . . . . 1.6100000000000001 112.817 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -69.27 -49.05 59.64 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.413 -1.328 . . . . 4.9800000000000004 107.413 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 64.1 p -83.77 -19.54 34.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.937 0.495 . . . . 2.0800000000000001 111.596 174.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.96 34.36 58.92 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.51 1.052 . . . . 0.78000000000000003 110.831 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.73 136.52 52.54 Favored 'General case' 0 CA--C 1.523 -0.059 0 C-N-CA 124.631 1.172 . . . . 6.3600000000000003 110.527 -169.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.8 m -61.99 124.68 21.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.905 -1.146 . . . . 0.63 107.905 156.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.5 m -141.54 137.69 16.67 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 107.299 -1.371 . . . . 1.8799999999999999 107.299 -166.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.03 155.17 65.67 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.405 2.07 . . . . 0.73999999999999999 110.84 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -153.46 157.84 40.47 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.147 -1.057 . . . . 0.81999999999999995 108.147 167.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.6 120.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 105.961 -1.866 . . . . 1.72 105.961 172.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -84.84 -7.53 59.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.071 1.348 . . . . 2.6299999999999999 111.707 -172.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.09 -33.12 1.5 Allowed Glycine 0 CA--C 1.533 1.203 0 O-C-N 119.991 -1.693 . . . . 2.4100000000000001 113.221 172.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.96 25.73 18.9 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 126.059 1.79 . . . . 2.2599999999999998 110.478 -171.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.87 -160.71 0.72 Allowed 'General case' 0 C--N 1.34 0.195 0 N-CA-C 114.926 1.454 . . . . 4.1799999999999997 114.926 -164.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -31.02 -58.51 0.26 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 127.343 2.401 . . . . 3.3799999999999999 113.42 173.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.04 -161.88 46.89 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.995 -0.442 . . . . 1.8700000000000001 111.995 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -172.23 -169.8 0.67 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.976 1.71 . . . . 1.3700000000000001 109.776 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.73 -41.9 18.39 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.584 -1.407 . . . . 1.0700000000000001 109.584 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -73.89 67.06 1.2 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.879 0.371 . . . . 1.78 111.179 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -149.58 117.92 6.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.097 1.359 . . . . 2.1400000000000001 108.492 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -138.77 139.84 38.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.766 0.827 . . . . 1.1699999999999999 108.83 -166.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -63.44 -35.98 82.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.878 0.763 . . . . 3.1299999999999999 110.936 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.5 p -131.11 155.05 47.62 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.592 0.757 . . . . 1.51 111.314 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.92 -45.57 60.5 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.137 -0.69 . . . . 1.79 109.137 161.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.14 -53.72 7.72 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.821 0.449 . . . . 3.3900000000000001 110.498 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -64.71 -54.2 35.21 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.038 -0.356 . . . . 2.1200000000000001 110.038 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 t -49.64 -50.22 44.05 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.01 0.433 . . . . 0.46000000000000002 110.93 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -57.81 -60.89 3.01 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.743 1.217 . . . . 3.8700000000000001 109.111 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.05 -32.55 61.99 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.103 0.961 . . . . 2.0 112.851 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.5 mm -88.29 -50.4 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.29 0.636 . . . . 2.9100000000000001 110.82 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.8 t -78.46 -49.1 14.04 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.705 -0.622 . . . . 1.55 111.484 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -104.3 -151.23 0.44 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.025 1.73 . . . . 5.6299999999999999 109.442 171.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 104.847 -2.279 . . . . 5.5499999999999998 104.847 148.761 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 108.707 -0.849 . . . . 3.96 108.707 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp -55.41 -24.97 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.662 1.185 . . . . 3.8799999999999999 110.976 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m -40.73 -36.8 0.66 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.462 1.505 . . . . 1.6799999999999999 111.694 170.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -23.89 60.77 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.594 0.961 . . . . 2.6099999999999999 113.594 -176.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -72.29 144.66 87.21 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.695 0.68 . . . . 4.0999999999999996 109.893 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -83.54 169.27 12.37 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.252 1.968 . . . . 2.6099999999999999 112.193 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -60.3 140.42 57.1 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.906 1.283 . . . . 3.8100000000000001 107.914 153.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.49 ' CD ' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -158.24 134.47 9.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.529 0.732 . . . . 5.9400000000000004 109.763 176.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.56 -27.27 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.692 0.758 . . . . 2.1600000000000001 110.445 -173.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.4 179.07 9.69 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 121.932 0.74 . . . . 2.1200000000000001 111.77 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -81.25 53.2 1.98 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.605 -0.939 . . . . 8.5500000000000007 109.266 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.6 m -143.47 147.34 34.39 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.299 -1.371 . . . . 1.8700000000000001 107.299 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.71 39.11 3.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.411 0.685 . . . . 5.7300000000000004 111.953 -171.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.09 141.56 15.66 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.501 -1.04 . . . . 1.55 110.501 174.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -82.05 74.93 9.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.743 -0.836 . . . . 1.73 108.743 -176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -102.0 88.55 1.31 Allowed Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.114 0.966 . . . . 1.0 109.059 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.34 119.88 6.99 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.57 1.514 . . . . 0.62 109.322 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -116.7 178.05 4.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.823 2.049 . . . . 4.1100000000000003 108.919 169.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -116.62 139.69 50.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.989 1.716 . . . . 0.47999999999999998 108.373 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -120.79 148.01 44.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.931 -1.507 . . . . 0.85999999999999999 106.931 165.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -67.47 105.44 1.82 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.546 -1.65 . . . . 1.4399999999999999 106.546 158.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.57 103.57 3.59 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.149 -1.426 . . . . 1.9399999999999999 107.149 168.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 t -76.91 -9.46 58.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.215 -0.898 . . . . 1.49 112.593 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.85 -48.85 34.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.522 -1.288 . . . . 4.1900000000000004 107.522 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.8 p -92.0 -13.72 30.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.904 0.882 . . . . 2.27 112.589 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.03 33.67 84.4 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.134 0.873 . . . . 0.98999999999999999 111.108 -174.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 133.69 55.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 125.049 1.34 . . . . 6.1399999999999997 109.844 -170.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.3 m -64.55 124.01 20.74 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.063 -1.088 . . . . 0.51000000000000001 108.063 158.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.8 m -142.71 141.83 21.26 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.724 1.61 . . . . 1.6000000000000001 107.36 -165.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.45 153.9 50.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.45 2.1 . . . . 0.56999999999999995 111.693 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -153.87 159.25 41.72 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.884 1.273 . . . . 0.68000000000000005 108.054 169.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.55 120.5 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 106.734 -1.58 . . . . 1.8600000000000001 106.734 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.0 -23.81 59.49 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.162 0.585 . . . . 2.7400000000000002 112.392 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.14 -49.73 4.17 Favored Glycine 0 CA--C 1.522 0.489 0 O-C-N 121.08 -1.013 . . . . 2.3300000000000001 110.749 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.68 -31.18 2.03 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.396 -0.669 . . . . 1.78 113.062 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.05 176.23 7.17 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.371 1.085 . . . . 2.8999999999999999 108.38 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.23 43.62 25.21 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.922 -1.271 . . . . 2.75 109.922 -172.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.85 147.47 48.43 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.091 -1.203 . . . . 2.71 110.091 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.49 ' ND2' ' CD ' ' A' ' 8' ' ' LYS . 51.8 p30 -153.65 -174.45 4.96 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 105.758 -1.942 . . . . 1.8600000000000001 105.758 170.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.79 -43.7 65.66 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.906 -1.278 . . . . 1.51 109.906 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -75.17 67.11 1.77 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.471 0.708 . . . . 1.72 111.705 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.05 60.69 0.46 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.726 0.81 . . . . 2.0600000000000001 110.061 -160.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -104.07 142.1 35.05 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 123.622 0.769 . . . . 1.1299999999999999 110.822 -161.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -63.6 -41.91 98.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.549 1.068 . . . . 2.6499999999999999 110.542 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.1 p -118.21 152.24 36.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.751 0.82 . . . . 1.55 112.571 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.23 -46.68 54.92 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.55 0.74 . . . . 1.7 109.578 160.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.56 -51.8 11.41 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.246 0.618 . . . . 3.2400000000000002 110.586 176.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -65.25 -54.68 25.74 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 110.078 -0.341 . . . . 2.3799999999999999 110.078 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 t -48.28 -48.02 35.92 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.293 0.568 . . . . 0.52000000000000002 111.47 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -57.46 -62.65 1.63 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.908 1.283 . . . . 4.1299999999999999 108.794 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.04 -46.23 43.9 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.873 0.869 . . . . 1.74 112.64 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mp -75.64 -57.46 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 118.061 0.392 . . . . 3.02 110.272 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 16.0 t -82.94 -58.18 2.98 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.782 0.719 . . . . 1.6299999999999999 111.257 -170.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -81.59 62.71 5.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.838 0.455 . . . . 5.5700000000000003 110.772 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.335 0 O-C-N 124.149 0.906 . . . . 6.54 109.438 166.759 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.1 t . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 107.421 -1.326 . . . . 4.5499999999999998 107.421 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -13.26 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 114.07 1.137 . . . . 3.7999999999999998 114.07 -165.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.2 m -96.89 -12.61 23.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.792 0.437 . . . . 1.49 111.466 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.22 -37.47 8.9 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.087 0.955 . . . . 2.1099999999999999 108.754 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -59.2 132.24 87.58 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.54 -1.652 . . . . 4.1100000000000003 106.54 172.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -99.44 175.68 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.597 2.198 . . . . 1.6399999999999999 111.398 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -48.95 140.88 8.33 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.673 1.702 . . . . 3.6400000000000001 112.693 153.442 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.86 -176.61 5.27 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 102.709 -3.071 . . . . 5.8799999999999999 102.709 165.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 t -120.89 -84.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.82 -1.548 . . . . 2.2200000000000002 106.82 158.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.2 170.6 15.6 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 107.185 -2.366 . . . . 2.7599999999999998 107.185 -173.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -80.38 60.58 3.85 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.287 -1.005 . . . . 7.29 108.287 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.5 m -151.68 157.13 41.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.053 -1.091 . . . . 3.0899999999999999 108.053 -161.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.14 81.13 1.84 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.175 0.99 . . . . 6.9199999999999999 108.659 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.86 131.67 6.55 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.61 -1.396 . . . . 1.73 109.61 169.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -83.12 74.35 10.0 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.766 0.827 . . . . 2.1699999999999999 109.398 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -102.83 87.31 1.17 Allowed Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 107.879 -1.156 . . . . 1.5800000000000001 107.879 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.7 120.93 8.32 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 N-CA-C 108.038 -1.562 . . . . 0.78000000000000003 108.038 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -128.91 177.28 7.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.2 1.4 . . . . 4.9900000000000002 107.774 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -112.63 156.52 22.58 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.276 1.83 . . . . 0.59999999999999998 107.946 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.445 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 6.3 p90 -148.26 152.09 36.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.924 -1.139 . . . . 1.3500000000000001 107.924 175.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -76.07 100.08 4.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.987 -1.857 . . . . 1.3600000000000001 105.987 169.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -72.3 109.68 6.2 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.638 -1.245 . . . . 2.48 107.638 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.6 t -87.21 6.76 31.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.593 -0.718 . . . . 1.8100000000000001 111.631 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.5 -45.63 10.31 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 105.987 -1.857 . . . . 4.5 105.987 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.9 p -94.25 -25.98 16.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.581 2.752 . . . . 2.4199999999999999 111.602 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.53 59.9 3.95 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.015 -1.234 . . . . 1.3100000000000001 110.015 -173.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.5 144.96 17.24 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.826 1.313 . . . . 4.8200000000000003 112.938 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.5 m -73.84 119.21 17.75 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.352 -0.842 . . . . 0.52000000000000002 108.75 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.3 m -141.93 147.54 45.23 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 117.956 -1.021 . . . . 1.6799999999999999 109.205 -161.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.38 145.22 21.02 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.333 2.689 . . . . 0.63 112.702 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -147.7 161.07 41.95 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.602 1.561 . . . . 0.95999999999999996 108.268 173.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.87 118.57 37.57 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 105.57 -2.011 . . . . 1.79 105.57 170.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -72.77 -41.43 65.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.73 0.412 . . . . 2.9700000000000002 111.52 -171.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.15 -15.33 61.59 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 118.37 0.532 . . . . 2.1600000000000001 112.206 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.87 -51.72 4.61 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.626 1.213 . . . . 1.6200000000000001 110.145 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -178.9 4.77 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.036 1.334 . . . . 2.9900000000000002 109.928 170.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.99 49.74 65.42 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.604 -0.598 . . . . 2.5099999999999998 111.604 164.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.61 148.91 44.28 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.584 -0.95 . . . . 2.54 112.6 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -143.62 178.99 7.41 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 104.782 -2.303 . . . . 1.3200000000000001 104.782 157.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.05 -25.66 68.46 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.253 -0.739 . . . . 1.0 111.253 -175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -72.91 65.84 0.75 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.138 1.375 . . . . 2.52 110.471 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -162.07 97.16 1.02 Allowed 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.873 -0.517 . . . . 2.3300000000000001 110.466 -169.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.46 140.75 52.66 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.415 1.486 . . . . 1.0 110.282 -165.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.68 -32.39 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.603 1.092 . . . . 2.8700000000000001 111.501 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.9 p -143.76 156.6 44.56 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.277 0.631 . . . . 1.4399999999999999 111.809 -169.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -45.08 64.71 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 108.869 -0.789 . . . . 1.5800000000000001 108.869 160.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -43.9 -53.44 6.1 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.476 0.31 . . . . 3.3799999999999999 110.757 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -63.66 -57.04 11.29 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 117.951 0.341 . . . . 2.5699999999999998 110.136 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.9 t -49.12 -42.1 38.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.086 0.469 . . . . 0.64000000000000001 111.963 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -66.82 -54.78 19.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.161 1.384 . . . . 4.0199999999999996 109.684 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.73 -40.94 30.4 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.932 0.493 . . . . 1.7 111.955 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.18 -63.78 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.003 0.521 . . . . 3.0800000000000001 110.961 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 70.9 m -97.29 -25.83 15.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.971 0.908 . . . . 2.1899999999999999 113.355 -166.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.99 118.42 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.31 2.644 . . . . 7.4299999999999997 108.955 -171.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 105.029 -2.211 . . . . 10.5 105.029 158.601 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 107.692 -1.225 . . . . 3.8700000000000001 107.692 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.2 pt -49.63 -34.02 8.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 118.422 0.556 . . . . 2.6400000000000001 110.451 169.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.0 m -51.05 -24.93 4.25 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.27 0.628 . . . . 1.7 112.685 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.59 -35.66 67.97 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.216 0.462 . . . . 1.78 110.336 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 110.02 3.58 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.206 1.003 . . . . 4.2699999999999996 111.873 -164.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.95 146.0 69.94 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 CA-C-N 120.912 1.361 . . . . 1.8600000000000001 110.83 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -34.05 133.67 0.21 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 128.589 2.755 . . . . 4.7800000000000002 112.62 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -138.73 149.01 44.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.162 2.585 . . . . 6.2999999999999998 108.118 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.5 t -117.82 -22.63 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.365 1.066 . . . . 2.1400000000000001 111.759 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.17 150.64 0.77 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-O 122.391 0.995 . . . . 2.1600000000000001 112.612 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.29 50.23 0.9 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.587 -0.949 . . . . 8.9900000000000002 111.721 -178.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.1 m -126.3 142.71 51.42 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.37 0.668 . . . . 2.0099999999999998 111.098 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 78.33 8.71 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.27 -1.011 . . . . 8.8499999999999996 108.27 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.97 -179.77 22.43 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.02 -1.232 . . . . 1.51 110.02 168.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -146.53 117.86 7.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.899 1.28 . . . . 1.6699999999999999 107.793 -176.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -145.1 119.03 5.55 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 106.847 -1.538 . . . . 1.0900000000000001 106.847 175.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.9 134.37 23.5 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.643 1.562 . . . . 1.3500000000000001 109.055 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.2 mmt-85 -140.82 176.26 8.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.506 1.122 . . . . 4.0300000000000002 108.519 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -125.28 136.97 54.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.068 1.747 . . . . 0.60999999999999999 107.634 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -118.93 150.97 39.01 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.338 -1.356 . . . . 1.1299999999999999 107.338 171.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.24 100.33 2.08 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.215 -2.142 . . . . 2.4300000000000002 105.215 161.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.39 104.02 3.63 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.844 -1.539 . . . . 2.0600000000000001 106.844 171.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 t -82.62 -0.14 45.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.394 -0.812 . . . . 1.47 112.564 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.98 -47.55 12.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.947 -1.501 . . . . 3.7000000000000002 106.947 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.5 p -79.48 -30.15 41.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.719 1.208 . . . . 1.99 111.167 170.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.23 29.78 44.17 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.83 1.205 . . . . 0.80000000000000004 111.309 -172.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -129.19 147.35 51.03 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 118.858 1.329 . . . . 5.46 110.131 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 57.8 m -69.86 135.09 49.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.152 -1.425 . . . . 0.73999999999999999 107.152 166.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 m -151.72 139.42 12.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.06 -1.089 . . . . 1.55 108.06 -169.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.17 159.1 53.12 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.842 2.361 . . . . 0.5 111.101 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -158.47 163.53 37.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.952 1.301 . . . . 0.84999999999999998 108.158 171.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.7 mm -93.11 115.35 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.545 -1.65 . . . . 2.5899999999999999 106.545 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.03 -19.34 61.21 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.789 0.836 . . . . 2.6099999999999999 111.678 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.47 -45.78 3.31 Favored Glycine 0 CA--C 1.525 0.681 0 O-C-N 121.303 -0.873 . . . . 2.4700000000000002 110.951 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.32 -24.43 3.38 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 124.074 0.845 . . . . 1.28 111.86 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -145.04 176.55 9.42 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.545 1.138 . . . . 2.25 109.426 -172.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 41.52 44.61 4.19 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.262 1.411 . . . . 3.3999999999999999 114.245 171.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.95 -133.66 7.31 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.602 -1.399 . . . . 2.4100000000000001 109.602 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -152.94 -168.51 3.06 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.337 1.855 . . . . 1.46 107.028 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.27 -12.07 65.94 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.928 0.775 . . . . 1.1499999999999999 113.035 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -79.15 63.76 3.88 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 118.5 1.15 . . . . 1.8999999999999999 107.913 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -159.44 87.91 0.84 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.818 -0.808 . . . . 2.98 108.818 -146.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -126.41 150.64 48.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.751 0.82 . . . . 0.78000000000000003 110.497 -159.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.86 -42.81 98.62 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.474 0.709 . . . . 2.6699999999999999 109.917 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.6 p -135.37 159.35 41.86 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.26 0.624 . . . . 1.5600000000000001 112.091 -170.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.01 -47.4 61.62 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.67 0.788 . . . . 2.0899999999999999 110.041 160.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -48.15 -49.96 30.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.485 0.314 . . . . 3.9300000000000002 110.179 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -67.67 -52.47 37.6 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 110.198 -0.297 . . . . 2.71 110.198 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.0 t -49.88 -46.28 51.52 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.387 0.675 . . . . 0.47999999999999998 111.207 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -59.52 -73.24 0.09 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.752 -1.203 . . . . 3.5899999999999999 107.752 172.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -42.3 -43.55 3.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.589 1.156 . . . . 2.1299999999999999 113.577 -172.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.26 -40.74 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 122.855 0.462 . . . . 2.48 111.875 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.0 t -100.53 -44.64 5.8 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.979 1.103 . . . . 1.6599999999999999 113.979 -170.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.32 149.48 28.71 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.803 1.641 . . . . 5.7999999999999998 108.368 -160.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.235 0 O-C-N 122.296 -0.252 . . . . 6.1799999999999997 110.449 173.265 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 117.809 -1.091 . . . . 4.0499999999999998 109.347 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.8 pt -43.89 -31.56 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.497 1.519 . . . . 3.4700000000000002 113.702 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 t -31.85 -45.3 0.1 Allowed 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.279 1.832 . . . . 2.4900000000000002 113.738 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.16 -21.0 61.51 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 125.32 1.638 . . . . 2.3900000000000001 111.723 -164.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -62.84 157.85 56.88 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.361 0.982 . . . . 3.2200000000000002 109.489 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -88.33 166.65 6.58 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.588 2.192 . . . . 1.3700000000000001 111.132 173.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -44.63 132.02 6.51 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.013 0.925 . . . . 3.2599999999999998 108.67 157.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.0 tttm -158.57 99.03 1.56 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 104.807 -2.294 . . . . 5.9800000000000004 104.807 -169.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.78 -43.04 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.521 0.728 . . . . 1.8799999999999999 111.809 -168.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.84 151.11 27.76 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.682 -1.367 . . . . 2.0 109.682 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -80.75 50.66 1.38 Allowed 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.967 -0.725 . . . . 6.4500000000000002 112.872 -166.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.47 142.01 39.43 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 107.578 -1.267 . . . . 1.6899999999999999 107.578 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -85.32 54.72 3.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.208 0.603 . . . . 6.54 109.617 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.53 173.15 25.74 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.618 -0.593 . . . . 1.6699999999999999 111.618 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -137.65 79.58 1.75 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.992 1.317 . . . . 1.4399999999999999 107.814 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -116.1 107.25 48.05 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 106.96 -1.496 . . . . 1.1599999999999999 106.96 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.21 133.99 40.37 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 CA-C-N 120.637 1.263 . . . . 0.78000000000000003 109.097 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -131.55 172.3 12.39 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.836 -1.172 . . . . 4.0300000000000002 107.836 170.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.06 144.67 36.77 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.682 1.593 . . . . 0.62 107.501 170.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.437 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 1.8 p90 -131.22 161.19 32.79 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.568 -0.901 . . . . 0.97999999999999998 108.568 169.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -73.16 105.39 4.57 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.64 -1.985 . . . . 1.8 105.64 156.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 6.4 t70 -73.45 118.52 16.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.895 -1.52 . . . . 2.29 106.895 169.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 t -86.26 -25.44 25.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.186 0.994 . . . . 2.1400000000000001 108.799 -174.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -61.94 -43.79 98.11 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 127.178 2.191 . . . . 4.2400000000000002 107.082 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.1 p -96.24 -36.57 10.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.825 2.05 . . . . 2.1200000000000001 110.759 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.64 48.82 4.83 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.208 1.385 . . . . 0.92000000000000004 110.506 -173.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.04 147.04 31.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 128.29 2.636 . . . . 4.8200000000000003 111.92 -172.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.9 m -69.75 123.14 20.64 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.802 -0.814 . . . . 0.64000000000000001 108.802 171.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.4 m -147.33 148.86 32.95 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 124.353 1.061 . . . . 1.7 108.457 -161.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.75 151.58 36.4 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.969 2.446 . . . . 0.5 112.148 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -149.91 163.2 38.69 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.537 1.535 . . . . 0.64000000000000001 107.743 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.56 120.24 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 107.958 -1.127 . . . . 2.0800000000000001 107.958 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -95.79 143.96 26.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.535 1.934 . . . . 2.2200000000000002 107.427 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.33 0.77 88.67 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.509 -0.606 . . . . 1.8999999999999999 113.068 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.94 6.16 77.82 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.796 1.298 . . . . 1.72 112.125 -172.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.98 -156.06 0.31 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.291 1.037 . . . . 3.4300000000000002 111.393 -174.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -38.81 -41.96 1.37 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.429 1.49 . . . . 3.79 114.173 169.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.95 -141.01 46.11 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.698 -1.361 . . . . 1.6299999999999999 109.698 -177.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -179.95 -160.53 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.786 2.034 . . . . 1.27 108.634 174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.62 -44.14 16.77 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 118.685 0.675 . . . . 1.0600000000000001 111.447 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -73.87 64.94 1.01 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.92 1.288 . . . . 3.0499999999999998 109.314 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -159.14 74.31 0.63 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.082 0.953 . . . . 2.0699999999999998 109.375 -168.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -103.34 153.59 20.28 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 124.049 0.939 . . . . 0.93000000000000005 110.371 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.25 -48.63 79.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.325 -0.62 . . . . 2.6600000000000001 109.325 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.1 p -130.87 161.06 32.67 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.243 0.831 . . . . 1.96 113.243 -164.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.45 -49.46 61.69 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.713 -0.847 . . . . 1.95 108.713 159.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -42.54 -51.88 4.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.427 0.558 . . . . 3.3199999999999998 110.504 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -61.31 -56.54 19.37 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.07 -0.49 . . . . 2.1499999999999999 111.044 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.9 t -52.75 -41.15 63.77 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.924 0.868 . . . . 0.93999999999999995 112.368 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -60.74 3.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.973 2.109 . . . . 3.6800000000000002 109.165 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.72 -44.29 93.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.77 0.828 . . . . 2.04 111.347 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.49 -40.75 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.259 1.023 . . . . 2.7599999999999998 110.991 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.9 t -144.49 -70.2 0.29 Allowed 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 112.551 0.574 . . . . 1.8799999999999999 112.551 -166.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.418 HH12 ' C ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -82.99 65.84 8.31 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.28 -1.378 . . . . 5.8499999999999996 107.28 -169.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.418 ' C ' HH12 ' A' ' 54' ' ' ARG . . . . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 117.619 -1.182 . . . . 4.8700000000000001 111.265 -177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 CA--C 1.504 -0.822 0 CA-C-O 118.026 -0.988 . . . . 5.6299999999999999 108.87 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp -31.75 -34.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 127.768 2.427 . . . . 3.8100000000000001 116.934 -147.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.9 m -72.55 -12.77 61.21 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.674 -0.641 . . . . 1.8600000000000001 111.835 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -52.5 10.75 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.192 -1.04 . . . . 2.48 108.192 165.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.14 108.08 1.46 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.347 1.459 . . . . 4.5300000000000002 111.544 -174.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.06 175.43 10.91 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 CA-C-N 120.698 1.285 . . . . 2.2400000000000002 112.031 -173.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -40.96 133.65 2.12 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 126.189 1.795 . . . . 3.8599999999999999 111.206 167.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -156.6 130.92 8.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.842 2.057 . . . . 5.9000000000000004 105.922 170.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.68 -52.37 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 N-CA-C 109.547 -0.538 . . . . 2.0299999999999998 109.547 -170.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.0 28.86 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.465 -1.854 . . . . 2.2000000000000002 108.465 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -94.59 14.38 21.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.007 0.523 . . . . 6.6299999999999999 111.128 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.0 m -145.36 160.07 42.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 105.877 -1.897 . . . . 2.1699999999999999 105.877 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -74.09 -73.11 0.24 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.918 0.326 . . . . 6.0800000000000001 110.273 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.51 -179.91 0.53 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.56 1.076 . . . . 1.8899999999999999 113.571 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -148.12 76.0 1.36 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.7 0.8 . . . . 2.23 109.73 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -114.64 100.36 53.09 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.851 -0.796 . . . . 1.28 108.851 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.59 118.5 5.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.49 1.46 . . . . 0.69999999999999996 109.771 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -125.19 -179.61 4.66 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 127.24 2.216 . . . . 4.1100000000000003 109.292 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -123.29 143.86 49.8 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.288 2.235 . . . . 0.54000000000000004 107.661 171.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -126.28 154.15 43.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.133 -1.432 . . . . 0.80000000000000004 107.133 170.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.14 104.45 5.72 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.726 -1.583 . . . . 1.51 106.726 160.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.03 117.01 17.3 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.118 1.367 . . . . 1.97 107.769 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 t -86.47 -20.79 27.59 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 122.191 -0.318 . . . . 1.3799999999999999 110.37 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -65.56 -46.4 79.62 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 126.859 2.064 . . . . 4.1600000000000001 106.75 -173.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.4 p -88.71 -29.85 19.54 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.374 1.869 . . . . 1.9099999999999999 110.413 170.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.73 54.45 7.36 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.348 -1.501 . . . . 0.84999999999999998 109.348 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -146.1 157.21 43.84 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 126.813 2.045 . . . . 5.6699999999999999 108.129 -172.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 95.7 m -80.48 142.43 34.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.321 -1.362 . . . . 0.72999999999999998 107.321 161.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.9 m -154.32 141.39 13.42 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.327 -0.99 . . . . 1.55 108.327 -169.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.76 154.83 59.01 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.954 2.436 . . . . 0.44 111.177 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -158.03 160.89 37.93 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.083 0.953 . . . . 0.58999999999999997 109.179 172.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -89.65 115.01 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 107.309 -1.367 . . . . 1.8899999999999999 107.309 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -85.37 149.77 25.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.612 1.565 . . . . 2.27 107.581 167.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.81 13.64 34.91 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.601 1.096 . . . . 1.8600000000000001 113.273 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.4 -52.29 4.71 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.891 1.234 . . . . 1.6599999999999999 110.237 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.42 122.37 40.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.093 0.949 . . . . 2.6299999999999999 111.268 -165.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.94 -66.25 3.8 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.613 1.101 . . . . 2.73 110.836 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 36.58 -118.38 0.47 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.03 1.3 . . . . 2.29 112.366 -172.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -172.46 179.9 2.38 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 127.984 2.513 . . . . 1.3200000000000001 107.272 165.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.09 -32.24 72.78 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 112.176 -0.37 . . . . 1.3200000000000001 112.176 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -75.45 70.56 2.33 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.889 0.875 . . . . 1.6799999999999999 109.831 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -158.62 78.61 0.79 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.897 1.279 . . . . 2.2200000000000002 108.069 -157.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -115.71 144.45 43.93 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.316 1.446 . . . . 0.93000000000000005 110.433 -162.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.89 -38.3 90.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.294 0.952 . . . . 3.1699999999999999 111.579 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -133.49 161.69 33.9 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.277 0.631 . . . . 1.51 111.987 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 tp -51.8 -49.69 62.24 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.638 -0.875 . . . . 2.3300000000000001 108.638 159.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -45.93 -48.58 16.24 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.183 0.901 . . . . 3.6800000000000002 110.38 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -66.03 -54.42 26.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.375 -0.232 . . . . 2.6899999999999999 110.375 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.3 t -53.62 -48.41 69.34 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.437 0.637 . . . . 0.5 111.895 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -54.19 -55.18 30.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.876 2.47 . . . . 3.3599999999999999 110.055 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.23 -43.46 78.64 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.666 0.386 . . . . 1.6499999999999999 110.957 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.4 mm -68.25 -45.13 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 118.916 -0.564 . . . . 2.8799999999999999 111.126 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.7 m -128.76 -97.33 0.38 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.833 0.742 . . . . 2.5099999999999998 110.991 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.89 155.29 6.78 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.843 0.747 . . . . 6.9699999999999998 111.608 -163.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.304 0 C-N-CA 127.647 2.379 . . . . 10.66 113.57 169.074 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 117.826 -1.083 . . . . 4.0499999999999998 109.357 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 pt -52.06 -41.31 31.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-N 118.967 0.803 . . . . 2.9300000000000002 110.8 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.9 m -57.71 -18.35 20.42 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.536 0.734 . . . . 1.9299999999999999 112.617 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.01 -25.23 32.4 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.256 0.935 . . . . 1.5800000000000001 110.792 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -64.41 144.36 98.53 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 118.787 0.721 . . . . 4.5899999999999999 110.699 -174.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.81 -173.63 1.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.038 2.492 . . . . 1.47 110.702 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -77.83 141.73 38.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.08 1.352 . . . . 4.2800000000000002 111.411 161.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HD2' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -159.16 139.9 12.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.116 -2.55 . . . . 5.9100000000000001 104.116 -176.666 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.7 t -63.15 -44.89 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 120.144 1.338 . . . . 2.4399999999999999 109.506 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.52 144.69 15.74 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.823 -1.711 . . . . 2.4399999999999999 108.823 -171.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -80.66 59.32 3.57 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.13 -0.629 . . . . 6.5499999999999998 112.682 -165.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.4 m -143.35 144.03 31.91 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 108.837 -0.801 . . . . 2.3700000000000001 108.837 167.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -90.08 72.04 7.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.682 0.793 . . . . 5.7400000000000002 109.457 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.07 -174.96 13.79 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.636 -0.985 . . . . 1.27 110.636 172.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -142.05 93.89 2.6 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.323 1.449 . . . . 1.48 107.354 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -124.75 105.74 29.73 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 108.486 -0.931 . . . . 1.1499999999999999 108.486 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.4 100.18 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.572 1.514 . . . . 1.22 109.477 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.6 mmt85 -106.81 179.84 4.15 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.512 1.525 . . . . 4.5899999999999999 108.345 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -119.53 145.09 46.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.253 1.421 . . . . 0.5 108.333 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -124.02 150.42 44.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.144 -1.428 . . . . 0.93000000000000005 107.144 167.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -75.56 102.0 5.11 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.307 -1.738 . . . . 1.9299999999999999 106.307 162.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.44 104.95 4.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.619 -1.252 . . . . 2.21 107.619 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.2 t -84.0 -1.63 55.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.048 -0.977 . . . . 1.8400000000000001 112.824 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.29 -48.12 10.77 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.936 -1.505 . . . . 5.25 106.936 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 64.7 p -82.32 -32.14 29.58 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.431 1.092 . . . . 2.1299999999999999 110.603 175.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.92 4.84 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.008 -1.237 . . . . 0.95999999999999996 110.008 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.51 135.61 22.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.904 0.882 . . . . 6.8099999999999996 111.809 -169.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.3 m -69.5 126.45 29.79 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.215 -1.402 . . . . 0.45000000000000001 107.215 163.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.2 m -147.68 138.41 12.99 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.321 -0.992 . . . . 1.6200000000000001 108.321 -163.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 157.47 57.66 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.516 2.144 . . . . 0.38 111.015 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -158.17 155.65 29.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.343 1.057 . . . . 0.78000000000000003 109.401 170.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.4 mm -84.51 109.2 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.871 -1.159 . . . . 2.3500000000000001 107.871 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -87.12 146.15 26.16 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.693 1.197 . . . . 2.2999999999999998 109.616 174.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.08 -28.78 53.2 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.585 1.564 . . . . 1.8100000000000001 112.488 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.59 -40.89 1.71 Allowed Glycine 0 C--N 1.339 0.706 0 CA-C-N 117.738 0.769 . . . . 1.9099999999999999 111.294 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -154.29 165.2 37.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.6 -0.889 . . . . 3.9199999999999999 108.6 -174.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.24 49.14 81.75 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.962 0.791 . . . . 2.98 111.9 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.0 -121.37 4.16 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.115 -1.194 . . . . 2.4700000000000002 110.115 174.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.468 ' ND2' ' HD2' ' A' ' 8' ' ' LYS . 29.4 p30 -157.03 -179.73 8.49 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.965 1.306 . . . . 1.27 107.559 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.58 -21.67 74.73 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.347 -0.696 . . . . 1.1100000000000001 113.821 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -78.26 70.65 4.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.092 1.446 . . . . 1.53 108.065 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -158.84 85.35 0.82 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.017 1.727 . . . . 3.4399999999999999 108.046 -169.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -114.29 147.15 39.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.502 1.121 . . . . 0.93999999999999995 109.587 -164.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.14 -39.2 93.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.937 0.399 . . . . 2.6200000000000001 110.475 -174.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.6 p -141.33 163.04 34.02 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.689 0.795 . . . . 1.6200000000000001 110.735 -169.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.61 -45.97 66.82 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 109.402 -0.592 . . . . 1.8 109.402 162.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -47.56 -51.11 22.06 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.973 0.352 . . . . 3.3399999999999999 110.509 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -69.56 -49.4 54.6 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.264 -0.273 . . . . 2.21 110.264 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 t -50.66 -44.02 57.51 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.381 0.61 . . . . 0.55000000000000004 111.143 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -62.94 -58.39 7.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.46 1.104 . . . . 4.9199999999999999 109.603 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.11 -41.38 17.2 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.782 0.676 . . . . 2.1200000000000001 111.429 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.03 -53.3 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.767 0.427 . . . . 2.77 112.028 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 78.7 m -110.61 -21.63 12.02 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.392 1.256 . . . . 2.8399999999999999 114.392 -163.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -117.44 62.5 0.74 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.893 1.677 . . . . 6.4500000000000002 110.432 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 105.18 -2.155 . . . . 6.8899999999999997 105.18 173.277 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 117.577 -1.202 . . . . 3.96 108.855 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.8 pt -47.07 -31.4 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 124.086 0.866 . . . . 2.6099999999999999 111.905 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.5 m -49.87 -26.29 3.93 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.493 1.117 . . . . 1.8 112.743 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.27 -26.51 62.02 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.289 0.495 . . . . 1.8100000000000001 110.433 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -61.06 137.87 94.14 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 108.597 -0.89 . . . . 3.52 108.597 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.16 170.2 20.52 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.864 1.709 . . . . 1.54 111.769 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -51.76 140.69 18.6 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.164 0.983 . . . . 3.3700000000000001 110.697 156.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 132.54 8.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 113.756 -1.565 . . . . 6.4500000000000002 106.943 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -67.48 -39.95 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.479 -0.934 . . . . 2.0800000000000001 108.479 172.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.48 33.38 8.63 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.836 0.732 . . . . 3.2400000000000002 111.655 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 48.71 60.55 3.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.254 1.821 . . . . 9.1099999999999994 113.391 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -153.89 152.15 30.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.774 -0.825 . . . . 1.98 108.774 168.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -82.82 70.36 9.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.853 -1.166 . . . . 5.5 107.853 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.23 149.85 16.97 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 109.39 -1.484 . . . . 1.4299999999999999 109.39 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -120.14 72.6 0.94 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.923 -1.51 . . . . 1.3400000000000001 106.923 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -102.73 96.01 7.05 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 107.092 -1.447 . . . . 0.93999999999999995 107.092 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -60.97 127.15 21.45 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 N-CA-C 108.879 -1.239 . . . . 0.64000000000000001 108.879 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -135.49 179.98 6.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.71 1.604 . . . . 3.3900000000000001 107.642 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -119.8 149.17 42.48 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.101 1.76 . . . . 0.63 107.949 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.475 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 2.2 p90 -134.03 157.26 46.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.866 -1.902 . . . . 0.88 105.866 170.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -71.34 105.89 3.67 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.377 -1.712 . . . . 1.3899999999999999 106.377 159.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.475 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 7.5 t0 -71.65 115.31 10.69 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.855 -1.535 . . . . 2.25 106.855 172.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 t -94.46 -9.25 36.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 123.8 0.688 . . . . 1.6200000000000001 109.674 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.45 -43.68 72.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.451 -2.055 . . . . 4.2999999999999998 105.451 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.8 p -98.89 -40.08 8.27 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.564 2.346 . . . . 1.6899999999999999 112.846 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 60.9 1.26 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.94 -1.264 . . . . 1.05 109.94 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -157.63 138.36 13.1 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 124.16 0.984 . . . . 6.0099999999999998 109.556 -163.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.6 m -72.85 122.38 21.5 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 120.617 -1.302 . . . . 0.56000000000000005 107.594 165.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.4 m -143.06 145.34 32.51 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 108.507 -0.923 . . . . 1.5700000000000001 108.507 -162.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.51 153.21 65.64 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.789 2.326 . . . . 0.51000000000000001 111.188 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -155.76 163.21 40.14 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.195 -1.409 . . . . 1.1299999999999999 107.195 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.11 126.47 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 N-CA-C 108.01 -1.107 . . . . 2.0 108.01 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -105.91 148.66 27.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.515 1.126 . . . . 2.2999999999999998 108.384 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.83 -9.57 62.42 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.711 1.148 . . . . 1.8300000000000001 113.028 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 14.05 80.65 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.155 0.977 . . . . 1.6399999999999999 112.395 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.5 m -145.96 178.48 8.16 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 107.016 -1.476 . . . . 2.4399999999999999 107.016 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.64 -69.17 2.1 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.383 1.944 . . . . 3.0699999999999998 110.674 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.67 -163.98 3.52 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.326 1.917 . . . . 1.98 113.578 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.5 p30 170.46 -160.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.256 3.822 . . . . 1.9099999999999999 104.759 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.38 -44.52 7.93 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.76 1.164 . . . . 1.24 110.287 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -74.88 78.26 2.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.105 0.955 . . . . 1.5600000000000001 112.134 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -156.55 115.38 3.39 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.763 1.625 . . . . 2.23 108.002 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -133.95 155.65 49.56 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 124.762 1.225 . . . . 0.77000000000000002 108.73 -168.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -80.2 -31.22 38.75 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.463 -0.773 . . . . 2.9700000000000002 111.633 -174.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.1 p -145.73 165.01 30.03 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.761 0.824 . . . . 1.9099999999999999 110.08 -173.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.57 -46.55 70.32 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 109.558 -0.534 . . . . 1.9099999999999999 109.558 163.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -47.03 -52.19 15.53 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 110.039 -0.356 . . . . 3.4500000000000002 110.039 175.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 tp-100 -66.94 -51.73 51.72 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.283 -0.265 . . . . 4.0700000000000003 110.283 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -51.84 -48.59 63.89 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 122.911 0.484 . . . . 0.58999999999999997 110.882 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.4 -58.13 9.82 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.943 0.897 . . . . 3.2200000000000002 109.273 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.19 -41.64 62.82 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.514 0.725 . . . . 1.76 111.763 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.3 mm -70.43 -51.66 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.39 0.276 . . . . 2.3999999999999999 110.522 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.7 t -81.86 -44.53 16.74 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.044 0.757 . . . . 1.49 113.044 -164.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.4 mtp85 -134.01 -159.76 0.99 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.893 2.077 . . . . 6.1900000000000004 110.85 -169.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 104.57 -2.382 . . . . 5.7199999999999998 104.57 117.858 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.3 pt . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 112.295 0.479 . . . . 1.92 112.295 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 89.0 m -34.55 -42.58 0.15 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.827 1.251 . . . . 1.57 111.441 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.95 -17.39 62.08 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.909 1.077 . . . . 1.4 113.909 -170.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -73.39 143.29 82.59 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 119.889 1.222 . . . . 3.03 110.819 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.22 -179.18 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.215 2.61 . . . . 1.32 109.936 166.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.51 134.64 55.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.663 0.744 . . . . 2.61 110.591 170.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -139.34 128.25 23.55 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.461 1.904 . . . . 5.66 106.076 170.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.6 t -75.45 -85.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.122 -1.436 . . . . 1.8 107.122 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.96 179.24 30.0 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 107.861 -2.096 . . . . 1.85 107.861 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -72.1 -48.73 41.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.725 -1.213 . . . . 5.66 107.725 174.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.1 m -71.08 150.31 45.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.105 -1.072 . . . . 2.16 108.105 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.45 20.21 13.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.703 0.801 . . . . 7.07 110.363 -170.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.25 147.9 50.91 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.9 -0.88 . . . . 1.64 110.9 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -81.7 73.3 8.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.728 0.775 . . . . 1.51 108.912 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -99.35 93.13 2.05 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 106.895 -1.52 . . . . 0.98 106.895 166.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.6 125.19 13.93 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 N-CA-C 108.064 -1.552 . . . . 0.55 108.064 171.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -132.78 176.47 8.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.345 1.458 . . . . 3.7 107.279 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -118.25 139.37 51.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.847 1.659 . . . . 0.68 108.394 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -118.26 148.89 41.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.903 -1.888 . . . . 0.84 105.903 168.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -70.78 100.02 1.82 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.47 -2.419 . . . . 1.19 104.47 160.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -71.88 77.96 0.89 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 105.602 -1.999 . . . . 2.37 105.602 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.0 t -61.71 -18.87 61.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.419 1.088 . . . . 1.29 110.342 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -62.06 -44.37 96.82 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 105.459 -2.052 . . . . 4.39 105.459 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.7 p -94.58 -24.55 17.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.52 1.528 . . . . 1.07 114.04 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.43 19.37 64.38 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.766 1.174 . . . . 0.81 112.418 -165.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HB2' ' HZ2' ' A' ' 27' ' ' LYS . 8.2 mtmp? -103.4 163.28 12.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.644 1.178 . . . . 5.63 109.99 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.5 m -90.28 138.95 31.12 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 105.55 -2.018 . . . . 0.68 105.55 148.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.1 m -156.13 145.73 15.39 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 118.377 -0.82 . . . . 0.81 109.212 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.33 153.27 61.49 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.074 2.516 . . . . 0.46 112.11 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -154.68 166.1 34.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.543 1.937 . . . . 0.42 105.93 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.99 127.76 50.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 106.67 -1.604 . . . . 0.74 106.67 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -85.93 -77.42 0.3 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.177 0.991 . . . . 2.55 110.957 -172.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.67 98.17 0.51 Allowed Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.861 -1.296 . . . . 3.11 109.861 -168.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -32.41 -63.45 0.28 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 127.219 2.343 . . . . 2.17 114.071 -171.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.254 0.8 OUTLIER -74.47 121.66 21.83 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.534 0.938 . . . . 2.85 113.534 -176.402 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.48 18.97 26.66 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.043 1.783 . . . . 2.5 113.357 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.24 162.93 39.35 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.309 1.055 . . . . 1.67 113.691 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -118.79 -169.25 1.69 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.111 1.365 . . . . 1.47 110.513 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.44 -44.1 6.68 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.446 -1.062 . . . . 0.86 110.446 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -72.75 73.95 1.1 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.432 0.634 . . . . 1.61 110.549 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -159.33 96.37 1.29 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.833 1.253 . . . . 1.94 108.555 -166.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -125.19 141.4 52.12 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 124.821 1.248 . . . . 0.72 111.343 -165.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -55.47 -34.6 64.67 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.511 0.724 . . . . 3.1 111.547 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.7 p -141.12 160.05 40.92 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.794 0.838 . . . . 0.55 112.061 -169.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -51.37 -48.12 62.63 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-O 117.941 -1.028 . . . . 0.6 108.839 158.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -39.41 -56.5 1.58 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.063 0.847 . . . . 2.07 110.766 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -70.11 -50.28 42.35 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 121.164 -0.214 . . . . 4.51 110.812 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.8 t -52.9 -32.78 47.13 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 122.064 0.935 . . . . 0.94 112.143 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -73.83 -72.68 0.26 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 124.677 1.191 . . . . 4.01 107.952 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -41.76 -45.15 3.46 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.798 1.639 . . . . 0.58 112.439 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.8 mm -73.18 -33.5 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 119.344 -0.36 . . . . 1.68 111.852 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 113.33 0.863 . . . . 1.31 113.33 -171.713 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.634 HD12 ' N ' ' A' ' 3' ' ' CYS . 2.2 pp . . . . . 0 C--O 1.224 -0.25 0 N-CA-C 112.938 0.718 . . . . 2.34 112.938 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.634 ' N ' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -50.65 -32.44 19.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.31 1.044 . . . . 1.78 111.955 177.852 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -30.31 64.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.058 0.543 . . . . 1.8 112.409 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -77.14 131.04 73.42 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.599 -0.889 . . . . 4.1 108.599 -170.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.81 -176.48 3.06 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.071 1.847 . . . . 1.44 113.602 -164.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 20' ' ' TYR . 3.2 ttpm? -61.61 153.29 28.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.245 1.018 . . . . 2.74 109.301 157.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.501 ' CD ' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -155.95 173.83 16.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.918 -2.253 . . . . 5.73 104.918 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.0 -87.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 106.236 -1.764 . . . . 1.46 106.236 160.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.93 -171.01 43.21 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.84 -1.704 . . . . 1.88 108.84 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -120.24 24.81 10.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.292 1.037 . . . . 6.89 110.62 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.3 m -138.83 159.73 41.43 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.55 -1.648 . . . . 2.28 106.55 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -79.75 55.97 2.17 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.883 0.473 . . . . 4.62 110.594 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.8 159.57 29.3 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.331 -0.707 . . . . 1.47 111.331 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -140.41 73.05 1.41 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.781 -1.563 . . . . 1.94 106.781 171.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.89 97.03 22.25 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 108.632 -0.877 . . . . 0.82 108.632 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.0 118.27 5.12 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 120.462 1.201 . . . . 0.96 109.153 172.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -120.88 179.3 4.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 127.571 2.349 . . . . 3.86 108.429 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -117.83 148.39 42.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.584 2.354 . . . . 0.99 107.729 167.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 7' ' ' LYS . 2.3 p90 -134.32 156.02 49.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.498 -1.667 . . . . 1.27 106.498 166.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -66.77 112.28 4.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.558 -1.645 . . . . 1.51 106.558 159.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -93.08 122.3 35.31 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 123.898 0.749 . . . . 1.76 110.49 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -89.2 -5.25 57.84 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 117.82 -1.086 . . . . 1.83 111.938 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -71.19 -48.86 49.06 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.624 -1.621 . . . . 4.69 106.624 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.8 p -88.16 -30.81 19.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.695 1.198 . . . . 1.69 112.73 174.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.33 26.75 29.7 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.1 0.857 . . . . 0.99 111.952 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -142.49 154.32 44.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.189 1.396 . . . . 4.76 110.819 -167.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.7 m -68.99 121.27 16.29 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 108.224 -1.028 . . . . 0.64 108.224 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.2 m -144.65 145.07 26.93 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 123.512 0.725 . . . . 0.73 109.183 -160.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.48 154.44 68.83 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.913 2.409 . . . . 0.73 111.723 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -155.66 158.07 37.7 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.652 -1.24 . . . . 0.68 107.652 166.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -94.92 118.33 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 N-CA-C 107.48 -1.304 . . . . 1.36 107.48 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -91.49 145.17 24.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.881 1.272 . . . . 2.09 109.82 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.26 22.61 37.69 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.786 1.184 . . . . 1.6 112.734 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.92 -46.34 3.64 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.629 1.214 . . . . 1.41 111.99 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.0 155.45 49.96 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.564 1.146 . . . . 2.14 110.325 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.07 47.79 35.97 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.285 -0.726 . . . . 2.78 111.285 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.96 -153.42 29.31 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.736 0.684 . . . . 1.36 111.907 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.501 ' ND2' ' CD ' ' A' ' 8' ' ' LYS . 17.5 p30 -149.36 -171.52 3.91 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.93 -1.878 . . . . 1.84 105.93 165.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.51 -35.01 85.94 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.907 0.776 . . . . 0.66 112.175 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -76.65 70.76 3.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.572 1.149 . . . . 1.82 109.731 -176.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.92 63.48 0.65 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.071 -0.714 . . . . 2.1 109.071 -161.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -104.41 146.89 28.2 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.722 1.209 . . . . 0.82 109.519 -162.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -64.54 -40.01 94.82 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.873 1.669 . . . . 2.83 110.58 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -126.03 153.73 43.99 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.998 1.111 . . . . 0.48 113.998 -167.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.85 -47.22 42.84 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.557 1.143 . . . . 0.54 110.273 159.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -44.16 -53.77 6.2 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.416 0.686 . . . . 2.08 110.408 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -64.92 -52.37 56.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 119.534 -0.269 . . . . 2.45 110.44 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.0 t -48.25 -52.68 20.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.533 0.682 . . . . 0.71 111.436 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.9 ttm-85 -57.0 -62.05 2.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.726 1.211 . . . . 2.79 109.927 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.97 -38.06 64.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.513 0.725 . . . . 0.72 111.993 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.4 mt -75.41 -53.53 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 122.91 0.484 . . . . 1.52 110.75 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.9 t . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 113.584 0.957 . . . . 1.57 113.584 -171.157 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 112.157 0.429 . . . . 1.89 112.157 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.02 -13.32 1.86 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.89 1.676 . . . . 2.34 114.324 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.03 -33.97 70.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.198 -1.038 . . . . 2.67 108.198 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -77.98 137.98 61.41 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.44 -0.948 . . . . 3.51 108.44 167.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -80.13 -179.68 5.46 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.064 1.842 . . . . 1.46 110.072 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -39.87 139.13 0.68 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 115.496 1.665 . . . . 3.11 115.496 149.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -157.36 151.53 24.77 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 129.128 2.971 . . . . 4.96 104.853 168.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.3 t -136.7 -60.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.09 0.471 . . . . 2.09 111.961 -160.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.67 65.96 3.09 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 114.679 0.632 . . . . 3.62 114.679 -155.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.78 -18.51 5.57 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.49 0.716 . . . . 6.52 112.245 164.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.5 m -130.88 160.81 33.35 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 106.845 -1.539 . . . . 1.91 106.845 161.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -120.69 52.94 1.14 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.503 1.121 . . . . 4.99 109.727 -170.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.16 139.61 15.49 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.316 -1.113 . . . . 1.76 110.316 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -82.64 74.48 9.6 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.078 -0.712 . . . . 1.16 109.078 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -101.7 92.44 2.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 118.204 -0.903 . . . . 1.03 109.998 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.21 111.36 2.24 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.977 1.784 . . . . 0.73 109.586 174.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HG3' HD21 ' A' ' 42' ' ' ASN . 9.0 mmt85 -120.66 -179.08 3.88 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.897 1.679 . . . . 3.19 108.891 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -120.0 146.48 45.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.735 1.614 . . . . 0.4 108.538 172.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 6.0 p90 -127.76 152.22 48.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.451 -1.315 . . . . 0.7 107.451 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -68.04 101.9 1.21 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.071 -1.825 . . . . 1.32 106.071 158.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -73.44 138.06 44.95 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.412 -0.588 . . . . 2.22 109.412 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.7 t -108.2 -8.37 15.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.692 1.197 . . . . 1.64 111.068 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.64 -50.25 45.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.363 -1.347 . . . . 4.22 107.363 168.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.9 p -89.14 -28.23 20.19 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.798 0.839 . . . . 1.27 112.231 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.06 39.7 18.97 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.317 -0.713 . . . . 0.9 111.352 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -148.69 148.09 29.64 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.614 1.207 . . . . 4.26 110.414 -166.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.8 m -68.7 118.4 11.64 Favored 'General case' 0 CA--C 1.526 0.049 0 N-CA-C 108.572 -0.899 . . . . 0.52 108.572 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.2 m -136.71 142.02 37.43 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 124.928 1.291 . . . . 0.56 108.718 -164.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.52 154.45 50.15 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.016 2.478 . . . . 0.45 111.453 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -159.64 158.24 31.16 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.577 1.151 . . . . 0.76 109.176 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.1 mm -86.3 119.87 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 106.64 -1.615 . . . . 1.18 106.64 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -80.09 -19.78 46.64 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.018 0.747 . . . . 3.42 113.018 -168.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.29 -46.46 3.41 Favored Glycine 0 CA--C 1.527 0.821 0 O-C-N 120.979 -1.076 . . . . 1.15 110.45 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.8 -30.94 3.85 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.21 0.909 . . . . 1.79 112.953 165.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.69 159.42 39.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.736 0.814 . . . . 2.47 111.607 -169.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.0 5.03 51.32 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.192 0.901 . . . . 3.15 112.414 -166.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.17 -149.71 3.5 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.395 0.998 . . . . 1.83 110.943 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -151.56 -176.24 5.52 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.709 1.204 . . . . 1.28 108.629 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.38 -5.14 90.22 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.549 -1.14 . . . . 1.1 113.152 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -78.15 65.58 3.56 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.961 1.88 . . . . 1.59 107.073 170.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.425 HD21 ' HG3' ' A' ' 18' ' ' ARG . 20.6 t-20 -159.0 112.68 2.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.929 -1.137 . . . . 2.44 107.929 -165.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -136.24 148.5 48.08 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.549 1.14 . . . . 0.71 108.206 -165.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.46 -38.59 84.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.337 0.517 . . . . 2.6 109.779 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.5 p -135.66 160.14 39.43 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.873 0.869 . . . . 0.7 111.707 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.66 -46.81 58.73 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 123.393 0.677 . . . . 0.62 109.803 161.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -49.32 -49.59 43.29 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.099 -0.334 . . . . 2.6 110.099 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -67.22 -50.61 60.11 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.024 -0.362 . . . . 1.91 110.024 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.8 t -50.63 -46.15 58.08 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.507 0.67 . . . . 0.61 111.184 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -59.15 -59.8 4.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.806 1.242 . . . . 2.75 109.727 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.54 -41.93 54.52 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.359 0.664 . . . . 0.66 111.824 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.92 -50.39 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 122.962 0.505 . . . . 1.48 111.236 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 114.783 1.401 . . . . 2.0 114.783 -156.699 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.222 -0.36 0 CA-C-O 120.835 0.35 . . . . 2.05 111.234 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 66.4 m -45.13 -32.95 1.99 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.488 1.515 . . . . 1.34 112.093 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.55 7.14 47.25 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.617 0.599 . . . . 2.69 112.617 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.16 127.5 92.03 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.56 1.073 . . . . 3.29 109.165 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.11 145.61 49.83 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.797 2.331 . . . . 2.08 107.337 170.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -76.07 132.58 40.18 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 117.932 -1.507 . . . . 8.43 112.087 -164.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.86 148.1 39.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.789 2.036 . . . . 5.56 107.251 168.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -80.87 -87.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.746 -1.575 . . . . 2.22 106.746 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.57 55.09 0.03 OUTLIER Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.357 0.503 . . . . 3.48 112.657 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.25 47.55 0.69 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.63 1.972 . . . . 5.29 113.679 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.8 m -96.53 164.25 12.69 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.237 0.615 . . . . 3.72 111.343 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -140.33 58.86 1.57 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.425 -1.324 . . . . 6.7 107.425 170.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.49 171.97 31.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 108.35 -1.9 . . . . 1.24 108.35 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -125.71 102.36 7.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.78 1.232 . . . . 1.21 108.43 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -131.9 105.15 13.96 Favored Pre-proline 0 C--O 1.233 0.207 0 N-CA-C 106.364 -1.717 . . . . 1.25 106.364 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.67 132.04 21.1 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.92 1.747 . . . . 0.64 108.773 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -136.97 178.91 6.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.678 1.591 . . . . 3.53 107.356 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -122.27 145.46 48.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.508 1.523 . . . . 0.48 109.3 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -130.97 150.56 52.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.063 -1.088 . . . . 0.89 108.063 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -72.34 101.42 2.88 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 166.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.79 109.57 6.48 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.541 -1.281 . . . . 2.04 107.541 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -85.62 -7.07 59.05 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.017 0.927 . . . . 1.39 111.971 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -71.01 -55.64 7.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.828 -1.545 . . . . 7.4 106.828 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 p -85.37 -19.03 32.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.774 -1.103 . . . . 1.21 111.986 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.22 41.47 69.05 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.129 -1.188 . . . . 1.15 110.129 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.08 131.81 45.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.072 0.949 . . . . 5.35 109.893 -170.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.535 ' HB2' HD13 ' A' ' 46' ' ' LEU . 56.0 m -67.44 113.01 4.96 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.041 -1.466 . . . . 0.68 107.041 159.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.2 m -126.93 137.25 30.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 126.767 2.027 . . . . 0.73 107.825 -165.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.55 156.21 58.26 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.633 2.222 . . . . 0.42 111.022 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -161.63 165.8 27.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.47 1.508 . . . . 0.62 107.588 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.28 118.72 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 107.62 -1.252 . . . . 0.83 107.62 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -77.45 -42.68 35.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.67 0.788 . . . . 2.35 110.834 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.7 -16.92 43.15 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.978 -0.901 . . . . 1.75 112.895 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.75 25.17 21.24 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 118.171 0.986 . . . . 1.9 113.24 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.86 159.98 9.97 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.323 1.062 . . . . 2.94 109.939 -171.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.85 32.9 59.48 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.221 1.391 . . . . 2.31 114.575 169.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.43 -163.28 9.76 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 122.263 0.924 . . . . 1.36 115.276 -168.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -156.7 -179.75 8.49 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 127.686 2.394 . . . . 1.38 106.377 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.99 -40.03 95.09 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 118.237 0.472 . . . . 0.79 113.411 -169.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -77.34 57.57 1.52 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.466 1.106 . . . . 1.73 111.25 -167.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.75 76.75 1.02 Allowed 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.251 -0.905 . . . . 2.42 110.725 -148.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -122.04 145.24 48.34 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.11 1.364 . . . . 0.84 111.802 -152.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -57.12 -39.06 74.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.487 1.115 . . . . 2.77 111.533 -173.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -144.94 161.15 40.06 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.139 0.576 . . . . 0.64 110.109 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.535 HD13 ' HB2' ' A' ' 28' ' ' CYS . 1.2 tp -52.12 -48.46 64.82 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 118.514 -0.755 . . . . 0.63 109.012 164.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -43.63 -53.9 5.38 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.477 -0.564 . . . . 2.52 109.477 176.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -69.72 -46.51 65.8 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.835 -0.432 . . . . 1.97 109.835 -171.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.4 t -51.97 -49.35 63.39 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 121.078 0.466 . . . . 0.59 110.726 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -60.98 -61.19 2.76 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.223 -1.028 . . . . 5.28 108.223 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -43.8 -48.44 8.18 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.473 1.509 . . . . 0.61 111.55 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -67.4 -50.85 58.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.655 0.382 . . . . 1.67 111.048 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 32.1 m . . . . . 0 CA--C 1.529 0.139 0 O-C-N 122.071 -0.393 . . . . 2.27 112.054 -172.112 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.2 pt . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 113.321 0.86 . . . . 1.86 113.321 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.6 m -56.38 -41.3 76.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.643 -0.661 . . . . 1.48 110.172 160.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.4 -27.47 41.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.592 1.157 . . . . 1.73 111.99 -173.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 50.5 mt-10 -58.32 139.38 84.47 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 106.974 -1.491 . . . . 3.18 106.974 166.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -102.56 -175.77 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.836 2.357 . . . . 1.24 110.821 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.0 132.3 37.5 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.114 -0.699 . . . . 2.76 109.114 167.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.25 136.6 15.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.487 -2.042 . . . . 4.92 105.487 172.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t -74.11 -71.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.131 0.878 . . . . 1.6 108.971 -174.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.69 178.34 17.74 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.232 -1.547 . . . . 1.78 109.232 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -79.01 37.28 0.3 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 117.842 0.821 . . . . 5.55 110.688 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.8 m -166.34 158.86 14.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 105.513 -2.032 . . . . 1.78 105.513 -166.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -139.6 41.53 2.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.399 0.68 . . . . 6.2 110.543 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.81 152.1 49.99 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 109.981 -1.247 . . . . 1.36 109.981 173.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -82.4 74.15 9.39 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.721 -0.87 . . . . 1.35 109.032 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.58 91.0 3.05 Favored Pre-proline 0 CA--C 1.529 0.169 0 N-CA-C 108.77 -0.826 . . . . 0.79 108.77 171.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -62.81 122.63 11.01 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 N-CA-C 108.702 -1.307 . . . . 0.85 108.702 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -130.65 176.39 8.22 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.059 1.744 . . . . 3.48 107.984 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -109.01 148.95 29.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.837 1.255 . . . . 0.6 108.488 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -131.51 153.58 49.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.323 -1.362 . . . . 0.93 107.323 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -82.71 107.01 15.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.171 -1.789 . . . . 1.2 106.171 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.16 112.88 15.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.275 -1.009 . . . . 2.1 108.275 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 t -88.5 -0.56 57.35 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 117.966 -1.016 . . . . 1.22 113.106 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -82.63 -48.98 10.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.498 -1.668 . . . . 5.21 106.498 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.4 p -79.63 -30.71 41.47 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.769 1.228 . . . . 1.1 110.062 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.39 57.06 5.77 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.056 -1.618 . . . . 0.88 109.056 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.28 160.89 37.55 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.18 0.992 . . . . 4.62 110.039 -177.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.0 m -85.99 128.72 34.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.652 0.781 . . . . 0.58 109.075 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -144.06 144.91 27.99 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.52 1.128 . . . . 0.5 108.306 -161.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.43 155.2 45.79 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.969 2.446 . . . . 0.49 112.265 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.25 169.5 23.09 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.526 1.53 . . . . 0.7 108.114 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.18 119.13 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.307 -0.998 . . . . 0.86 108.307 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -89.39 143.57 26.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.32 1.848 . . . . 1.97 109.963 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.3 -36.59 91.3 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.412 -0.66 . . . . 1.09 113.381 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.86 18.9 28.32 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.125 0.869 . . . . 2.21 112.894 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.4 m -141.95 -159.18 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.559 1.144 . . . . 3.19 108.162 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -15.55 -60.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 C-N-CA 128.27 2.843 . . . . 4.43 115.664 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.42 -133.79 12.14 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 119.336 -0.702 . . . . 1.37 111.545 168.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 168.66 -173.42 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 128.904 2.881 . . . . 1.98 106.851 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.17 -44.94 10.69 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.767 -0.933 . . . . 0.8 110.767 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 11.4 t-20 -73.65 67.94 1.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.72 1.208 . . . . 2.94 110.057 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -163.15 88.12 0.58 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.736 1.214 . . . . 2.12 109.791 -168.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -121.21 148.76 43.81 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.432 1.093 . . . . 1.32 111.537 -162.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.45 -38.26 80.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.853 0.461 . . . . 2.94 111.022 -174.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.3 p -142.28 165.83 26.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.516 0.726 . . . . 0.56 110.561 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -47.76 79.01 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.814 0.846 . . . . 0.55 110.675 166.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -48.82 -53.61 18.59 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.316 -0.624 . . . . 2.3 109.316 175.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -65.44 -49.98 67.11 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.541 -0.54 . . . . 2.37 109.541 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.5 t -50.3 -51.95 40.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.549 0.69 . . . . 0.98 110.933 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -65.27 -49.18 70.56 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.466 -0.788 . . . . 3.85 109.815 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.87 -44.42 82.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.388 0.675 . . . . 1.21 111.624 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.3 mt -69.95 -51.78 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 122.579 0.352 . . . . 2.15 110.667 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.528 0.126 0 N-CA-C 112.504 0.557 . . . . 2.41 112.504 -174.066 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.3 pt . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 111.774 0.287 . . . . 1.7 111.774 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.7 m -77.36 -27.88 52.79 Favored 'General case' 0 C--O 1.222 -0.359 0 O-C-N 121.87 -0.519 . . . . 1.36 110.655 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.92 -30.77 19.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.494 -0.928 . . . . 1.75 108.494 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -52.99 139.04 44.51 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 108.006 -1.109 . . . . 2.79 108.006 165.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -98.79 175.74 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.747 2.298 . . . . 1.42 111.064 172.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.28 138.88 31.24 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.853 -1.067 . . . . 3.17 110.1 160.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 132.4 8.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 128.242 2.617 . . . . 4.57 106.378 176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.1 t -75.51 -86.02 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.103 -1.073 . . . . 2.32 108.103 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.74 147.57 0.6 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 123.606 0.622 . . . . 2.32 113.005 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 65.16 -55.47 0.31 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.871 2.868 . . . . 8.21 115.808 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.7 m -140.06 166.57 24.29 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.299 1.04 . . . . 1.88 109.73 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -133.28 33.0 3.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.087 0.955 . . . . 6.19 110.787 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.75 146.72 42.27 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.071 -1.212 . . . . 1.45 110.071 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -81.79 72.4 8.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.883 0.849 . . . . 1.14 108.718 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -101.57 95.95 5.78 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 107.761 -1.2 . . . . 0.81 107.761 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.1 131.02 29.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 N-CA-C 108.511 -1.38 . . . . 0.72 108.511 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -135.11 174.89 10.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.46 -1.311 . . . . 3.52 107.46 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -111.08 146.65 36.39 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.703 1.201 . . . . 0.46 108.311 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -129.75 152.13 49.59 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.634 -1.247 . . . . 0.96 107.634 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.47 102.42 5.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 103.892 -2.633 . . . . 1.48 103.892 160.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -72.08 109.98 6.24 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.82 -1.918 . . . . 2.24 105.82 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 t -86.27 -14.75 42.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.508 -0.553 . . . . 1.13 109.508 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -63.09 -44.43 95.72 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.846 -1.909 . . . . 4.35 105.846 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.7 p -91.95 -40.83 10.91 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.952 2.501 . . . . 1.21 111.465 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.03 21.89 24.32 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.926 1.727 . . . . 1.04 112.398 -169.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -120.93 151.16 40.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.936 1.694 . . . . 4.53 109.195 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -73.15 136.68 44.82 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 120.664 -1.273 . . . . 0.58 108.093 168.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.8 m -155.11 147.24 17.4 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.431 -0.795 . . . . 0.78 108.947 -169.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.44 152.18 29.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.285 2.657 . . . . 0.64 111.774 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -150.72 158.41 44.12 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 124.831 1.252 . . . . 0.51 108.867 172.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.07 118.79 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 105.726 -1.953 . . . . 0.83 105.726 168.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.79 -54.06 9.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.408 0.683 . . . . 2.84 110.569 -173.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.29 -27.81 7.52 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.208 -0.757 . . . . 1.14 111.208 -173.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.64 -45.36 1.4 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.419 1.009 . . . . 1.5 111.364 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 m -106.4 157.73 17.41 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.577 1.151 . . . . 2.64 108.745 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 30.83 60.95 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.499 -0.612 . . . . 2.17 113.459 166.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.18 157.96 46.12 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 118.442 1.121 . . . . 2.04 111.75 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -117.17 -163.1 0.9 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.557 1.543 . . . . 1.05 108.495 170.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.98 69.39 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.17 -1.172 . . . . 0.87 110.17 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -75.17 58.8 0.94 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.678 1.591 . . . . 2.69 111.522 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -155.29 78.57 1.02 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.935 -0.478 . . . . 2.05 110.202 -161.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -109.77 154.57 22.76 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.247 1.019 . . . . 0.72 110.983 -164.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -67.01 -44.54 80.05 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.833 -0.542 . . . . 2.45 109.564 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 78.3 p -131.28 154.29 48.66 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.958 0.725 . . . . 0.67 112.958 -169.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.02 -47.01 22.38 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.5 1.12 . . . . 0.83 110.037 159.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.3 -50.72 15.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.241 0.616 . . . . 2.24 110.598 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -65.89 -53.62 37.17 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 119.038 -0.506 . . . . 2.68 110.842 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 t -47.39 -44.29 24.2 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.555 0.693 . . . . 0.6 111.656 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.1 ttm-85 -62.14 -70.41 0.2 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.499 1.12 . . . . 2.72 109.576 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.02 -40.81 45.81 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.204 1.402 . . . . 0.54 112.939 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mm -63.68 -39.3 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 123.99 0.916 . . . . 1.42 110.638 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 17.5 t . . . . . 0 C--N 1.339 0.115 0 N-CA-C 113.005 0.742 . . . . 1.73 113.005 -165.9 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.1 pt . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 113.098 0.777 . . . . 1.73 113.098 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.9 m -73.37 -32.65 64.63 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.811 0.444 . . . . 1.59 111.096 166.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.2 -35.51 31.26 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.908 -0.495 . . . . 1.71 110.134 -177.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -60.01 135.43 90.42 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 117.853 -1.07 . . . . 4.06 109.125 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -104.58 177.2 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.994 2.463 . . . . 1.58 111.757 170.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -36.54 134.07 0.49 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 126.958 2.103 . . . . 2.65 112.911 166.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.07 135.81 9.45 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 113.282 -1.781 . . . . 4.71 109.132 166.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.61 -49.87 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.063 -0.717 . . . . 1.3 109.063 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.95 85.42 0.97 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.705 0.669 . . . . 3.69 112.815 165.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 87.9 mtm-85 65.66 -52.52 0.37 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 128.89 2.876 . . . . 8.8 115.027 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 m -71.87 169.44 15.8 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.114 0.566 . . . . 2.35 109.984 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -129.42 31.03 4.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.012 1.325 . . . . 7.31 109.493 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.83 177.67 48.21 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.808 -1.317 . . . . 1.43 109.808 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -124.96 87.61 2.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.091 0.956 . . . . 1.89 108.73 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -111.57 103.13 54.76 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 108.096 -1.076 . . . . 0.88 108.096 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.6 125.17 14.99 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 N-CA-C 108.874 -1.241 . . . . 0.89 108.874 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -134.2 175.71 9.25 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.468 1.507 . . . . 2.55 107.886 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -103.64 149.28 25.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.942 1.297 . . . . 0.79 108.06 167.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -128.32 157.45 40.93 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.726 -1.583 . . . . 0.79 106.726 166.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -78.84 103.0 8.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.056 -1.831 . . . . 1.33 106.056 163.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -77.4 111.38 13.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.619 -0.882 . . . . 1.83 108.619 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 t -89.3 9.83 24.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.531 0.733 . . . . 1.67 111.892 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -86.68 -45.29 11.13 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.16 -1.792 . . . . 4.49 106.16 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.1 p -93.76 -31.71 14.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 130.263 3.425 . . . . 1.07 111.684 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.35 30.93 12.47 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.436 1.493 . . . . 0.95 112.765 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -143.61 148.11 35.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.19 1.396 . . . . 4.36 111.502 -161.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 78.8 m -71.31 128.23 35.21 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 120.18 -1.575 . . . . 0.5 109.663 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.1 m -149.4 147.33 22.98 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 117.965 -1.016 . . . . 0.56 109.253 -161.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.78 150.0 34.34 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.319 2.679 . . . . 0.53 112.219 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -153.42 171.83 18.05 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.17 1.388 . . . . 0.59 109.014 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.58 107.86 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.765 -0.828 . . . . 1.33 108.765 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -78.47 139.68 38.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.21 1.004 . . . . 2.17 108.706 170.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.12 -43.03 49.39 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-O 119.365 -0.686 . . . . 1.31 112.385 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.62 -9.03 13.02 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.149 0.88 . . . . 1.63 113.448 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.0 m -113.34 -131.11 0.32 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.155 -1.424 . . . . 2.85 107.155 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.04 -62.78 0.04 OUTLIER Glycine 0 C--N 1.338 0.694 0 C-N-CA 127.881 2.657 . . . . 3.0 115.193 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.26 -134.16 8.04 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.506 -1.038 . . . . 1.93 110.506 -166.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -170.0 177.0 4.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 128.21 2.604 . . . . 1.27 106.139 171.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.17 -25.12 73.49 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.193 -0.763 . . . . 0.69 111.193 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -73.7 55.61 0.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.649 1.58 . . . . 2.71 109.908 174.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -147.53 120.57 8.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.521 -1.289 . . . . 2.4 107.521 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -138.6 147.72 43.3 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.49 1.116 . . . . 0.7 108.898 -165.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -78.68 -25.13 44.77 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.884 -0.51 . . . . 3.1 110.92 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -142.42 155.42 45.1 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.512 0.725 . . . . 0.69 111.021 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.13 -45.59 53.12 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 109.297 -0.631 . . . . 0.79 109.297 160.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -44.77 -53.77 7.03 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.939 0.496 . . . . 2.23 110.543 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -63.97 -54.12 39.47 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 110.161 -0.311 . . . . 1.81 110.161 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -48.58 -49.74 35.4 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.31 0.576 . . . . 0.54 111.503 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -59.93 -64.43 0.95 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.613 1.165 . . . . 2.54 109.165 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -44.55 -45.64 9.49 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.508 1.123 . . . . 0.77 111.699 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.8 mm -71.29 -56.71 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.888 0.875 . . . . 1.65 110.739 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 113.225 0.824 . . . . 1.51 113.225 -168.051 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.9 pt . . . . . 0 C--O 1.225 -0.229 0 N-CA-C 112.025 0.38 . . . . 2.24 112.025 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.8 t -32.23 -41.44 0.05 Allowed 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 126.88 2.072 . . . . 1.82 114.708 169.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.72 -22.82 61.57 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.138 -1.392 . . . . 1.8 111.186 -169.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.43 149.76 94.45 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 118.879 0.763 . . . . 3.06 109.395 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.68 173.16 13.32 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.137 1.891 . . . . 1.06 110.259 170.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -54.32 141.88 28.51 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.782 0.801 . . . . 2.64 109.471 160.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -143.94 133.05 22.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.602 -1.629 . . . . 5.89 106.602 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.84 -55.19 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.295 0.498 . . . . 1.57 110.144 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.64 -157.83 22.53 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 108.39 -1.884 . . . . 2.18 108.39 -175.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -24.13 4.59 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.886 0.875 . . . . 6.23 112.22 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.42 ' HB2' ' H ' ' A' ' 36' ' ' CYS . 64.9 m -79.12 158.26 27.79 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.539 -0.911 . . . . 2.5 108.539 166.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -106.28 45.84 0.96 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.836 0.855 . . . . 5.21 110.15 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.98 176.15 54.11 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.167 -0.773 . . . . 1.18 111.167 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -124.44 81.07 1.9 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.15 1.38 . . . . 1.19 107.287 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -105.99 104.67 50.46 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 108.027 -1.101 . . . . 1.16 108.027 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -65.07 112.96 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 N-CA-C 108.544 -1.368 . . . . 0.62 108.544 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -121.69 178.34 4.89 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.934 2.094 . . . . 3.6 109.211 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -127.32 146.15 50.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.131 1.772 . . . . 0.53 108.313 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -135.25 153.29 51.96 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.167 -1.42 . . . . 0.81 107.167 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -65.57 103.16 0.81 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.482 -1.673 . . . . 1.31 106.482 161.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -78.54 114.91 17.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.376 -1.713 . . . . 1.95 106.376 169.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 t -86.28 -16.64 36.95 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.404 0.281 . . . . 1.66 110.275 -175.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -67.2 -45.52 76.61 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 126.673 1.989 . . . . 3.67 106.139 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.7 p -88.16 -35.6 17.31 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.246 1.818 . . . . 1.21 110.981 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.48 44.18 8.82 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.845 -1.302 . . . . 0.91 109.845 -171.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.54 141.93 43.4 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.842 1.657 . . . . 5.84 110.162 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.5 m -65.61 113.47 4.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.099 -1.074 . . . . 0.81 108.099 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.7 m -132.94 144.13 51.54 Favored Pre-proline 0 C--N 1.332 -0.185 0 C-N-CA 125.65 1.58 . . . . 0.55 108.613 -163.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.31 156.3 62.21 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.732 2.288 . . . . 0.48 111.697 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -155.21 161.76 41.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.839 1.255 . . . . 0.6 108.051 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.9 mm -93.67 112.39 26.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 108.136 -1.061 . . . . 1.24 108.136 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -90.19 147.14 23.75 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.691 1.196 . . . . 2.26 109.366 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.48 -6.68 89.16 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.252 1.406 . . . . 1.06 113.536 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.78 -49.87 1.41 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.915 1.358 . . . . 1.72 111.581 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.42 ' H ' ' HB2' ' A' ' 12' ' ' CYS . 0.6 OUTLIER -127.23 144.74 50.98 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.127 0.971 . . . . 2.4 110.379 173.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.51 12.47 41.28 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.669 1.604 . . . . 2.19 112.745 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.03 148.88 47.87 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 118.313 1.056 . . . . 2.17 113.094 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -91.01 -161.18 0.79 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.411 1.484 . . . . 1.69 109.732 171.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.27 -45.67 6.13 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.914 -1.275 . . . . 0.89 109.914 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -73.76 72.68 1.52 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.624 0.712 . . . . 1.53 110.158 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -159.95 93.79 1.09 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.745 1.218 . . . . 2.27 108.704 -163.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -131.66 141.63 49.64 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 123.208 0.603 . . . . 1.12 111.056 -160.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -54.52 -43.68 72.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.747 0.819 . . . . 2.7 110.833 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.7 p -137.01 158.28 44.83 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.172 0.511 . . . . 0.69 112.363 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.24 -46.93 62.47 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.167 -0.679 . . . . 0.57 109.167 159.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -46.59 -50.67 17.07 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.223 0.465 . . . . 1.84 110.437 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -65.08 -53.9 38.38 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.764 0.426 . . . . 2.96 110.215 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.0 t -51.83 -45.06 63.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.868 0.842 . . . . 0.54 111.246 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -64.56 -53.76 42.76 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.153 1.381 . . . . 2.98 109.349 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.6 -43.11 56.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.768 0.427 . . . . 0.73 111.167 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.4 mt -69.26 -57.05 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.045 0.538 . . . . 1.96 111.719 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 114.022 1.119 . . . . 1.58 114.022 -166.858 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 pt . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 114.37 1.248 . . . . 1.95 114.37 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.3 m -55.61 -35.91 66.36 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.896 -0.502 . . . . 1.55 112.226 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.05 -19.37 20.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.947 0.499 . . . . 1.57 111.088 -162.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -72.56 146.21 88.38 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 118.208 0.458 . . . . 4.25 110.323 -161.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.36 166.49 29.14 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.499 2.132 . . . . 1.84 113.092 -169.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -57.68 147.27 28.1 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 107.702 -1.221 . . . . 2.66 107.702 169.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -154.92 69.74 0.74 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.966 0.888 . . . . 6.06 110.791 -156.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.3 t -60.35 -44.67 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.392 -0.596 . . . . 1.8 109.392 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.7 -146.26 18.16 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 107.972 -2.051 . . . . 2.96 107.972 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -154.15 55.11 0.71 Allowed 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.086 -0.709 . . . . 7.68 109.086 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.0 m -150.16 150.56 31.81 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.29 1.036 . . . . 2.85 108.247 -165.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -77.81 63.87 2.95 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.975 0.51 . . . . 7.14 110.351 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -116.2 153.42 17.47 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.733 -1.747 . . . . 1.44 108.733 168.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -144.56 81.2 1.65 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.537 -0.912 . . . . 1.6 108.537 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.33 100.13 45.21 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 108.148 -1.056 . . . . 1.37 108.148 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.71 126.0 17.27 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.32 1.346 . . . . 0.61 109.418 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -137.64 176.24 8.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.493 1.517 . . . . 3.57 108.305 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -121.2 142.44 49.9 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.556 1.543 . . . . 0.54 108.52 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -128.36 152.15 48.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.965 -1.494 . . . . 1.07 106.965 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -73.03 104.14 4.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.637 -1.616 . . . . 1.34 106.637 168.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.16 105.96 4.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.084 -1.45 . . . . 2.04 107.084 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.2 t -81.17 -6.9 59.36 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.154 -0.927 . . . . 1.43 112.831 -173.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -76.09 -49.95 16.03 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.211 -1.403 . . . . 5.24 107.211 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.4 p -88.97 -12.64 40.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.708 0.803 . . . . 1.4 111.752 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.7 37.17 76.36 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.924 1.249 . . . . 0.81 111.119 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -137.96 135.49 36.07 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.316 1.046 . . . . 4.44 110.747 -163.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 90.6 m -66.04 124.45 22.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.347 -0.983 . . . . 0.6 108.347 170.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.5 m -141.37 138.99 18.15 Favored Pre-proline 0 N--CA 1.451 -0.401 0 C-N-CA 124.701 1.2 . . . . 0.84 107.862 -164.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.03 156.89 61.55 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.456 2.104 . . . . 0.65 111.06 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.1 157.86 36.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.215 -1.402 . . . . 0.87 107.215 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.63 116.24 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 105.293 -2.114 . . . . 0.88 105.293 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -86.28 131.2 34.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.53 -1.285 . . . . 2.33 107.53 173.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.52 18.38 56.33 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.851 -0.416 . . . . 1.64 112.408 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.62 -53.83 4.73 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.854 -1.698 . . . . 2.75 108.854 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.6 m -64.3 168.97 5.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.391 1.076 . . . . 2.85 108.73 162.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.15 39.77 62.32 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 109.816 -1.314 . . . . 3.33 109.816 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.95 57.55 5.04 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.655 -1.497 . . . . 2.67 112.686 -171.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -81.68 173.54 12.23 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.146 0.973 . . . . 1.98 108.912 161.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.62 -23.45 72.85 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.519 0.581 . . . . 0.67 114.051 -166.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -77.15 74.76 3.72 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.972 0.886 . . . . 1.74 109.724 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -152.17 96.52 2.2 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.071 0.548 . . . . 2.2 109.96 -160.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -124.35 148.46 47.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.137 0.575 . . . . 1.25 109.492 -170.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -77.06 -27.55 54.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.971 -0.381 . . . . 4.73 109.971 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.9 p -137.0 162.43 33.31 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.819 0.848 . . . . 0.96 112.208 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.77 -49.26 39.38 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.254 1.021 . . . . 0.91 110.101 159.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -46.8 -50.5 18.22 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.701 0.4 . . . . 2.19 110.085 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -66.42 -52.57 45.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 119.235 -0.412 . . . . 3.97 111.2 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 t -47.9 -49.74 28.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.606 0.639 . . . . 0.5 111.212 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -56.71 -65.44 0.61 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.49 1.116 . . . . 3.2 109.538 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.62 -40.0 71.55 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.05 0.94 . . . . 1.06 112.949 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mp -74.19 -52.1 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 119.258 -0.401 . . . . 2.47 110.094 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.0 t . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 119.097 0.862 . . . . 1.55 112.546 -170.01 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.224 -0.264 0 N-CA-C 113.166 0.802 . . . . 3.48 113.166 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -18.46 60.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.286 0.565 . . . . 1.89 111.692 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.81 -44.2 12.67 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.388 1.075 . . . . 1.93 110.741 168.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.2 116.15 20.46 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.787 -0.625 . . . . 4.16 110.221 -174.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.93 153.53 42.2 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.502 1.468 . . . . 1.4 110.791 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.88 143.93 9.3 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 122.123 0.963 . . . . 2.59 112.52 163.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.99 128.78 10.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.257 1.823 . . . . 5.3 106.274 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.0 t -72.86 -51.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.11 -0.7 . . . . 1.37 109.11 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.9 143.87 15.6 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.119 1.342 . . . . 2.46 109.838 -172.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -76.81 67.11 2.82 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.857 -0.79 . . . . 9.86 108.893 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 m -107.05 178.57 4.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.414 1.086 . . . . 3.36 109.919 -171.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -122.28 68.05 0.94 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.404 -1.332 . . . . 8.29 107.404 167.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.14 165.97 35.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.325 -1.51 . . . . 1.51 109.325 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -146.37 99.36 3.21 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.099 1.759 . . . . 1.45 106.283 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -123.64 100.86 37.4 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 107.66 -1.237 . . . . 0.93 107.66 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.2 125.73 17.7 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 108.484 -1.391 . . . . 0.54 108.484 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.6 mmt-85 -135.66 174.47 10.58 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.388 1.475 . . . . 3.38 108.347 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -115.85 140.98 48.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.241 1.417 . . . . 0.4 108.154 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.459 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 7.4 p90 -123.6 152.65 41.68 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.331 -1.359 . . . . 0.68 107.331 169.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -66.64 105.66 1.6 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.24 -1.763 . . . . 1.05 106.24 155.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 6.5 t70 -72.05 116.87 12.96 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.767 -1.938 . . . . 1.83 105.767 168.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.65 -25.11 28.71 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.745 -0.835 . . . . 1.29 108.745 -169.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -63.73 -45.9 87.85 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 128.208 2.603 . . . . 3.9 106.636 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.8 p -84.9 -34.24 22.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.101 1.36 . . . . 1.07 110.783 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.9 37.01 23.73 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.146 1.355 . . . . 1.22 110.494 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.93 156.75 43.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.779 1.232 . . . . 6.82 110.384 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.2 m -67.34 139.03 57.2 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.398 -0.814 . . . . 0.75 109.435 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -156.65 146.15 15.3 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.874 -1.158 . . . . 0.91 107.874 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.66 156.49 49.11 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.091 2.528 . . . . 0.39 111.695 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -153.69 162.95 40.79 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.414 1.486 . . . . 0.43 107.359 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -96.05 113.67 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.862 -1.903 . . . . 0.76 105.862 170.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -81.57 139.77 34.87 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.639 -1.245 . . . . 2.12 107.639 169.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.26 -11.24 85.53 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 121.725 -0.609 . . . . 1.03 112.653 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.27 -43.88 1.7 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.206 -1.158 . . . . 1.51 110.206 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.9 159.03 15.19 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.131 1.773 . . . . 2.35 111.374 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.09 37.59 93.05 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 114.759 0.664 . . . . 2.69 114.759 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.61 -153.6 15.81 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.887 0.844 . . . . 1.31 112.815 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -160.38 -163.32 1.08 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.381 2.272 . . . . 1.44 105.675 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.21 -20.84 68.83 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.566 1.076 . . . . 0.79 112.239 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -81.5 63.97 6.02 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 118.502 1.151 . . . . 1.62 110.069 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -159.09 78.24 0.74 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.914 -0.584 . . . . 1.74 109.544 -155.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -112.99 154.5 26.36 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.465 0.706 . . . . 0.85 110.916 -167.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.24 -39.73 94.56 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.803 -0.814 . . . . 3.04 108.803 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.8 p -130.66 150.59 51.78 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.142 1.164 . . . . 0.53 114.142 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.9 -46.11 42.33 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.224 1.41 . . . . 0.71 110.242 159.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.42 -49.96 23.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.704 0.802 . . . . 2.05 110.488 175.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -64.46 -54.96 24.39 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 119.186 -0.435 . . . . 2.3 110.358 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.25 -43.54 42.91 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.294 1.045 . . . . 0.65 111.509 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -60.61 -58.77 7.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.864 1.266 . . . . 4.91 111.516 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.32 -43.55 67.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.621 0.769 . . . . 0.62 112.298 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.5 -44.17 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.899 0.88 . . . . 1.76 110.331 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 113.058 0.762 . . . . 1.89 113.058 -171.802 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.8 pt . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 111.927 0.343 . . . . 1.73 111.927 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.2 m -49.1 -27.35 3.33 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.343 1.057 . . . . 1.35 112.704 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -33.26 66.13 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.912 -0.492 . . . . 1.39 111.038 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.44 119.21 44.6 Favored Pre-proline 0 C--O 1.225 -0.2 0 CA-C-O 118.11 -0.947 . . . . 4.9 109.072 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.08 173.51 12.03 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 120.802 1.322 . . . . 1.34 111.626 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -45.21 131.56 7.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.115 -1.402 . . . . 2.79 110.52 157.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -159.17 137.01 10.25 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.711 2.004 . . . . 5.17 106.722 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.52 -66.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.799 0.727 . . . . 1.31 109.782 -172.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.77 -178.82 19.1 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.241 -1.543 . . . . 1.84 109.241 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -68.06 -43.36 78.81 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.915 -0.772 . . . . 6.46 108.915 172.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.2 m -71.52 151.97 43.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.269 -1.752 . . . . 2.03 106.269 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -138.09 46.95 2.03 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.448 0.699 . . . . 6.45 109.134 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.94 153.91 34.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.269 -1.532 . . . . 1.42 109.269 170.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -83.1 77.8 9.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.981 -0.717 . . . . 1.19 109.523 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -101.31 94.35 3.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.071 -0.715 . . . . 0.78 109.071 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.67 122.33 10.39 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 CA-C-N 120.548 1.232 . . . . 0.5 108.935 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -130.7 177.99 6.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 125.578 1.551 . . . . 3.7 107.268 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -117.53 142.49 47.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.794 1.638 . . . . 0.38 108.144 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -124.84 150.43 46.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.567 -1.642 . . . . 0.81 106.567 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.9 102.34 0.77 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 104.559 -2.386 . . . . 1.4 104.559 157.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.39 103.22 3.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.243 -1.762 . . . . 2.08 106.243 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 t -74.9 -15.33 60.71 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.258 0.623 . . . . 1.14 110.66 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -62.4 -41.66 98.84 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.446 1.098 . . . . 4.34 108.107 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.5 p -105.33 -25.66 12.31 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.783 2.833 . . . . 0.84 112.911 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.1 30.39 22.97 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.867 2.175 . . . . 0.98 113.233 -173.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -136.65 138.2 40.87 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.152 1.476 . . . . 4.49 110.96 -161.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 m -70.48 120.17 15.73 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 120.491 -1.38 . . . . 0.57 108.952 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.9 m -140.72 145.65 40.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.637 1.175 . . . . 0.51 108.868 -163.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.65 151.25 41.16 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.218 2.612 . . . . 0.46 111.899 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -154.64 162.99 40.88 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.349 1.46 . . . . 0.51 108.27 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.39 113.15 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.02 -1.474 . . . . 0.67 107.02 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -80.83 145.19 31.53 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.526 1.13 . . . . 1.98 108.004 168.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.31 -31.3 47.16 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.992 0.806 . . . . 1.04 114.012 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.42 17.35 24.51 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.391 0.996 . . . . 1.75 113.115 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -125.57 -156.93 0.76 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.125 1.37 . . . . 2.87 109.403 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.48 67.61 0.26 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.868 1.699 . . . . 2.61 110.254 163.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.33 -83.92 0.09 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.135 -1.586 . . . . 2.42 109.135 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -177.85 -174.13 0.43 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 127.431 2.292 . . . . 1.16 108.061 167.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.55 -20.51 61.81 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.463 0.554 . . . . 0.99 112.69 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -80.24 64.89 5.21 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.372 1.086 . . . . 1.7 108.577 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -154.9 69.39 0.73 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.824 -0.806 . . . . 1.92 108.824 -151.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -106.77 163.41 12.95 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.438 1.495 . . . . 0.67 111.309 -162.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -30.43 35.29 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.671 -0.643 . . . . 3.37 110.59 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.8 p -146.97 162.38 38.88 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.244 0.618 . . . . 0.66 110.852 -173.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -46.11 70.31 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 123.432 0.693 . . . . 0.58 109.855 163.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -47.82 -51.95 20.8 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.91 -0.404 . . . . 2.35 109.91 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -68.96 -49.98 53.17 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.361 -0.237 . . . . 1.99 110.361 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -50.49 -47.65 57.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.509 0.671 . . . . 0.58 110.699 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -61.89 -58.86 6.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 123.921 0.889 . . . . 4.4 110.097 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.64 -45.61 63.38 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.502 0.721 . . . . 0.61 111.584 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.5 mm -65.63 -54.58 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 122.661 0.385 . . . . 1.51 110.014 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.5 t . . . . . 0 CA--C 1.528 0.127 0 N-CA-C 112.781 0.66 . . . . 1.75 112.781 -168.145 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.4 pt . . . . . 0 C--O 1.226 -0.166 0 CA-C-O 120.708 0.29 . . . . 1.78 110.756 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.4 m -47.76 -28.5 2.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.644 0.778 . . . . 1.26 112.302 176.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.34 -17.03 55.34 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.025 -0.988 . . . . 1.87 112.419 -172.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.77 148.91 81.58 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 120.511 1.505 . . . . 3.21 111.518 -173.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.2 170.15 20.84 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.665 2.243 . . . . 1.6 110.29 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.452 ' HE2' ' CE1' ' A' ' 20' ' ' TYR . 26.7 ttmt -67.99 140.84 56.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.255 -0.646 . . . . 4.3 109.255 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.53 149.92 30.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.505 -1.665 . . . . 5.45 106.505 176.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.6 t -90.73 -72.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 108.915 -0.772 . . . . 1.48 108.915 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.96 173.48 34.46 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 108.838 -1.705 . . . . 1.77 108.838 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -74.23 -43.17 58.14 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.289 -1.374 . . . . 8.96 107.289 168.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.24 144.21 50.14 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.059 -1.83 . . . . 2.37 106.059 166.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -59.61 2.64 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 119.041 -0.504 . . . . 6.31 109.963 -173.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.19 -178.28 0.62 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.314 1.435 . . . . 1.79 115.839 166.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -147.99 95.26 2.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.402 1.081 . . . . 1.08 108.986 170.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.2 107.17 13.54 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 109.121 -0.696 . . . . 0.84 109.121 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.81 117.81 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.628 1.552 . . . . 0.72 110.208 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -120.22 176.94 5.21 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 126.921 2.088 . . . . 3.22 109.238 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -123.63 140.69 52.74 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.779 2.031 . . . . 0.51 107.559 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.452 ' CE1' ' HE2' ' A' ' 7' ' ' LYS . 1.3 p90 -122.55 150.65 42.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.852 -1.906 . . . . 1.03 105.852 169.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -68.57 107.74 3.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.381 -2.081 . . . . 1.44 105.381 159.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.07 111.98 7.77 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.884 -1.525 . . . . 2.23 106.884 170.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 t -88.06 1.53 54.04 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.004 -0.998 . . . . 1.24 112.945 -171.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -85.0 -50.07 7.77 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.862 -1.533 . . . . 5.72 106.862 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.3 p -83.43 -26.07 30.68 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.862 0.865 . . . . 1.31 111.357 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.08 31.27 53.39 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.867 1.222 . . . . 1.05 111.126 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.2 131.61 53.55 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 118.751 1.275 . . . . 4.64 110.548 -169.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.8 m -62.31 129.02 38.83 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 107.439 -1.319 . . . . 0.48 107.439 168.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.408 HG23 ' HD2' ' A' ' 30' ' ' PRO . 11.0 m -156.28 149.62 18.78 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.899 -1.148 . . . . 0.95 107.899 -165.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.408 ' HD2' HG23 ' A' ' 29' ' ' THR . 57.3 Cg_endo -73.97 157.88 46.62 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.101 2.534 . . . . 0.54 114.528 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -154.07 164.3 38.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.257 1.423 . . . . 0.6 108.869 167.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.9 mm -98.93 104.87 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.575 -1.268 . . . . 0.89 107.575 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -73.4 152.75 40.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.498 -0.927 . . . . 2.25 108.498 168.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.53 13.27 47.18 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 114.365 0.506 . . . . 1.18 114.365 -172.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.76 -48.86 2.8 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 118.645 1.223 . . . . 1.49 110.943 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.52 128.04 38.5 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.712 0.805 . . . . 2.65 111.834 174.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.14 52.5 0.24 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.522 2.01 . . . . 2.46 108.548 -170.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.15 164.73 54.35 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.065 -0.814 . . . . 1.97 111.065 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -156.8 -173.2 4.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.206 -1.775 . . . . 1.55 106.206 171.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.09 -47.29 9.37 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.023 -1.231 . . . . 0.79 110.023 -172.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.11 65.92 2.19 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.929 0.492 . . . . 1.56 110.926 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.0 66.12 0.91 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.343 1.057 . . . . 2.1 109.859 -159.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -108.65 140.93 41.35 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.726 0.81 . . . . 0.75 110.994 -160.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.15 -42.29 80.76 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.252 0.933 . . . . 2.52 110.722 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.9 p -138.98 163.5 32.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.615 0.766 . . . . 0.55 111.507 -169.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.79 -47.7 67.37 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.207 0.603 . . . . 0.5 109.548 162.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -48.69 -48.68 39.94 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.998 -0.371 . . . . 2.11 109.998 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -68.58 -51.54 41.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.517 0.327 . . . . 2.25 110.641 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.5 t -51.13 -48.53 61.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.548 0.69 . . . . 0.54 111.092 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -57.49 -60.34 3.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.224 1.01 . . . . 2.76 109.129 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.75 -43.6 27.36 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.479 0.712 . . . . 0.74 112.204 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.38 -59.35 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.945 0.339 . . . . 1.36 110.151 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.532 0.277 0 C-N-CA 119.95 -0.7 . . . . 1.62 112.522 -164.696 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 119.343 -0.36 . . . . 2.32 111.774 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.3 m -33.12 -45.84 0.15 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.069 1.347 . . . . 1.68 111.165 166.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.44 -22.25 61.12 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.589 0.959 . . . . 1.54 113.589 -169.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -65.71 146.16 99.0 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 119.787 1.176 . . . . 3.09 111.027 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.32 169.91 21.45 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.949 1.766 . . . . 1.15 110.735 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -56.68 143.03 37.82 Favored 'General case' 0 N--CA 1.46 0.051 0 C-N-CA 125.506 1.523 . . . . 2.51 111.327 161.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -146.75 99.01 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.038 1.735 . . . . 5.36 110.196 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.3 -42.09 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.442 -0.577 . . . . 1.51 109.442 174.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.62 -178.33 42.52 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.67 -0.972 . . . . 1.99 110.67 -172.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.06 55.56 2.53 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.985 -0.715 . . . . 7.69 112.105 -170.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.9 m -147.58 165.44 30.36 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.917 1.287 . . . . 1.85 107.573 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -139.42 20.55 2.56 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.236 0.615 . . . . 5.93 112.103 -177.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.71 145.19 38.14 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.255 -1.138 . . . . 1.56 110.255 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -81.95 73.32 9.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.69 0.757 . . . . 1.76 109.097 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -102.42 90.75 2.28 Favored Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 108.03 -1.1 . . . . 0.89 108.03 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.56 136.45 46.41 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.207 1.271 . . . . 0.94 109.549 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -140.43 179.35 6.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.051 2.141 . . . . 2.76 107.62 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -122.95 147.23 46.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.892 2.077 . . . . 0.52 108.391 169.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -128.61 155.81 44.37 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.955 -1.869 . . . . 1.08 105.955 166.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -75.99 101.93 5.43 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.341 -1.355 . . . . 1.46 107.341 164.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -72.35 98.66 2.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.28 -1.378 . . . . 1.8 107.28 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -72.26 -14.69 61.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.245 -0.883 . . . . 1.24 112.817 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -69.27 -49.05 59.64 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.413 -1.328 . . . . 4.98 107.413 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 64.1 p -83.77 -19.54 34.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.937 0.495 . . . . 0.97 111.596 174.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.96 34.36 58.92 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.51 1.052 . . . . 0.78 110.831 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.73 136.52 52.54 Favored 'General case' 0 CA--C 1.523 -0.059 0 C-N-CA 124.631 1.172 . . . . 5.52 110.527 -169.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.8 m -61.99 124.68 21.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.905 -1.146 . . . . 0.63 107.905 156.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.5 m -141.54 137.69 16.67 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 107.299 -1.371 . . . . 0.89 107.299 -166.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.03 155.17 65.67 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.405 2.07 . . . . 0.72 110.84 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -153.46 157.84 40.47 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.147 -1.057 . . . . 0.71 108.147 167.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.6 120.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 105.961 -1.866 . . . . 1.0 105.961 172.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -84.84 -7.53 59.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.071 1.348 . . . . 2.63 111.707 -172.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.09 -33.12 1.5 Allowed Glycine 0 CA--C 1.533 1.203 0 O-C-N 119.991 -1.693 . . . . 1.45 113.221 172.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.96 25.73 18.9 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 126.059 1.79 . . . . 2.26 110.478 -171.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.87 -160.71 0.72 Allowed 'General case' 0 C--N 1.34 0.195 0 N-CA-C 114.926 1.454 . . . . 2.85 114.926 -164.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -31.02 -58.51 0.26 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 127.343 2.401 . . . . 3.38 113.42 173.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.04 -161.88 46.89 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.995 -0.442 . . . . 1.29 111.995 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -172.23 -169.8 0.67 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.976 1.71 . . . . 1.16 109.776 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.73 -41.9 18.39 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.584 -1.407 . . . . 0.89 109.584 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -73.89 67.06 1.2 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.879 0.371 . . . . 1.78 111.179 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -149.58 117.92 6.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.097 1.359 . . . . 2.14 108.492 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -138.77 139.84 38.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.766 0.827 . . . . 0.93 108.83 -166.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -63.44 -35.98 82.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.878 0.763 . . . . 3.13 110.936 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.5 p -131.11 155.05 47.62 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.592 0.757 . . . . 0.46 111.314 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.92 -45.57 60.5 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.137 -0.69 . . . . 0.62 109.137 161.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.14 -53.72 7.72 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.821 0.449 . . . . 2.16 110.498 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -64.71 -54.2 35.21 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.038 -0.356 . . . . 1.8 110.038 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 t -49.64 -50.22 44.05 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.01 0.433 . . . . 0.46 110.93 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -57.81 -60.89 3.01 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.743 1.217 . . . . 3.02 109.111 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.05 -32.55 61.99 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.103 0.961 . . . . 0.69 112.851 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.5 mm -88.29 -50.4 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.29 0.636 . . . . 1.84 110.82 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.8 t . . . . . 0 CA--C 1.532 0.253 0 O-C-N 121.705 -0.622 . . . . 1.55 111.484 -175.84 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.569 0.224 . . . . 2.75 110.976 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m -40.73 -36.8 0.66 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.462 1.505 . . . . 1.68 111.694 170.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -23.89 60.77 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.594 0.961 . . . . 1.76 113.594 -176.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -72.29 144.66 87.21 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.695 0.68 . . . . 4.1 109.893 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -83.54 169.27 12.37 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.252 1.968 . . . . 2.16 112.193 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -60.3 140.42 57.1 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.906 1.283 . . . . 2.92 107.914 153.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.515 ' HD2' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -158.24 134.47 9.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.529 0.732 . . . . 5.08 109.763 176.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.56 -27.27 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.692 0.758 . . . . 2.16 110.445 -173.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.4 179.07 9.69 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 121.932 0.74 . . . . 2.1 111.77 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -81.25 53.2 1.98 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.605 -0.939 . . . . 7.97 109.266 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.6 m -143.47 147.34 34.39 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.299 -1.371 . . . . 1.68 107.299 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.71 39.11 3.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.411 0.685 . . . . 4.96 111.953 -171.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.09 141.56 15.66 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.501 -1.04 . . . . 1.55 110.501 174.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -82.05 74.93 9.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.743 -0.836 . . . . 1.35 108.743 -176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -102.0 88.55 1.31 Allowed Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.114 0.966 . . . . 0.79 109.059 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.34 119.88 6.99 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.57 1.514 . . . . 0.55 109.322 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -116.7 178.05 4.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.823 2.049 . . . . 3.37 108.919 169.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -116.62 139.69 50.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.989 1.716 . . . . 0.4 108.373 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -120.79 148.01 44.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.931 -1.507 . . . . 0.72 106.931 165.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -67.47 105.44 1.82 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.546 -1.65 . . . . 0.99 106.546 158.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.57 103.57 3.59 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.149 -1.426 . . . . 1.94 107.149 168.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 t -76.91 -9.46 58.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.215 -0.898 . . . . 1.17 112.593 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.85 -48.85 34.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.522 -1.288 . . . . 4.19 107.522 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.8 p -92.0 -13.72 30.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.904 0.882 . . . . 1.19 112.589 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.03 33.67 84.4 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.134 0.873 . . . . 0.99 111.108 -174.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 133.69 55.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 125.049 1.34 . . . . 5.29 109.844 -170.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.3 m -64.55 124.01 20.74 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.063 -1.088 . . . . 0.51 108.063 158.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.8 m -142.71 141.83 21.26 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.724 1.61 . . . . 0.56 107.36 -165.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.45 153.9 50.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.45 2.1 . . . . 0.52 111.693 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -153.87 159.25 41.72 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.884 1.273 . . . . 0.54 108.054 169.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.55 120.5 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 106.734 -1.58 . . . . 0.8 106.734 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.0 -23.81 59.49 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.162 0.585 . . . . 2.74 112.392 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.14 -49.73 4.17 Favored Glycine 0 CA--C 1.522 0.489 0 O-C-N 121.08 -1.013 . . . . 1.42 110.749 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.68 -31.18 2.03 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.396 -0.669 . . . . 1.54 113.062 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.05 176.23 7.17 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.371 1.085 . . . . 2.33 108.38 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.23 43.62 25.21 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.922 -1.271 . . . . 2.75 109.922 -172.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.85 147.47 48.43 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.091 -1.203 . . . . 2.11 110.091 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' ND2' ' HD2' ' A' ' 8' ' ' LYS . 51.8 p30 -153.65 -174.45 4.96 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 105.758 -1.942 . . . . 1.62 105.758 170.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.79 -43.7 65.66 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.906 -1.278 . . . . 1.3 109.906 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -75.17 67.11 1.77 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.471 0.708 . . . . 1.72 111.705 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.05 60.69 0.46 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.726 0.81 . . . . 2.05 110.061 -160.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -104.07 142.1 35.05 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 123.622 0.769 . . . . 0.93 110.822 -161.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -63.6 -41.91 98.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.549 1.068 . . . . 2.65 110.542 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.1 p -118.21 152.24 36.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.751 0.82 . . . . 0.64 112.571 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.23 -46.68 54.92 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.55 0.74 . . . . 0.55 109.578 160.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.56 -51.8 11.41 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.246 0.618 . . . . 2.01 110.586 176.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -65.25 -54.68 25.74 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 110.078 -0.341 . . . . 2.38 110.078 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 t -48.28 -48.02 35.92 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.293 0.568 . . . . 0.52 111.47 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -57.46 -62.65 1.63 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.908 1.283 . . . . 3.24 108.794 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.04 -46.23 43.9 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.873 0.869 . . . . 0.74 112.64 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mp -75.64 -57.46 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 118.061 0.392 . . . . 1.64 110.272 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 16.0 t . . . . . 0 C--N 1.34 0.173 0 CA-C-N 118.782 0.719 . . . . 1.63 111.257 -170.373 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.525 HG22 ' HA3' ' A' ' 40' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 114.07 1.137 . . . . 2.76 114.07 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.2 m -96.89 -12.61 23.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.792 0.437 . . . . 1.49 111.466 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.22 -37.47 8.9 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.087 0.955 . . . . 1.54 108.754 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -59.2 132.24 87.58 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.54 -1.652 . . . . 4.11 106.54 172.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -99.44 175.68 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.597 2.198 . . . . 1.42 111.398 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -48.95 140.88 8.33 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.673 1.702 . . . . 2.93 112.693 153.442 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.86 -176.61 5.27 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 102.709 -3.071 . . . . 5.02 102.709 165.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 t -120.89 -84.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.82 -1.548 . . . . 2.03 106.82 158.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.2 170.6 15.6 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 107.185 -2.366 . . . . 2.76 107.185 -173.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -80.38 60.58 3.85 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.287 -1.005 . . . . 6.51 108.287 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.5 m -151.68 157.13 41.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.053 -1.091 . . . . 3.09 108.053 -161.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.14 81.13 1.84 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.175 0.99 . . . . 5.92 108.659 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.86 131.67 6.55 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.61 -1.396 . . . . 1.73 109.61 169.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -83.12 74.35 10.0 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.766 0.827 . . . . 2.17 109.398 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -102.83 87.31 1.17 Allowed Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 107.879 -1.156 . . . . 1.28 107.879 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.7 120.93 8.32 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 N-CA-C 108.038 -1.562 . . . . 0.67 108.038 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -128.91 177.28 7.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.2 1.4 . . . . 3.86 107.774 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -112.63 156.52 22.58 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.276 1.83 . . . . 0.53 107.946 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 31' ' ' PHE . 6.3 p90 -148.26 152.09 36.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.924 -1.139 . . . . 1.35 107.924 175.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -76.07 100.08 4.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.987 -1.857 . . . . 0.92 105.987 169.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 20' ' ' TYR . 11.0 t70 -72.3 109.68 6.2 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.638 -1.245 . . . . 2.48 107.638 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.6 t -87.21 6.76 31.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.593 -0.718 . . . . 1.81 111.631 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.5 -45.63 10.31 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 105.987 -1.857 . . . . 4.5 105.987 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.9 p -94.25 -25.98 16.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.581 2.752 . . . . 1.43 111.602 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.53 59.9 3.95 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.015 -1.234 . . . . 1.31 110.015 -173.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.5 144.96 17.24 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.826 1.313 . . . . 4.09 112.938 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.5 m -73.84 119.21 17.75 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.352 -0.842 . . . . 0.52 108.75 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.3 m -141.93 147.54 45.23 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 117.956 -1.021 . . . . 0.58 109.205 -161.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.38 145.22 21.02 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.333 2.689 . . . . 0.63 112.702 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -147.7 161.07 41.95 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.602 1.561 . . . . 0.65 108.268 173.709 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.87 118.57 37.57 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 105.57 -2.011 . . . . 0.99 105.57 170.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -72.77 -41.43 65.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.73 0.412 . . . . 2.97 111.52 -171.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.15 -15.33 61.59 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 118.37 0.532 . . . . 1.18 112.206 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.87 -51.72 4.61 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.626 1.213 . . . . 1.62 110.145 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -178.9 4.77 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.036 1.334 . . . . 2.99 109.928 170.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.99 49.74 65.42 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.604 -0.598 . . . . 2.51 111.604 164.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.61 148.91 44.28 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.584 -0.95 . . . . 1.87 112.6 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -143.62 178.99 7.41 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 104.782 -2.303 . . . . 1.08 104.782 157.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 2' ' ' ILE . . . -75.05 -25.66 68.46 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.253 -0.739 . . . . 0.83 111.253 -175.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -72.91 65.84 0.75 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.138 1.375 . . . . 2.52 110.471 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -162.07 97.16 1.02 Allowed 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.873 -0.517 . . . . 2.07 110.466 -169.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.46 140.75 52.66 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.415 1.486 . . . . 0.81 110.282 -165.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.68 -32.39 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.603 1.092 . . . . 2.87 111.501 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.9 p -143.76 156.6 44.56 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.277 0.631 . . . . 0.47 111.809 -169.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -45.08 64.71 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 108.869 -0.789 . . . . 0.5 108.869 160.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -43.9 -53.44 6.1 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.476 0.31 . . . . 2.16 110.757 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -63.66 -57.04 11.29 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 117.951 0.341 . . . . 1.94 110.136 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.9 t -49.12 -42.1 38.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.086 0.469 . . . . 0.64 111.963 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -66.82 -54.78 19.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.161 1.384 . . . . 3.17 109.684 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.73 -40.94 30.4 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.932 0.493 . . . . 0.67 111.955 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.18 -63.78 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.003 0.521 . . . . 1.82 110.961 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 123.971 0.908 . . . . 2.19 113.355 -166.939 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.2 pt . . . . . 0 C--O 1.224 -0.275 0 N-CA-C 110.451 -0.203 . . . . 1.68 110.451 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.0 m -51.05 -24.93 4.25 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.27 0.628 . . . . 1.4 112.685 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.59 -35.66 67.97 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.216 0.462 . . . . 1.47 110.336 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 110.02 3.58 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.206 1.003 . . . . 4.27 111.873 -164.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.95 146.0 69.94 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 CA-C-N 120.912 1.361 . . . . 1.45 110.83 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -34.05 133.67 0.21 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 128.589 2.755 . . . . 3.66 112.62 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -138.73 149.01 44.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.162 2.585 . . . . 5.36 108.118 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.5 t -117.82 -22.63 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.365 1.066 . . . . 1.94 111.759 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.17 150.64 0.77 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-O 122.391 0.995 . . . . 2.16 112.612 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.29 50.23 0.9 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.587 -0.949 . . . . 7.88 111.721 -178.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.1 m -126.3 142.71 51.42 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.37 0.668 . . . . 2.01 111.098 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 78.33 8.71 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.27 -1.011 . . . . 7.8 108.27 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.97 -179.77 22.43 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.02 -1.232 . . . . 1.51 110.02 168.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -146.53 117.86 7.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.899 1.28 . . . . 1.67 107.793 -176.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -145.1 119.03 5.55 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 106.847 -1.538 . . . . 0.93 106.847 175.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.9 134.37 23.5 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.643 1.562 . . . . 1.15 109.055 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.2 mmt-85 -140.82 176.26 8.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.506 1.122 . . . . 2.98 108.519 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -125.28 136.97 54.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.068 1.747 . . . . 0.61 107.634 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -118.93 150.97 39.01 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.338 -1.356 . . . . 0.92 107.338 171.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.24 100.33 2.08 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.215 -2.142 . . . . 1.65 105.215 161.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.39 104.02 3.63 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.844 -1.539 . . . . 2.06 106.844 171.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 t -82.62 -0.14 45.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.394 -0.812 . . . . 1.29 112.564 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.98 -47.55 12.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.947 -1.501 . . . . 3.7 106.947 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.5 p -79.48 -30.15 41.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.719 1.208 . . . . 0.96 111.167 170.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.23 29.78 44.17 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.83 1.205 . . . . 0.8 111.309 -172.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -129.19 147.35 51.03 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 118.858 1.329 . . . . 4.55 110.131 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 57.8 m -69.86 135.09 49.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.152 -1.425 . . . . 0.74 107.152 166.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 m -151.72 139.42 12.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.06 -1.089 . . . . 0.55 108.06 -169.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.17 159.1 53.12 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.842 2.361 . . . . 0.5 111.101 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -158.47 163.53 37.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.952 1.301 . . . . 0.68 108.158 171.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.7 mm -93.11 115.35 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.545 -1.65 . . . . 1.27 106.545 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.03 -19.34 61.21 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.789 0.836 . . . . 2.61 111.678 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.47 -45.78 3.31 Favored Glycine 0 CA--C 1.525 0.681 0 O-C-N 121.303 -0.873 . . . . 1.58 110.951 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.32 -24.43 3.38 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 124.074 0.845 . . . . 1.28 111.86 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -145.04 176.55 9.42 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.545 1.138 . . . . 2.2 109.426 -172.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 41.52 44.61 4.19 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.262 1.411 . . . . 3.4 114.245 171.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.95 -133.66 7.31 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.602 -1.399 . . . . 2.03 109.602 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -152.94 -168.51 3.06 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.337 1.855 . . . . 1.39 107.028 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.27 -12.07 65.94 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.928 0.775 . . . . 0.84 113.035 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -79.15 63.76 3.88 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 118.5 1.15 . . . . 1.9 107.913 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -159.44 87.91 0.84 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.818 -0.808 . . . . 1.92 108.818 -146.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -126.41 150.64 48.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.751 0.82 . . . . 0.62 110.497 -159.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.86 -42.81 98.62 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.474 0.709 . . . . 2.67 109.917 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.6 p -135.37 159.35 41.86 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.26 0.624 . . . . 0.59 112.091 -170.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.01 -47.4 61.62 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.67 0.788 . . . . 0.72 110.041 160.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -48.15 -49.96 30.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.485 0.314 . . . . 2.64 110.179 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -67.67 -52.47 37.6 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 110.198 -0.297 . . . . 2.11 110.198 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.0 t -49.88 -46.28 51.52 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.387 0.675 . . . . 0.48 111.207 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -59.52 -73.24 0.09 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.752 -1.203 . . . . 2.74 107.752 172.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -42.3 -43.55 3.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.589 1.156 . . . . 0.84 113.577 -172.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.26 -40.74 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 122.855 0.462 . . . . 1.4 111.875 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.532 0.272 0 N-CA-C 113.979 1.103 . . . . 1.66 113.979 -170.134 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.8 pt . . . . . 0 N--CA 1.467 0.377 0 N-CA-C 113.702 1.001 . . . . 2.42 113.702 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 t -31.85 -45.3 0.1 Allowed 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.279 1.832 . . . . 1.91 113.738 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.16 -21.0 61.51 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 125.32 1.638 . . . . 2.09 111.723 -164.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -62.84 157.85 56.88 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.361 0.982 . . . . 3.22 109.489 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -88.33 166.65 6.58 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.588 2.192 . . . . 1.12 111.132 173.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -44.63 132.02 6.51 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.013 0.925 . . . . 2.65 108.67 157.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.0 tttm -158.57 99.03 1.56 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 104.807 -2.294 . . . . 5.17 104.807 -169.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.78 -43.04 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.521 0.728 . . . . 1.31 111.809 -168.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.84 151.11 27.76 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.682 -1.367 . . . . 1.9 109.682 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -80.75 50.66 1.38 Allowed 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.967 -0.725 . . . . 5.61 112.872 -166.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.47 142.01 39.43 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 107.578 -1.267 . . . . 1.69 107.578 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -85.32 54.72 3.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.208 0.603 . . . . 5.62 109.617 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.53 173.15 25.74 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.618 -0.593 . . . . 1.67 111.618 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -137.65 79.58 1.75 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.992 1.317 . . . . 1.1 107.814 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -116.1 107.25 48.05 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 106.96 -1.496 . . . . 1.01 106.96 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.21 133.99 40.37 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 CA-C-N 120.637 1.263 . . . . 0.78 109.097 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -131.55 172.3 12.39 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.836 -1.172 . . . . 3.06 107.836 170.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.06 144.67 36.77 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.682 1.593 . . . . 0.5 107.501 170.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.46 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 1.8 p90 -131.22 161.19 32.79 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.568 -0.901 . . . . 0.72 108.568 169.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -73.16 105.39 4.57 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.64 -1.985 . . . . 1.37 105.64 156.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 6.4 t70 -73.45 118.52 16.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.895 -1.52 . . . . 2.29 106.895 169.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 t -86.26 -25.44 25.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.186 0.994 . . . . 1.72 108.799 -174.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -61.94 -43.79 98.11 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 127.178 2.191 . . . . 4.24 107.082 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.1 p -96.24 -36.57 10.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.825 2.05 . . . . 1.17 110.759 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.64 48.82 4.83 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.208 1.385 . . . . 0.88 110.506 -173.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.04 147.04 31.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 128.29 2.636 . . . . 4.17 111.92 -172.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.9 m -69.75 123.14 20.64 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.802 -0.814 . . . . 0.64 108.802 171.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.4 m -147.33 148.86 32.95 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 124.353 1.061 . . . . 0.62 108.457 -161.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.75 151.58 36.4 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.969 2.446 . . . . 0.49 112.148 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -149.91 163.2 38.69 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.537 1.535 . . . . 0.5 107.743 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.56 120.24 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 107.958 -1.127 . . . . 0.85 107.958 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -95.79 143.96 26.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.535 1.934 . . . . 2.22 107.427 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.33 0.77 88.67 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.509 -0.606 . . . . 1.08 113.068 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.94 6.16 77.82 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.796 1.298 . . . . 1.72 112.125 -172.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.98 -156.06 0.31 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.291 1.037 . . . . 3.01 111.393 -174.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -38.81 -41.96 1.37 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.429 1.49 . . . . 3.79 114.173 169.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.95 -141.01 46.11 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.698 -1.361 . . . . 1.47 109.698 -177.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -179.95 -160.53 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.786 2.034 . . . . 1.06 108.634 174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.62 -44.14 16.77 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 118.685 0.675 . . . . 0.78 111.447 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -73.87 64.94 1.01 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.92 1.288 . . . . 3.05 109.314 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -159.14 74.31 0.63 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.082 0.953 . . . . 2.07 109.375 -168.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -103.34 153.59 20.28 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 124.049 0.939 . . . . 0.77 110.371 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.25 -48.63 79.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.325 -0.62 . . . . 2.66 109.325 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.1 p -130.87 161.06 32.67 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.243 0.831 . . . . 0.84 113.243 -164.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.45 -49.46 61.69 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.713 -0.847 . . . . 0.85 108.713 159.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -42.54 -51.88 4.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.427 0.558 . . . . 2.13 110.504 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -61.31 -56.54 19.37 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.07 -0.49 . . . . 1.95 111.044 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.9 t -52.75 -41.15 63.77 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.924 0.868 . . . . 0.91 112.368 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -60.74 3.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.973 2.109 . . . . 2.88 109.165 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.72 -44.29 93.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.77 0.828 . . . . 0.81 111.347 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.49 -40.75 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.259 1.023 . . . . 1.57 110.991 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.9 t . . . . . 0 CA--C 1.522 -0.109 0 N-CA-C 112.551 0.574 . . . . 1.7 112.551 -166.644 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.225 -0.227 0 N-CA-C 116.934 2.198 . . . . 2.44 116.934 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.9 m -72.55 -12.77 61.21 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.674 -0.641 . . . . 1.86 111.835 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -52.5 10.75 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.192 -1.04 . . . . 1.79 108.192 165.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.14 108.08 1.46 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.347 1.459 . . . . 4.53 111.544 -174.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.06 175.43 10.91 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 CA-C-N 120.698 1.285 . . . . 1.7 112.031 -173.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -40.96 133.65 2.12 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 126.189 1.795 . . . . 3.09 111.206 167.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -156.6 130.92 8.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.842 2.057 . . . . 5.0 105.922 170.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.68 -52.37 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 N-CA-C 109.547 -0.538 . . . . 1.5 109.547 -170.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.0 28.86 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.465 -1.854 . . . . 2.19 108.465 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -94.59 14.38 21.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.007 0.523 . . . . 5.9 111.128 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.0 m -145.36 160.07 42.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 105.877 -1.897 . . . . 2.17 105.877 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -74.09 -73.11 0.24 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.918 0.326 . . . . 5.48 110.273 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.51 -179.91 0.53 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.56 1.076 . . . . 1.7 113.571 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -148.12 76.0 1.36 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.7 0.8 . . . . 1.52 109.73 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -114.64 100.36 53.09 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.851 -0.796 . . . . 0.95 108.851 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.59 118.5 5.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.49 1.46 . . . . 0.62 109.771 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -125.19 -179.61 4.66 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 127.24 2.216 . . . . 3.45 109.292 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -123.29 143.86 49.8 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.288 2.235 . . . . 0.44 107.661 171.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -126.28 154.15 43.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.133 -1.432 . . . . 0.67 107.133 170.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.14 104.45 5.72 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.726 -1.583 . . . . 0.96 106.726 160.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.03 117.01 17.3 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.118 1.367 . . . . 1.97 107.769 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 t -86.47 -20.79 27.59 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 122.191 -0.318 . . . . 1.07 110.37 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -65.56 -46.4 79.62 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 126.859 2.064 . . . . 4.16 106.75 -173.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.4 p -88.71 -29.85 19.54 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.374 1.869 . . . . 0.85 110.413 170.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.73 54.45 7.36 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.348 -1.501 . . . . 0.85 109.348 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -146.1 157.21 43.84 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 126.813 2.045 . . . . 4.72 108.129 -172.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 95.7 m -80.48 142.43 34.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.321 -1.362 . . . . 0.73 107.321 161.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.9 m -154.32 141.39 13.42 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.327 -0.99 . . . . 0.5 108.327 -169.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.76 154.83 59.01 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.954 2.436 . . . . 0.44 111.177 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -158.03 160.89 37.93 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.083 0.953 . . . . 0.47 109.179 172.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -89.65 115.01 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 107.309 -1.367 . . . . 0.84 107.309 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -85.37 149.77 25.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.612 1.565 . . . . 2.27 107.581 167.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.81 13.64 34.91 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.601 1.096 . . . . 1.38 113.273 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.4 -52.29 4.71 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.891 1.234 . . . . 1.66 110.237 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.42 122.37 40.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.093 0.949 . . . . 2.18 111.268 -165.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.94 -66.25 3.8 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.613 1.101 . . . . 2.73 110.836 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 36.58 -118.38 0.47 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.03 1.3 . . . . 2.29 112.366 -172.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -172.46 179.9 2.38 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 127.984 2.513 . . . . 1.32 107.272 165.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.09 -32.24 72.78 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 112.176 -0.37 . . . . 1.11 112.176 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -75.45 70.56 2.33 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.889 0.875 . . . . 1.68 109.831 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -158.62 78.61 0.79 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.897 1.279 . . . . 1.77 108.069 -157.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -115.71 144.45 43.93 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.316 1.446 . . . . 0.78 110.433 -162.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.89 -38.3 90.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.294 0.952 . . . . 3.17 111.579 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -133.49 161.69 33.9 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.277 0.631 . . . . 0.49 111.987 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 tp -51.8 -49.69 62.24 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.638 -0.875 . . . . 1.06 108.638 159.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -45.93 -48.58 16.24 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.183 0.901 . . . . 2.36 110.38 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -66.03 -54.42 26.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.375 -0.232 . . . . 2.16 110.375 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.3 t -53.62 -48.41 69.34 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.437 0.637 . . . . 0.5 111.895 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -54.19 -55.18 30.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.876 2.47 . . . . 2.59 110.055 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.23 -43.46 78.64 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.666 0.386 . . . . 0.68 110.957 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.4 mm -68.25 -45.13 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 118.916 -0.564 . . . . 1.88 111.126 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.7 m . . . . . 0 C--N 1.34 0.19 0 CA-C-N 118.833 0.742 . . . . 2.51 110.991 -175.64 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 pt . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 120.825 0.345 . . . . 1.87 110.8 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.9 m -57.71 -18.35 20.42 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.536 0.734 . . . . 1.93 112.617 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.01 -25.23 32.4 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.256 0.935 . . . . 1.33 110.792 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -64.41 144.36 98.53 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 118.787 0.721 . . . . 4.59 110.699 -174.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.81 -173.63 1.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.038 2.492 . . . . 1.27 110.702 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -77.83 141.73 38.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.08 1.352 . . . . 3.4 111.411 161.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.62 ' HD2' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -159.16 139.9 12.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.116 -2.55 . . . . 5.3 104.116 -176.666 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.7 t -63.15 -44.89 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 120.144 1.338 . . . . 1.62 109.506 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.52 144.69 15.74 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.823 -1.711 . . . . 2.28 108.823 -171.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -80.66 59.32 3.57 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.13 -0.629 . . . . 5.86 112.682 -165.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.4 m -143.35 144.03 31.91 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 108.837 -0.801 . . . . 2.37 108.837 167.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -90.08 72.04 7.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.682 0.793 . . . . 4.91 109.457 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.07 -174.96 13.79 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.636 -0.985 . . . . 1.27 110.636 172.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -142.05 93.89 2.6 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.323 1.449 . . . . 1.48 107.354 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -124.75 105.74 29.73 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 108.486 -0.931 . . . . 0.92 108.486 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.4 100.18 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.572 1.514 . . . . 1.22 109.477 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.444 ' HG3' HD21 ' A' ' 42' ' ' ASN . 8.6 mmt85 -106.81 179.84 4.15 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.512 1.525 . . . . 3.39 108.345 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -119.53 145.09 46.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.253 1.421 . . . . 0.41 108.333 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -124.02 150.42 44.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.144 -1.428 . . . . 0.75 107.144 167.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -75.56 102.0 5.11 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.307 -1.738 . . . . 1.21 106.307 162.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.44 104.95 4.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.619 -1.252 . . . . 2.21 107.619 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.2 t -84.0 -1.63 55.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.048 -0.977 . . . . 1.65 112.824 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.29 -48.12 10.77 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.936 -1.505 . . . . 5.25 106.936 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 64.7 p -82.32 -32.14 29.58 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.431 1.092 . . . . 1.13 110.603 175.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.92 4.84 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.008 -1.237 . . . . 0.96 110.008 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.51 135.61 22.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.904 0.882 . . . . 5.91 111.809 -169.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.3 m -69.5 126.45 29.79 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.215 -1.402 . . . . 0.45 107.215 163.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.2 m -147.68 138.41 12.99 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.321 -0.992 . . . . 0.51 108.321 -163.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 157.47 57.66 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.516 2.144 . . . . 0.38 111.015 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -158.17 155.65 29.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.343 1.057 . . . . 0.53 109.401 170.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.4 mm -84.51 109.2 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.871 -1.159 . . . . 1.11 107.871 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -87.12 146.15 26.16 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.693 1.197 . . . . 2.3 109.616 174.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.08 -28.78 53.2 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.585 1.564 . . . . 1.15 112.488 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.59 -40.89 1.71 Allowed Glycine 0 C--N 1.339 0.706 0 CA-C-N 117.738 0.769 . . . . 1.91 111.294 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -154.29 165.2 37.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.6 -0.889 . . . . 3.35 108.6 -174.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.24 49.14 81.75 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.962 0.791 . . . . 2.98 111.9 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.0 -121.37 4.16 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.115 -1.194 . . . . 1.78 110.115 174.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.62 ' ND2' ' HD2' ' A' ' 8' ' ' LYS . 29.4 p30 -157.03 -179.73 8.49 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.965 1.306 . . . . 1.27 107.559 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.58 -21.67 74.73 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.347 -0.696 . . . . 0.86 113.821 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -78.26 70.65 4.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.092 1.446 . . . . 1.53 108.065 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.444 HD21 ' HG3' ' A' ' 18' ' ' ARG . 14.5 t-20 -158.84 85.35 0.82 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.017 1.727 . . . . 2.11 108.046 -169.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -114.29 147.15 39.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.502 1.121 . . . . 0.78 109.587 -164.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.14 -39.2 93.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.937 0.399 . . . . 2.62 110.475 -174.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.6 p -141.33 163.04 34.02 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.689 0.795 . . . . 0.54 110.735 -169.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.61 -45.97 66.82 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 109.402 -0.592 . . . . 0.49 109.402 162.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -47.56 -51.11 22.06 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.973 0.352 . . . . 2.0 110.509 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -69.56 -49.4 54.6 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.264 -0.273 . . . . 2.21 110.264 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 t -50.66 -44.02 57.51 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.381 0.61 . . . . 0.55 111.143 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -62.94 -58.39 7.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.46 1.104 . . . . 3.82 109.603 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.11 -41.38 17.2 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.782 0.676 . . . . 0.83 111.429 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.03 -53.3 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.767 0.427 . . . . 1.58 112.028 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 78.7 m . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 114.392 1.256 . . . . 2.84 114.392 -163.98 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.8 pt . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.008 0.432 . . . . 1.65 111.905 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.5 m -49.87 -26.29 3.93 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.493 1.117 . . . . 1.26 112.743 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.27 -26.51 62.02 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.289 0.495 . . . . 1.35 110.433 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -61.06 137.87 94.14 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 108.597 -0.89 . . . . 3.52 108.597 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.16 170.2 20.52 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.864 1.709 . . . . 1.23 111.769 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 20' ' ' TYR . 1.6 ttpm? -51.76 140.69 18.6 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.164 0.983 . . . . 2.66 110.697 156.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 132.54 8.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 113.756 -1.565 . . . . 5.67 106.943 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -67.48 -39.95 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.479 -0.934 . . . . 1.39 108.479 172.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.48 33.38 8.63 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.836 0.732 . . . . 3.24 111.655 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 48.71 60.55 3.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.254 1.821 . . . . 8.39 113.391 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -153.89 152.15 30.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.774 -0.825 . . . . 1.78 108.774 168.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -82.82 70.36 9.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.853 -1.166 . . . . 4.84 107.853 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.23 149.85 16.97 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 109.39 -1.484 . . . . 1.29 109.39 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -120.14 72.6 0.94 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.923 -1.51 . . . . 1.22 106.923 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -102.73 96.01 7.05 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 107.092 -1.447 . . . . 0.74 107.092 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -60.97 127.15 21.45 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 N-CA-C 108.879 -1.239 . . . . 0.56 108.879 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -135.49 179.98 6.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.71 1.604 . . . . 2.6 107.642 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -119.8 149.17 42.48 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.101 1.76 . . . . 0.47 107.949 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.492 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 2.2 p90 -134.03 157.26 46.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.866 -1.902 . . . . 0.66 105.866 170.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -71.34 105.89 3.67 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.377 -1.712 . . . . 0.95 106.377 159.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.492 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 7.5 t0 -71.65 115.31 10.69 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.855 -1.535 . . . . 2.25 106.855 172.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 t -94.46 -9.25 36.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 123.8 0.688 . . . . 1.33 109.674 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.45 -43.68 72.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.451 -2.055 . . . . 4.3 105.451 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.8 p -98.89 -40.08 8.27 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.564 2.346 . . . . 1.09 112.846 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 60.9 1.26 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.94 -1.264 . . . . 1.05 109.94 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -157.63 138.36 13.1 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 124.16 0.984 . . . . 5.15 109.556 -163.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.6 m -72.85 122.38 21.5 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 120.617 -1.302 . . . . 0.56 107.594 165.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.4 m -143.06 145.34 32.51 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 108.507 -0.923 . . . . 0.62 108.507 -162.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.51 153.21 65.64 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.789 2.326 . . . . 0.51 111.188 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -155.76 163.21 40.14 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.195 -1.409 . . . . 0.68 107.195 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.11 126.47 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 N-CA-C 108.01 -1.107 . . . . 0.9 108.01 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -105.91 148.66 27.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.515 1.126 . . . . 2.3 108.384 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.83 -9.57 62.42 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.711 1.148 . . . . 1.14 113.028 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 14.05 80.65 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.155 0.977 . . . . 1.64 112.395 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.5 m -145.96 178.48 8.16 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 107.016 -1.476 . . . . 2.16 107.016 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.64 -69.17 2.1 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.383 1.944 . . . . 3.07 110.674 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.67 -163.98 3.52 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.326 1.917 . . . . 1.43 113.578 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.5 p30 170.46 -160.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.256 3.822 . . . . 1.6 104.759 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.38 -44.52 7.93 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.76 1.164 . . . . 0.99 110.287 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -74.88 78.26 2.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.105 0.955 . . . . 1.56 112.134 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -156.55 115.38 3.39 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.763 1.625 . . . . 2.23 108.002 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -133.95 155.65 49.56 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 124.762 1.225 . . . . 0.64 108.73 -168.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -80.2 -31.22 38.75 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.463 -0.773 . . . . 2.97 111.633 -174.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.1 p -145.73 165.01 30.03 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.761 0.824 . . . . 0.69 110.08 -173.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.57 -46.55 70.32 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 109.558 -0.534 . . . . 0.58 109.558 163.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -47.03 -52.19 15.53 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 110.039 -0.356 . . . . 2.1 110.039 175.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 tp-100 -66.94 -51.73 51.72 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.283 -0.265 . . . . 3.96 110.283 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -51.84 -48.59 63.89 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 122.911 0.484 . . . . 0.59 110.882 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.4 -58.13 9.82 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.943 0.897 . . . . 2.48 109.273 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.19 -41.64 62.82 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.514 0.725 . . . . 0.74 111.763 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.3 mm -70.43 -51.66 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.39 0.276 . . . . 1.5 110.522 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.7 t . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 113.044 0.757 . . . . 1.49 113.044 -164.879 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 107.314 -1.365 . . . . 3.13 107.314 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.3 pt -53.05 -22.58 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.717 0.807 . . . . 1.92 112.295 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 89.0 m -34.55 -42.58 0.15 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.827 1.251 . . . . 1.57 111.441 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.95 -17.39 62.08 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.909 1.077 . . . . 1.4 113.909 -170.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -73.39 143.29 82.59 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 119.889 1.222 . . . . 3.03 110.819 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.22 -179.18 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.215 2.61 . . . . 1.32 109.936 166.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.51 134.64 55.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.663 0.744 . . . . 2.61 110.591 170.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -139.34 128.25 23.55 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.461 1.904 . . . . 5.66 106.076 170.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.6 t -75.45 -85.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.122 -1.436 . . . . 1.8 107.122 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.96 179.24 30.0 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 107.861 -2.096 . . . . 1.85 107.861 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -72.1 -48.73 41.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.725 -1.213 . . . . 5.66 107.725 174.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.1 m -71.08 150.31 45.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.105 -1.072 . . . . 2.16 108.105 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.45 20.21 13.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.703 0.801 . . . . 7.07 110.363 -170.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.25 147.9 50.91 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.9 -0.88 . . . . 1.64 110.9 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -81.7 73.3 8.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.728 0.775 . . . . 1.51 108.912 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -99.35 93.13 2.05 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 106.895 -1.52 . . . . 0.98 106.895 166.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.6 125.19 13.93 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 N-CA-C 108.064 -1.552 . . . . 0.55 108.064 171.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -132.78 176.47 8.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.345 1.458 . . . . 3.7 107.279 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -118.25 139.37 51.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.847 1.659 . . . . 0.68 108.394 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -118.26 148.89 41.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.903 -1.888 . . . . 0.84 105.903 168.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -70.78 100.02 1.82 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.47 -2.419 . . . . 1.19 104.47 160.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -71.88 77.96 0.89 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 105.602 -1.999 . . . . 2.37 105.602 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.0 t -61.71 -18.87 61.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.419 1.088 . . . . 1.29 110.342 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -62.06 -44.37 96.82 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 105.459 -2.052 . . . . 4.39 105.459 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.7 p -94.58 -24.55 17.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.52 1.528 . . . . 1.07 114.04 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.43 19.37 64.38 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.766 1.174 . . . . 0.81 112.418 -165.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HB2' ' HZ2' ' A' ' 27' ' ' LYS . 8.2 mtmp? -103.4 163.28 12.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.644 1.178 . . . . 5.63 109.99 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.5 m -90.28 138.95 31.12 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 105.55 -2.018 . . . . 0.68 105.55 148.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.1 m -156.13 145.73 15.39 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 118.377 -0.82 . . . . 0.81 109.212 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.33 153.27 61.49 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.074 2.516 . . . . 0.46 112.11 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -154.68 166.1 34.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.543 1.937 . . . . 0.42 105.93 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.99 127.76 50.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 106.67 -1.604 . . . . 0.74 106.67 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -85.93 -77.42 0.3 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.177 0.991 . . . . 2.55 110.957 -172.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.67 98.17 0.51 Allowed Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.861 -1.296 . . . . 3.11 109.861 -168.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -32.41 -63.45 0.28 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 127.219 2.343 . . . . 2.17 114.071 -171.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.254 0.8 OUTLIER -74.47 121.66 21.83 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.534 0.938 . . . . 2.85 113.534 -176.402 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.48 18.97 26.66 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.043 1.783 . . . . 2.5 113.357 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.24 162.93 39.35 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.309 1.055 . . . . 1.67 113.691 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -118.79 -169.25 1.69 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.111 1.365 . . . . 1.47 110.513 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.44 -44.1 6.68 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.446 -1.062 . . . . 0.86 110.446 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -72.75 73.95 1.1 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.432 0.634 . . . . 1.61 110.549 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -159.33 96.37 1.29 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.833 1.253 . . . . 1.94 108.555 -166.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -125.19 141.4 52.12 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 124.821 1.248 . . . . 0.72 111.343 -165.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -55.47 -34.6 64.67 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.511 0.724 . . . . 3.1 111.547 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.7 p -141.12 160.05 40.92 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.794 0.838 . . . . 0.55 112.061 -169.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -51.37 -48.12 62.63 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-O 117.941 -1.028 . . . . 0.6 108.839 158.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -39.41 -56.5 1.58 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.063 0.847 . . . . 2.07 110.766 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -70.11 -50.28 42.35 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 121.164 -0.214 . . . . 4.51 110.812 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.8 t -52.9 -32.78 47.13 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 122.064 0.935 . . . . 0.94 112.143 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -73.83 -72.68 0.26 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 124.677 1.191 . . . . 4.01 107.952 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -41.76 -45.15 3.46 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.798 1.639 . . . . 0.58 112.439 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.8 mm -73.18 -33.5 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 119.344 -0.36 . . . . 1.68 111.852 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -106.68 -52.52 2.76 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.33 0.863 . . . . 1.31 113.33 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.486 HH11 ' HG3' ' A' ' 54' ' ' ARG . 8.1 mtm-85 -130.43 120.7 24.62 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.468 1.907 . . . . 5.82 111.211 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 117.549 -1.215 . . . . 4.87 110.0 161.208 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 118.267 -0.873 . . . . 3.11 109.416 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.634 HD12 ' N ' ' A' ' 3' ' ' CYS . 2.2 pp -53.97 -31.57 21.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 O-C-N 124.13 0.894 . . . . 2.34 112.938 -168.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.634 ' N ' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -50.65 -32.44 19.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.31 1.044 . . . . 1.78 111.955 177.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -30.31 64.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.058 0.543 . . . . 1.8 112.409 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -77.14 131.04 73.42 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.599 -0.889 . . . . 4.1 108.599 -170.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.81 -176.48 3.06 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.071 1.847 . . . . 1.44 113.602 -164.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 20' ' ' TYR . 3.2 ttpm? -61.61 153.29 28.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.245 1.018 . . . . 2.74 109.301 157.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.501 ' CD ' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -155.95 173.83 16.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.918 -2.253 . . . . 5.73 104.918 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.0 -87.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 106.236 -1.764 . . . . 1.46 106.236 160.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.93 -171.01 43.21 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.84 -1.704 . . . . 1.88 108.84 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -120.24 24.81 10.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.292 1.037 . . . . 6.89 110.62 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.3 m -138.83 159.73 41.43 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.55 -1.648 . . . . 2.28 106.55 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -79.75 55.97 2.17 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.883 0.473 . . . . 4.62 110.594 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.8 159.57 29.3 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.331 -0.707 . . . . 1.47 111.331 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -140.41 73.05 1.41 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.781 -1.563 . . . . 1.94 106.781 171.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.89 97.03 22.25 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 108.632 -0.877 . . . . 0.82 108.632 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.0 118.27 5.12 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 120.462 1.201 . . . . 0.96 109.153 172.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -120.88 179.3 4.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 127.571 2.349 . . . . 3.86 108.429 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -117.83 148.39 42.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.584 2.354 . . . . 0.99 107.729 167.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 7' ' ' LYS . 2.3 p90 -134.32 156.02 49.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.498 -1.667 . . . . 1.27 106.498 166.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -66.77 112.28 4.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.558 -1.645 . . . . 1.51 106.558 159.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -93.08 122.3 35.31 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 123.898 0.749 . . . . 1.76 110.49 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -89.2 -5.25 57.84 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 117.82 -1.086 . . . . 1.83 111.938 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -71.19 -48.86 49.06 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.624 -1.621 . . . . 4.69 106.624 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.8 p -88.16 -30.81 19.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.695 1.198 . . . . 1.69 112.73 174.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.33 26.75 29.7 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.1 0.857 . . . . 0.99 111.952 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -142.49 154.32 44.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.189 1.396 . . . . 4.76 110.819 -167.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.7 m -68.99 121.27 16.29 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 108.224 -1.028 . . . . 0.64 108.224 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.2 m -144.65 145.07 26.93 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 123.512 0.725 . . . . 0.73 109.183 -160.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.48 154.44 68.83 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.913 2.409 . . . . 0.73 111.723 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -155.66 158.07 37.7 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.652 -1.24 . . . . 0.68 107.652 166.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -94.92 118.33 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 N-CA-C 107.48 -1.304 . . . . 1.36 107.48 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -91.49 145.17 24.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.881 1.272 . . . . 2.09 109.82 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.26 22.61 37.69 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.786 1.184 . . . . 1.6 112.734 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.92 -46.34 3.64 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.629 1.214 . . . . 1.41 111.99 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.0 155.45 49.96 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.564 1.146 . . . . 2.14 110.325 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.07 47.79 35.97 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.285 -0.726 . . . . 2.78 111.285 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.96 -153.42 29.31 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.736 0.684 . . . . 1.36 111.907 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.501 ' ND2' ' CD ' ' A' ' 8' ' ' LYS . 17.5 p30 -149.36 -171.52 3.91 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.93 -1.878 . . . . 1.84 105.93 165.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.51 -35.01 85.94 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.907 0.776 . . . . 0.66 112.175 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -76.65 70.76 3.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.572 1.149 . . . . 1.82 109.731 -176.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.92 63.48 0.65 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.071 -0.714 . . . . 2.1 109.071 -161.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -104.41 146.89 28.2 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.722 1.209 . . . . 0.82 109.519 -162.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -64.54 -40.01 94.82 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.873 1.669 . . . . 2.83 110.58 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -126.03 153.73 43.99 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.998 1.111 . . . . 0.48 113.998 -167.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.85 -47.22 42.84 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.557 1.143 . . . . 0.54 110.273 159.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -44.16 -53.77 6.2 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.416 0.686 . . . . 2.08 110.408 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -64.92 -52.37 56.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 119.534 -0.269 . . . . 2.45 110.44 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.0 t -48.25 -52.68 20.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.533 0.682 . . . . 0.71 111.436 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.9 ttm-85 -57.0 -62.05 2.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.726 1.211 . . . . 2.79 109.927 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.97 -38.06 64.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.513 0.725 . . . . 0.72 111.993 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.4 mt -75.41 -53.53 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 122.91 0.484 . . . . 1.52 110.75 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.9 t -99.47 -37.74 9.07 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.584 0.957 . . . . 1.57 113.584 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -111.49 -152.45 0.5 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.551 1.54 . . . . 4.48 109.856 -169.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 104.478 -2.416 . . . . 4.81 104.478 161.011 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 117.789 -1.1 . . . . 2.8 109.221 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -44.61 -38.17 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.632 1.173 . . . . 1.89 112.157 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.02 -13.32 1.86 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.89 1.676 . . . . 2.34 114.324 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.03 -33.97 70.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.198 -1.038 . . . . 2.67 108.198 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -77.98 137.98 61.41 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.44 -0.948 . . . . 3.51 108.44 167.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -80.13 -179.68 5.46 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.064 1.842 . . . . 1.46 110.072 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -39.87 139.13 0.68 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 115.496 1.665 . . . . 3.11 115.496 149.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -157.36 151.53 24.77 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 129.128 2.971 . . . . 4.96 104.853 168.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.3 t -136.7 -60.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.09 0.471 . . . . 2.09 111.961 -160.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.67 65.96 3.09 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 114.679 0.632 . . . . 3.62 114.679 -155.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.78 -18.51 5.57 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.49 0.716 . . . . 6.52 112.245 164.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.5 m -130.88 160.81 33.35 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 106.845 -1.539 . . . . 1.91 106.845 161.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -120.69 52.94 1.14 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.503 1.121 . . . . 4.99 109.727 -170.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.16 139.61 15.49 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.316 -1.113 . . . . 1.76 110.316 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -82.64 74.48 9.6 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.078 -0.712 . . . . 1.16 109.078 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -101.7 92.44 2.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 118.204 -0.903 . . . . 1.03 109.998 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.21 111.36 2.24 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.977 1.784 . . . . 0.73 109.586 174.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HG3' HD21 ' A' ' 42' ' ' ASN . 9.0 mmt85 -120.66 -179.08 3.88 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.897 1.679 . . . . 3.19 108.891 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -120.0 146.48 45.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.735 1.614 . . . . 0.4 108.538 172.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 6.0 p90 -127.76 152.22 48.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.451 -1.315 . . . . 0.7 107.451 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -68.04 101.9 1.21 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.071 -1.825 . . . . 1.32 106.071 158.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -73.44 138.06 44.95 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.412 -0.588 . . . . 2.22 109.412 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.7 t -108.2 -8.37 15.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.692 1.197 . . . . 1.64 111.068 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.64 -50.25 45.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.363 -1.347 . . . . 4.22 107.363 168.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.9 p -89.14 -28.23 20.19 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.798 0.839 . . . . 1.27 112.231 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.06 39.7 18.97 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.317 -0.713 . . . . 0.9 111.352 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -148.69 148.09 29.64 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.614 1.207 . . . . 4.26 110.414 -166.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.8 m -68.7 118.4 11.64 Favored 'General case' 0 CA--C 1.526 0.049 0 N-CA-C 108.572 -0.899 . . . . 0.52 108.572 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.2 m -136.71 142.02 37.43 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 124.928 1.291 . . . . 0.56 108.718 -164.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.52 154.45 50.15 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.016 2.478 . . . . 0.45 111.453 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -159.64 158.24 31.16 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.577 1.151 . . . . 0.76 109.176 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.1 mm -86.3 119.87 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 106.64 -1.615 . . . . 1.18 106.64 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -80.09 -19.78 46.64 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.018 0.747 . . . . 3.42 113.018 -168.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.29 -46.46 3.41 Favored Glycine 0 CA--C 1.527 0.821 0 O-C-N 120.979 -1.076 . . . . 1.15 110.45 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.8 -30.94 3.85 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.21 0.909 . . . . 1.79 112.953 165.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.69 159.42 39.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.736 0.814 . . . . 2.47 111.607 -169.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.0 5.03 51.32 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.192 0.901 . . . . 3.15 112.414 -166.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.17 -149.71 3.5 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.395 0.998 . . . . 1.83 110.943 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -151.56 -176.24 5.52 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.709 1.204 . . . . 1.28 108.629 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.38 -5.14 90.22 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.549 -1.14 . . . . 1.1 113.152 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -78.15 65.58 3.56 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.961 1.88 . . . . 1.59 107.073 170.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.425 HD21 ' HG3' ' A' ' 18' ' ' ARG . 20.6 t-20 -159.0 112.68 2.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.929 -1.137 . . . . 2.44 107.929 -165.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -136.24 148.5 48.08 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.549 1.14 . . . . 0.71 108.206 -165.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.46 -38.59 84.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.337 0.517 . . . . 2.6 109.779 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.5 p -135.66 160.14 39.43 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.873 0.869 . . . . 0.7 111.707 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.66 -46.81 58.73 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 123.393 0.677 . . . . 0.62 109.803 161.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -49.32 -49.59 43.29 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.099 -0.334 . . . . 2.6 110.099 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -67.22 -50.61 60.11 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.024 -0.362 . . . . 1.91 110.024 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.8 t -50.63 -46.15 58.08 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.507 0.67 . . . . 0.61 111.184 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -59.15 -59.8 4.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.806 1.242 . . . . 2.75 109.727 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.54 -41.93 54.52 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.359 0.664 . . . . 0.66 111.824 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.92 -50.39 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 122.962 0.505 . . . . 1.48 111.236 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.0 t -129.24 -5.63 4.87 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.783 1.401 . . . . 2.0 114.783 -156.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -117.75 -156.82 0.65 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.609 1.564 . . . . 5.65 108.591 167.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 104.075 -2.565 . . . . 4.75 104.075 148.005 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 107.347 -1.353 . . . . 3.32 107.347 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -50.56 -29.51 6.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 O-C-N 123.888 0.743 . . . . 2.05 111.234 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 66.4 m -45.13 -32.95 1.99 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.488 1.515 . . . . 1.34 112.093 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.55 7.14 47.25 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.617 0.599 . . . . 2.69 112.617 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.16 127.5 92.03 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.56 1.073 . . . . 3.29 109.165 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.11 145.61 49.83 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.797 2.331 . . . . 2.08 107.337 170.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -76.07 132.58 40.18 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 117.932 -1.507 . . . . 8.43 112.087 -164.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.86 148.1 39.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.789 2.036 . . . . 5.56 107.251 168.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -80.87 -87.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.746 -1.575 . . . . 2.22 106.746 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.57 55.09 0.03 OUTLIER Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.357 0.503 . . . . 3.48 112.657 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.25 47.55 0.69 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.63 1.972 . . . . 5.29 113.679 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.8 m -96.53 164.25 12.69 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.237 0.615 . . . . 3.72 111.343 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -140.33 58.86 1.57 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.425 -1.324 . . . . 6.7 107.425 170.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.49 171.97 31.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 108.35 -1.9 . . . . 1.24 108.35 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -125.71 102.36 7.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.78 1.232 . . . . 1.21 108.43 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -131.9 105.15 13.96 Favored Pre-proline 0 C--O 1.233 0.207 0 N-CA-C 106.364 -1.717 . . . . 1.25 106.364 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.67 132.04 21.1 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.92 1.747 . . . . 0.64 108.773 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -136.97 178.91 6.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.678 1.591 . . . . 3.53 107.356 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -122.27 145.46 48.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.508 1.523 . . . . 0.48 109.3 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -130.97 150.56 52.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.063 -1.088 . . . . 0.89 108.063 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -72.34 101.42 2.88 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 166.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.79 109.57 6.48 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.541 -1.281 . . . . 2.04 107.541 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -85.62 -7.07 59.05 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.017 0.927 . . . . 1.39 111.971 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -71.01 -55.64 7.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.828 -1.545 . . . . 7.4 106.828 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 p -85.37 -19.03 32.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.774 -1.103 . . . . 1.21 111.986 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.22 41.47 69.05 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.129 -1.188 . . . . 1.15 110.129 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.08 131.81 45.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.072 0.949 . . . . 5.35 109.893 -170.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.535 ' HB2' HD13 ' A' ' 46' ' ' LEU . 56.0 m -67.44 113.01 4.96 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.041 -1.466 . . . . 0.68 107.041 159.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.2 m -126.93 137.25 30.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 126.767 2.027 . . . . 0.73 107.825 -165.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.55 156.21 58.26 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.633 2.222 . . . . 0.42 111.022 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -161.63 165.8 27.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.47 1.508 . . . . 0.62 107.588 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.28 118.72 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 107.62 -1.252 . . . . 0.83 107.62 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -77.45 -42.68 35.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.67 0.788 . . . . 2.35 110.834 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.7 -16.92 43.15 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.978 -0.901 . . . . 1.75 112.895 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.75 25.17 21.24 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 118.171 0.986 . . . . 1.9 113.24 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.86 159.98 9.97 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.323 1.062 . . . . 2.94 109.939 -171.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.85 32.9 59.48 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.221 1.391 . . . . 2.31 114.575 169.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.43 -163.28 9.76 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 122.263 0.924 . . . . 1.36 115.276 -168.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -156.7 -179.75 8.49 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 127.686 2.394 . . . . 1.38 106.377 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.99 -40.03 95.09 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 118.237 0.472 . . . . 0.79 113.411 -169.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -77.34 57.57 1.52 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.466 1.106 . . . . 1.73 111.25 -167.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.75 76.75 1.02 Allowed 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.251 -0.905 . . . . 2.42 110.725 -148.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -122.04 145.24 48.34 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.11 1.364 . . . . 0.84 111.802 -152.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -57.12 -39.06 74.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.487 1.115 . . . . 2.77 111.533 -173.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -144.94 161.15 40.06 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.139 0.576 . . . . 0.64 110.109 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.535 HD13 ' HB2' ' A' ' 28' ' ' CYS . 1.2 tp -52.12 -48.46 64.82 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 118.514 -0.755 . . . . 0.63 109.012 164.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -43.63 -53.9 5.38 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.477 -0.564 . . . . 2.52 109.477 176.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -69.72 -46.51 65.8 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.835 -0.432 . . . . 1.97 109.835 -171.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.4 t -51.97 -49.35 63.39 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 121.078 0.466 . . . . 0.59 110.726 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -60.98 -61.19 2.76 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.223 -1.028 . . . . 5.28 108.223 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -43.8 -48.44 8.18 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.473 1.509 . . . . 0.61 111.55 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -67.4 -50.85 58.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.655 0.382 . . . . 1.67 111.048 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 32.1 m -76.85 -52.81 8.81 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.071 -0.393 . . . . 2.27 112.054 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.432 HH21 ' C ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -138.07 107.87 6.29 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 125.583 1.553 . . . . 8.46 109.654 171.079 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.432 ' C ' HH21 ' A' ' 54' ' ' ARG . . . . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 118.858 -0.591 . . . . 5.92 109.975 162.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 118.144 -0.932 . . . . 2.99 109.201 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.2 pt -71.73 -5.53 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.082 0.953 . . . . 1.86 113.321 -171.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.6 m -56.38 -41.3 76.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.643 -0.661 . . . . 1.48 110.172 160.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.4 -27.47 41.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.592 1.157 . . . . 1.73 111.99 -173.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 50.5 mt-10 -58.32 139.38 84.47 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 106.974 -1.491 . . . . 3.18 106.974 166.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -102.56 -175.77 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.836 2.357 . . . . 1.24 110.821 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.0 132.3 37.5 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.114 -0.699 . . . . 2.76 109.114 167.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.25 136.6 15.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.487 -2.042 . . . . 4.92 105.487 172.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t -74.11 -71.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.131 0.878 . . . . 1.6 108.971 -174.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.69 178.34 17.74 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.232 -1.547 . . . . 1.78 109.232 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -79.01 37.28 0.3 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 117.842 0.821 . . . . 5.55 110.688 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.8 m -166.34 158.86 14.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 105.513 -2.032 . . . . 1.78 105.513 -166.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -139.6 41.53 2.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.399 0.68 . . . . 6.2 110.543 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.81 152.1 49.99 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 109.981 -1.247 . . . . 1.36 109.981 173.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -82.4 74.15 9.39 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.721 -0.87 . . . . 1.35 109.032 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.58 91.0 3.05 Favored Pre-proline 0 CA--C 1.529 0.169 0 N-CA-C 108.77 -0.826 . . . . 0.79 108.77 171.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -62.81 122.63 11.01 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 N-CA-C 108.702 -1.307 . . . . 0.85 108.702 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -130.65 176.39 8.22 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.059 1.744 . . . . 3.48 107.984 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -109.01 148.95 29.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.837 1.255 . . . . 0.6 108.488 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -131.51 153.58 49.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.323 -1.362 . . . . 0.93 107.323 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -82.71 107.01 15.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.171 -1.789 . . . . 1.2 106.171 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.16 112.88 15.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.275 -1.009 . . . . 2.1 108.275 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 t -88.5 -0.56 57.35 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 117.966 -1.016 . . . . 1.22 113.106 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -82.63 -48.98 10.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.498 -1.668 . . . . 5.21 106.498 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.4 p -79.63 -30.71 41.47 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.769 1.228 . . . . 1.1 110.062 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.39 57.06 5.77 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.056 -1.618 . . . . 0.88 109.056 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.28 160.89 37.55 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.18 0.992 . . . . 4.62 110.039 -177.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.0 m -85.99 128.72 34.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.652 0.781 . . . . 0.58 109.075 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -144.06 144.91 27.99 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.52 1.128 . . . . 0.5 108.306 -161.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.43 155.2 45.79 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.969 2.446 . . . . 0.49 112.265 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.25 169.5 23.09 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.526 1.53 . . . . 0.7 108.114 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.18 119.13 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.307 -0.998 . . . . 0.86 108.307 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -89.39 143.57 26.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.32 1.848 . . . . 1.97 109.963 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.3 -36.59 91.3 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.412 -0.66 . . . . 1.09 113.381 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.86 18.9 28.32 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.125 0.869 . . . . 2.21 112.894 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.4 m -141.95 -159.18 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.559 1.144 . . . . 3.19 108.162 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -15.55 -60.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 C-N-CA 128.27 2.843 . . . . 4.43 115.664 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.42 -133.79 12.14 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 119.336 -0.702 . . . . 1.37 111.545 168.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 168.66 -173.42 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 128.904 2.881 . . . . 1.98 106.851 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.17 -44.94 10.69 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.767 -0.933 . . . . 0.8 110.767 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 11.4 t-20 -73.65 67.94 1.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.72 1.208 . . . . 2.94 110.057 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -163.15 88.12 0.58 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.736 1.214 . . . . 2.12 109.791 -168.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -121.21 148.76 43.81 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.432 1.093 . . . . 1.32 111.537 -162.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.45 -38.26 80.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.853 0.461 . . . . 2.94 111.022 -174.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.3 p -142.28 165.83 26.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.516 0.726 . . . . 0.56 110.561 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -47.76 79.01 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.814 0.846 . . . . 0.55 110.675 166.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -48.82 -53.61 18.59 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.316 -0.624 . . . . 2.3 109.316 175.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -65.44 -49.98 67.11 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.541 -0.54 . . . . 2.37 109.541 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.5 t -50.3 -51.95 40.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.549 0.69 . . . . 0.98 110.933 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -65.27 -49.18 70.56 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.466 -0.788 . . . . 3.85 109.815 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.87 -44.42 82.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.388 0.675 . . . . 1.21 111.624 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.3 mt -69.95 -51.78 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 122.579 0.352 . . . . 2.15 110.667 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.6 t -73.26 -53.59 10.49 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.504 0.557 . . . . 2.41 112.504 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 7.8 mtp-105 -83.65 166.42 18.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 114.608 1.336 . . . . 5.66 114.608 -167.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 104.468 -2.419 . . . . 6.66 104.468 139.398 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 108.704 -0.851 . . . . 3.06 108.704 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.3 pt -64.31 -15.54 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.393 0.677 . . . . 1.7 111.774 171.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.7 m -77.36 -27.88 52.79 Favored 'General case' 0 C--O 1.222 -0.359 0 O-C-N 121.87 -0.519 . . . . 1.36 110.655 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.92 -30.77 19.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.494 -0.928 . . . . 1.75 108.494 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -52.99 139.04 44.51 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 108.006 -1.109 . . . . 2.79 108.006 165.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -98.79 175.74 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.747 2.298 . . . . 1.42 111.064 172.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.28 138.88 31.24 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.853 -1.067 . . . . 3.17 110.1 160.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 132.4 8.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 128.242 2.617 . . . . 4.57 106.378 176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.1 t -75.51 -86.02 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.103 -1.073 . . . . 2.32 108.103 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.74 147.57 0.6 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 123.606 0.622 . . . . 2.32 113.005 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 65.16 -55.47 0.31 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.871 2.868 . . . . 8.21 115.808 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.7 m -140.06 166.57 24.29 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.299 1.04 . . . . 1.88 109.73 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -133.28 33.0 3.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.087 0.955 . . . . 6.19 110.787 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.75 146.72 42.27 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.071 -1.212 . . . . 1.45 110.071 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -81.79 72.4 8.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.883 0.849 . . . . 1.14 108.718 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -101.57 95.95 5.78 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 107.761 -1.2 . . . . 0.81 107.761 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.1 131.02 29.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 N-CA-C 108.511 -1.38 . . . . 0.72 108.511 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -135.11 174.89 10.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.46 -1.311 . . . . 3.52 107.46 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -111.08 146.65 36.39 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.703 1.201 . . . . 0.46 108.311 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -129.75 152.13 49.59 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.634 -1.247 . . . . 0.96 107.634 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.47 102.42 5.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 103.892 -2.633 . . . . 1.48 103.892 160.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -72.08 109.98 6.24 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.82 -1.918 . . . . 2.24 105.82 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 t -86.27 -14.75 42.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.508 -0.553 . . . . 1.13 109.508 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -63.09 -44.43 95.72 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.846 -1.909 . . . . 4.35 105.846 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.7 p -91.95 -40.83 10.91 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.952 2.501 . . . . 1.21 111.465 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.03 21.89 24.32 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.926 1.727 . . . . 1.04 112.398 -169.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -120.93 151.16 40.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.936 1.694 . . . . 4.53 109.195 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -73.15 136.68 44.82 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 120.664 -1.273 . . . . 0.58 108.093 168.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.8 m -155.11 147.24 17.4 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.431 -0.795 . . . . 0.78 108.947 -169.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.44 152.18 29.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.285 2.657 . . . . 0.64 111.774 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -150.72 158.41 44.12 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 124.831 1.252 . . . . 0.51 108.867 172.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.07 118.79 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 105.726 -1.953 . . . . 0.83 105.726 168.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.79 -54.06 9.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.408 0.683 . . . . 2.84 110.569 -173.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.29 -27.81 7.52 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.208 -0.757 . . . . 1.14 111.208 -173.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.64 -45.36 1.4 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.419 1.009 . . . . 1.5 111.364 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 m -106.4 157.73 17.41 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.577 1.151 . . . . 2.64 108.745 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 30.83 60.95 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.499 -0.612 . . . . 2.17 113.459 166.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.18 157.96 46.12 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 118.442 1.121 . . . . 2.04 111.75 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -117.17 -163.1 0.9 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.557 1.543 . . . . 1.05 108.495 170.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.98 69.39 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.17 -1.172 . . . . 0.87 110.17 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -75.17 58.8 0.94 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.678 1.591 . . . . 2.69 111.522 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -155.29 78.57 1.02 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.935 -0.478 . . . . 2.05 110.202 -161.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -109.77 154.57 22.76 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.247 1.019 . . . . 0.72 110.983 -164.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -67.01 -44.54 80.05 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.833 -0.542 . . . . 2.45 109.564 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 78.3 p -131.28 154.29 48.66 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.958 0.725 . . . . 0.67 112.958 -169.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.02 -47.01 22.38 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.5 1.12 . . . . 0.83 110.037 159.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.3 -50.72 15.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.241 0.616 . . . . 2.24 110.598 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -65.89 -53.62 37.17 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 119.038 -0.506 . . . . 2.68 110.842 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 t -47.39 -44.29 24.2 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.555 0.693 . . . . 0.6 111.656 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.1 ttm-85 -62.14 -70.41 0.2 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.499 1.12 . . . . 2.72 109.576 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.02 -40.81 45.81 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.204 1.402 . . . . 0.54 112.939 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mm -63.68 -39.3 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 123.99 0.916 . . . . 1.42 110.638 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 17.5 t -107.84 -52.2 2.8 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 113.005 0.742 . . . . 1.73 113.005 -165.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -129.09 -154.83 0.66 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.626 1.57 . . . . 4.36 110.18 -160.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 105.919 -1.882 . . . . 5.11 105.919 170.502 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 118.44 -0.791 . . . . 4.27 109.384 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.1 pt -71.19 -14.31 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 113.098 0.777 . . . . 1.73 113.098 -168.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.9 m -73.37 -32.65 64.63 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.811 0.444 . . . . 1.59 111.096 166.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.2 -35.51 31.26 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.908 -0.495 . . . . 1.71 110.134 -177.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -60.01 135.43 90.42 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 117.853 -1.07 . . . . 4.06 109.125 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -104.58 177.2 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.994 2.463 . . . . 1.58 111.757 170.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -36.54 134.07 0.49 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 126.958 2.103 . . . . 2.65 112.911 166.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.07 135.81 9.45 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 113.282 -1.781 . . . . 4.71 109.132 166.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.61 -49.87 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.063 -0.717 . . . . 1.3 109.063 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.95 85.42 0.97 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.705 0.669 . . . . 3.69 112.815 165.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 87.9 mtm-85 65.66 -52.52 0.37 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 128.89 2.876 . . . . 8.8 115.027 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 m -71.87 169.44 15.8 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.114 0.566 . . . . 2.35 109.984 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -129.42 31.03 4.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.012 1.325 . . . . 7.31 109.493 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.83 177.67 48.21 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.808 -1.317 . . . . 1.43 109.808 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -124.96 87.61 2.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.091 0.956 . . . . 1.89 108.73 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -111.57 103.13 54.76 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 108.096 -1.076 . . . . 0.88 108.096 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.6 125.17 14.99 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 N-CA-C 108.874 -1.241 . . . . 0.89 108.874 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -134.2 175.71 9.25 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.468 1.507 . . . . 2.55 107.886 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -103.64 149.28 25.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.942 1.297 . . . . 0.79 108.06 167.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -128.32 157.45 40.93 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.726 -1.583 . . . . 0.79 106.726 166.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -78.84 103.0 8.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.056 -1.831 . . . . 1.33 106.056 163.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -77.4 111.38 13.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.619 -0.882 . . . . 1.83 108.619 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 t -89.3 9.83 24.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.531 0.733 . . . . 1.67 111.892 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -86.68 -45.29 11.13 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.16 -1.792 . . . . 4.49 106.16 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.1 p -93.76 -31.71 14.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 130.263 3.425 . . . . 1.07 111.684 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.35 30.93 12.47 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.436 1.493 . . . . 0.95 112.765 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -143.61 148.11 35.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.19 1.396 . . . . 4.36 111.502 -161.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 78.8 m -71.31 128.23 35.21 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 120.18 -1.575 . . . . 0.5 109.663 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.1 m -149.4 147.33 22.98 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 117.965 -1.016 . . . . 0.56 109.253 -161.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.78 150.0 34.34 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.319 2.679 . . . . 0.53 112.219 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -153.42 171.83 18.05 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.17 1.388 . . . . 0.59 109.014 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.58 107.86 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.765 -0.828 . . . . 1.33 108.765 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -78.47 139.68 38.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.21 1.004 . . . . 2.17 108.706 170.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.12 -43.03 49.39 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-O 119.365 -0.686 . . . . 1.31 112.385 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.62 -9.03 13.02 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.149 0.88 . . . . 1.63 113.448 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.0 m -113.34 -131.11 0.32 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.155 -1.424 . . . . 2.85 107.155 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.04 -62.78 0.04 OUTLIER Glycine 0 C--N 1.338 0.694 0 C-N-CA 127.881 2.657 . . . . 3.0 115.193 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.26 -134.16 8.04 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.506 -1.038 . . . . 1.93 110.506 -166.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -170.0 177.0 4.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 128.21 2.604 . . . . 1.27 106.139 171.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.17 -25.12 73.49 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.193 -0.763 . . . . 0.69 111.193 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -73.7 55.61 0.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.649 1.58 . . . . 2.71 109.908 174.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -147.53 120.57 8.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.521 -1.289 . . . . 2.4 107.521 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -138.6 147.72 43.3 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.49 1.116 . . . . 0.7 108.898 -165.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -78.68 -25.13 44.77 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.884 -0.51 . . . . 3.1 110.92 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -142.42 155.42 45.1 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.512 0.725 . . . . 0.69 111.021 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.13 -45.59 53.12 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 109.297 -0.631 . . . . 0.79 109.297 160.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -44.77 -53.77 7.03 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.939 0.496 . . . . 2.23 110.543 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -63.97 -54.12 39.47 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 110.161 -0.311 . . . . 1.81 110.161 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -48.58 -49.74 35.4 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.31 0.576 . . . . 0.54 111.503 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -59.93 -64.43 0.95 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.613 1.165 . . . . 2.54 109.165 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -44.55 -45.64 9.49 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.508 1.123 . . . . 0.77 111.699 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.8 mm -71.29 -56.71 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.888 0.875 . . . . 1.65 110.739 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 46.5 t -88.09 -44.9 10.6 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.225 0.824 . . . . 1.51 113.225 -168.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.85 82.98 1.63 Allowed 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.633 1.573 . . . . 5.32 111.006 176.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 118.275 -0.869 . . . . 5.29 112.335 -176.794 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 107.383 -1.34 . . . . 3.92 107.383 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.9 pt -47.11 -32.58 2.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 124.574 1.15 . . . . 2.24 112.025 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.8 t -32.23 -41.44 0.05 Allowed 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 126.88 2.072 . . . . 1.82 114.708 169.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.72 -22.82 61.57 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.138 -1.392 . . . . 1.8 111.186 -169.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.43 149.76 94.45 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 118.879 0.763 . . . . 3.06 109.395 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.68 173.16 13.32 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.137 1.891 . . . . 1.06 110.259 170.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -54.32 141.88 28.51 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.782 0.801 . . . . 2.64 109.471 160.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -143.94 133.05 22.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.602 -1.629 . . . . 5.89 106.602 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.84 -55.19 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.295 0.498 . . . . 1.57 110.144 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.64 -157.83 22.53 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 108.39 -1.884 . . . . 2.18 108.39 -175.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -24.13 4.59 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.886 0.875 . . . . 6.23 112.22 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.42 ' HB2' ' H ' ' A' ' 36' ' ' CYS . 64.9 m -79.12 158.26 27.79 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.539 -0.911 . . . . 2.5 108.539 166.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -106.28 45.84 0.96 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.836 0.855 . . . . 5.21 110.15 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.98 176.15 54.11 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.167 -0.773 . . . . 1.18 111.167 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -124.44 81.07 1.9 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.15 1.38 . . . . 1.19 107.287 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -105.99 104.67 50.46 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 108.027 -1.101 . . . . 1.16 108.027 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -65.07 112.96 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 N-CA-C 108.544 -1.368 . . . . 0.62 108.544 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -121.69 178.34 4.89 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.934 2.094 . . . . 3.6 109.211 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -127.32 146.15 50.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.131 1.772 . . . . 0.53 108.313 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -135.25 153.29 51.96 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.167 -1.42 . . . . 0.81 107.167 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 55' ' ' ALA . 46.9 t80 -65.57 103.16 0.81 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.482 -1.673 . . . . 1.31 106.482 161.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -78.54 114.91 17.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.376 -1.713 . . . . 1.95 106.376 169.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 t -86.28 -16.64 36.95 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.404 0.281 . . . . 1.66 110.275 -175.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -67.2 -45.52 76.61 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 126.673 1.989 . . . . 3.67 106.139 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.7 p -88.16 -35.6 17.31 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.246 1.818 . . . . 1.21 110.981 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.48 44.18 8.82 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.845 -1.302 . . . . 0.91 109.845 -171.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.54 141.93 43.4 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.842 1.657 . . . . 5.84 110.162 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.5 m -65.61 113.47 4.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.099 -1.074 . . . . 0.81 108.099 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.7 m -132.94 144.13 51.54 Favored Pre-proline 0 C--N 1.332 -0.185 0 C-N-CA 125.65 1.58 . . . . 0.55 108.613 -163.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.31 156.3 62.21 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.732 2.288 . . . . 0.48 111.697 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -155.21 161.76 41.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.839 1.255 . . . . 0.6 108.051 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.9 mm -93.67 112.39 26.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 108.136 -1.061 . . . . 1.24 108.136 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -90.19 147.14 23.75 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.691 1.196 . . . . 2.26 109.366 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.48 -6.68 89.16 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.252 1.406 . . . . 1.06 113.536 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.78 -49.87 1.41 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.915 1.358 . . . . 1.72 111.581 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.42 ' H ' ' HB2' ' A' ' 12' ' ' CYS . 0.6 OUTLIER -127.23 144.74 50.98 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.127 0.971 . . . . 2.4 110.379 173.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.51 12.47 41.28 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.669 1.604 . . . . 2.19 112.745 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.03 148.88 47.87 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 118.313 1.056 . . . . 2.17 113.094 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -91.01 -161.18 0.79 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.411 1.484 . . . . 1.69 109.732 171.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.27 -45.67 6.13 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.914 -1.275 . . . . 0.89 109.914 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -73.76 72.68 1.52 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.624 0.712 . . . . 1.53 110.158 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -159.95 93.79 1.09 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.745 1.218 . . . . 2.27 108.704 -163.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -131.66 141.63 49.64 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 123.208 0.603 . . . . 1.12 111.056 -160.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -54.52 -43.68 72.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.747 0.819 . . . . 2.7 110.833 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.7 p -137.01 158.28 44.83 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.172 0.511 . . . . 0.69 112.363 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.24 -46.93 62.47 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.167 -0.679 . . . . 0.57 109.167 159.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -46.59 -50.67 17.07 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.223 0.465 . . . . 1.84 110.437 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -65.08 -53.9 38.38 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.764 0.426 . . . . 2.96 110.215 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.0 t -51.83 -45.06 63.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.868 0.842 . . . . 0.54 111.246 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.417 HH21 ' C ' ' A' ' 55' ' ' ALA . 30.9 ttm180 -64.56 -53.76 42.76 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.153 1.381 . . . . 2.98 109.349 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.6 -43.11 56.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.768 0.427 . . . . 0.73 111.167 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.4 mt -69.26 -57.05 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.045 0.538 . . . . 1.96 111.719 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -120.97 -24.4 5.61 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.022 1.119 . . . . 1.58 114.022 -166.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.275 0.3 OUTLIER 67.56 118.25 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 130.929 3.692 . . . . 6.94 110.719 -177.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.417 ' C ' HH21 ' A' ' 50' ' ' ARG . . . . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 127.473 2.309 . . . . 8.98 106.448 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 118.68 -0.676 . . . . 4.45 110.051 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 pt -55.8 -28.65 24.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 114.37 1.248 . . . . 1.95 114.37 -162.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.3 m -55.61 -35.91 66.36 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.896 -0.502 . . . . 1.55 112.226 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.05 -19.37 20.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.947 0.499 . . . . 1.57 111.088 -162.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -72.56 146.21 88.38 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 118.208 0.458 . . . . 4.25 110.323 -161.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.36 166.49 29.14 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.499 2.132 . . . . 1.84 113.092 -169.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -57.68 147.27 28.1 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 107.702 -1.221 . . . . 2.66 107.702 169.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -154.92 69.74 0.74 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.966 0.888 . . . . 6.06 110.791 -156.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.3 t -60.35 -44.67 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.392 -0.596 . . . . 1.8 109.392 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.7 -146.26 18.16 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 107.972 -2.051 . . . . 2.96 107.972 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -154.15 55.11 0.71 Allowed 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.086 -0.709 . . . . 7.68 109.086 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.0 m -150.16 150.56 31.81 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.29 1.036 . . . . 2.85 108.247 -165.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -77.81 63.87 2.95 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.975 0.51 . . . . 7.14 110.351 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -116.2 153.42 17.47 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.733 -1.747 . . . . 1.44 108.733 168.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -144.56 81.2 1.65 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.537 -0.912 . . . . 1.6 108.537 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.33 100.13 45.21 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 108.148 -1.056 . . . . 1.37 108.148 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.71 126.0 17.27 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.32 1.346 . . . . 0.61 109.418 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -137.64 176.24 8.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.493 1.517 . . . . 3.57 108.305 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -121.2 142.44 49.9 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.556 1.543 . . . . 0.54 108.52 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -128.36 152.15 48.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.965 -1.494 . . . . 1.07 106.965 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -73.03 104.14 4.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.637 -1.616 . . . . 1.34 106.637 168.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.16 105.96 4.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.084 -1.45 . . . . 2.04 107.084 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.2 t -81.17 -6.9 59.36 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.154 -0.927 . . . . 1.43 112.831 -173.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -76.09 -49.95 16.03 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.211 -1.403 . . . . 5.24 107.211 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.4 p -88.97 -12.64 40.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.708 0.803 . . . . 1.4 111.752 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.7 37.17 76.36 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.924 1.249 . . . . 0.81 111.119 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -137.96 135.49 36.07 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.316 1.046 . . . . 4.44 110.747 -163.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 90.6 m -66.04 124.45 22.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.347 -0.983 . . . . 0.6 108.347 170.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.5 m -141.37 138.99 18.15 Favored Pre-proline 0 N--CA 1.451 -0.401 0 C-N-CA 124.701 1.2 . . . . 0.84 107.862 -164.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.03 156.89 61.55 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.456 2.104 . . . . 0.65 111.06 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.1 157.86 36.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.215 -1.402 . . . . 0.87 107.215 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.63 116.24 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 105.293 -2.114 . . . . 0.88 105.293 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -86.28 131.2 34.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.53 -1.285 . . . . 2.33 107.53 173.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.52 18.38 56.33 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.851 -0.416 . . . . 1.64 112.408 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.62 -53.83 4.73 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.854 -1.698 . . . . 2.75 108.854 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.6 m -64.3 168.97 5.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.391 1.076 . . . . 2.85 108.73 162.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.15 39.77 62.32 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 109.816 -1.314 . . . . 3.33 109.816 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.95 57.55 5.04 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.655 -1.497 . . . . 2.67 112.686 -171.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -81.68 173.54 12.23 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.146 0.973 . . . . 1.98 108.912 161.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.62 -23.45 72.85 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.519 0.581 . . . . 0.67 114.051 -166.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -77.15 74.76 3.72 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.972 0.886 . . . . 1.74 109.724 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -152.17 96.52 2.2 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.071 0.548 . . . . 2.2 109.96 -160.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -124.35 148.46 47.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.137 0.575 . . . . 1.25 109.492 -170.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -77.06 -27.55 54.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.971 -0.381 . . . . 4.73 109.971 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.9 p -137.0 162.43 33.31 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.819 0.848 . . . . 0.96 112.208 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.77 -49.26 39.38 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.254 1.021 . . . . 0.91 110.101 159.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -46.8 -50.5 18.22 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.701 0.4 . . . . 2.19 110.085 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -66.42 -52.57 45.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 119.235 -0.412 . . . . 3.97 111.2 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 t -47.9 -49.74 28.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.606 0.639 . . . . 0.5 111.212 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -56.71 -65.44 0.61 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.49 1.116 . . . . 3.2 109.538 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.62 -40.0 71.55 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.05 0.94 . . . . 1.06 112.949 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mp -74.19 -52.1 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 119.258 -0.401 . . . . 2.47 110.094 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.0 t -79.56 -47.87 14.79 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.097 0.862 . . . . 1.55 112.546 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -125.97 -151.68 0.49 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.6 1.96 . . . . 4.34 109.155 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 105.423 -2.066 . . . . 4.7 105.423 163.142 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.529 -0.545 . . . . 4.21 109.529 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pp -63.76 -29.39 47.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 113.166 0.802 . . . . 3.48 113.166 -156.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -18.46 60.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.286 0.565 . . . . 1.89 111.692 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.81 -44.2 12.67 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.388 1.075 . . . . 1.93 110.741 168.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.2 116.15 20.46 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.787 -0.625 . . . . 4.16 110.221 -174.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.93 153.53 42.2 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.502 1.468 . . . . 1.4 110.791 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.88 143.93 9.3 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 122.123 0.963 . . . . 2.59 112.52 163.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.99 128.78 10.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.257 1.823 . . . . 5.3 106.274 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.0 t -72.86 -51.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.11 -0.7 . . . . 1.37 109.11 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.9 143.87 15.6 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.119 1.342 . . . . 2.46 109.838 -172.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -76.81 67.11 2.82 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.857 -0.79 . . . . 9.86 108.893 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 m -107.05 178.57 4.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.414 1.086 . . . . 3.36 109.919 -171.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -122.28 68.05 0.94 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.404 -1.332 . . . . 8.29 107.404 167.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.14 165.97 35.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.325 -1.51 . . . . 1.51 109.325 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -146.37 99.36 3.21 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.099 1.759 . . . . 1.45 106.283 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -123.64 100.86 37.4 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 107.66 -1.237 . . . . 0.93 107.66 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.2 125.73 17.7 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 108.484 -1.391 . . . . 0.54 108.484 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.6 mmt-85 -135.66 174.47 10.58 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.388 1.475 . . . . 3.38 108.347 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -115.85 140.98 48.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.241 1.417 . . . . 0.4 108.154 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.459 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 7.4 p90 -123.6 152.65 41.68 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.331 -1.359 . . . . 0.68 107.331 169.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -66.64 105.66 1.6 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.24 -1.763 . . . . 1.05 106.24 155.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 6.5 t70 -72.05 116.87 12.96 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.767 -1.938 . . . . 1.83 105.767 168.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.65 -25.11 28.71 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.745 -0.835 . . . . 1.29 108.745 -169.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -63.73 -45.9 87.85 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 128.208 2.603 . . . . 3.9 106.636 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.8 p -84.9 -34.24 22.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.101 1.36 . . . . 1.07 110.783 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.9 37.01 23.73 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.146 1.355 . . . . 1.22 110.494 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' NZ ' ' OXT' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -146.93 156.75 43.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.779 1.232 . . . . 6.82 110.384 -174.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.2 m -67.34 139.03 57.2 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.398 -0.814 . . . . 0.75 109.435 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -156.65 146.15 15.3 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.874 -1.158 . . . . 0.91 107.874 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.66 156.49 49.11 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.091 2.528 . . . . 0.39 111.695 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -153.69 162.95 40.79 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.414 1.486 . . . . 0.43 107.359 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -96.05 113.67 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.862 -1.903 . . . . 0.76 105.862 170.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -81.57 139.77 34.87 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.639 -1.245 . . . . 2.12 107.639 169.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.26 -11.24 85.53 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 121.725 -0.609 . . . . 1.03 112.653 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.27 -43.88 1.7 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.206 -1.158 . . . . 1.51 110.206 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.9 159.03 15.19 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.131 1.773 . . . . 2.35 111.374 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.09 37.59 93.05 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 114.759 0.664 . . . . 2.69 114.759 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.61 -153.6 15.81 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.887 0.844 . . . . 1.31 112.815 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -160.38 -163.32 1.08 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.381 2.272 . . . . 1.44 105.675 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.21 -20.84 68.83 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.566 1.076 . . . . 0.79 112.239 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -81.5 63.97 6.02 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 118.502 1.151 . . . . 1.62 110.069 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -159.09 78.24 0.74 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.914 -0.584 . . . . 1.74 109.544 -155.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -112.99 154.5 26.36 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.465 0.706 . . . . 0.85 110.916 -167.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.24 -39.73 94.56 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.803 -0.814 . . . . 3.04 108.803 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.8 p -130.66 150.59 51.78 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.142 1.164 . . . . 0.53 114.142 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.9 -46.11 42.33 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.224 1.41 . . . . 0.71 110.242 159.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.42 -49.96 23.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.704 0.802 . . . . 2.05 110.488 175.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -64.46 -54.96 24.39 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 119.186 -0.435 . . . . 2.3 110.358 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.25 -43.54 42.91 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.294 1.045 . . . . 0.65 111.509 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -60.61 -58.77 7.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.864 1.266 . . . . 4.91 111.516 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.32 -43.55 67.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.621 0.769 . . . . 0.62 112.298 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.5 -44.17 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.899 0.88 . . . . 1.76 110.331 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 10.7 t -147.94 -54.51 0.21 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.058 0.762 . . . . 1.89 113.058 -171.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.15 136.38 52.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.301 1.223 . . . . 7.74 114.301 -153.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' OXT' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . 0 N--CA 1.453 -0.298 0 C-N-CA 125.587 1.555 . . . . 6.97 107.685 163.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 117.94 -1.028 . . . . 2.9 109.3 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.8 pt -45.24 -34.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.168 0.987 . . . . 1.73 111.927 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.2 m -49.1 -27.35 3.33 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.343 1.057 . . . . 1.35 112.704 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -33.26 66.13 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.912 -0.492 . . . . 1.39 111.038 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.44 119.21 44.6 Favored Pre-proline 0 C--O 1.225 -0.2 0 CA-C-O 118.11 -0.947 . . . . 4.9 109.072 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.08 173.51 12.03 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 120.802 1.322 . . . . 1.34 111.626 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -45.21 131.56 7.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.115 -1.402 . . . . 2.79 110.52 157.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -159.17 137.01 10.25 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.711 2.004 . . . . 5.17 106.722 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.52 -66.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.799 0.727 . . . . 1.31 109.782 -172.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.77 -178.82 19.1 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.241 -1.543 . . . . 1.84 109.241 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -68.06 -43.36 78.81 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.915 -0.772 . . . . 6.46 108.915 172.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.2 m -71.52 151.97 43.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.269 -1.752 . . . . 2.03 106.269 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -138.09 46.95 2.03 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.448 0.699 . . . . 6.45 109.134 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.94 153.91 34.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.269 -1.532 . . . . 1.42 109.269 170.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -83.1 77.8 9.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.981 -0.717 . . . . 1.19 109.523 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -101.31 94.35 3.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.071 -0.715 . . . . 0.78 109.071 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.67 122.33 10.39 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 CA-C-N 120.548 1.232 . . . . 0.5 108.935 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -130.7 177.99 6.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 125.578 1.551 . . . . 3.7 107.268 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -117.53 142.49 47.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.794 1.638 . . . . 0.38 108.144 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -124.84 150.43 46.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.567 -1.642 . . . . 0.81 106.567 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.9 102.34 0.77 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 104.559 -2.386 . . . . 1.4 104.559 157.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.39 103.22 3.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.243 -1.762 . . . . 2.08 106.243 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 t -74.9 -15.33 60.71 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.258 0.623 . . . . 1.14 110.66 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -62.4 -41.66 98.84 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.446 1.098 . . . . 4.34 108.107 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.5 p -105.33 -25.66 12.31 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.783 2.833 . . . . 0.84 112.911 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.1 30.39 22.97 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.867 2.175 . . . . 0.98 113.233 -173.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -136.65 138.2 40.87 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.152 1.476 . . . . 4.49 110.96 -161.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 m -70.48 120.17 15.73 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 120.491 -1.38 . . . . 0.57 108.952 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.9 m -140.72 145.65 40.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.637 1.175 . . . . 0.51 108.868 -163.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.65 151.25 41.16 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.218 2.612 . . . . 0.46 111.899 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -154.64 162.99 40.88 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.349 1.46 . . . . 0.51 108.27 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.39 113.15 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.02 -1.474 . . . . 0.67 107.02 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -80.83 145.19 31.53 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.526 1.13 . . . . 1.98 108.004 168.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.31 -31.3 47.16 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.992 0.806 . . . . 1.04 114.012 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.42 17.35 24.51 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.391 0.996 . . . . 1.75 113.115 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -125.57 -156.93 0.76 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.125 1.37 . . . . 2.87 109.403 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.48 67.61 0.26 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.868 1.699 . . . . 2.61 110.254 163.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.33 -83.92 0.09 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.135 -1.586 . . . . 2.42 109.135 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -177.85 -174.13 0.43 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 127.431 2.292 . . . . 1.16 108.061 167.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.55 -20.51 61.81 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.463 0.554 . . . . 0.99 112.69 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -80.24 64.89 5.21 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.372 1.086 . . . . 1.7 108.577 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -154.9 69.39 0.73 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.824 -0.806 . . . . 1.92 108.824 -151.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -106.77 163.41 12.95 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.438 1.495 . . . . 0.67 111.309 -162.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -30.43 35.29 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.671 -0.643 . . . . 3.37 110.59 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.8 p -146.97 162.38 38.88 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.244 0.618 . . . . 0.66 110.852 -173.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -46.11 70.31 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 123.432 0.693 . . . . 0.58 109.855 163.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -47.82 -51.95 20.8 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.91 -0.404 . . . . 2.35 109.91 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -68.96 -49.98 53.17 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.361 -0.237 . . . . 1.99 110.361 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -50.49 -47.65 57.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.509 0.671 . . . . 0.58 110.699 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -61.89 -58.86 6.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 123.921 0.889 . . . . 4.4 110.097 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.64 -45.61 63.38 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.502 0.721 . . . . 0.61 111.584 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.5 mm -65.63 -54.58 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 122.661 0.385 . . . . 1.51 110.014 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.5 t -81.26 -57.03 3.68 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.781 0.66 . . . . 1.75 112.781 -168.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -125.84 67.06 1.18 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.706 2.002 . . . . 4.29 108.695 -166.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 118.14 -0.933 . . . . 5.83 110.035 174.579 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 108.151 -1.055 . . . . 3.26 108.151 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.4 pt -51.58 -30.93 11.9 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 C-N-CA 123.304 0.642 . . . . 1.78 110.756 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.4 m -47.76 -28.5 2.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.644 0.778 . . . . 1.26 112.302 176.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.34 -17.03 55.34 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.025 -0.988 . . . . 1.87 112.419 -172.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.77 148.91 81.58 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 120.511 1.505 . . . . 3.21 111.518 -173.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.2 170.15 20.84 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.665 2.243 . . . . 1.6 110.29 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.452 ' HE2' ' CE1' ' A' ' 20' ' ' TYR . 26.7 ttmt -67.99 140.84 56.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.255 -0.646 . . . . 4.3 109.255 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.53 149.92 30.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.505 -1.665 . . . . 5.45 106.505 176.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.6 t -90.73 -72.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 108.915 -0.772 . . . . 1.48 108.915 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.96 173.48 34.46 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 108.838 -1.705 . . . . 1.77 108.838 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -74.23 -43.17 58.14 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.289 -1.374 . . . . 8.96 107.289 168.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.24 144.21 50.14 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.059 -1.83 . . . . 2.37 106.059 166.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -59.61 2.64 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 119.041 -0.504 . . . . 6.31 109.963 -173.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.19 -178.28 0.62 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.314 1.435 . . . . 1.79 115.839 166.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -147.99 95.26 2.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.402 1.081 . . . . 1.08 108.986 170.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.2 107.17 13.54 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 109.121 -0.696 . . . . 0.84 109.121 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.81 117.81 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.628 1.552 . . . . 0.72 110.208 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -120.22 176.94 5.21 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 126.921 2.088 . . . . 3.22 109.238 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -123.63 140.69 52.74 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.779 2.031 . . . . 0.51 107.559 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.452 ' CE1' ' HE2' ' A' ' 7' ' ' LYS . 1.3 p90 -122.55 150.65 42.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.852 -1.906 . . . . 1.03 105.852 169.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -68.57 107.74 3.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.381 -2.081 . . . . 1.44 105.381 159.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.07 111.98 7.77 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.884 -1.525 . . . . 2.23 106.884 170.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 t -88.06 1.53 54.04 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.004 -0.998 . . . . 1.24 112.945 -171.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -85.0 -50.07 7.77 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.862 -1.533 . . . . 5.72 106.862 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.3 p -83.43 -26.07 30.68 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.862 0.865 . . . . 1.31 111.357 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.08 31.27 53.39 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.867 1.222 . . . . 1.05 111.126 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.2 131.61 53.55 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 118.751 1.275 . . . . 4.64 110.548 -169.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.8 m -62.31 129.02 38.83 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 107.439 -1.319 . . . . 0.48 107.439 168.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.408 HG23 ' HD2' ' A' ' 30' ' ' PRO . 11.0 m -156.28 149.62 18.78 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.899 -1.148 . . . . 0.95 107.899 -165.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.408 ' HD2' HG23 ' A' ' 29' ' ' THR . 57.3 Cg_endo -73.97 157.88 46.62 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.101 2.534 . . . . 0.54 114.528 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -154.07 164.3 38.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.257 1.423 . . . . 0.6 108.869 167.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.9 mm -98.93 104.87 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.575 -1.268 . . . . 0.89 107.575 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -73.4 152.75 40.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.498 -0.927 . . . . 2.25 108.498 168.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.53 13.27 47.18 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 114.365 0.506 . . . . 1.18 114.365 -172.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.76 -48.86 2.8 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 118.645 1.223 . . . . 1.49 110.943 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.52 128.04 38.5 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.712 0.805 . . . . 2.65 111.834 174.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.14 52.5 0.24 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.522 2.01 . . . . 2.46 108.548 -170.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.15 164.73 54.35 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.065 -0.814 . . . . 1.97 111.065 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -156.8 -173.2 4.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.206 -1.775 . . . . 1.55 106.206 171.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.09 -47.29 9.37 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.023 -1.231 . . . . 0.79 110.023 -172.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.11 65.92 2.19 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.929 0.492 . . . . 1.56 110.926 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.0 66.12 0.91 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.343 1.057 . . . . 2.1 109.859 -159.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -108.65 140.93 41.35 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.726 0.81 . . . . 0.75 110.994 -160.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.15 -42.29 80.76 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.252 0.933 . . . . 2.52 110.722 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.9 p -138.98 163.5 32.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.615 0.766 . . . . 0.55 111.507 -169.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.79 -47.7 67.37 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.207 0.603 . . . . 0.5 109.548 162.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -48.69 -48.68 39.94 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.998 -0.371 . . . . 2.11 109.998 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -68.58 -51.54 41.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.517 0.327 . . . . 2.25 110.641 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.5 t -51.13 -48.53 61.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.548 0.69 . . . . 0.54 111.092 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -57.49 -60.34 3.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.224 1.01 . . . . 2.76 109.129 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.75 -43.6 27.36 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.479 0.712 . . . . 0.74 112.204 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.38 -59.35 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.945 0.339 . . . . 1.36 110.151 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.3 t -81.38 -47.11 13.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 119.95 -0.7 . . . . 1.62 112.522 -164.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -126.26 77.99 1.73 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.299 3.039 . . . . 5.02 110.222 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 118.202 -0.904 . . . . 6.34 109.786 169.158 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 107.942 -1.132 . . . . 3.51 107.942 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.35 -24.84 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.618 0.767 . . . . 2.32 111.774 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.3 m -33.12 -45.84 0.15 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.069 1.347 . . . . 1.68 111.165 166.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.44 -22.25 61.12 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.589 0.959 . . . . 1.54 113.589 -169.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -65.71 146.16 99.0 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 119.787 1.176 . . . . 3.09 111.027 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.32 169.91 21.45 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.949 1.766 . . . . 1.15 110.735 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -56.68 143.03 37.82 Favored 'General case' 0 N--CA 1.46 0.051 0 C-N-CA 125.506 1.523 . . . . 2.51 111.327 161.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -146.75 99.01 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.038 1.735 . . . . 5.36 110.196 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.3 -42.09 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.442 -0.577 . . . . 1.51 109.442 174.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.62 -178.33 42.52 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.67 -0.972 . . . . 1.99 110.67 -172.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.06 55.56 2.53 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.985 -0.715 . . . . 7.69 112.105 -170.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.9 m -147.58 165.44 30.36 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.917 1.287 . . . . 1.85 107.573 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -139.42 20.55 2.56 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.236 0.615 . . . . 5.93 112.103 -177.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.71 145.19 38.14 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.255 -1.138 . . . . 1.56 110.255 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -81.95 73.32 9.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.69 0.757 . . . . 1.76 109.097 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -102.42 90.75 2.28 Favored Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 108.03 -1.1 . . . . 0.89 108.03 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.56 136.45 46.41 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.207 1.271 . . . . 0.94 109.549 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -140.43 179.35 6.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.051 2.141 . . . . 2.76 107.62 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -122.95 147.23 46.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.892 2.077 . . . . 0.52 108.391 169.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -128.61 155.81 44.37 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.955 -1.869 . . . . 1.08 105.955 166.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -75.99 101.93 5.43 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.341 -1.355 . . . . 1.46 107.341 164.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -72.35 98.66 2.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.28 -1.378 . . . . 1.8 107.28 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -72.26 -14.69 61.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.245 -0.883 . . . . 1.24 112.817 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -69.27 -49.05 59.64 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.413 -1.328 . . . . 4.98 107.413 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 64.1 p -83.77 -19.54 34.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.937 0.495 . . . . 0.97 111.596 174.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.96 34.36 58.92 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.51 1.052 . . . . 0.78 110.831 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.73 136.52 52.54 Favored 'General case' 0 CA--C 1.523 -0.059 0 C-N-CA 124.631 1.172 . . . . 5.52 110.527 -169.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.8 m -61.99 124.68 21.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.905 -1.146 . . . . 0.63 107.905 156.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.5 m -141.54 137.69 16.67 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 107.299 -1.371 . . . . 0.89 107.299 -166.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.03 155.17 65.67 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.405 2.07 . . . . 0.72 110.84 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -153.46 157.84 40.47 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.147 -1.057 . . . . 0.71 108.147 167.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.6 120.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 105.961 -1.866 . . . . 1.0 105.961 172.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -84.84 -7.53 59.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.071 1.348 . . . . 2.63 111.707 -172.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.09 -33.12 1.5 Allowed Glycine 0 CA--C 1.533 1.203 0 O-C-N 119.991 -1.693 . . . . 1.45 113.221 172.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.96 25.73 18.9 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 126.059 1.79 . . . . 2.26 110.478 -171.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.87 -160.71 0.72 Allowed 'General case' 0 C--N 1.34 0.195 0 N-CA-C 114.926 1.454 . . . . 2.85 114.926 -164.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -31.02 -58.51 0.26 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 127.343 2.401 . . . . 3.38 113.42 173.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.04 -161.88 46.89 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.995 -0.442 . . . . 1.29 111.995 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -172.23 -169.8 0.67 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.976 1.71 . . . . 1.16 109.776 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.73 -41.9 18.39 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.584 -1.407 . . . . 0.89 109.584 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -73.89 67.06 1.2 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.879 0.371 . . . . 1.78 111.179 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -149.58 117.92 6.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.097 1.359 . . . . 2.14 108.492 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -138.77 139.84 38.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.766 0.827 . . . . 0.93 108.83 -166.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -63.44 -35.98 82.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.878 0.763 . . . . 3.13 110.936 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.5 p -131.11 155.05 47.62 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.592 0.757 . . . . 0.46 111.314 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.92 -45.57 60.5 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.137 -0.69 . . . . 0.62 109.137 161.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.14 -53.72 7.72 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.821 0.449 . . . . 2.16 110.498 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -64.71 -54.2 35.21 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.038 -0.356 . . . . 1.8 110.038 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 t -49.64 -50.22 44.05 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.01 0.433 . . . . 0.46 110.93 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -57.81 -60.89 3.01 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.743 1.217 . . . . 3.02 109.111 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.05 -32.55 61.99 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.103 0.961 . . . . 0.69 112.851 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.5 mm -88.29 -50.4 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.29 0.636 . . . . 1.84 110.82 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.8 t -78.46 -49.1 14.04 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.705 -0.622 . . . . 1.55 111.484 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -104.3 -151.23 0.44 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.025 1.73 . . . . 4.82 109.442 171.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 104.847 -2.279 . . . . 4.84 104.847 148.761 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 108.707 -0.849 . . . . 3.49 108.707 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp -55.41 -24.97 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.662 1.185 . . . . 2.75 110.976 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m -40.73 -36.8 0.66 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.462 1.505 . . . . 1.68 111.694 170.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -23.89 60.77 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.594 0.961 . . . . 1.76 113.594 -176.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -72.29 144.66 87.21 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.695 0.68 . . . . 4.1 109.893 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -83.54 169.27 12.37 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.252 1.968 . . . . 2.16 112.193 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -60.3 140.42 57.1 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.906 1.283 . . . . 2.92 107.914 153.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.515 ' HD2' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -158.24 134.47 9.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.529 0.732 . . . . 5.08 109.763 176.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.56 -27.27 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.692 0.758 . . . . 2.16 110.445 -173.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.4 179.07 9.69 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 121.932 0.74 . . . . 2.1 111.77 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -81.25 53.2 1.98 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.605 -0.939 . . . . 7.97 109.266 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.6 m -143.47 147.34 34.39 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.299 -1.371 . . . . 1.68 107.299 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.71 39.11 3.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.411 0.685 . . . . 4.96 111.953 -171.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.09 141.56 15.66 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.501 -1.04 . . . . 1.55 110.501 174.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -82.05 74.93 9.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.743 -0.836 . . . . 1.35 108.743 -176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -102.0 88.55 1.31 Allowed Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.114 0.966 . . . . 0.79 109.059 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.34 119.88 6.99 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.57 1.514 . . . . 0.55 109.322 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -116.7 178.05 4.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.823 2.049 . . . . 3.37 108.919 169.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -116.62 139.69 50.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.989 1.716 . . . . 0.4 108.373 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -120.79 148.01 44.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.931 -1.507 . . . . 0.72 106.931 165.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -67.47 105.44 1.82 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.546 -1.65 . . . . 0.99 106.546 158.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.57 103.57 3.59 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.149 -1.426 . . . . 1.94 107.149 168.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 t -76.91 -9.46 58.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.215 -0.898 . . . . 1.17 112.593 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.85 -48.85 34.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.522 -1.288 . . . . 4.19 107.522 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.8 p -92.0 -13.72 30.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.904 0.882 . . . . 1.19 112.589 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.03 33.67 84.4 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.134 0.873 . . . . 0.99 111.108 -174.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 133.69 55.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 125.049 1.34 . . . . 5.29 109.844 -170.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.3 m -64.55 124.01 20.74 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.063 -1.088 . . . . 0.51 108.063 158.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.8 m -142.71 141.83 21.26 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.724 1.61 . . . . 0.56 107.36 -165.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.45 153.9 50.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.45 2.1 . . . . 0.52 111.693 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -153.87 159.25 41.72 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.884 1.273 . . . . 0.54 108.054 169.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.55 120.5 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 106.734 -1.58 . . . . 0.8 106.734 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.0 -23.81 59.49 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.162 0.585 . . . . 2.74 112.392 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.14 -49.73 4.17 Favored Glycine 0 CA--C 1.522 0.489 0 O-C-N 121.08 -1.013 . . . . 1.42 110.749 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.68 -31.18 2.03 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.396 -0.669 . . . . 1.54 113.062 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.05 176.23 7.17 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.371 1.085 . . . . 2.33 108.38 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.23 43.62 25.21 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.922 -1.271 . . . . 2.75 109.922 -172.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.85 147.47 48.43 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.091 -1.203 . . . . 2.11 110.091 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' ND2' ' HD2' ' A' ' 8' ' ' LYS . 51.8 p30 -153.65 -174.45 4.96 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 105.758 -1.942 . . . . 1.62 105.758 170.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.79 -43.7 65.66 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.906 -1.278 . . . . 1.3 109.906 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -75.17 67.11 1.77 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.471 0.708 . . . . 1.72 111.705 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.05 60.69 0.46 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.726 0.81 . . . . 2.05 110.061 -160.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -104.07 142.1 35.05 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 123.622 0.769 . . . . 0.93 110.822 -161.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -63.6 -41.91 98.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.549 1.068 . . . . 2.65 110.542 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.1 p -118.21 152.24 36.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.751 0.82 . . . . 0.64 112.571 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.23 -46.68 54.92 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.55 0.74 . . . . 0.55 109.578 160.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.56 -51.8 11.41 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.246 0.618 . . . . 2.01 110.586 176.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -65.25 -54.68 25.74 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 110.078 -0.341 . . . . 2.38 110.078 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 t -48.28 -48.02 35.92 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.293 0.568 . . . . 0.52 111.47 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -57.46 -62.65 1.63 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.908 1.283 . . . . 3.24 108.794 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.04 -46.23 43.9 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.873 0.869 . . . . 0.74 112.64 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mp -75.64 -57.46 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 118.061 0.392 . . . . 1.64 110.272 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 16.0 t -82.94 -58.18 2.98 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.782 0.719 . . . . 1.63 111.257 -170.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -81.59 62.71 5.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.838 0.455 . . . . 4.69 110.772 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.335 0 O-C-N 124.149 0.906 . . . . 6.28 109.438 166.759 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.1 t . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 107.421 -1.326 . . . . 3.52 107.421 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.525 HG22 ' HA3' ' A' ' 40' ' ' GLY . 0.1 OUTLIER -67.2 -13.26 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 114.07 1.137 . . . . 2.76 114.07 -165.631 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.2 m -96.89 -12.61 23.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.792 0.437 . . . . 1.49 111.466 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.22 -37.47 8.9 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.087 0.955 . . . . 1.54 108.754 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -59.2 132.24 87.58 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.54 -1.652 . . . . 4.11 106.54 172.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -99.44 175.68 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.597 2.198 . . . . 1.42 111.398 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -48.95 140.88 8.33 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.673 1.702 . . . . 2.93 112.693 153.442 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.86 -176.61 5.27 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 102.709 -3.071 . . . . 5.02 102.709 165.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 t -120.89 -84.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.82 -1.548 . . . . 2.03 106.82 158.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.2 170.6 15.6 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 107.185 -2.366 . . . . 2.76 107.185 -173.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -80.38 60.58 3.85 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.287 -1.005 . . . . 6.51 108.287 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.5 m -151.68 157.13 41.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.053 -1.091 . . . . 3.09 108.053 -161.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.14 81.13 1.84 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.175 0.99 . . . . 5.92 108.659 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.86 131.67 6.55 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.61 -1.396 . . . . 1.73 109.61 169.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -83.12 74.35 10.0 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.766 0.827 . . . . 2.17 109.398 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -102.83 87.31 1.17 Allowed Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 107.879 -1.156 . . . . 1.28 107.879 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.7 120.93 8.32 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 N-CA-C 108.038 -1.562 . . . . 0.67 108.038 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -128.91 177.28 7.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.2 1.4 . . . . 3.86 107.774 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -112.63 156.52 22.58 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.276 1.83 . . . . 0.53 107.946 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 31' ' ' PHE . 6.3 p90 -148.26 152.09 36.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.924 -1.139 . . . . 1.35 107.924 175.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -76.07 100.08 4.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.987 -1.857 . . . . 0.92 105.987 169.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 20' ' ' TYR . 11.0 t70 -72.3 109.68 6.2 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.638 -1.245 . . . . 2.48 107.638 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.6 t -87.21 6.76 31.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.593 -0.718 . . . . 1.81 111.631 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.5 -45.63 10.31 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 105.987 -1.857 . . . . 4.5 105.987 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.9 p -94.25 -25.98 16.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.581 2.752 . . . . 1.43 111.602 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.53 59.9 3.95 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.015 -1.234 . . . . 1.31 110.015 -173.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.5 144.96 17.24 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.826 1.313 . . . . 4.09 112.938 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.5 m -73.84 119.21 17.75 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.352 -0.842 . . . . 0.52 108.75 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.3 m -141.93 147.54 45.23 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 117.956 -1.021 . . . . 0.58 109.205 -161.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.38 145.22 21.02 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.333 2.689 . . . . 0.63 112.702 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -147.7 161.07 41.95 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.602 1.561 . . . . 0.65 108.268 173.709 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.87 118.57 37.57 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 105.57 -2.011 . . . . 0.99 105.57 170.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -72.77 -41.43 65.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.73 0.412 . . . . 2.97 111.52 -171.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.15 -15.33 61.59 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 118.37 0.532 . . . . 1.18 112.206 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.87 -51.72 4.61 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.626 1.213 . . . . 1.62 110.145 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -178.9 4.77 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.036 1.334 . . . . 2.99 109.928 170.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.99 49.74 65.42 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.604 -0.598 . . . . 2.51 111.604 164.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.61 148.91 44.28 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.584 -0.95 . . . . 1.87 112.6 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -143.62 178.99 7.41 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 104.782 -2.303 . . . . 1.08 104.782 157.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 2' ' ' ILE . . . -75.05 -25.66 68.46 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.253 -0.739 . . . . 0.83 111.253 -175.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -72.91 65.84 0.75 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.138 1.375 . . . . 2.52 110.471 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -162.07 97.16 1.02 Allowed 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.873 -0.517 . . . . 2.07 110.466 -169.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.46 140.75 52.66 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.415 1.486 . . . . 0.81 110.282 -165.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.68 -32.39 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.603 1.092 . . . . 2.87 111.501 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.9 p -143.76 156.6 44.56 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.277 0.631 . . . . 0.47 111.809 -169.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -45.08 64.71 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 108.869 -0.789 . . . . 0.5 108.869 160.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -43.9 -53.44 6.1 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.476 0.31 . . . . 2.16 110.757 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -63.66 -57.04 11.29 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 117.951 0.341 . . . . 1.94 110.136 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.9 t -49.12 -42.1 38.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.086 0.469 . . . . 0.64 111.963 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -66.82 -54.78 19.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.161 1.384 . . . . 3.17 109.684 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.73 -40.94 30.4 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.932 0.493 . . . . 0.67 111.955 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.18 -63.78 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.003 0.521 . . . . 1.82 110.961 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 70.9 m -97.29 -25.83 15.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.971 0.908 . . . . 2.19 113.355 -166.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.99 118.42 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.31 2.644 . . . . 6.57 108.955 -171.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 105.029 -2.211 . . . . 9.34 105.029 158.601 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 107.692 -1.225 . . . . 3.35 107.692 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.2 pt -49.63 -34.02 8.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 118.422 0.556 . . . . 1.68 110.451 169.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.0 m -51.05 -24.93 4.25 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.27 0.628 . . . . 1.4 112.685 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.59 -35.66 67.97 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.216 0.462 . . . . 1.47 110.336 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 110.02 3.58 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.206 1.003 . . . . 4.27 111.873 -164.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.95 146.0 69.94 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 CA-C-N 120.912 1.361 . . . . 1.45 110.83 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -34.05 133.67 0.21 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 128.589 2.755 . . . . 3.66 112.62 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -138.73 149.01 44.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.162 2.585 . . . . 5.36 108.118 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.5 t -117.82 -22.63 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.365 1.066 . . . . 1.94 111.759 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.17 150.64 0.77 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-O 122.391 0.995 . . . . 2.16 112.612 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.29 50.23 0.9 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.587 -0.949 . . . . 7.88 111.721 -178.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.1 m -126.3 142.71 51.42 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.37 0.668 . . . . 2.01 111.098 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 78.33 8.71 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.27 -1.011 . . . . 7.8 108.27 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.97 -179.77 22.43 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.02 -1.232 . . . . 1.51 110.02 168.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -146.53 117.86 7.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.899 1.28 . . . . 1.67 107.793 -176.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -145.1 119.03 5.55 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 106.847 -1.538 . . . . 0.93 106.847 175.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.9 134.37 23.5 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.643 1.562 . . . . 1.15 109.055 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.2 mmt-85 -140.82 176.26 8.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.506 1.122 . . . . 2.98 108.519 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -125.28 136.97 54.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.068 1.747 . . . . 0.61 107.634 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -118.93 150.97 39.01 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.338 -1.356 . . . . 0.92 107.338 171.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.24 100.33 2.08 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.215 -2.142 . . . . 1.65 105.215 161.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.39 104.02 3.63 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.844 -1.539 . . . . 2.06 106.844 171.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 t -82.62 -0.14 45.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.394 -0.812 . . . . 1.29 112.564 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.98 -47.55 12.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.947 -1.501 . . . . 3.7 106.947 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.5 p -79.48 -30.15 41.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.719 1.208 . . . . 0.96 111.167 170.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.23 29.78 44.17 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.83 1.205 . . . . 0.8 111.309 -172.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -129.19 147.35 51.03 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 118.858 1.329 . . . . 4.55 110.131 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 57.8 m -69.86 135.09 49.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.152 -1.425 . . . . 0.74 107.152 166.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 m -151.72 139.42 12.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.06 -1.089 . . . . 0.55 108.06 -169.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.17 159.1 53.12 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.842 2.361 . . . . 0.5 111.101 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -158.47 163.53 37.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.952 1.301 . . . . 0.68 108.158 171.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.7 mm -93.11 115.35 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.545 -1.65 . . . . 1.27 106.545 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.03 -19.34 61.21 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.789 0.836 . . . . 2.61 111.678 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.47 -45.78 3.31 Favored Glycine 0 CA--C 1.525 0.681 0 O-C-N 121.303 -0.873 . . . . 1.58 110.951 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.32 -24.43 3.38 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 124.074 0.845 . . . . 1.28 111.86 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -145.04 176.55 9.42 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.545 1.138 . . . . 2.2 109.426 -172.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 41.52 44.61 4.19 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.262 1.411 . . . . 3.4 114.245 171.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.95 -133.66 7.31 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.602 -1.399 . . . . 2.03 109.602 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -152.94 -168.51 3.06 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.337 1.855 . . . . 1.39 107.028 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.27 -12.07 65.94 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.928 0.775 . . . . 0.84 113.035 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -79.15 63.76 3.88 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 118.5 1.15 . . . . 1.9 107.913 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -159.44 87.91 0.84 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.818 -0.808 . . . . 1.92 108.818 -146.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -126.41 150.64 48.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.751 0.82 . . . . 0.62 110.497 -159.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.86 -42.81 98.62 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.474 0.709 . . . . 2.67 109.917 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.6 p -135.37 159.35 41.86 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.26 0.624 . . . . 0.59 112.091 -170.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.01 -47.4 61.62 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.67 0.788 . . . . 0.72 110.041 160.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -48.15 -49.96 30.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.485 0.314 . . . . 2.64 110.179 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -67.67 -52.47 37.6 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 110.198 -0.297 . . . . 2.11 110.198 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.0 t -49.88 -46.28 51.52 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.387 0.675 . . . . 0.48 111.207 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -59.52 -73.24 0.09 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.752 -1.203 . . . . 2.74 107.752 172.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -42.3 -43.55 3.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.589 1.156 . . . . 0.84 113.577 -172.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.26 -40.74 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 122.855 0.462 . . . . 1.4 111.875 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.0 t -100.53 -44.64 5.8 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.979 1.103 . . . . 1.66 113.979 -170.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.32 149.48 28.71 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.803 1.641 . . . . 5.01 108.368 -160.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.235 0 O-C-N 122.296 -0.252 . . . . 5.3 110.449 173.265 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 117.809 -1.091 . . . . 3.45 109.347 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.8 pt -43.89 -31.56 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.497 1.519 . . . . 2.42 113.702 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 t -31.85 -45.3 0.1 Allowed 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.279 1.832 . . . . 1.91 113.738 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.16 -21.0 61.51 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 125.32 1.638 . . . . 2.09 111.723 -164.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -62.84 157.85 56.88 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.361 0.982 . . . . 3.22 109.489 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -88.33 166.65 6.58 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.588 2.192 . . . . 1.12 111.132 173.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -44.63 132.02 6.51 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.013 0.925 . . . . 2.65 108.67 157.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.0 tttm -158.57 99.03 1.56 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 104.807 -2.294 . . . . 5.17 104.807 -169.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.78 -43.04 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.521 0.728 . . . . 1.31 111.809 -168.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.84 151.11 27.76 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.682 -1.367 . . . . 1.9 109.682 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -80.75 50.66 1.38 Allowed 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.967 -0.725 . . . . 5.61 112.872 -166.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.47 142.01 39.43 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 107.578 -1.267 . . . . 1.69 107.578 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -85.32 54.72 3.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.208 0.603 . . . . 5.62 109.617 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.53 173.15 25.74 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.618 -0.593 . . . . 1.67 111.618 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -137.65 79.58 1.75 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.992 1.317 . . . . 1.1 107.814 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -116.1 107.25 48.05 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 106.96 -1.496 . . . . 1.01 106.96 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.21 133.99 40.37 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 CA-C-N 120.637 1.263 . . . . 0.78 109.097 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -131.55 172.3 12.39 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.836 -1.172 . . . . 3.06 107.836 170.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.06 144.67 36.77 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.682 1.593 . . . . 0.5 107.501 170.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.46 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 1.8 p90 -131.22 161.19 32.79 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.568 -0.901 . . . . 0.72 108.568 169.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -73.16 105.39 4.57 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.64 -1.985 . . . . 1.37 105.64 156.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 6.4 t70 -73.45 118.52 16.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.895 -1.52 . . . . 2.29 106.895 169.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 t -86.26 -25.44 25.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.186 0.994 . . . . 1.72 108.799 -174.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -61.94 -43.79 98.11 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 127.178 2.191 . . . . 4.24 107.082 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.1 p -96.24 -36.57 10.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.825 2.05 . . . . 1.17 110.759 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.64 48.82 4.83 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.208 1.385 . . . . 0.88 110.506 -173.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.04 147.04 31.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 128.29 2.636 . . . . 4.17 111.92 -172.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.9 m -69.75 123.14 20.64 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.802 -0.814 . . . . 0.64 108.802 171.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.4 m -147.33 148.86 32.95 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 124.353 1.061 . . . . 0.62 108.457 -161.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.75 151.58 36.4 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.969 2.446 . . . . 0.49 112.148 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -149.91 163.2 38.69 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.537 1.535 . . . . 0.5 107.743 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.56 120.24 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 107.958 -1.127 . . . . 0.85 107.958 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -95.79 143.96 26.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.535 1.934 . . . . 2.22 107.427 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.33 0.77 88.67 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.509 -0.606 . . . . 1.08 113.068 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.94 6.16 77.82 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.796 1.298 . . . . 1.72 112.125 -172.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.98 -156.06 0.31 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.291 1.037 . . . . 3.01 111.393 -174.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -38.81 -41.96 1.37 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.429 1.49 . . . . 3.79 114.173 169.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.95 -141.01 46.11 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.698 -1.361 . . . . 1.47 109.698 -177.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -179.95 -160.53 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.786 2.034 . . . . 1.06 108.634 174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.62 -44.14 16.77 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 118.685 0.675 . . . . 0.78 111.447 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -73.87 64.94 1.01 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.92 1.288 . . . . 3.05 109.314 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -159.14 74.31 0.63 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.082 0.953 . . . . 2.07 109.375 -168.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -103.34 153.59 20.28 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 124.049 0.939 . . . . 0.77 110.371 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.25 -48.63 79.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.325 -0.62 . . . . 2.66 109.325 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.1 p -130.87 161.06 32.67 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.243 0.831 . . . . 0.84 113.243 -164.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.45 -49.46 61.69 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.713 -0.847 . . . . 0.85 108.713 159.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -42.54 -51.88 4.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.427 0.558 . . . . 2.13 110.504 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -61.31 -56.54 19.37 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.07 -0.49 . . . . 1.95 111.044 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.9 t -52.75 -41.15 63.77 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.924 0.868 . . . . 0.91 112.368 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -60.74 3.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.973 2.109 . . . . 2.88 109.165 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.72 -44.29 93.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.77 0.828 . . . . 0.81 111.347 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.49 -40.75 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.259 1.023 . . . . 1.57 110.991 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.9 t -144.49 -70.2 0.29 Allowed 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 112.551 0.574 . . . . 1.7 112.551 -166.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -82.99 65.84 8.31 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.28 -1.378 . . . . 4.66 107.28 -169.843 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 117.619 -1.182 . . . . 4.57 111.265 -177.769 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 CA--C 1.504 -0.822 0 CA-C-O 118.026 -0.988 . . . . 4.89 108.87 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp -31.75 -34.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 127.768 2.427 . . . . 2.44 116.934 -147.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.9 m -72.55 -12.77 61.21 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.674 -0.641 . . . . 1.86 111.835 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -52.5 10.75 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.192 -1.04 . . . . 1.79 108.192 165.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.14 108.08 1.46 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.347 1.459 . . . . 4.53 111.544 -174.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.06 175.43 10.91 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 CA-C-N 120.698 1.285 . . . . 1.7 112.031 -173.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -40.96 133.65 2.12 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 126.189 1.795 . . . . 3.09 111.206 167.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -156.6 130.92 8.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.842 2.057 . . . . 5.0 105.922 170.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.68 -52.37 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 N-CA-C 109.547 -0.538 . . . . 1.5 109.547 -170.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.0 28.86 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.465 -1.854 . . . . 2.19 108.465 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -94.59 14.38 21.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.007 0.523 . . . . 5.9 111.128 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.0 m -145.36 160.07 42.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 105.877 -1.897 . . . . 2.17 105.877 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -74.09 -73.11 0.24 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.918 0.326 . . . . 5.48 110.273 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.51 -179.91 0.53 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.56 1.076 . . . . 1.7 113.571 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -148.12 76.0 1.36 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.7 0.8 . . . . 1.52 109.73 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -114.64 100.36 53.09 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.851 -0.796 . . . . 0.95 108.851 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.59 118.5 5.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.49 1.46 . . . . 0.62 109.771 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -125.19 -179.61 4.66 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 127.24 2.216 . . . . 3.45 109.292 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -123.29 143.86 49.8 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.288 2.235 . . . . 0.44 107.661 171.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -126.28 154.15 43.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.133 -1.432 . . . . 0.67 107.133 170.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.14 104.45 5.72 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.726 -1.583 . . . . 0.96 106.726 160.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.03 117.01 17.3 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.118 1.367 . . . . 1.97 107.769 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 t -86.47 -20.79 27.59 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 122.191 -0.318 . . . . 1.07 110.37 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -65.56 -46.4 79.62 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 126.859 2.064 . . . . 4.16 106.75 -173.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.4 p -88.71 -29.85 19.54 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.374 1.869 . . . . 0.85 110.413 170.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.73 54.45 7.36 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.348 -1.501 . . . . 0.85 109.348 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -146.1 157.21 43.84 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 126.813 2.045 . . . . 4.72 108.129 -172.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 95.7 m -80.48 142.43 34.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.321 -1.362 . . . . 0.73 107.321 161.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.9 m -154.32 141.39 13.42 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.327 -0.99 . . . . 0.5 108.327 -169.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.76 154.83 59.01 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.954 2.436 . . . . 0.44 111.177 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -158.03 160.89 37.93 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.083 0.953 . . . . 0.47 109.179 172.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -89.65 115.01 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 107.309 -1.367 . . . . 0.84 107.309 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -85.37 149.77 25.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.612 1.565 . . . . 2.27 107.581 167.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.81 13.64 34.91 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.601 1.096 . . . . 1.38 113.273 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.4 -52.29 4.71 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.891 1.234 . . . . 1.66 110.237 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.42 122.37 40.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.093 0.949 . . . . 2.18 111.268 -165.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.94 -66.25 3.8 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.613 1.101 . . . . 2.73 110.836 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 36.58 -118.38 0.47 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.03 1.3 . . . . 2.29 112.366 -172.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -172.46 179.9 2.38 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 127.984 2.513 . . . . 1.32 107.272 165.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.09 -32.24 72.78 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 112.176 -0.37 . . . . 1.11 112.176 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -75.45 70.56 2.33 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.889 0.875 . . . . 1.68 109.831 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -158.62 78.61 0.79 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.897 1.279 . . . . 1.77 108.069 -157.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -115.71 144.45 43.93 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.316 1.446 . . . . 0.78 110.433 -162.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.89 -38.3 90.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.294 0.952 . . . . 3.17 111.579 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -133.49 161.69 33.9 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.277 0.631 . . . . 0.49 111.987 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 tp -51.8 -49.69 62.24 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.638 -0.875 . . . . 1.06 108.638 159.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -45.93 -48.58 16.24 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.183 0.901 . . . . 2.36 110.38 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -66.03 -54.42 26.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.375 -0.232 . . . . 2.16 110.375 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.3 t -53.62 -48.41 69.34 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.437 0.637 . . . . 0.5 111.895 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -54.19 -55.18 30.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.876 2.47 . . . . 2.59 110.055 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.23 -43.46 78.64 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.666 0.386 . . . . 0.68 110.957 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.4 mm -68.25 -45.13 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 118.916 -0.564 . . . . 1.88 111.126 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.7 m -128.76 -97.33 0.38 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.833 0.742 . . . . 2.51 110.991 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.89 155.29 6.78 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.843 0.747 . . . . 6.16 111.608 -163.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.304 0 C-N-CA 127.647 2.379 . . . . 9.46 113.57 169.074 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 117.826 -1.083 . . . . 3.67 109.357 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 pt -52.06 -41.31 31.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-N 118.967 0.803 . . . . 1.87 110.8 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.9 m -57.71 -18.35 20.42 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.536 0.734 . . . . 1.93 112.617 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.01 -25.23 32.4 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.256 0.935 . . . . 1.33 110.792 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -64.41 144.36 98.53 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 118.787 0.721 . . . . 4.59 110.699 -174.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.81 -173.63 1.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.038 2.492 . . . . 1.27 110.702 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -77.83 141.73 38.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.08 1.352 . . . . 3.4 111.411 161.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.62 ' HD2' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -159.16 139.9 12.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.116 -2.55 . . . . 5.3 104.116 -176.666 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.7 t -63.15 -44.89 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 120.144 1.338 . . . . 1.62 109.506 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.52 144.69 15.74 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.823 -1.711 . . . . 2.28 108.823 -171.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -80.66 59.32 3.57 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.13 -0.629 . . . . 5.86 112.682 -165.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.4 m -143.35 144.03 31.91 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 108.837 -0.801 . . . . 2.37 108.837 167.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -90.08 72.04 7.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.682 0.793 . . . . 4.91 109.457 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.07 -174.96 13.79 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.636 -0.985 . . . . 1.27 110.636 172.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -142.05 93.89 2.6 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.323 1.449 . . . . 1.48 107.354 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -124.75 105.74 29.73 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 108.486 -0.931 . . . . 0.92 108.486 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.4 100.18 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.572 1.514 . . . . 1.22 109.477 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.444 ' HG3' HD21 ' A' ' 42' ' ' ASN . 8.6 mmt85 -106.81 179.84 4.15 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.512 1.525 . . . . 3.39 108.345 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -119.53 145.09 46.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.253 1.421 . . . . 0.41 108.333 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -124.02 150.42 44.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.144 -1.428 . . . . 0.75 107.144 167.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -75.56 102.0 5.11 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.307 -1.738 . . . . 1.21 106.307 162.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.44 104.95 4.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.619 -1.252 . . . . 2.21 107.619 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.2 t -84.0 -1.63 55.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.048 -0.977 . . . . 1.65 112.824 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.29 -48.12 10.77 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.936 -1.505 . . . . 5.25 106.936 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 64.7 p -82.32 -32.14 29.58 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.431 1.092 . . . . 1.13 110.603 175.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.92 4.84 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.008 -1.237 . . . . 0.96 110.008 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.51 135.61 22.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.904 0.882 . . . . 5.91 111.809 -169.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.3 m -69.5 126.45 29.79 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.215 -1.402 . . . . 0.45 107.215 163.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.2 m -147.68 138.41 12.99 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.321 -0.992 . . . . 0.51 108.321 -163.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 157.47 57.66 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.516 2.144 . . . . 0.38 111.015 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -158.17 155.65 29.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.343 1.057 . . . . 0.53 109.401 170.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.4 mm -84.51 109.2 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.871 -1.159 . . . . 1.11 107.871 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -87.12 146.15 26.16 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.693 1.197 . . . . 2.3 109.616 174.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.08 -28.78 53.2 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.585 1.564 . . . . 1.15 112.488 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.59 -40.89 1.71 Allowed Glycine 0 C--N 1.339 0.706 0 CA-C-N 117.738 0.769 . . . . 1.91 111.294 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -154.29 165.2 37.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.6 -0.889 . . . . 3.35 108.6 -174.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.24 49.14 81.75 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.962 0.791 . . . . 2.98 111.9 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.0 -121.37 4.16 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.115 -1.194 . . . . 1.78 110.115 174.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.62 ' ND2' ' HD2' ' A' ' 8' ' ' LYS . 29.4 p30 -157.03 -179.73 8.49 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.965 1.306 . . . . 1.27 107.559 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.58 -21.67 74.73 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.347 -0.696 . . . . 0.86 113.821 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -78.26 70.65 4.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.092 1.446 . . . . 1.53 108.065 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.444 HD21 ' HG3' ' A' ' 18' ' ' ARG . 14.5 t-20 -158.84 85.35 0.82 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.017 1.727 . . . . 2.11 108.046 -169.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -114.29 147.15 39.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.502 1.121 . . . . 0.78 109.587 -164.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.14 -39.2 93.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.937 0.399 . . . . 2.62 110.475 -174.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.6 p -141.33 163.04 34.02 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.689 0.795 . . . . 0.54 110.735 -169.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.61 -45.97 66.82 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 109.402 -0.592 . . . . 0.49 109.402 162.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -47.56 -51.11 22.06 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.973 0.352 . . . . 2.0 110.509 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -69.56 -49.4 54.6 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.264 -0.273 . . . . 2.21 110.264 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 t -50.66 -44.02 57.51 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.381 0.61 . . . . 0.55 111.143 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -62.94 -58.39 7.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.46 1.104 . . . . 3.82 109.603 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.11 -41.38 17.2 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.782 0.676 . . . . 0.83 111.429 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.03 -53.3 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.767 0.427 . . . . 1.58 112.028 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 78.7 m -110.61 -21.63 12.02 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.392 1.256 . . . . 2.84 114.392 -163.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -117.44 62.5 0.74 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.893 1.677 . . . . 5.58 110.432 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 105.18 -2.155 . . . . 6.89 105.18 173.277 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 117.577 -1.202 . . . . 3.4 108.855 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.8 pt -47.07 -31.4 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 124.086 0.866 . . . . 1.65 111.905 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.5 m -49.87 -26.29 3.93 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.493 1.117 . . . . 1.26 112.743 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.27 -26.51 62.02 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.289 0.495 . . . . 1.35 110.433 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -61.06 137.87 94.14 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 108.597 -0.89 . . . . 3.52 108.597 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.16 170.2 20.52 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.864 1.709 . . . . 1.23 111.769 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 20' ' ' TYR . 1.6 ttpm? -51.76 140.69 18.6 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.164 0.983 . . . . 2.66 110.697 156.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 132.54 8.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 113.756 -1.565 . . . . 5.67 106.943 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -67.48 -39.95 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.479 -0.934 . . . . 1.39 108.479 172.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.48 33.38 8.63 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.836 0.732 . . . . 3.24 111.655 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 48.71 60.55 3.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.254 1.821 . . . . 8.39 113.391 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -153.89 152.15 30.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.774 -0.825 . . . . 1.78 108.774 168.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -82.82 70.36 9.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.853 -1.166 . . . . 4.84 107.853 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.23 149.85 16.97 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 109.39 -1.484 . . . . 1.29 109.39 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -120.14 72.6 0.94 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.923 -1.51 . . . . 1.22 106.923 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -102.73 96.01 7.05 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 107.092 -1.447 . . . . 0.74 107.092 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -60.97 127.15 21.45 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 N-CA-C 108.879 -1.239 . . . . 0.56 108.879 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -135.49 179.98 6.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.71 1.604 . . . . 2.6 107.642 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -119.8 149.17 42.48 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.101 1.76 . . . . 0.47 107.949 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.492 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 2.2 p90 -134.03 157.26 46.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.866 -1.902 . . . . 0.66 105.866 170.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -71.34 105.89 3.67 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.377 -1.712 . . . . 0.95 106.377 159.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.492 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 7.5 t0 -71.65 115.31 10.69 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.855 -1.535 . . . . 2.25 106.855 172.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 t -94.46 -9.25 36.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 123.8 0.688 . . . . 1.33 109.674 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.45 -43.68 72.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.451 -2.055 . . . . 4.3 105.451 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.8 p -98.89 -40.08 8.27 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.564 2.346 . . . . 1.09 112.846 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 60.9 1.26 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.94 -1.264 . . . . 1.05 109.94 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -157.63 138.36 13.1 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 124.16 0.984 . . . . 5.15 109.556 -163.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.6 m -72.85 122.38 21.5 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 120.617 -1.302 . . . . 0.56 107.594 165.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.4 m -143.06 145.34 32.51 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 108.507 -0.923 . . . . 0.62 108.507 -162.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.51 153.21 65.64 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.789 2.326 . . . . 0.51 111.188 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -155.76 163.21 40.14 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.195 -1.409 . . . . 0.68 107.195 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.11 126.47 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 N-CA-C 108.01 -1.107 . . . . 0.9 108.01 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -105.91 148.66 27.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.515 1.126 . . . . 2.3 108.384 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.83 -9.57 62.42 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.711 1.148 . . . . 1.14 113.028 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 14.05 80.65 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.155 0.977 . . . . 1.64 112.395 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.5 m -145.96 178.48 8.16 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 107.016 -1.476 . . . . 2.16 107.016 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.64 -69.17 2.1 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.383 1.944 . . . . 3.07 110.674 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.67 -163.98 3.52 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.326 1.917 . . . . 1.43 113.578 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.5 p30 170.46 -160.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.256 3.822 . . . . 1.6 104.759 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.38 -44.52 7.93 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.76 1.164 . . . . 0.99 110.287 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -74.88 78.26 2.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.105 0.955 . . . . 1.56 112.134 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -156.55 115.38 3.39 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.763 1.625 . . . . 2.23 108.002 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -133.95 155.65 49.56 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 124.762 1.225 . . . . 0.64 108.73 -168.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -80.2 -31.22 38.75 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.463 -0.773 . . . . 2.97 111.633 -174.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.1 p -145.73 165.01 30.03 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.761 0.824 . . . . 0.69 110.08 -173.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.57 -46.55 70.32 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 109.558 -0.534 . . . . 0.58 109.558 163.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -47.03 -52.19 15.53 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 110.039 -0.356 . . . . 2.1 110.039 175.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 tp-100 -66.94 -51.73 51.72 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.283 -0.265 . . . . 3.96 110.283 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -51.84 -48.59 63.89 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 122.911 0.484 . . . . 0.59 110.882 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.4 -58.13 9.82 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.943 0.897 . . . . 2.48 109.273 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.19 -41.64 62.82 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.514 0.725 . . . . 0.74 111.763 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.3 mm -70.43 -51.66 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.39 0.276 . . . . 1.5 110.522 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.7 t -81.86 -44.53 16.74 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.044 0.757 . . . . 1.49 113.044 -164.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.4 mtp85 -134.01 -159.76 0.99 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.893 2.077 . . . . 5.33 110.85 -169.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 104.57 -2.382 . . . . 4.91 104.57 117.858 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.3 pt . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 112.295 0.479 . . . . 1.9199999999999999 112.295 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 89.0 m -34.55 -42.58 0.15 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.827 1.251 . . . . 1.5700000000000001 111.441 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.95 -17.39 62.08 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.909 1.077 . . . . 1.3999999999999999 113.909 -170.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -73.39 143.29 82.59 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 119.889 1.222 . . . . 3.0299999999999998 110.819 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.22 -179.18 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.215 2.61 . . . . 1.3200000000000001 109.936 166.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.51 134.64 55.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.663 0.744 . . . . 2.6099999999999999 110.591 170.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -139.34 128.25 23.55 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.461 1.904 . . . . 5.6600000000000001 106.076 170.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.6 t -75.45 -85.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.122 -1.436 . . . . 1.8 107.122 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.96 179.24 30.0 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 107.861 -2.096 . . . . 1.8500000000000001 107.861 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -72.1 -48.73 41.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.725 -1.213 . . . . 5.6600000000000001 107.725 174.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.1 m -71.08 150.31 45.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.105 -1.072 . . . . 2.1600000000000001 108.105 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.45 20.21 13.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.703 0.801 . . . . 7.0700000000000003 110.363 -170.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.25 147.9 50.91 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.9 -0.88 . . . . 1.6399999999999999 110.9 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -81.7 73.3 8.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.728 0.775 . . . . 1.51 108.912 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -99.35 93.13 2.05 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 106.895 -1.52 . . . . 0.97999999999999998 106.895 166.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.6 125.19 13.93 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 N-CA-C 108.064 -1.552 . . . . 0.55000000000000004 108.064 171.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -132.78 176.47 8.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.345 1.458 . . . . 3.7000000000000002 107.279 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -118.25 139.37 51.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.847 1.659 . . . . 0.68000000000000005 108.394 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -118.26 148.89 41.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.903 -1.888 . . . . 0.83999999999999997 105.903 168.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -70.78 100.02 1.82 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.47 -2.419 . . . . 1.1899999999999999 104.47 160.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -71.88 77.96 0.89 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 105.602 -1.999 . . . . 2.3700000000000001 105.602 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.0 t -61.71 -18.87 61.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.419 1.088 . . . . 1.29 110.342 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -62.06 -44.37 96.82 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 105.459 -2.052 . . . . 4.3899999999999997 105.459 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.7 p -94.58 -24.55 17.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.52 1.528 . . . . 1.0700000000000001 114.04 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.43 19.37 64.38 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.766 1.174 . . . . 0.81000000000000005 112.418 -165.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HB2' ' HZ2' ' A' ' 27' ' ' LYS . 8.2 mtmp? -103.4 163.28 12.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.644 1.178 . . . . 5.6299999999999999 109.99 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.5 m -90.28 138.95 31.12 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 105.55 -2.018 . . . . 0.68000000000000005 105.55 148.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.1 m -156.13 145.73 15.39 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 118.377 -0.82 . . . . 0.81000000000000005 109.212 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.33 153.27 61.49 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.074 2.516 . . . . 0.46000000000000002 112.11 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -154.68 166.1 34.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.543 1.937 . . . . 0.41999999999999998 105.93 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.99 127.76 50.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 106.67 -1.604 . . . . 0.73999999999999999 106.67 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -85.93 -77.42 0.3 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.177 0.991 . . . . 2.5499999999999998 110.957 -172.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.67 98.17 0.51 Allowed Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.861 -1.296 . . . . 3.1099999999999999 109.861 -168.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -32.41 -63.45 0.28 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 127.219 2.343 . . . . 2.1699999999999999 114.071 -171.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.254 0.8 OUTLIER -74.47 121.66 21.83 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.534 0.938 . . . . 2.8500000000000001 113.534 -176.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.48 18.97 26.66 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.043 1.783 . . . . 2.5 113.357 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.24 162.93 39.35 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.309 1.055 . . . . 1.6699999999999999 113.691 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -118.79 -169.25 1.69 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.111 1.365 . . . . 1.47 110.513 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.44 -44.1 6.68 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.446 -1.062 . . . . 0.85999999999999999 110.446 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -72.75 73.95 1.1 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.432 0.634 . . . . 1.6100000000000001 110.549 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -159.33 96.37 1.29 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.833 1.253 . . . . 1.9399999999999999 108.555 -166.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -125.19 141.4 52.12 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 124.821 1.248 . . . . 0.71999999999999997 111.343 -165.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -55.47 -34.6 64.67 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.511 0.724 . . . . 3.1000000000000001 111.547 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.7 p -141.12 160.05 40.92 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.794 0.838 . . . . 0.55000000000000004 112.061 -169.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -51.37 -48.12 62.63 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-O 117.941 -1.028 . . . . 0.59999999999999998 108.839 158.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -39.41 -56.5 1.58 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.063 0.847 . . . . 2.0699999999999998 110.766 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -70.11 -50.28 42.35 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 121.164 -0.214 . . . . 4.5099999999999998 110.812 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.8 t -52.9 -32.78 47.13 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 122.064 0.935 . . . . 0.93999999999999995 112.143 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -73.83 -72.68 0.26 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 124.677 1.191 . . . . 4.0099999999999998 107.952 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -41.76 -45.15 3.46 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.798 1.639 . . . . 0.57999999999999996 112.439 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.8 mm -73.18 -33.5 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 119.344 -0.36 . . . . 1.6799999999999999 111.852 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 113.33 0.863 . . . . 1.3100000000000001 113.33 -171.713 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.634 HD12 ' N ' ' A' ' 3' ' ' CYS . 2.2 pp . . . . . 0 C--O 1.224 -0.25 0 N-CA-C 112.938 0.718 . . . . 2.3399999999999999 112.938 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.634 ' N ' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -50.65 -32.44 19.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.31 1.044 . . . . 1.78 111.955 177.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -30.31 64.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.058 0.543 . . . . 1.8 112.409 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -77.14 131.04 73.42 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.599 -0.889 . . . . 4.0999999999999996 108.599 -170.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.81 -176.48 3.06 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.071 1.847 . . . . 1.4399999999999999 113.602 -164.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 20' ' ' TYR . 3.2 ttpm? -61.61 153.29 28.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.245 1.018 . . . . 2.7400000000000002 109.301 157.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.501 ' CD ' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -155.95 173.83 16.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.918 -2.253 . . . . 5.7300000000000004 104.918 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.0 -87.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 106.236 -1.764 . . . . 1.46 106.236 160.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.93 -171.01 43.21 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.84 -1.704 . . . . 1.8799999999999999 108.84 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -120.24 24.81 10.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.292 1.037 . . . . 6.8899999999999997 110.62 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.3 m -138.83 159.73 41.43 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.55 -1.648 . . . . 2.2799999999999998 106.55 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -79.75 55.97 2.17 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.883 0.473 . . . . 4.6200000000000001 110.594 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.8 159.57 29.3 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.331 -0.707 . . . . 1.47 111.331 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -140.41 73.05 1.41 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.781 -1.563 . . . . 1.9399999999999999 106.781 171.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.89 97.03 22.25 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 108.632 -0.877 . . . . 0.81999999999999995 108.632 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.0 118.27 5.12 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 120.462 1.201 . . . . 0.95999999999999996 109.153 172.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -120.88 179.3 4.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 127.571 2.349 . . . . 3.8599999999999999 108.429 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -117.83 148.39 42.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.584 2.354 . . . . 0.98999999999999999 107.729 167.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 7' ' ' LYS . 2.3 p90 -134.32 156.02 49.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.498 -1.667 . . . . 1.27 106.498 166.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -66.77 112.28 4.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.558 -1.645 . . . . 1.51 106.558 159.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -93.08 122.3 35.31 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 123.898 0.749 . . . . 1.76 110.49 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -89.2 -5.25 57.84 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 117.82 -1.086 . . . . 1.8300000000000001 111.938 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -71.19 -48.86 49.06 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.624 -1.621 . . . . 4.6900000000000004 106.624 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.8 p -88.16 -30.81 19.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.695 1.198 . . . . 1.6899999999999999 112.73 174.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.33 26.75 29.7 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.1 0.857 . . . . 0.98999999999999999 111.952 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -142.49 154.32 44.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.189 1.396 . . . . 4.7599999999999998 110.819 -167.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.7 m -68.99 121.27 16.29 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 108.224 -1.028 . . . . 0.64000000000000001 108.224 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.2 m -144.65 145.07 26.93 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 123.512 0.725 . . . . 0.72999999999999998 109.183 -160.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.48 154.44 68.83 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.913 2.409 . . . . 0.72999999999999998 111.723 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -155.66 158.07 37.7 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.652 -1.24 . . . . 0.68000000000000005 107.652 166.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -94.92 118.33 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 N-CA-C 107.48 -1.304 . . . . 1.3600000000000001 107.48 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -91.49 145.17 24.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.881 1.272 . . . . 2.0899999999999999 109.82 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.26 22.61 37.69 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.786 1.184 . . . . 1.6000000000000001 112.734 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.92 -46.34 3.64 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.629 1.214 . . . . 1.4099999999999999 111.99 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.0 155.45 49.96 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.564 1.146 . . . . 2.1400000000000001 110.325 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.07 47.79 35.97 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.285 -0.726 . . . . 2.7799999999999998 111.285 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.96 -153.42 29.31 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.736 0.684 . . . . 1.3600000000000001 111.907 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.501 ' ND2' ' CD ' ' A' ' 8' ' ' LYS . 17.5 p30 -149.36 -171.52 3.91 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.93 -1.878 . . . . 1.8400000000000001 105.93 165.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.51 -35.01 85.94 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.907 0.776 . . . . 0.66000000000000003 112.175 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -76.65 70.76 3.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.572 1.149 . . . . 1.8200000000000001 109.731 -176.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.92 63.48 0.65 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.071 -0.714 . . . . 2.1000000000000001 109.071 -161.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -104.41 146.89 28.2 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.722 1.209 . . . . 0.81999999999999995 109.519 -162.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -64.54 -40.01 94.82 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.873 1.669 . . . . 2.8300000000000001 110.58 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -126.03 153.73 43.99 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.998 1.111 . . . . 0.47999999999999998 113.998 -167.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.85 -47.22 42.84 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.557 1.143 . . . . 0.54000000000000004 110.273 159.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -44.16 -53.77 6.2 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.416 0.686 . . . . 2.0800000000000001 110.408 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -64.92 -52.37 56.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 119.534 -0.269 . . . . 2.4500000000000002 110.44 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.0 t -48.25 -52.68 20.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.533 0.682 . . . . 0.70999999999999996 111.436 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.9 ttm-85 -57.0 -62.05 2.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.726 1.211 . . . . 2.79 109.927 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.97 -38.06 64.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.513 0.725 . . . . 0.71999999999999997 111.993 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.4 mt -75.41 -53.53 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 122.91 0.484 . . . . 1.52 110.75 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.9 t . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 113.584 0.957 . . . . 1.5700000000000001 113.584 -171.157 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 112.157 0.429 . . . . 1.8899999999999999 112.157 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.02 -13.32 1.86 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.89 1.676 . . . . 2.3399999999999999 114.324 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.03 -33.97 70.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.198 -1.038 . . . . 2.6699999999999999 108.198 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -77.98 137.98 61.41 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.44 -0.948 . . . . 3.5099999999999998 108.44 167.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -80.13 -179.68 5.46 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.064 1.842 . . . . 1.46 110.072 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -39.87 139.13 0.68 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 115.496 1.665 . . . . 3.1099999999999999 115.496 149.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -157.36 151.53 24.77 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 129.128 2.971 . . . . 4.96 104.853 168.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.3 t -136.7 -60.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.09 0.471 . . . . 2.0899999999999999 111.961 -160.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.67 65.96 3.09 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 114.679 0.632 . . . . 3.6200000000000001 114.679 -155.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.78 -18.51 5.57 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.49 0.716 . . . . 6.5199999999999996 112.245 164.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.5 m -130.88 160.81 33.35 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 106.845 -1.539 . . . . 1.9099999999999999 106.845 161.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -120.69 52.94 1.14 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.503 1.121 . . . . 4.9900000000000002 109.727 -170.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.16 139.61 15.49 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.316 -1.113 . . . . 1.76 110.316 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -82.64 74.48 9.6 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.078 -0.712 . . . . 1.1599999999999999 109.078 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -101.7 92.44 2.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 118.204 -0.903 . . . . 1.03 109.998 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.21 111.36 2.24 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.977 1.784 . . . . 0.72999999999999998 109.586 174.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HG3' HD21 ' A' ' 42' ' ' ASN . 9.0 mmt85 -120.66 -179.08 3.88 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.897 1.679 . . . . 3.1899999999999999 108.891 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -120.0 146.48 45.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.735 1.614 . . . . 0.40000000000000002 108.538 172.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 6.0 p90 -127.76 152.22 48.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.451 -1.315 . . . . 0.69999999999999996 107.451 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -68.04 101.9 1.21 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.071 -1.825 . . . . 1.3200000000000001 106.071 158.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -73.44 138.06 44.95 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.412 -0.588 . . . . 2.2200000000000002 109.412 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.7 t -108.2 -8.37 15.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.692 1.197 . . . . 1.6399999999999999 111.068 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.64 -50.25 45.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.363 -1.347 . . . . 4.2199999999999998 107.363 168.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.9 p -89.14 -28.23 20.19 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.798 0.839 . . . . 1.27 112.231 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.06 39.7 18.97 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.317 -0.713 . . . . 0.90000000000000002 111.352 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -148.69 148.09 29.64 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.614 1.207 . . . . 4.2599999999999998 110.414 -166.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.8 m -68.7 118.4 11.64 Favored 'General case' 0 CA--C 1.526 0.049 0 N-CA-C 108.572 -0.899 . . . . 0.52000000000000002 108.572 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.2 m -136.71 142.02 37.43 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 124.928 1.291 . . . . 0.56000000000000005 108.718 -164.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.52 154.45 50.15 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.016 2.478 . . . . 0.45000000000000001 111.453 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -159.64 158.24 31.16 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.577 1.151 . . . . 0.76000000000000001 109.176 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.1 mm -86.3 119.87 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 106.64 -1.615 . . . . 1.1799999999999999 106.64 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -80.09 -19.78 46.64 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.018 0.747 . . . . 3.4199999999999999 113.018 -168.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.29 -46.46 3.41 Favored Glycine 0 CA--C 1.527 0.821 0 O-C-N 120.979 -1.076 . . . . 1.1499999999999999 110.45 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.8 -30.94 3.85 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.21 0.909 . . . . 1.79 112.953 165.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.69 159.42 39.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.736 0.814 . . . . 2.4700000000000002 111.607 -169.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.0 5.03 51.32 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.192 0.901 . . . . 3.1499999999999999 112.414 -166.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.17 -149.71 3.5 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.395 0.998 . . . . 1.8300000000000001 110.943 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -151.56 -176.24 5.52 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.709 1.204 . . . . 1.28 108.629 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.38 -5.14 90.22 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.549 -1.14 . . . . 1.1000000000000001 113.152 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -78.15 65.58 3.56 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.961 1.88 . . . . 1.5900000000000001 107.073 170.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.425 HD21 ' HG3' ' A' ' 18' ' ' ARG . 20.6 t-20 -159.0 112.68 2.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.929 -1.137 . . . . 2.4399999999999999 107.929 -165.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -136.24 148.5 48.08 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.549 1.14 . . . . 0.70999999999999996 108.206 -165.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.46 -38.59 84.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.337 0.517 . . . . 2.6000000000000001 109.779 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.5 p -135.66 160.14 39.43 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.873 0.869 . . . . 0.69999999999999996 111.707 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.66 -46.81 58.73 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 123.393 0.677 . . . . 0.62 109.803 161.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -49.32 -49.59 43.29 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.099 -0.334 . . . . 2.6000000000000001 110.099 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -67.22 -50.61 60.11 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.024 -0.362 . . . . 1.9099999999999999 110.024 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.8 t -50.63 -46.15 58.08 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.507 0.67 . . . . 0.60999999999999999 111.184 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -59.15 -59.8 4.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.806 1.242 . . . . 2.75 109.727 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.54 -41.93 54.52 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.359 0.664 . . . . 0.66000000000000003 111.824 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.92 -50.39 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 122.962 0.505 . . . . 1.48 111.236 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 114.783 1.401 . . . . 2.0 114.783 -156.699 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.222 -0.36 0 CA-C-O 120.835 0.35 . . . . 2.0499999999999998 111.234 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 66.4 m -45.13 -32.95 1.99 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.488 1.515 . . . . 1.3400000000000001 112.093 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.55 7.14 47.25 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.617 0.599 . . . . 2.6899999999999999 112.617 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.16 127.5 92.03 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.56 1.073 . . . . 3.29 109.165 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.11 145.61 49.83 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.797 2.331 . . . . 2.0800000000000001 107.337 170.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -76.07 132.58 40.18 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 117.932 -1.507 . . . . 8.4299999999999997 112.087 -164.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.86 148.1 39.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.789 2.036 . . . . 5.5599999999999996 107.251 168.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -80.87 -87.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.746 -1.575 . . . . 2.2200000000000002 106.746 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.57 55.09 0.03 OUTLIER Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.357 0.503 . . . . 3.48 112.657 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.25 47.55 0.69 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.63 1.972 . . . . 5.29 113.679 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.8 m -96.53 164.25 12.69 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.237 0.615 . . . . 3.7200000000000002 111.343 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -140.33 58.86 1.57 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.425 -1.324 . . . . 6.7000000000000002 107.425 170.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.49 171.97 31.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 108.35 -1.9 . . . . 1.24 108.35 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -125.71 102.36 7.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.78 1.232 . . . . 1.21 108.43 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -131.9 105.15 13.96 Favored Pre-proline 0 C--O 1.233 0.207 0 N-CA-C 106.364 -1.717 . . . . 1.25 106.364 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.67 132.04 21.1 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.92 1.747 . . . . 0.64000000000000001 108.773 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -136.97 178.91 6.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.678 1.591 . . . . 3.5299999999999998 107.356 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -122.27 145.46 48.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.508 1.523 . . . . 0.47999999999999998 109.3 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -130.97 150.56 52.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.063 -1.088 . . . . 0.89000000000000001 108.063 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -72.34 101.42 2.88 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 166.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.79 109.57 6.48 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.541 -1.281 . . . . 2.04 107.541 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -85.62 -7.07 59.05 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.017 0.927 . . . . 1.3899999999999999 111.971 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -71.01 -55.64 7.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.828 -1.545 . . . . 7.4000000000000004 106.828 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 p -85.37 -19.03 32.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.774 -1.103 . . . . 1.21 111.986 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.22 41.47 69.05 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.129 -1.188 . . . . 1.1499999999999999 110.129 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.08 131.81 45.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.072 0.949 . . . . 5.3499999999999996 109.893 -170.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.535 ' HB2' HD13 ' A' ' 46' ' ' LEU . 56.0 m -67.44 113.01 4.96 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.041 -1.466 . . . . 0.68000000000000005 107.041 159.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.2 m -126.93 137.25 30.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 126.767 2.027 . . . . 0.72999999999999998 107.825 -165.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.55 156.21 58.26 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.633 2.222 . . . . 0.41999999999999998 111.022 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -161.63 165.8 27.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.47 1.508 . . . . 0.62 107.588 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.28 118.72 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 107.62 -1.252 . . . . 0.82999999999999996 107.62 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -77.45 -42.68 35.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.67 0.788 . . . . 2.3500000000000001 110.834 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.7 -16.92 43.15 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.978 -0.901 . . . . 1.75 112.895 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.75 25.17 21.24 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 118.171 0.986 . . . . 1.8999999999999999 113.24 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.86 159.98 9.97 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.323 1.062 . . . . 2.9399999999999999 109.939 -171.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.85 32.9 59.48 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.221 1.391 . . . . 2.3100000000000001 114.575 169.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.43 -163.28 9.76 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 122.263 0.924 . . . . 1.3600000000000001 115.276 -168.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -156.7 -179.75 8.49 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 127.686 2.394 . . . . 1.3799999999999999 106.377 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.99 -40.03 95.09 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 118.237 0.472 . . . . 0.79000000000000004 113.411 -169.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -77.34 57.57 1.52 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.466 1.106 . . . . 1.73 111.25 -167.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.75 76.75 1.02 Allowed 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.251 -0.905 . . . . 2.4199999999999999 110.725 -148.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -122.04 145.24 48.34 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.11 1.364 . . . . 0.83999999999999997 111.802 -152.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -57.12 -39.06 74.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.487 1.115 . . . . 2.77 111.533 -173.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -144.94 161.15 40.06 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.139 0.576 . . . . 0.64000000000000001 110.109 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.535 HD13 ' HB2' ' A' ' 28' ' ' CYS . 1.2 tp -52.12 -48.46 64.82 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 118.514 -0.755 . . . . 0.63 109.012 164.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -43.63 -53.9 5.38 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.477 -0.564 . . . . 2.52 109.477 176.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -69.72 -46.51 65.8 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.835 -0.432 . . . . 1.97 109.835 -171.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.4 t -51.97 -49.35 63.39 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 121.078 0.466 . . . . 0.58999999999999997 110.726 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -60.98 -61.19 2.76 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.223 -1.028 . . . . 5.2800000000000002 108.223 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -43.8 -48.44 8.18 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.473 1.509 . . . . 0.60999999999999999 111.55 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -67.4 -50.85 58.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.655 0.382 . . . . 1.6699999999999999 111.048 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 32.1 m . . . . . 0 CA--C 1.529 0.139 0 O-C-N 122.071 -0.393 . . . . 2.27 112.054 -172.112 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.2 pt . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 113.321 0.86 . . . . 1.8600000000000001 113.321 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.6 m -56.38 -41.3 76.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.643 -0.661 . . . . 1.48 110.172 160.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.4 -27.47 41.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.592 1.157 . . . . 1.73 111.99 -173.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 50.5 mt-10 -58.32 139.38 84.47 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 106.974 -1.491 . . . . 3.1800000000000002 106.974 166.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -102.56 -175.77 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.836 2.357 . . . . 1.24 110.821 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.0 132.3 37.5 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.114 -0.699 . . . . 2.7599999999999998 109.114 167.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.25 136.6 15.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.487 -2.042 . . . . 4.9199999999999999 105.487 172.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t -74.11 -71.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.131 0.878 . . . . 1.6000000000000001 108.971 -174.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.69 178.34 17.74 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.232 -1.547 . . . . 1.78 109.232 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -79.01 37.28 0.3 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 117.842 0.821 . . . . 5.5499999999999998 110.688 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.8 m -166.34 158.86 14.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 105.513 -2.032 . . . . 1.78 105.513 -166.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -139.6 41.53 2.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.399 0.68 . . . . 6.2000000000000002 110.543 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.81 152.1 49.99 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 109.981 -1.247 . . . . 1.3600000000000001 109.981 173.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -82.4 74.15 9.39 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.721 -0.87 . . . . 1.3500000000000001 109.032 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.58 91.0 3.05 Favored Pre-proline 0 CA--C 1.529 0.169 0 N-CA-C 108.77 -0.826 . . . . 0.79000000000000004 108.77 171.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -62.81 122.63 11.01 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 N-CA-C 108.702 -1.307 . . . . 0.84999999999999998 108.702 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -130.65 176.39 8.22 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.059 1.744 . . . . 3.48 107.984 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -109.01 148.95 29.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.837 1.255 . . . . 0.59999999999999998 108.488 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -131.51 153.58 49.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.323 -1.362 . . . . 0.93000000000000005 107.323 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -82.71 107.01 15.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.171 -1.789 . . . . 1.2 106.171 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.16 112.88 15.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.275 -1.009 . . . . 2.1000000000000001 108.275 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 t -88.5 -0.56 57.35 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 117.966 -1.016 . . . . 1.22 113.106 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -82.63 -48.98 10.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.498 -1.668 . . . . 5.21 106.498 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.4 p -79.63 -30.71 41.47 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.769 1.228 . . . . 1.1000000000000001 110.062 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.39 57.06 5.77 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.056 -1.618 . . . . 0.88 109.056 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.28 160.89 37.55 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.18 0.992 . . . . 4.6200000000000001 110.039 -177.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.0 m -85.99 128.72 34.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.652 0.781 . . . . 0.57999999999999996 109.075 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -144.06 144.91 27.99 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.52 1.128 . . . . 0.5 108.306 -161.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.43 155.2 45.79 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.969 2.446 . . . . 0.48999999999999999 112.265 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.25 169.5 23.09 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.526 1.53 . . . . 0.69999999999999996 108.114 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.18 119.13 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.307 -0.998 . . . . 0.85999999999999999 108.307 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -89.39 143.57 26.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.32 1.848 . . . . 1.97 109.963 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.3 -36.59 91.3 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.412 -0.66 . . . . 1.0900000000000001 113.381 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.86 18.9 28.32 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.125 0.869 . . . . 2.21 112.894 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.4 m -141.95 -159.18 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.559 1.144 . . . . 3.1899999999999999 108.162 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -15.55 -60.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 C-N-CA 128.27 2.843 . . . . 4.4299999999999997 115.664 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.42 -133.79 12.14 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 119.336 -0.702 . . . . 1.3700000000000001 111.545 168.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 168.66 -173.42 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 128.904 2.881 . . . . 1.98 106.851 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.17 -44.94 10.69 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.767 -0.933 . . . . 0.80000000000000004 110.767 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 11.4 t-20 -73.65 67.94 1.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.72 1.208 . . . . 2.9399999999999999 110.057 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -163.15 88.12 0.58 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.736 1.214 . . . . 2.1200000000000001 109.791 -168.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -121.21 148.76 43.81 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.432 1.093 . . . . 1.3200000000000001 111.537 -162.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.45 -38.26 80.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.853 0.461 . . . . 2.9399999999999999 111.022 -174.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.3 p -142.28 165.83 26.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.516 0.726 . . . . 0.56000000000000005 110.561 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -47.76 79.01 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.814 0.846 . . . . 0.55000000000000004 110.675 166.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -48.82 -53.61 18.59 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.316 -0.624 . . . . 2.2999999999999998 109.316 175.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -65.44 -49.98 67.11 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.541 -0.54 . . . . 2.3700000000000001 109.541 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.5 t -50.3 -51.95 40.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.549 0.69 . . . . 0.97999999999999998 110.933 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -65.27 -49.18 70.56 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.466 -0.788 . . . . 3.8500000000000001 109.815 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.87 -44.42 82.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.388 0.675 . . . . 1.21 111.624 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.3 mt -69.95 -51.78 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 122.579 0.352 . . . . 2.1499999999999999 110.667 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.528 0.126 0 N-CA-C 112.504 0.557 . . . . 2.4100000000000001 112.504 -174.066 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.3 pt . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 111.774 0.287 . . . . 1.7 111.774 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.7 m -77.36 -27.88 52.79 Favored 'General case' 0 C--O 1.222 -0.359 0 O-C-N 121.87 -0.519 . . . . 1.3600000000000001 110.655 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.92 -30.77 19.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.494 -0.928 . . . . 1.75 108.494 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -52.99 139.04 44.51 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 108.006 -1.109 . . . . 2.79 108.006 165.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -98.79 175.74 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.747 2.298 . . . . 1.4199999999999999 111.064 172.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.28 138.88 31.24 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.853 -1.067 . . . . 3.1699999999999999 110.1 160.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 132.4 8.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 128.242 2.617 . . . . 4.5700000000000003 106.378 176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.1 t -75.51 -86.02 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.103 -1.073 . . . . 2.3199999999999998 108.103 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.74 147.57 0.6 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 123.606 0.622 . . . . 2.3199999999999998 113.005 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 65.16 -55.47 0.31 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.871 2.868 . . . . 8.2100000000000009 115.808 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.7 m -140.06 166.57 24.29 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.299 1.04 . . . . 1.8799999999999999 109.73 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -133.28 33.0 3.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.087 0.955 . . . . 6.1900000000000004 110.787 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.75 146.72 42.27 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.071 -1.212 . . . . 1.45 110.071 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -81.79 72.4 8.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.883 0.849 . . . . 1.1399999999999999 108.718 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -101.57 95.95 5.78 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 107.761 -1.2 . . . . 0.81000000000000005 107.761 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.1 131.02 29.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 N-CA-C 108.511 -1.38 . . . . 0.71999999999999997 108.511 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -135.11 174.89 10.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.46 -1.311 . . . . 3.52 107.46 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -111.08 146.65 36.39 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.703 1.201 . . . . 0.46000000000000002 108.311 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -129.75 152.13 49.59 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.634 -1.247 . . . . 0.95999999999999996 107.634 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.47 102.42 5.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 103.892 -2.633 . . . . 1.48 103.892 160.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -72.08 109.98 6.24 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.82 -1.918 . . . . 2.2400000000000002 105.82 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 t -86.27 -14.75 42.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.508 -0.553 . . . . 1.1299999999999999 109.508 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -63.09 -44.43 95.72 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.846 -1.909 . . . . 4.3499999999999996 105.846 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.7 p -91.95 -40.83 10.91 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.952 2.501 . . . . 1.21 111.465 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.03 21.89 24.32 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.926 1.727 . . . . 1.04 112.398 -169.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -120.93 151.16 40.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.936 1.694 . . . . 4.5300000000000002 109.195 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -73.15 136.68 44.82 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 120.664 -1.273 . . . . 0.57999999999999996 108.093 168.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.8 m -155.11 147.24 17.4 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.431 -0.795 . . . . 0.78000000000000003 108.947 -169.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.44 152.18 29.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.285 2.657 . . . . 0.64000000000000001 111.774 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -150.72 158.41 44.12 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 124.831 1.252 . . . . 0.51000000000000001 108.867 172.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.07 118.79 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 105.726 -1.953 . . . . 0.82999999999999996 105.726 168.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.79 -54.06 9.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.408 0.683 . . . . 2.8399999999999999 110.569 -173.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.29 -27.81 7.52 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.208 -0.757 . . . . 1.1399999999999999 111.208 -173.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.64 -45.36 1.4 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.419 1.009 . . . . 1.5 111.364 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 m -106.4 157.73 17.41 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.577 1.151 . . . . 2.6400000000000001 108.745 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 30.83 60.95 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.499 -0.612 . . . . 2.1699999999999999 113.459 166.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.18 157.96 46.12 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 118.442 1.121 . . . . 2.04 111.75 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -117.17 -163.1 0.9 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.557 1.543 . . . . 1.05 108.495 170.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.98 69.39 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.17 -1.172 . . . . 0.87 110.17 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -75.17 58.8 0.94 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.678 1.591 . . . . 2.6899999999999999 111.522 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.29 78.57 1.02 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.935 -0.478 . . . . 2.0499999999999998 110.202 -161.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -109.77 154.57 22.76 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.247 1.019 . . . . 0.71999999999999997 110.983 -164.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -67.01 -44.54 80.05 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.833 -0.542 . . . . 2.4500000000000002 109.564 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 78.3 p -131.28 154.29 48.66 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.958 0.725 . . . . 0.67000000000000004 112.958 -169.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.02 -47.01 22.38 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.5 1.12 . . . . 0.82999999999999996 110.037 159.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.3 -50.72 15.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.241 0.616 . . . . 2.2400000000000002 110.598 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -65.89 -53.62 37.17 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 119.038 -0.506 . . . . 2.6800000000000002 110.842 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 t -47.39 -44.29 24.2 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.555 0.693 . . . . 0.59999999999999998 111.656 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.1 ttm-85 -62.14 -70.41 0.2 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.499 1.12 . . . . 2.7200000000000002 109.576 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.02 -40.81 45.81 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.204 1.402 . . . . 0.54000000000000004 112.939 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mm -63.68 -39.3 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 123.99 0.916 . . . . 1.4199999999999999 110.638 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 17.5 t . . . . . 0 C--N 1.339 0.115 0 N-CA-C 113.005 0.742 . . . . 1.73 113.005 -165.9 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.1 pt . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 113.098 0.777 . . . . 1.73 113.098 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.9 m -73.37 -32.65 64.63 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.811 0.444 . . . . 1.5900000000000001 111.096 166.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.2 -35.51 31.26 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.908 -0.495 . . . . 1.71 110.134 -177.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -60.01 135.43 90.42 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 117.853 -1.07 . . . . 4.0599999999999996 109.125 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -104.58 177.2 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.994 2.463 . . . . 1.5800000000000001 111.757 170.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -36.54 134.07 0.49 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 126.958 2.103 . . . . 2.6499999999999999 112.911 166.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.07 135.81 9.45 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 113.282 -1.781 . . . . 4.71 109.132 166.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.61 -49.87 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.063 -0.717 . . . . 1.3 109.063 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.95 85.42 0.97 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.705 0.669 . . . . 3.6899999999999999 112.815 165.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 87.9 mtm-85 65.66 -52.52 0.37 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 128.89 2.876 . . . . 8.8000000000000007 115.027 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 m -71.87 169.44 15.8 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.114 0.566 . . . . 2.3500000000000001 109.984 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -129.42 31.03 4.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.012 1.325 . . . . 7.3099999999999996 109.493 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.83 177.67 48.21 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.808 -1.317 . . . . 1.4299999999999999 109.808 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -124.96 87.61 2.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.091 0.956 . . . . 1.8899999999999999 108.73 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -111.57 103.13 54.76 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 108.096 -1.076 . . . . 0.88 108.096 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.6 125.17 14.99 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 N-CA-C 108.874 -1.241 . . . . 0.89000000000000001 108.874 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -134.2 175.71 9.25 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.468 1.507 . . . . 2.5499999999999998 107.886 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -103.64 149.28 25.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.942 1.297 . . . . 0.79000000000000004 108.06 167.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -128.32 157.45 40.93 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.726 -1.583 . . . . 0.79000000000000004 106.726 166.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -78.84 103.0 8.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.056 -1.831 . . . . 1.3300000000000001 106.056 163.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -77.4 111.38 13.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.619 -0.882 . . . . 1.8300000000000001 108.619 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 t -89.3 9.83 24.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.531 0.733 . . . . 1.6699999999999999 111.892 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -86.68 -45.29 11.13 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.16 -1.792 . . . . 4.4900000000000002 106.16 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.1 p -93.76 -31.71 14.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 130.263 3.425 . . . . 1.0700000000000001 111.684 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.35 30.93 12.47 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.436 1.493 . . . . 0.94999999999999996 112.765 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -143.61 148.11 35.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.19 1.396 . . . . 4.3600000000000003 111.502 -161.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 78.8 m -71.31 128.23 35.21 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 120.18 -1.575 . . . . 0.5 109.663 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.1 m -149.4 147.33 22.98 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 117.965 -1.016 . . . . 0.56000000000000005 109.253 -161.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.78 150.0 34.34 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.319 2.679 . . . . 0.53000000000000003 112.219 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -153.42 171.83 18.05 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.17 1.388 . . . . 0.58999999999999997 109.014 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.58 107.86 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.765 -0.828 . . . . 1.3300000000000001 108.765 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -78.47 139.68 38.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.21 1.004 . . . . 2.1699999999999999 108.706 170.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.12 -43.03 49.39 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-O 119.365 -0.686 . . . . 1.3100000000000001 112.385 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.62 -9.03 13.02 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.149 0.88 . . . . 1.6299999999999999 113.448 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.0 m -113.34 -131.11 0.32 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.155 -1.424 . . . . 2.8500000000000001 107.155 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.04 -62.78 0.04 OUTLIER Glycine 0 C--N 1.338 0.694 0 C-N-CA 127.881 2.657 . . . . 3.0 115.193 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.26 -134.16 8.04 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.506 -1.038 . . . . 1.9299999999999999 110.506 -166.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -170.0 177.0 4.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 128.21 2.604 . . . . 1.27 106.139 171.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.17 -25.12 73.49 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.193 -0.763 . . . . 0.68999999999999995 111.193 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -73.7 55.61 0.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.649 1.58 . . . . 2.71 109.908 174.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -147.53 120.57 8.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.521 -1.289 . . . . 2.3999999999999999 107.521 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -138.6 147.72 43.3 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.49 1.116 . . . . 0.69999999999999996 108.898 -165.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -78.68 -25.13 44.77 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.884 -0.51 . . . . 3.1000000000000001 110.92 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -142.42 155.42 45.1 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.512 0.725 . . . . 0.68999999999999995 111.021 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.13 -45.59 53.12 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 109.297 -0.631 . . . . 0.79000000000000004 109.297 160.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -44.77 -53.77 7.03 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.939 0.496 . . . . 2.23 110.543 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -63.97 -54.12 39.47 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 110.161 -0.311 . . . . 1.8100000000000001 110.161 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -48.58 -49.74 35.4 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.31 0.576 . . . . 0.54000000000000004 111.503 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -59.93 -64.43 0.95 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.613 1.165 . . . . 2.54 109.165 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -44.55 -45.64 9.49 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.508 1.123 . . . . 0.77000000000000002 111.699 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.8 mm -71.29 -56.71 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.888 0.875 . . . . 1.6499999999999999 110.739 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 113.225 0.824 . . . . 1.51 113.225 -168.051 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.9 pt . . . . . 0 C--O 1.225 -0.229 0 N-CA-C 112.025 0.38 . . . . 2.2400000000000002 112.025 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.8 t -32.23 -41.44 0.05 Allowed 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 126.88 2.072 . . . . 1.8200000000000001 114.708 169.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.72 -22.82 61.57 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.138 -1.392 . . . . 1.8 111.186 -169.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.43 149.76 94.45 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 118.879 0.763 . . . . 3.0600000000000001 109.395 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.68 173.16 13.32 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.137 1.891 . . . . 1.0600000000000001 110.259 170.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -54.32 141.88 28.51 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.782 0.801 . . . . 2.6400000000000001 109.471 160.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -143.94 133.05 22.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.602 -1.629 . . . . 5.8899999999999997 106.602 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.84 -55.19 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.295 0.498 . . . . 1.5700000000000001 110.144 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.64 -157.83 22.53 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 108.39 -1.884 . . . . 2.1800000000000002 108.39 -175.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -24.13 4.59 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.886 0.875 . . . . 6.2300000000000004 112.22 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.42 ' HB2' ' H ' ' A' ' 36' ' ' CYS . 64.9 m -79.12 158.26 27.79 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.539 -0.911 . . . . 2.5 108.539 166.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -106.28 45.84 0.96 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.836 0.855 . . . . 5.21 110.15 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.98 176.15 54.11 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.167 -0.773 . . . . 1.1799999999999999 111.167 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -124.44 81.07 1.9 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.15 1.38 . . . . 1.1899999999999999 107.287 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -105.99 104.67 50.46 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 108.027 -1.101 . . . . 1.1599999999999999 108.027 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -65.07 112.96 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 N-CA-C 108.544 -1.368 . . . . 0.62 108.544 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -121.69 178.34 4.89 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.934 2.094 . . . . 3.6000000000000001 109.211 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -127.32 146.15 50.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.131 1.772 . . . . 0.53000000000000003 108.313 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -135.25 153.29 51.96 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.167 -1.42 . . . . 0.81000000000000005 107.167 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -65.57 103.16 0.81 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.482 -1.673 . . . . 1.3100000000000001 106.482 161.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -78.54 114.91 17.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.376 -1.713 . . . . 1.95 106.376 169.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 t -86.28 -16.64 36.95 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.404 0.281 . . . . 1.6599999999999999 110.275 -175.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -67.2 -45.52 76.61 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 126.673 1.989 . . . . 3.6699999999999999 106.139 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.7 p -88.16 -35.6 17.31 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.246 1.818 . . . . 1.21 110.981 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.48 44.18 8.82 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.845 -1.302 . . . . 0.91000000000000003 109.845 -171.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.54 141.93 43.4 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.842 1.657 . . . . 5.8399999999999999 110.162 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.5 m -65.61 113.47 4.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.099 -1.074 . . . . 0.81000000000000005 108.099 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.7 m -132.94 144.13 51.54 Favored Pre-proline 0 C--N 1.332 -0.185 0 C-N-CA 125.65 1.58 . . . . 0.55000000000000004 108.613 -163.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.31 156.3 62.21 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.732 2.288 . . . . 0.47999999999999998 111.697 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -155.21 161.76 41.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.839 1.255 . . . . 0.59999999999999998 108.051 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.9 mm -93.67 112.39 26.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 108.136 -1.061 . . . . 1.24 108.136 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -90.19 147.14 23.75 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.691 1.196 . . . . 2.2599999999999998 109.366 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.48 -6.68 89.16 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.252 1.406 . . . . 1.0600000000000001 113.536 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.78 -49.87 1.41 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.915 1.358 . . . . 1.72 111.581 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.42 ' H ' ' HB2' ' A' ' 12' ' ' CYS . 0.6 OUTLIER -127.23 144.74 50.98 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.127 0.971 . . . . 2.3999999999999999 110.379 173.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.51 12.47 41.28 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.669 1.604 . . . . 2.1899999999999999 112.745 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.03 148.88 47.87 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 118.313 1.056 . . . . 2.1699999999999999 113.094 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -91.01 -161.18 0.79 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.411 1.484 . . . . 1.6899999999999999 109.732 171.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.27 -45.67 6.13 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.914 -1.275 . . . . 0.89000000000000001 109.914 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -73.76 72.68 1.52 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.624 0.712 . . . . 1.53 110.158 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -159.95 93.79 1.09 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.745 1.218 . . . . 2.27 108.704 -163.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -131.66 141.63 49.64 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 123.208 0.603 . . . . 1.1200000000000001 111.056 -160.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -54.52 -43.68 72.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.747 0.819 . . . . 2.7000000000000002 110.833 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.7 p -137.01 158.28 44.83 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.172 0.511 . . . . 0.68999999999999995 112.363 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.24 -46.93 62.47 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.167 -0.679 . . . . 0.56999999999999995 109.167 159.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -46.59 -50.67 17.07 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.223 0.465 . . . . 1.8400000000000001 110.437 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -65.08 -53.9 38.38 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.764 0.426 . . . . 2.96 110.215 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.0 t -51.83 -45.06 63.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.868 0.842 . . . . 0.54000000000000004 111.246 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -64.56 -53.76 42.76 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.153 1.381 . . . . 2.98 109.349 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.6 -43.11 56.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.768 0.427 . . . . 0.72999999999999998 111.167 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.4 mt -69.26 -57.05 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.045 0.538 . . . . 1.96 111.719 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 114.022 1.119 . . . . 1.5800000000000001 114.022 -166.858 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 pt . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 114.37 1.248 . . . . 1.95 114.37 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.3 m -55.61 -35.91 66.36 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.896 -0.502 . . . . 1.55 112.226 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.05 -19.37 20.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.947 0.499 . . . . 1.5700000000000001 111.088 -162.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -72.56 146.21 88.38 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 118.208 0.458 . . . . 4.25 110.323 -161.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.36 166.49 29.14 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.499 2.132 . . . . 1.8400000000000001 113.092 -169.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -57.68 147.27 28.1 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 107.702 -1.221 . . . . 2.6600000000000001 107.702 169.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -154.92 69.74 0.74 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.966 0.888 . . . . 6.0599999999999996 110.791 -156.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.3 t -60.35 -44.67 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.392 -0.596 . . . . 1.8 109.392 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.7 -146.26 18.16 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 107.972 -2.051 . . . . 2.96 107.972 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -154.15 55.11 0.71 Allowed 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.086 -0.709 . . . . 7.6799999999999997 109.086 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.0 m -150.16 150.56 31.81 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.29 1.036 . . . . 2.8500000000000001 108.247 -165.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -77.81 63.87 2.95 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.975 0.51 . . . . 7.1399999999999997 110.351 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -116.2 153.42 17.47 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.733 -1.747 . . . . 1.4399999999999999 108.733 168.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -144.56 81.2 1.65 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.537 -0.912 . . . . 1.6000000000000001 108.537 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.33 100.13 45.21 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 108.148 -1.056 . . . . 1.3700000000000001 108.148 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.71 126.0 17.27 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.32 1.346 . . . . 0.60999999999999999 109.418 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -137.64 176.24 8.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.493 1.517 . . . . 3.5699999999999998 108.305 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -121.2 142.44 49.9 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.556 1.543 . . . . 0.54000000000000004 108.52 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -128.36 152.15 48.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.965 -1.494 . . . . 1.0700000000000001 106.965 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -73.03 104.14 4.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.637 -1.616 . . . . 1.3400000000000001 106.637 168.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.16 105.96 4.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.084 -1.45 . . . . 2.04 107.084 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.2 t -81.17 -6.9 59.36 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.154 -0.927 . . . . 1.4299999999999999 112.831 -173.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -76.09 -49.95 16.03 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.211 -1.403 . . . . 5.2400000000000002 107.211 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.4 p -88.97 -12.64 40.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.708 0.803 . . . . 1.3999999999999999 111.752 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.7 37.17 76.36 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.924 1.249 . . . . 0.81000000000000005 111.119 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -137.96 135.49 36.07 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.316 1.046 . . . . 4.4400000000000004 110.747 -163.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 90.6 m -66.04 124.45 22.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.347 -0.983 . . . . 0.59999999999999998 108.347 170.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.5 m -141.37 138.99 18.15 Favored Pre-proline 0 N--CA 1.451 -0.401 0 C-N-CA 124.701 1.2 . . . . 0.83999999999999997 107.862 -164.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.03 156.89 61.55 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.456 2.104 . . . . 0.65000000000000002 111.06 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.1 157.86 36.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.215 -1.402 . . . . 0.87 107.215 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.63 116.24 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 105.293 -2.114 . . . . 0.88 105.293 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -86.28 131.2 34.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.53 -1.285 . . . . 2.3300000000000001 107.53 173.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.52 18.38 56.33 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.851 -0.416 . . . . 1.6399999999999999 112.408 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.62 -53.83 4.73 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.854 -1.698 . . . . 2.75 108.854 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.6 m -64.3 168.97 5.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.391 1.076 . . . . 2.8500000000000001 108.73 162.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.15 39.77 62.32 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 109.816 -1.314 . . . . 3.3300000000000001 109.816 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.95 57.55 5.04 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.655 -1.497 . . . . 2.6699999999999999 112.686 -171.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -81.68 173.54 12.23 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.146 0.973 . . . . 1.98 108.912 161.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.62 -23.45 72.85 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.519 0.581 . . . . 0.67000000000000004 114.051 -166.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -77.15 74.76 3.72 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.972 0.886 . . . . 1.74 109.724 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -152.17 96.52 2.2 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.071 0.548 . . . . 2.2000000000000002 109.96 -160.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -124.35 148.46 47.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.137 0.575 . . . . 1.25 109.492 -170.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -77.06 -27.55 54.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.971 -0.381 . . . . 4.7300000000000004 109.971 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.9 p -137.0 162.43 33.31 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.819 0.848 . . . . 0.95999999999999996 112.208 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.77 -49.26 39.38 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.254 1.021 . . . . 0.91000000000000003 110.101 159.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -46.8 -50.5 18.22 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.701 0.4 . . . . 2.1899999999999999 110.085 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -66.42 -52.57 45.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 119.235 -0.412 . . . . 3.9700000000000002 111.2 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 t -47.9 -49.74 28.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.606 0.639 . . . . 0.5 111.212 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -56.71 -65.44 0.61 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.49 1.116 . . . . 3.2000000000000002 109.538 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.62 -40.0 71.55 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.05 0.94 . . . . 1.0600000000000001 112.949 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mp -74.19 -52.1 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 119.258 -0.401 . . . . 2.4700000000000002 110.094 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.0 t . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 119.097 0.862 . . . . 1.55 112.546 -170.01 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.224 -0.264 0 N-CA-C 113.166 0.802 . . . . 3.48 113.166 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -18.46 60.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.286 0.565 . . . . 1.8899999999999999 111.692 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.81 -44.2 12.67 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.388 1.075 . . . . 1.9299999999999999 110.741 168.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.2 116.15 20.46 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.787 -0.625 . . . . 4.1600000000000001 110.221 -174.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.93 153.53 42.2 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.502 1.468 . . . . 1.3999999999999999 110.791 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.88 143.93 9.3 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 122.123 0.963 . . . . 2.5899999999999999 112.52 163.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.99 128.78 10.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.257 1.823 . . . . 5.2999999999999998 106.274 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.0 t -72.86 -51.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.11 -0.7 . . . . 1.3700000000000001 109.11 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.9 143.87 15.6 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.119 1.342 . . . . 2.46 109.838 -172.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -76.81 67.11 2.82 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.857 -0.79 . . . . 9.8599999999999994 108.893 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 m -107.05 178.57 4.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.414 1.086 . . . . 3.3599999999999999 109.919 -171.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -122.28 68.05 0.94 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.404 -1.332 . . . . 8.2899999999999991 107.404 167.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.14 165.97 35.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.325 -1.51 . . . . 1.51 109.325 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -146.37 99.36 3.21 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.099 1.759 . . . . 1.45 106.283 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -123.64 100.86 37.4 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 107.66 -1.237 . . . . 0.93000000000000005 107.66 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.2 125.73 17.7 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 108.484 -1.391 . . . . 0.54000000000000004 108.484 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.6 mmt-85 -135.66 174.47 10.58 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.388 1.475 . . . . 3.3799999999999999 108.347 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -115.85 140.98 48.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.241 1.417 . . . . 0.40000000000000002 108.154 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.459 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 7.4 p90 -123.6 152.65 41.68 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.331 -1.359 . . . . 0.68000000000000005 107.331 169.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -66.64 105.66 1.6 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.24 -1.763 . . . . 1.05 106.24 155.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 6.5 t70 -72.05 116.87 12.96 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.767 -1.938 . . . . 1.8300000000000001 105.767 168.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.65 -25.11 28.71 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.745 -0.835 . . . . 1.29 108.745 -169.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -63.73 -45.9 87.85 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 128.208 2.603 . . . . 3.8999999999999999 106.636 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.8 p -84.9 -34.24 22.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.101 1.36 . . . . 1.0700000000000001 110.783 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.9 37.01 23.73 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.146 1.355 . . . . 1.22 110.494 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.93 156.75 43.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.779 1.232 . . . . 6.8200000000000003 110.384 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.2 m -67.34 139.03 57.2 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.398 -0.814 . . . . 0.75 109.435 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -156.65 146.15 15.3 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.874 -1.158 . . . . 0.91000000000000003 107.874 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.66 156.49 49.11 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.091 2.528 . . . . 0.39000000000000001 111.695 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -153.69 162.95 40.79 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.414 1.486 . . . . 0.42999999999999999 107.359 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -96.05 113.67 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.862 -1.903 . . . . 0.76000000000000001 105.862 170.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -81.57 139.77 34.87 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.639 -1.245 . . . . 2.1200000000000001 107.639 169.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.26 -11.24 85.53 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 121.725 -0.609 . . . . 1.03 112.653 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.27 -43.88 1.7 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.206 -1.158 . . . . 1.51 110.206 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.9 159.03 15.19 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.131 1.773 . . . . 2.3500000000000001 111.374 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.09 37.59 93.05 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 114.759 0.664 . . . . 2.6899999999999999 114.759 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.61 -153.6 15.81 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.887 0.844 . . . . 1.3100000000000001 112.815 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -160.38 -163.32 1.08 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.381 2.272 . . . . 1.4399999999999999 105.675 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.21 -20.84 68.83 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.566 1.076 . . . . 0.79000000000000004 112.239 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -81.5 63.97 6.02 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 118.502 1.151 . . . . 1.6200000000000001 110.069 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -159.09 78.24 0.74 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.914 -0.584 . . . . 1.74 109.544 -155.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -112.99 154.5 26.36 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.465 0.706 . . . . 0.84999999999999998 110.916 -167.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.24 -39.73 94.56 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.803 -0.814 . . . . 3.04 108.803 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.8 p -130.66 150.59 51.78 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.142 1.164 . . . . 0.53000000000000003 114.142 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.9 -46.11 42.33 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.224 1.41 . . . . 0.70999999999999996 110.242 159.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.42 -49.96 23.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.704 0.802 . . . . 2.0499999999999998 110.488 175.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -64.46 -54.96 24.39 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 119.186 -0.435 . . . . 2.2999999999999998 110.358 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.25 -43.54 42.91 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.294 1.045 . . . . 0.65000000000000002 111.509 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -60.61 -58.77 7.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.864 1.266 . . . . 4.9100000000000001 111.516 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.32 -43.55 67.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.621 0.769 . . . . 0.62 112.298 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.5 -44.17 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.899 0.88 . . . . 1.76 110.331 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 113.058 0.762 . . . . 1.8899999999999999 113.058 -171.802 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.8 pt . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 111.927 0.343 . . . . 1.73 111.927 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.2 m -49.1 -27.35 3.33 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.343 1.057 . . . . 1.3500000000000001 112.704 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -33.26 66.13 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.912 -0.492 . . . . 1.3899999999999999 111.038 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.44 119.21 44.6 Favored Pre-proline 0 C--O 1.225 -0.2 0 CA-C-O 118.11 -0.947 . . . . 4.9000000000000004 109.072 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.08 173.51 12.03 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 120.802 1.322 . . . . 1.3400000000000001 111.626 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -45.21 131.56 7.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.115 -1.402 . . . . 2.79 110.52 157.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -159.17 137.01 10.25 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.711 2.004 . . . . 5.1699999999999999 106.722 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.52 -66.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.799 0.727 . . . . 1.3100000000000001 109.782 -172.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.77 -178.82 19.1 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.241 -1.543 . . . . 1.8400000000000001 109.241 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -68.06 -43.36 78.81 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.915 -0.772 . . . . 6.46 108.915 172.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.2 m -71.52 151.97 43.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.269 -1.752 . . . . 2.0299999999999998 106.269 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -138.09 46.95 2.03 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.448 0.699 . . . . 6.4500000000000002 109.134 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.94 153.91 34.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.269 -1.532 . . . . 1.4199999999999999 109.269 170.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -83.1 77.8 9.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.981 -0.717 . . . . 1.1899999999999999 109.523 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -101.31 94.35 3.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.071 -0.715 . . . . 0.78000000000000003 109.071 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.67 122.33 10.39 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 CA-C-N 120.548 1.232 . . . . 0.5 108.935 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -130.7 177.99 6.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 125.578 1.551 . . . . 3.7000000000000002 107.268 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -117.53 142.49 47.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.794 1.638 . . . . 0.38 108.144 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -124.84 150.43 46.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.567 -1.642 . . . . 0.81000000000000005 106.567 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.9 102.34 0.77 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 104.559 -2.386 . . . . 1.3999999999999999 104.559 157.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.39 103.22 3.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.243 -1.762 . . . . 2.0800000000000001 106.243 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 t -74.9 -15.33 60.71 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.258 0.623 . . . . 1.1399999999999999 110.66 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -62.4 -41.66 98.84 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.446 1.098 . . . . 4.3399999999999999 108.107 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.5 p -105.33 -25.66 12.31 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.783 2.833 . . . . 0.83999999999999997 112.911 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.1 30.39 22.97 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.867 2.175 . . . . 0.97999999999999998 113.233 -173.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -136.65 138.2 40.87 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.152 1.476 . . . . 4.4900000000000002 110.96 -161.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 m -70.48 120.17 15.73 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 120.491 -1.38 . . . . 0.56999999999999995 108.952 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.9 m -140.72 145.65 40.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.637 1.175 . . . . 0.51000000000000001 108.868 -163.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.65 151.25 41.16 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.218 2.612 . . . . 0.46000000000000002 111.899 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -154.64 162.99 40.88 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.349 1.46 . . . . 0.51000000000000001 108.27 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.39 113.15 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.02 -1.474 . . . . 0.67000000000000004 107.02 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -80.83 145.19 31.53 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.526 1.13 . . . . 1.98 108.004 168.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.31 -31.3 47.16 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.992 0.806 . . . . 1.04 114.012 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.42 17.35 24.51 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.391 0.996 . . . . 1.75 113.115 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -125.57 -156.93 0.76 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.125 1.37 . . . . 2.8700000000000001 109.403 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.48 67.61 0.26 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.868 1.699 . . . . 2.6099999999999999 110.254 163.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.33 -83.92 0.09 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.135 -1.586 . . . . 2.4199999999999999 109.135 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -177.85 -174.13 0.43 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 127.431 2.292 . . . . 1.1599999999999999 108.061 167.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.55 -20.51 61.81 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.463 0.554 . . . . 0.98999999999999999 112.69 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -80.24 64.89 5.21 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.372 1.086 . . . . 1.7 108.577 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.9 69.39 0.73 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.824 -0.806 . . . . 1.9199999999999999 108.824 -151.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -106.77 163.41 12.95 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.438 1.495 . . . . 0.67000000000000004 111.309 -162.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -30.43 35.29 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.671 -0.643 . . . . 3.3700000000000001 110.59 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.8 p -146.97 162.38 38.88 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.244 0.618 . . . . 0.66000000000000003 110.852 -173.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -46.11 70.31 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 123.432 0.693 . . . . 0.57999999999999996 109.855 163.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -47.82 -51.95 20.8 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.91 -0.404 . . . . 2.3500000000000001 109.91 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -68.96 -49.98 53.17 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.361 -0.237 . . . . 1.99 110.361 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -50.49 -47.65 57.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.509 0.671 . . . . 0.57999999999999996 110.699 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -61.89 -58.86 6.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 123.921 0.889 . . . . 4.4000000000000004 110.097 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.64 -45.61 63.38 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.502 0.721 . . . . 0.60999999999999999 111.584 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.5 mm -65.63 -54.58 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 122.661 0.385 . . . . 1.51 110.014 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.5 t . . . . . 0 CA--C 1.528 0.127 0 N-CA-C 112.781 0.66 . . . . 1.75 112.781 -168.145 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.4 pt . . . . . 0 C--O 1.226 -0.166 0 CA-C-O 120.708 0.29 . . . . 1.78 110.756 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.4 m -47.76 -28.5 2.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.644 0.778 . . . . 1.26 112.302 176.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.34 -17.03 55.34 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.025 -0.988 . . . . 1.8700000000000001 112.419 -172.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.77 148.91 81.58 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 120.511 1.505 . . . . 3.21 111.518 -173.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.2 170.15 20.84 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.665 2.243 . . . . 1.6000000000000001 110.29 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.452 ' HE2' ' CE1' ' A' ' 20' ' ' TYR . 26.7 ttmt -67.99 140.84 56.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.255 -0.646 . . . . 4.2999999999999998 109.255 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.53 149.92 30.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.505 -1.665 . . . . 5.4500000000000002 106.505 176.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.6 t -90.73 -72.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 108.915 -0.772 . . . . 1.48 108.915 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.96 173.48 34.46 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 108.838 -1.705 . . . . 1.77 108.838 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -74.23 -43.17 58.14 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.289 -1.374 . . . . 8.9600000000000009 107.289 168.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.24 144.21 50.14 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.059 -1.83 . . . . 2.3700000000000001 106.059 166.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -59.61 2.64 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 119.041 -0.504 . . . . 6.3099999999999996 109.963 -173.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.19 -178.28 0.62 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.314 1.435 . . . . 1.79 115.839 166.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -147.99 95.26 2.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.402 1.081 . . . . 1.0800000000000001 108.986 170.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.2 107.17 13.54 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 109.121 -0.696 . . . . 0.83999999999999997 109.121 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.81 117.81 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.628 1.552 . . . . 0.71999999999999997 110.208 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -120.22 176.94 5.21 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 126.921 2.088 . . . . 3.2200000000000002 109.238 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -123.63 140.69 52.74 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.779 2.031 . . . . 0.51000000000000001 107.559 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.452 ' CE1' ' HE2' ' A' ' 7' ' ' LYS . 1.3 p90 -122.55 150.65 42.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.852 -1.906 . . . . 1.03 105.852 169.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -68.57 107.74 3.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.381 -2.081 . . . . 1.4399999999999999 105.381 159.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.07 111.98 7.77 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.884 -1.525 . . . . 2.23 106.884 170.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 t -88.06 1.53 54.04 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.004 -0.998 . . . . 1.24 112.945 -171.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -85.0 -50.07 7.77 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.862 -1.533 . . . . 5.7199999999999998 106.862 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.3 p -83.43 -26.07 30.68 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.862 0.865 . . . . 1.3100000000000001 111.357 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.08 31.27 53.39 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.867 1.222 . . . . 1.05 111.126 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.2 131.61 53.55 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 118.751 1.275 . . . . 4.6399999999999997 110.548 -169.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.8 m -62.31 129.02 38.83 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 107.439 -1.319 . . . . 0.47999999999999998 107.439 168.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.408 HG23 ' HD2' ' A' ' 30' ' ' PRO . 11.0 m -156.28 149.62 18.78 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.899 -1.148 . . . . 0.94999999999999996 107.899 -165.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.408 ' HD2' HG23 ' A' ' 29' ' ' THR . 57.3 Cg_endo -73.97 157.88 46.62 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.101 2.534 . . . . 0.54000000000000004 114.528 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -154.07 164.3 38.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.257 1.423 . . . . 0.59999999999999998 108.869 167.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.9 mm -98.93 104.87 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.575 -1.268 . . . . 0.89000000000000001 107.575 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -73.4 152.75 40.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.498 -0.927 . . . . 2.25 108.498 168.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.53 13.27 47.18 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 114.365 0.506 . . . . 1.1799999999999999 114.365 -172.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.76 -48.86 2.8 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 118.645 1.223 . . . . 1.49 110.943 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.52 128.04 38.5 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.712 0.805 . . . . 2.6499999999999999 111.834 174.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.14 52.5 0.24 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.522 2.01 . . . . 2.46 108.548 -170.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.15 164.73 54.35 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.065 -0.814 . . . . 1.97 111.065 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -156.8 -173.2 4.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.206 -1.775 . . . . 1.55 106.206 171.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.09 -47.29 9.37 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.023 -1.231 . . . . 0.79000000000000004 110.023 -172.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.11 65.92 2.19 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.929 0.492 . . . . 1.5600000000000001 110.926 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.0 66.12 0.91 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.343 1.057 . . . . 2.1000000000000001 109.859 -159.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -108.65 140.93 41.35 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.726 0.81 . . . . 0.75 110.994 -160.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.15 -42.29 80.76 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.252 0.933 . . . . 2.52 110.722 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.9 p -138.98 163.5 32.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.615 0.766 . . . . 0.55000000000000004 111.507 -169.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.79 -47.7 67.37 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.207 0.603 . . . . 0.5 109.548 162.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -48.69 -48.68 39.94 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.998 -0.371 . . . . 2.1099999999999999 109.998 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -68.58 -51.54 41.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.517 0.327 . . . . 2.25 110.641 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.5 t -51.13 -48.53 61.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.548 0.69 . . . . 0.54000000000000004 111.092 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -57.49 -60.34 3.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.224 1.01 . . . . 2.7599999999999998 109.129 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.75 -43.6 27.36 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.479 0.712 . . . . 0.73999999999999999 112.204 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.38 -59.35 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.945 0.339 . . . . 1.3600000000000001 110.151 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.532 0.277 0 C-N-CA 119.95 -0.7 . . . . 1.6200000000000001 112.522 -164.696 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 119.343 -0.36 . . . . 2.3199999999999998 111.774 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.3 m -33.12 -45.84 0.15 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.069 1.347 . . . . 1.6799999999999999 111.165 166.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.44 -22.25 61.12 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.589 0.959 . . . . 1.54 113.589 -169.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -65.71 146.16 99.0 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 119.787 1.176 . . . . 3.0899999999999999 111.027 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.32 169.91 21.45 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.949 1.766 . . . . 1.1499999999999999 110.735 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -56.68 143.03 37.82 Favored 'General case' 0 N--CA 1.46 0.051 0 C-N-CA 125.506 1.523 . . . . 2.5099999999999998 111.327 161.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -146.75 99.01 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.038 1.735 . . . . 5.3600000000000003 110.196 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.3 -42.09 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.442 -0.577 . . . . 1.51 109.442 174.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.62 -178.33 42.52 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.67 -0.972 . . . . 1.99 110.67 -172.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.06 55.56 2.53 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.985 -0.715 . . . . 7.6900000000000004 112.105 -170.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.9 m -147.58 165.44 30.36 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.917 1.287 . . . . 1.8500000000000001 107.573 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -139.42 20.55 2.56 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.236 0.615 . . . . 5.9299999999999997 112.103 -177.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.71 145.19 38.14 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.255 -1.138 . . . . 1.5600000000000001 110.255 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -81.95 73.32 9.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.69 0.757 . . . . 1.76 109.097 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -102.42 90.75 2.28 Favored Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 108.03 -1.1 . . . . 0.89000000000000001 108.03 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.56 136.45 46.41 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.207 1.271 . . . . 0.93999999999999995 109.549 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -140.43 179.35 6.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.051 2.141 . . . . 2.7599999999999998 107.62 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -122.95 147.23 46.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.892 2.077 . . . . 0.52000000000000002 108.391 169.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -128.61 155.81 44.37 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.955 -1.869 . . . . 1.0800000000000001 105.955 166.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -75.99 101.93 5.43 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.341 -1.355 . . . . 1.46 107.341 164.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -72.35 98.66 2.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.28 -1.378 . . . . 1.8 107.28 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -72.26 -14.69 61.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.245 -0.883 . . . . 1.24 112.817 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -69.27 -49.05 59.64 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.413 -1.328 . . . . 4.9800000000000004 107.413 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 64.1 p -83.77 -19.54 34.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.937 0.495 . . . . 0.96999999999999997 111.596 174.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.96 34.36 58.92 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.51 1.052 . . . . 0.78000000000000003 110.831 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.73 136.52 52.54 Favored 'General case' 0 CA--C 1.523 -0.059 0 C-N-CA 124.631 1.172 . . . . 5.5199999999999996 110.527 -169.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.8 m -61.99 124.68 21.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.905 -1.146 . . . . 0.63 107.905 156.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.5 m -141.54 137.69 16.67 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 107.299 -1.371 . . . . 0.89000000000000001 107.299 -166.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.03 155.17 65.67 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.405 2.07 . . . . 0.71999999999999997 110.84 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -153.46 157.84 40.47 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.147 -1.057 . . . . 0.70999999999999996 108.147 167.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.6 120.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 105.961 -1.866 . . . . 1.0 105.961 172.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -84.84 -7.53 59.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.071 1.348 . . . . 2.6299999999999999 111.707 -172.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.09 -33.12 1.5 Allowed Glycine 0 CA--C 1.533 1.203 0 O-C-N 119.991 -1.693 . . . . 1.45 113.221 172.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.96 25.73 18.9 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 126.059 1.79 . . . . 2.2599999999999998 110.478 -171.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.87 -160.71 0.72 Allowed 'General case' 0 C--N 1.34 0.195 0 N-CA-C 114.926 1.454 . . . . 2.8500000000000001 114.926 -164.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -31.02 -58.51 0.26 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 127.343 2.401 . . . . 3.3799999999999999 113.42 173.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.04 -161.88 46.89 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.995 -0.442 . . . . 1.29 111.995 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -172.23 -169.8 0.67 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.976 1.71 . . . . 1.1599999999999999 109.776 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.73 -41.9 18.39 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.584 -1.407 . . . . 0.89000000000000001 109.584 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -73.89 67.06 1.2 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.879 0.371 . . . . 1.78 111.179 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -149.58 117.92 6.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.097 1.359 . . . . 2.1400000000000001 108.492 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -138.77 139.84 38.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.766 0.827 . . . . 0.93000000000000005 108.83 -166.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -63.44 -35.98 82.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.878 0.763 . . . . 3.1299999999999999 110.936 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.5 p -131.11 155.05 47.62 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.592 0.757 . . . . 0.46000000000000002 111.314 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.92 -45.57 60.5 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.137 -0.69 . . . . 0.62 109.137 161.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.14 -53.72 7.72 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.821 0.449 . . . . 2.1600000000000001 110.498 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -64.71 -54.2 35.21 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.038 -0.356 . . . . 1.8 110.038 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 t -49.64 -50.22 44.05 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.01 0.433 . . . . 0.46000000000000002 110.93 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -57.81 -60.89 3.01 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.743 1.217 . . . . 3.02 109.111 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.05 -32.55 61.99 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.103 0.961 . . . . 0.68999999999999995 112.851 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.5 mm -88.29 -50.4 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.29 0.636 . . . . 1.8400000000000001 110.82 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.8 t . . . . . 0 CA--C 1.532 0.253 0 O-C-N 121.705 -0.622 . . . . 1.55 111.484 -175.84 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.569 0.224 . . . . 2.75 110.976 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m -40.73 -36.8 0.66 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.462 1.505 . . . . 1.6799999999999999 111.694 170.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -23.89 60.77 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.594 0.961 . . . . 1.76 113.594 -176.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -72.29 144.66 87.21 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.695 0.68 . . . . 4.0999999999999996 109.893 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -83.54 169.27 12.37 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.252 1.968 . . . . 2.1600000000000001 112.193 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -60.3 140.42 57.1 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.906 1.283 . . . . 2.9199999999999999 107.914 153.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.515 ' HD2' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -158.24 134.47 9.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.529 0.732 . . . . 5.0800000000000001 109.763 176.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.56 -27.27 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.692 0.758 . . . . 2.1600000000000001 110.445 -173.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.4 179.07 9.69 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 121.932 0.74 . . . . 2.1000000000000001 111.77 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -81.25 53.2 1.98 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.605 -0.939 . . . . 7.9699999999999998 109.266 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.6 m -143.47 147.34 34.39 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.299 -1.371 . . . . 1.6799999999999999 107.299 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.71 39.11 3.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.411 0.685 . . . . 4.96 111.953 -171.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.09 141.56 15.66 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.501 -1.04 . . . . 1.55 110.501 174.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -82.05 74.93 9.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.743 -0.836 . . . . 1.3500000000000001 108.743 -176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -102.0 88.55 1.31 Allowed Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.114 0.966 . . . . 0.79000000000000004 109.059 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.34 119.88 6.99 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.57 1.514 . . . . 0.55000000000000004 109.322 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -116.7 178.05 4.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.823 2.049 . . . . 3.3700000000000001 108.919 169.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -116.62 139.69 50.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.989 1.716 . . . . 0.40000000000000002 108.373 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -120.79 148.01 44.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.931 -1.507 . . . . 0.71999999999999997 106.931 165.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -67.47 105.44 1.82 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.546 -1.65 . . . . 0.98999999999999999 106.546 158.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.57 103.57 3.59 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.149 -1.426 . . . . 1.9399999999999999 107.149 168.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 t -76.91 -9.46 58.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.215 -0.898 . . . . 1.1699999999999999 112.593 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.85 -48.85 34.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.522 -1.288 . . . . 4.1900000000000004 107.522 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.8 p -92.0 -13.72 30.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.904 0.882 . . . . 1.1899999999999999 112.589 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.03 33.67 84.4 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.134 0.873 . . . . 0.98999999999999999 111.108 -174.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 133.69 55.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 125.049 1.34 . . . . 5.29 109.844 -170.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.3 m -64.55 124.01 20.74 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.063 -1.088 . . . . 0.51000000000000001 108.063 158.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.8 m -142.71 141.83 21.26 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.724 1.61 . . . . 0.56000000000000005 107.36 -165.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.45 153.9 50.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.45 2.1 . . . . 0.52000000000000002 111.693 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -153.87 159.25 41.72 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.884 1.273 . . . . 0.54000000000000004 108.054 169.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.55 120.5 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 106.734 -1.58 . . . . 0.80000000000000004 106.734 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.0 -23.81 59.49 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.162 0.585 . . . . 2.7400000000000002 112.392 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.14 -49.73 4.17 Favored Glycine 0 CA--C 1.522 0.489 0 O-C-N 121.08 -1.013 . . . . 1.4199999999999999 110.749 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.68 -31.18 2.03 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.396 -0.669 . . . . 1.54 113.062 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.05 176.23 7.17 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.371 1.085 . . . . 2.3300000000000001 108.38 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.23 43.62 25.21 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.922 -1.271 . . . . 2.75 109.922 -172.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.85 147.47 48.43 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.091 -1.203 . . . . 2.1099999999999999 110.091 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' ND2' ' HD2' ' A' ' 8' ' ' LYS . 51.8 p30 -153.65 -174.45 4.96 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 105.758 -1.942 . . . . 1.6200000000000001 105.758 170.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.79 -43.7 65.66 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.906 -1.278 . . . . 1.3 109.906 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -75.17 67.11 1.77 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.471 0.708 . . . . 1.72 111.705 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.05 60.69 0.46 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.726 0.81 . . . . 2.0499999999999998 110.061 -160.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -104.07 142.1 35.05 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 123.622 0.769 . . . . 0.93000000000000005 110.822 -161.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -63.6 -41.91 98.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.549 1.068 . . . . 2.6499999999999999 110.542 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.1 p -118.21 152.24 36.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.751 0.82 . . . . 0.64000000000000001 112.571 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.23 -46.68 54.92 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.55 0.74 . . . . 0.55000000000000004 109.578 160.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.56 -51.8 11.41 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.246 0.618 . . . . 2.0099999999999998 110.586 176.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -65.25 -54.68 25.74 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 110.078 -0.341 . . . . 2.3799999999999999 110.078 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 t -48.28 -48.02 35.92 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.293 0.568 . . . . 0.52000000000000002 111.47 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -57.46 -62.65 1.63 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.908 1.283 . . . . 3.2400000000000002 108.794 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.04 -46.23 43.9 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.873 0.869 . . . . 0.73999999999999999 112.64 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mp -75.64 -57.46 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 118.061 0.392 . . . . 1.6399999999999999 110.272 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 16.0 t . . . . . 0 C--N 1.34 0.173 0 CA-C-N 118.782 0.719 . . . . 1.6299999999999999 111.257 -170.373 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.525 HG22 ' HA3' ' A' ' 40' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 114.07 1.137 . . . . 2.7599999999999998 114.07 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.2 m -96.89 -12.61 23.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.792 0.437 . . . . 1.49 111.466 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.22 -37.47 8.9 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.087 0.955 . . . . 1.54 108.754 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -59.2 132.24 87.58 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.54 -1.652 . . . . 4.1100000000000003 106.54 172.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -99.44 175.68 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.597 2.198 . . . . 1.4199999999999999 111.398 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -48.95 140.88 8.33 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.673 1.702 . . . . 2.9300000000000002 112.693 153.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.86 -176.61 5.27 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 102.709 -3.071 . . . . 5.0199999999999996 102.709 165.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 t -120.89 -84.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.82 -1.548 . . . . 2.0299999999999998 106.82 158.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.2 170.6 15.6 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 107.185 -2.366 . . . . 2.7599999999999998 107.185 -173.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -80.38 60.58 3.85 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.287 -1.005 . . . . 6.5099999999999998 108.287 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.5 m -151.68 157.13 41.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.053 -1.091 . . . . 3.0899999999999999 108.053 -161.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.14 81.13 1.84 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.175 0.99 . . . . 5.9199999999999999 108.659 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.86 131.67 6.55 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.61 -1.396 . . . . 1.73 109.61 169.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -83.12 74.35 10.0 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.766 0.827 . . . . 2.1699999999999999 109.398 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -102.83 87.31 1.17 Allowed Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 107.879 -1.156 . . . . 1.28 107.879 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.7 120.93 8.32 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 N-CA-C 108.038 -1.562 . . . . 0.67000000000000004 108.038 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -128.91 177.28 7.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.2 1.4 . . . . 3.8599999999999999 107.774 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -112.63 156.52 22.58 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.276 1.83 . . . . 0.53000000000000003 107.946 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 31' ' ' PHE . 6.3 p90 -148.26 152.09 36.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.924 -1.139 . . . . 1.3500000000000001 107.924 175.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -76.07 100.08 4.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.987 -1.857 . . . . 0.92000000000000004 105.987 169.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 20' ' ' TYR . 11.0 t70 -72.3 109.68 6.2 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.638 -1.245 . . . . 2.48 107.638 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.6 t -87.21 6.76 31.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.593 -0.718 . . . . 1.8100000000000001 111.631 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.5 -45.63 10.31 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 105.987 -1.857 . . . . 4.5 105.987 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.9 p -94.25 -25.98 16.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.581 2.752 . . . . 1.4299999999999999 111.602 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.53 59.9 3.95 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.015 -1.234 . . . . 1.3100000000000001 110.015 -173.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.5 144.96 17.24 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.826 1.313 . . . . 4.0899999999999999 112.938 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.5 m -73.84 119.21 17.75 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.352 -0.842 . . . . 0.52000000000000002 108.75 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.3 m -141.93 147.54 45.23 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 117.956 -1.021 . . . . 0.57999999999999996 109.205 -161.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.38 145.22 21.02 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.333 2.689 . . . . 0.63 112.702 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -147.7 161.07 41.95 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.602 1.561 . . . . 0.65000000000000002 108.268 173.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.87 118.57 37.57 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 105.57 -2.011 . . . . 0.98999999999999999 105.57 170.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -72.77 -41.43 65.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.73 0.412 . . . . 2.9700000000000002 111.52 -171.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.15 -15.33 61.59 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 118.37 0.532 . . . . 1.1799999999999999 112.206 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.87 -51.72 4.61 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.626 1.213 . . . . 1.6200000000000001 110.145 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -178.9 4.77 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.036 1.334 . . . . 2.9900000000000002 109.928 170.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.99 49.74 65.42 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.604 -0.598 . . . . 2.5099999999999998 111.604 164.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.61 148.91 44.28 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.584 -0.95 . . . . 1.8700000000000001 112.6 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -143.62 178.99 7.41 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 104.782 -2.303 . . . . 1.0800000000000001 104.782 157.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 2' ' ' ILE . . . -75.05 -25.66 68.46 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.253 -0.739 . . . . 0.82999999999999996 111.253 -175.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -72.91 65.84 0.75 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.138 1.375 . . . . 2.52 110.471 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -162.07 97.16 1.02 Allowed 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.873 -0.517 . . . . 2.0699999999999998 110.466 -169.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.46 140.75 52.66 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.415 1.486 . . . . 0.81000000000000005 110.282 -165.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.68 -32.39 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.603 1.092 . . . . 2.8700000000000001 111.501 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.9 p -143.76 156.6 44.56 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.277 0.631 . . . . 0.46999999999999997 111.809 -169.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -45.08 64.71 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 108.869 -0.789 . . . . 0.5 108.869 160.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -43.9 -53.44 6.1 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.476 0.31 . . . . 2.1600000000000001 110.757 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -63.66 -57.04 11.29 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 117.951 0.341 . . . . 1.9399999999999999 110.136 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.9 t -49.12 -42.1 38.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.086 0.469 . . . . 0.64000000000000001 111.963 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -66.82 -54.78 19.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.161 1.384 . . . . 3.1699999999999999 109.684 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.73 -40.94 30.4 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.932 0.493 . . . . 0.67000000000000004 111.955 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.18 -63.78 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.003 0.521 . . . . 1.8200000000000001 110.961 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 123.971 0.908 . . . . 2.1899999999999999 113.355 -166.939 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.2 pt . . . . . 0 C--O 1.224 -0.275 0 N-CA-C 110.451 -0.203 . . . . 1.6799999999999999 110.451 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.0 m -51.05 -24.93 4.25 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.27 0.628 . . . . 1.3999999999999999 112.685 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.59 -35.66 67.97 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.216 0.462 . . . . 1.47 110.336 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 110.02 3.58 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.206 1.003 . . . . 4.2699999999999996 111.873 -164.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.95 146.0 69.94 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 CA-C-N 120.912 1.361 . . . . 1.45 110.83 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -34.05 133.67 0.21 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 128.589 2.755 . . . . 3.6600000000000001 112.62 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -138.73 149.01 44.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.162 2.585 . . . . 5.3600000000000003 108.118 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.5 t -117.82 -22.63 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.365 1.066 . . . . 1.9399999999999999 111.759 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.17 150.64 0.77 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-O 122.391 0.995 . . . . 2.1600000000000001 112.612 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.29 50.23 0.9 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.587 -0.949 . . . . 7.8799999999999999 111.721 -178.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.1 m -126.3 142.71 51.42 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.37 0.668 . . . . 2.0099999999999998 111.098 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 78.33 8.71 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.27 -1.011 . . . . 7.7999999999999998 108.27 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.97 -179.77 22.43 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.02 -1.232 . . . . 1.51 110.02 168.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -146.53 117.86 7.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.899 1.28 . . . . 1.6699999999999999 107.793 -176.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -145.1 119.03 5.55 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 106.847 -1.538 . . . . 0.93000000000000005 106.847 175.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.9 134.37 23.5 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.643 1.562 . . . . 1.1499999999999999 109.055 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.2 mmt-85 -140.82 176.26 8.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.506 1.122 . . . . 2.98 108.519 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -125.28 136.97 54.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.068 1.747 . . . . 0.60999999999999999 107.634 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -118.93 150.97 39.01 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.338 -1.356 . . . . 0.92000000000000004 107.338 171.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.24 100.33 2.08 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.215 -2.142 . . . . 1.6499999999999999 105.215 161.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.39 104.02 3.63 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.844 -1.539 . . . . 2.0600000000000001 106.844 171.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 t -82.62 -0.14 45.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.394 -0.812 . . . . 1.29 112.564 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.98 -47.55 12.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.947 -1.501 . . . . 3.7000000000000002 106.947 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.5 p -79.48 -30.15 41.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.719 1.208 . . . . 0.95999999999999996 111.167 170.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.23 29.78 44.17 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.83 1.205 . . . . 0.80000000000000004 111.309 -172.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -129.19 147.35 51.03 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 118.858 1.329 . . . . 4.5499999999999998 110.131 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 57.8 m -69.86 135.09 49.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.152 -1.425 . . . . 0.73999999999999999 107.152 166.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 m -151.72 139.42 12.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.06 -1.089 . . . . 0.55000000000000004 108.06 -169.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.17 159.1 53.12 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.842 2.361 . . . . 0.5 111.101 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -158.47 163.53 37.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.952 1.301 . . . . 0.68000000000000005 108.158 171.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.7 mm -93.11 115.35 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.545 -1.65 . . . . 1.27 106.545 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.03 -19.34 61.21 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.789 0.836 . . . . 2.6099999999999999 111.678 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.47 -45.78 3.31 Favored Glycine 0 CA--C 1.525 0.681 0 O-C-N 121.303 -0.873 . . . . 1.5800000000000001 110.951 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.32 -24.43 3.38 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 124.074 0.845 . . . . 1.28 111.86 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -145.04 176.55 9.42 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.545 1.138 . . . . 2.2000000000000002 109.426 -172.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 41.52 44.61 4.19 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.262 1.411 . . . . 3.3999999999999999 114.245 171.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.95 -133.66 7.31 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.602 -1.399 . . . . 2.0299999999999998 109.602 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -152.94 -168.51 3.06 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.337 1.855 . . . . 1.3899999999999999 107.028 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.27 -12.07 65.94 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.928 0.775 . . . . 0.83999999999999997 113.035 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -79.15 63.76 3.88 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 118.5 1.15 . . . . 1.8999999999999999 107.913 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -159.44 87.91 0.84 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.818 -0.808 . . . . 1.9199999999999999 108.818 -146.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -126.41 150.64 48.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.751 0.82 . . . . 0.62 110.497 -159.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.86 -42.81 98.62 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.474 0.709 . . . . 2.6699999999999999 109.917 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.6 p -135.37 159.35 41.86 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.26 0.624 . . . . 0.58999999999999997 112.091 -170.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.01 -47.4 61.62 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.67 0.788 . . . . 0.71999999999999997 110.041 160.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -48.15 -49.96 30.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.485 0.314 . . . . 2.6400000000000001 110.179 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -67.67 -52.47 37.6 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 110.198 -0.297 . . . . 2.1099999999999999 110.198 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.0 t -49.88 -46.28 51.52 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.387 0.675 . . . . 0.47999999999999998 111.207 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -59.52 -73.24 0.09 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.752 -1.203 . . . . 2.7400000000000002 107.752 172.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -42.3 -43.55 3.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.589 1.156 . . . . 0.83999999999999997 113.577 -172.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.26 -40.74 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 122.855 0.462 . . . . 1.3999999999999999 111.875 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.532 0.272 0 N-CA-C 113.979 1.103 . . . . 1.6599999999999999 113.979 -170.134 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.8 pt . . . . . 0 N--CA 1.467 0.377 0 N-CA-C 113.702 1.001 . . . . 2.4199999999999999 113.702 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 t -31.85 -45.3 0.1 Allowed 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.279 1.832 . . . . 1.9099999999999999 113.738 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.16 -21.0 61.51 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 125.32 1.638 . . . . 2.0899999999999999 111.723 -164.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -62.84 157.85 56.88 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.361 0.982 . . . . 3.2200000000000002 109.489 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -88.33 166.65 6.58 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.588 2.192 . . . . 1.1200000000000001 111.132 173.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -44.63 132.02 6.51 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.013 0.925 . . . . 2.6499999999999999 108.67 157.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.0 tttm -158.57 99.03 1.56 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 104.807 -2.294 . . . . 5.1699999999999999 104.807 -169.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.78 -43.04 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.521 0.728 . . . . 1.3100000000000001 111.809 -168.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.84 151.11 27.76 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.682 -1.367 . . . . 1.8999999999999999 109.682 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -80.75 50.66 1.38 Allowed 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.967 -0.725 . . . . 5.6100000000000003 112.872 -166.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.47 142.01 39.43 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 107.578 -1.267 . . . . 1.6899999999999999 107.578 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -85.32 54.72 3.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.208 0.603 . . . . 5.6200000000000001 109.617 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.53 173.15 25.74 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.618 -0.593 . . . . 1.6699999999999999 111.618 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -137.65 79.58 1.75 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.992 1.317 . . . . 1.1000000000000001 107.814 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -116.1 107.25 48.05 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 106.96 -1.496 . . . . 1.01 106.96 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.21 133.99 40.37 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 CA-C-N 120.637 1.263 . . . . 0.78000000000000003 109.097 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -131.55 172.3 12.39 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.836 -1.172 . . . . 3.0600000000000001 107.836 170.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.06 144.67 36.77 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.682 1.593 . . . . 0.5 107.501 170.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.46 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 1.8 p90 -131.22 161.19 32.79 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.568 -0.901 . . . . 0.71999999999999997 108.568 169.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -73.16 105.39 4.57 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.64 -1.985 . . . . 1.3700000000000001 105.64 156.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 6.4 t70 -73.45 118.52 16.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.895 -1.52 . . . . 2.29 106.895 169.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 t -86.26 -25.44 25.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.186 0.994 . . . . 1.72 108.799 -174.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -61.94 -43.79 98.11 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 127.178 2.191 . . . . 4.2400000000000002 107.082 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.1 p -96.24 -36.57 10.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.825 2.05 . . . . 1.1699999999999999 110.759 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.64 48.82 4.83 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.208 1.385 . . . . 0.88 110.506 -173.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.04 147.04 31.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 128.29 2.636 . . . . 4.1699999999999999 111.92 -172.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.9 m -69.75 123.14 20.64 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.802 -0.814 . . . . 0.64000000000000001 108.802 171.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.4 m -147.33 148.86 32.95 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 124.353 1.061 . . . . 0.62 108.457 -161.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.75 151.58 36.4 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.969 2.446 . . . . 0.48999999999999999 112.148 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -149.91 163.2 38.69 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.537 1.535 . . . . 0.5 107.743 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.56 120.24 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 107.958 -1.127 . . . . 0.84999999999999998 107.958 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -95.79 143.96 26.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.535 1.934 . . . . 2.2200000000000002 107.427 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.33 0.77 88.67 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.509 -0.606 . . . . 1.0800000000000001 113.068 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.94 6.16 77.82 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.796 1.298 . . . . 1.72 112.125 -172.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.98 -156.06 0.31 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.291 1.037 . . . . 3.0099999999999998 111.393 -174.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -38.81 -41.96 1.37 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.429 1.49 . . . . 3.79 114.173 169.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.95 -141.01 46.11 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.698 -1.361 . . . . 1.47 109.698 -177.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -179.95 -160.53 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.786 2.034 . . . . 1.0600000000000001 108.634 174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.62 -44.14 16.77 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 118.685 0.675 . . . . 0.78000000000000003 111.447 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -73.87 64.94 1.01 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.92 1.288 . . . . 3.0499999999999998 109.314 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -159.14 74.31 0.63 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.082 0.953 . . . . 2.0699999999999998 109.375 -168.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -103.34 153.59 20.28 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 124.049 0.939 . . . . 0.77000000000000002 110.371 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.25 -48.63 79.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.325 -0.62 . . . . 2.6600000000000001 109.325 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.1 p -130.87 161.06 32.67 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.243 0.831 . . . . 0.83999999999999997 113.243 -164.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.45 -49.46 61.69 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.713 -0.847 . . . . 0.84999999999999998 108.713 159.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -42.54 -51.88 4.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.427 0.558 . . . . 2.1299999999999999 110.504 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -61.31 -56.54 19.37 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.07 -0.49 . . . . 1.95 111.044 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.9 t -52.75 -41.15 63.77 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.924 0.868 . . . . 0.91000000000000003 112.368 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -60.74 3.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.973 2.109 . . . . 2.8799999999999999 109.165 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.72 -44.29 93.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.77 0.828 . . . . 0.81000000000000005 111.347 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.49 -40.75 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.259 1.023 . . . . 1.5700000000000001 110.991 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.9 t . . . . . 0 CA--C 1.522 -0.109 0 N-CA-C 112.551 0.574 . . . . 1.7 112.551 -166.644 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.225 -0.227 0 N-CA-C 116.934 2.198 . . . . 2.4399999999999999 116.934 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.9 m -72.55 -12.77 61.21 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.674 -0.641 . . . . 1.8600000000000001 111.835 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -52.5 10.75 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.192 -1.04 . . . . 1.79 108.192 165.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.14 108.08 1.46 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.347 1.459 . . . . 4.5300000000000002 111.544 -174.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.06 175.43 10.91 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 CA-C-N 120.698 1.285 . . . . 1.7 112.031 -173.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -40.96 133.65 2.12 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 126.189 1.795 . . . . 3.0899999999999999 111.206 167.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -156.6 130.92 8.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.842 2.057 . . . . 5.0 105.922 170.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.68 -52.37 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 N-CA-C 109.547 -0.538 . . . . 1.5 109.547 -170.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.0 28.86 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.465 -1.854 . . . . 2.1899999999999999 108.465 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -94.59 14.38 21.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.007 0.523 . . . . 5.9000000000000004 111.128 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.0 m -145.36 160.07 42.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 105.877 -1.897 . . . . 2.1699999999999999 105.877 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -74.09 -73.11 0.24 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.918 0.326 . . . . 5.4800000000000004 110.273 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.51 -179.91 0.53 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.56 1.076 . . . . 1.7 113.571 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -148.12 76.0 1.36 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.7 0.8 . . . . 1.52 109.73 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -114.64 100.36 53.09 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.851 -0.796 . . . . 0.94999999999999996 108.851 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.59 118.5 5.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.49 1.46 . . . . 0.62 109.771 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -125.19 -179.61 4.66 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 127.24 2.216 . . . . 3.4500000000000002 109.292 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -123.29 143.86 49.8 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.288 2.235 . . . . 0.44 107.661 171.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -126.28 154.15 43.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.133 -1.432 . . . . 0.67000000000000004 107.133 170.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.14 104.45 5.72 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.726 -1.583 . . . . 0.95999999999999996 106.726 160.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.03 117.01 17.3 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.118 1.367 . . . . 1.97 107.769 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 t -86.47 -20.79 27.59 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 122.191 -0.318 . . . . 1.0700000000000001 110.37 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -65.56 -46.4 79.62 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 126.859 2.064 . . . . 4.1600000000000001 106.75 -173.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.4 p -88.71 -29.85 19.54 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.374 1.869 . . . . 0.84999999999999998 110.413 170.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.73 54.45 7.36 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.348 -1.501 . . . . 0.84999999999999998 109.348 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -146.1 157.21 43.84 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 126.813 2.045 . . . . 4.7199999999999998 108.129 -172.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 95.7 m -80.48 142.43 34.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.321 -1.362 . . . . 0.72999999999999998 107.321 161.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.9 m -154.32 141.39 13.42 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.327 -0.99 . . . . 0.5 108.327 -169.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.76 154.83 59.01 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.954 2.436 . . . . 0.44 111.177 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -158.03 160.89 37.93 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.083 0.953 . . . . 0.46999999999999997 109.179 172.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -89.65 115.01 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 107.309 -1.367 . . . . 0.83999999999999997 107.309 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -85.37 149.77 25.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.612 1.565 . . . . 2.27 107.581 167.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.81 13.64 34.91 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.601 1.096 . . . . 1.3799999999999999 113.273 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.4 -52.29 4.71 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.891 1.234 . . . . 1.6599999999999999 110.237 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.42 122.37 40.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.093 0.949 . . . . 2.1800000000000002 111.268 -165.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.94 -66.25 3.8 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.613 1.101 . . . . 2.73 110.836 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 36.58 -118.38 0.47 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.03 1.3 . . . . 2.29 112.366 -172.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -172.46 179.9 2.38 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 127.984 2.513 . . . . 1.3200000000000001 107.272 165.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.09 -32.24 72.78 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 112.176 -0.37 . . . . 1.1100000000000001 112.176 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -75.45 70.56 2.33 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.889 0.875 . . . . 1.6799999999999999 109.831 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -158.62 78.61 0.79 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.897 1.279 . . . . 1.77 108.069 -157.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -115.71 144.45 43.93 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.316 1.446 . . . . 0.78000000000000003 110.433 -162.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.89 -38.3 90.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.294 0.952 . . . . 3.1699999999999999 111.579 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -133.49 161.69 33.9 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.277 0.631 . . . . 0.48999999999999999 111.987 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 tp -51.8 -49.69 62.24 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.638 -0.875 . . . . 1.0600000000000001 108.638 159.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -45.93 -48.58 16.24 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.183 0.901 . . . . 2.3599999999999999 110.38 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -66.03 -54.42 26.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.375 -0.232 . . . . 2.1600000000000001 110.375 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.3 t -53.62 -48.41 69.34 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.437 0.637 . . . . 0.5 111.895 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -54.19 -55.18 30.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.876 2.47 . . . . 2.5899999999999999 110.055 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.23 -43.46 78.64 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.666 0.386 . . . . 0.68000000000000005 110.957 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.4 mm -68.25 -45.13 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 118.916 -0.564 . . . . 1.8799999999999999 111.126 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.7 m . . . . . 0 C--N 1.34 0.19 0 CA-C-N 118.833 0.742 . . . . 2.5099999999999998 110.991 -175.64 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 pt . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 120.825 0.345 . . . . 1.8700000000000001 110.8 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.9 m -57.71 -18.35 20.42 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.536 0.734 . . . . 1.9299999999999999 112.617 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.01 -25.23 32.4 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.256 0.935 . . . . 1.3300000000000001 110.792 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -64.41 144.36 98.53 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 118.787 0.721 . . . . 4.5899999999999999 110.699 -174.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.81 -173.63 1.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.038 2.492 . . . . 1.27 110.702 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -77.83 141.73 38.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.08 1.352 . . . . 3.3999999999999999 111.411 161.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.62 ' HD2' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -159.16 139.9 12.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.116 -2.55 . . . . 5.2999999999999998 104.116 -176.666 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.7 t -63.15 -44.89 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 120.144 1.338 . . . . 1.6200000000000001 109.506 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.52 144.69 15.74 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.823 -1.711 . . . . 2.2799999999999998 108.823 -171.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -80.66 59.32 3.57 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.13 -0.629 . . . . 5.8600000000000003 112.682 -165.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.4 m -143.35 144.03 31.91 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 108.837 -0.801 . . . . 2.3700000000000001 108.837 167.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -90.08 72.04 7.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.682 0.793 . . . . 4.9100000000000001 109.457 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.07 -174.96 13.79 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.636 -0.985 . . . . 1.27 110.636 172.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -142.05 93.89 2.6 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.323 1.449 . . . . 1.48 107.354 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -124.75 105.74 29.73 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 108.486 -0.931 . . . . 0.92000000000000004 108.486 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.4 100.18 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.572 1.514 . . . . 1.22 109.477 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.444 ' HG3' HD21 ' A' ' 42' ' ' ASN . 8.6 mmt85 -106.81 179.84 4.15 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.512 1.525 . . . . 3.3900000000000001 108.345 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -119.53 145.09 46.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.253 1.421 . . . . 0.40999999999999998 108.333 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -124.02 150.42 44.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.144 -1.428 . . . . 0.75 107.144 167.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -75.56 102.0 5.11 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.307 -1.738 . . . . 1.21 106.307 162.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.44 104.95 4.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.619 -1.252 . . . . 2.21 107.619 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.2 t -84.0 -1.63 55.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.048 -0.977 . . . . 1.6499999999999999 112.824 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.29 -48.12 10.77 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.936 -1.505 . . . . 5.25 106.936 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 64.7 p -82.32 -32.14 29.58 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.431 1.092 . . . . 1.1299999999999999 110.603 175.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.92 4.84 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.008 -1.237 . . . . 0.95999999999999996 110.008 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.51 135.61 22.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.904 0.882 . . . . 5.9100000000000001 111.809 -169.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.3 m -69.5 126.45 29.79 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.215 -1.402 . . . . 0.45000000000000001 107.215 163.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.2 m -147.68 138.41 12.99 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.321 -0.992 . . . . 0.51000000000000001 108.321 -163.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 157.47 57.66 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.516 2.144 . . . . 0.38 111.015 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -158.17 155.65 29.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.343 1.057 . . . . 0.53000000000000003 109.401 170.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.4 mm -84.51 109.2 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.871 -1.159 . . . . 1.1100000000000001 107.871 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -87.12 146.15 26.16 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.693 1.197 . . . . 2.2999999999999998 109.616 174.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.08 -28.78 53.2 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.585 1.564 . . . . 1.1499999999999999 112.488 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.59 -40.89 1.71 Allowed Glycine 0 C--N 1.339 0.706 0 CA-C-N 117.738 0.769 . . . . 1.9099999999999999 111.294 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -154.29 165.2 37.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.6 -0.889 . . . . 3.3500000000000001 108.6 -174.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.24 49.14 81.75 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.962 0.791 . . . . 2.98 111.9 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.0 -121.37 4.16 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.115 -1.194 . . . . 1.78 110.115 174.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.62 ' ND2' ' HD2' ' A' ' 8' ' ' LYS . 29.4 p30 -157.03 -179.73 8.49 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.965 1.306 . . . . 1.27 107.559 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.58 -21.67 74.73 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.347 -0.696 . . . . 0.85999999999999999 113.821 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -78.26 70.65 4.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.092 1.446 . . . . 1.53 108.065 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.444 HD21 ' HG3' ' A' ' 18' ' ' ARG . 14.5 t-20 -158.84 85.35 0.82 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.017 1.727 . . . . 2.1099999999999999 108.046 -169.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -114.29 147.15 39.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.502 1.121 . . . . 0.78000000000000003 109.587 -164.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.14 -39.2 93.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.937 0.399 . . . . 2.6200000000000001 110.475 -174.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.6 p -141.33 163.04 34.02 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.689 0.795 . . . . 0.54000000000000004 110.735 -169.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.61 -45.97 66.82 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 109.402 -0.592 . . . . 0.48999999999999999 109.402 162.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -47.56 -51.11 22.06 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.973 0.352 . . . . 2.0 110.509 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -69.56 -49.4 54.6 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.264 -0.273 . . . . 2.21 110.264 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 t -50.66 -44.02 57.51 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.381 0.61 . . . . 0.55000000000000004 111.143 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -62.94 -58.39 7.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.46 1.104 . . . . 3.8199999999999998 109.603 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.11 -41.38 17.2 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.782 0.676 . . . . 0.82999999999999996 111.429 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.03 -53.3 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.767 0.427 . . . . 1.5800000000000001 112.028 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 78.7 m . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 114.392 1.256 . . . . 2.8399999999999999 114.392 -163.98 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.8 pt . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.008 0.432 . . . . 1.6499999999999999 111.905 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.5 m -49.87 -26.29 3.93 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.493 1.117 . . . . 1.26 112.743 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.27 -26.51 62.02 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.289 0.495 . . . . 1.3500000000000001 110.433 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -61.06 137.87 94.14 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 108.597 -0.89 . . . . 3.52 108.597 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.16 170.2 20.52 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.864 1.709 . . . . 1.23 111.769 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 20' ' ' TYR . 1.6 ttpm? -51.76 140.69 18.6 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.164 0.983 . . . . 2.6600000000000001 110.697 156.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 132.54 8.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 113.756 -1.565 . . . . 5.6699999999999999 106.943 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -67.48 -39.95 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.479 -0.934 . . . . 1.3899999999999999 108.479 172.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.48 33.38 8.63 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.836 0.732 . . . . 3.2400000000000002 111.655 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 48.71 60.55 3.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.254 1.821 . . . . 8.3900000000000006 113.391 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -153.89 152.15 30.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.774 -0.825 . . . . 1.78 108.774 168.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -82.82 70.36 9.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.853 -1.166 . . . . 4.8399999999999999 107.853 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.23 149.85 16.97 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 109.39 -1.484 . . . . 1.29 109.39 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -120.14 72.6 0.94 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.923 -1.51 . . . . 1.22 106.923 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -102.73 96.01 7.05 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 107.092 -1.447 . . . . 0.73999999999999999 107.092 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -60.97 127.15 21.45 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 N-CA-C 108.879 -1.239 . . . . 0.56000000000000005 108.879 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -135.49 179.98 6.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.71 1.604 . . . . 2.6000000000000001 107.642 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -119.8 149.17 42.48 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.101 1.76 . . . . 0.46999999999999997 107.949 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.492 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 2.2 p90 -134.03 157.26 46.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.866 -1.902 . . . . 0.66000000000000003 105.866 170.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -71.34 105.89 3.67 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.377 -1.712 . . . . 0.94999999999999996 106.377 159.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.492 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 7.5 t0 -71.65 115.31 10.69 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.855 -1.535 . . . . 2.25 106.855 172.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 t -94.46 -9.25 36.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 123.8 0.688 . . . . 1.3300000000000001 109.674 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.45 -43.68 72.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.451 -2.055 . . . . 4.2999999999999998 105.451 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.8 p -98.89 -40.08 8.27 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.564 2.346 . . . . 1.0900000000000001 112.846 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 60.9 1.26 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.94 -1.264 . . . . 1.05 109.94 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -157.63 138.36 13.1 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 124.16 0.984 . . . . 5.1500000000000004 109.556 -163.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.6 m -72.85 122.38 21.5 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 120.617 -1.302 . . . . 0.56000000000000005 107.594 165.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.4 m -143.06 145.34 32.51 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 108.507 -0.923 . . . . 0.62 108.507 -162.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.51 153.21 65.64 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.789 2.326 . . . . 0.51000000000000001 111.188 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -155.76 163.21 40.14 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.195 -1.409 . . . . 0.68000000000000005 107.195 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.11 126.47 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 N-CA-C 108.01 -1.107 . . . . 0.90000000000000002 108.01 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -105.91 148.66 27.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.515 1.126 . . . . 2.2999999999999998 108.384 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.83 -9.57 62.42 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.711 1.148 . . . . 1.1399999999999999 113.028 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 14.05 80.65 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.155 0.977 . . . . 1.6399999999999999 112.395 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.5 m -145.96 178.48 8.16 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 107.016 -1.476 . . . . 2.1600000000000001 107.016 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.64 -69.17 2.1 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.383 1.944 . . . . 3.0699999999999998 110.674 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.67 -163.98 3.52 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.326 1.917 . . . . 1.4299999999999999 113.578 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.5 p30 170.46 -160.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.256 3.822 . . . . 1.6000000000000001 104.759 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.38 -44.52 7.93 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.76 1.164 . . . . 0.98999999999999999 110.287 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -74.88 78.26 2.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.105 0.955 . . . . 1.5600000000000001 112.134 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -156.55 115.38 3.39 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.763 1.625 . . . . 2.23 108.002 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -133.95 155.65 49.56 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 124.762 1.225 . . . . 0.64000000000000001 108.73 -168.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -80.2 -31.22 38.75 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.463 -0.773 . . . . 2.9700000000000002 111.633 -174.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.1 p -145.73 165.01 30.03 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.761 0.824 . . . . 0.68999999999999995 110.08 -173.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.57 -46.55 70.32 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 109.558 -0.534 . . . . 0.57999999999999996 109.558 163.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -47.03 -52.19 15.53 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 110.039 -0.356 . . . . 2.1000000000000001 110.039 175.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 tp-100 -66.94 -51.73 51.72 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.283 -0.265 . . . . 3.96 110.283 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -51.84 -48.59 63.89 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 122.911 0.484 . . . . 0.58999999999999997 110.882 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.4 -58.13 9.82 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.943 0.897 . . . . 2.48 109.273 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.19 -41.64 62.82 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.514 0.725 . . . . 0.73999999999999999 111.763 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.3 mm -70.43 -51.66 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.39 0.276 . . . . 1.5 110.522 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.7 t . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 113.044 0.757 . . . . 1.49 113.044 -164.879 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 107.314 -1.365 . . . . 3.1299999999999999 107.314 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.3 pt -53.05 -22.58 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.717 0.807 . . . . 1.9199999999999999 112.295 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 89.0 m -34.55 -42.58 0.15 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.827 1.251 . . . . 1.5700000000000001 111.441 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.95 -17.39 62.08 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.909 1.077 . . . . 1.3999999999999999 113.909 -170.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -73.39 143.29 82.59 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 119.889 1.222 . . . . 3.0299999999999998 110.819 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.22 -179.18 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.215 2.61 . . . . 1.3200000000000001 109.936 166.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.51 134.64 55.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.663 0.744 . . . . 2.6099999999999999 110.591 170.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -139.34 128.25 23.55 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.461 1.904 . . . . 5.6600000000000001 106.076 170.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.6 t -75.45 -85.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.122 -1.436 . . . . 1.8 107.122 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.96 179.24 30.0 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 107.861 -2.096 . . . . 1.8500000000000001 107.861 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -72.1 -48.73 41.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.725 -1.213 . . . . 5.6600000000000001 107.725 174.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.1 m -71.08 150.31 45.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.105 -1.072 . . . . 2.1600000000000001 108.105 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.45 20.21 13.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.703 0.801 . . . . 7.0700000000000003 110.363 -170.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.25 147.9 50.91 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.9 -0.88 . . . . 1.6399999999999999 110.9 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -81.7 73.3 8.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.728 0.775 . . . . 1.51 108.912 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -99.35 93.13 2.05 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 106.895 -1.52 . . . . 0.97999999999999998 106.895 166.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.6 125.19 13.93 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 N-CA-C 108.064 -1.552 . . . . 0.55000000000000004 108.064 171.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -132.78 176.47 8.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.345 1.458 . . . . 3.7000000000000002 107.279 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -118.25 139.37 51.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.847 1.659 . . . . 0.68000000000000005 108.394 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -118.26 148.89 41.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.903 -1.888 . . . . 0.83999999999999997 105.903 168.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -70.78 100.02 1.82 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.47 -2.419 . . . . 1.1899999999999999 104.47 160.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -71.88 77.96 0.89 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 105.602 -1.999 . . . . 2.3700000000000001 105.602 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.0 t -61.71 -18.87 61.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.419 1.088 . . . . 1.29 110.342 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -62.06 -44.37 96.82 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 105.459 -2.052 . . . . 4.3899999999999997 105.459 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.7 p -94.58 -24.55 17.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.52 1.528 . . . . 1.0700000000000001 114.04 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.43 19.37 64.38 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.766 1.174 . . . . 0.81000000000000005 112.418 -165.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HB2' ' HZ2' ' A' ' 27' ' ' LYS . 8.2 mtmp? -103.4 163.28 12.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.644 1.178 . . . . 5.6299999999999999 109.99 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.5 m -90.28 138.95 31.12 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 105.55 -2.018 . . . . 0.68000000000000005 105.55 148.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.1 m -156.13 145.73 15.39 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 118.377 -0.82 . . . . 0.81000000000000005 109.212 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.33 153.27 61.49 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.074 2.516 . . . . 0.46000000000000002 112.11 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -154.68 166.1 34.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.543 1.937 . . . . 0.41999999999999998 105.93 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.99 127.76 50.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 106.67 -1.604 . . . . 0.73999999999999999 106.67 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -85.93 -77.42 0.3 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.177 0.991 . . . . 2.5499999999999998 110.957 -172.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.67 98.17 0.51 Allowed Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.861 -1.296 . . . . 3.1099999999999999 109.861 -168.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -32.41 -63.45 0.28 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 127.219 2.343 . . . . 2.1699999999999999 114.071 -171.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.254 0.8 OUTLIER -74.47 121.66 21.83 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.534 0.938 . . . . 2.8500000000000001 113.534 -176.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.48 18.97 26.66 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.043 1.783 . . . . 2.5 113.357 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.24 162.93 39.35 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.309 1.055 . . . . 1.6699999999999999 113.691 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -118.79 -169.25 1.69 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.111 1.365 . . . . 1.47 110.513 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.44 -44.1 6.68 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.446 -1.062 . . . . 0.85999999999999999 110.446 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -72.75 73.95 1.1 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.432 0.634 . . . . 1.6100000000000001 110.549 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -159.33 96.37 1.29 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.833 1.253 . . . . 1.9399999999999999 108.555 -166.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -125.19 141.4 52.12 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 124.821 1.248 . . . . 0.71999999999999997 111.343 -165.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -55.47 -34.6 64.67 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.511 0.724 . . . . 3.1000000000000001 111.547 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.7 p -141.12 160.05 40.92 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.794 0.838 . . . . 0.55000000000000004 112.061 -169.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -51.37 -48.12 62.63 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-O 117.941 -1.028 . . . . 0.59999999999999998 108.839 158.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -39.41 -56.5 1.58 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.063 0.847 . . . . 2.0699999999999998 110.766 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -70.11 -50.28 42.35 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 121.164 -0.214 . . . . 4.5099999999999998 110.812 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.8 t -52.9 -32.78 47.13 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 122.064 0.935 . . . . 0.93999999999999995 112.143 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -73.83 -72.68 0.26 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 124.677 1.191 . . . . 4.0099999999999998 107.952 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -41.76 -45.15 3.46 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.798 1.639 . . . . 0.57999999999999996 112.439 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.8 mm -73.18 -33.5 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 119.344 -0.36 . . . . 1.6799999999999999 111.852 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -106.68 -52.52 2.76 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.33 0.863 . . . . 1.3100000000000001 113.33 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.486 HH11 ' HG3' ' A' ' 54' ' ' ARG . 8.1 mtm-85 -130.43 120.7 24.62 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.468 1.907 . . . . 5.8200000000000003 111.211 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 117.549 -1.215 . . . . 4.8700000000000001 110.0 161.208 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 118.267 -0.873 . . . . 3.1099999999999999 109.416 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.634 HD12 ' N ' ' A' ' 3' ' ' CYS . 2.2 pp -53.97 -31.57 21.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 O-C-N 124.13 0.894 . . . . 2.3399999999999999 112.938 -168.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.634 ' N ' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -50.65 -32.44 19.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.31 1.044 . . . . 1.78 111.955 177.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -30.31 64.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.058 0.543 . . . . 1.8 112.409 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -77.14 131.04 73.42 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.599 -0.889 . . . . 4.0999999999999996 108.599 -170.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.81 -176.48 3.06 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.071 1.847 . . . . 1.4399999999999999 113.602 -164.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 20' ' ' TYR . 3.2 ttpm? -61.61 153.29 28.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.245 1.018 . . . . 2.7400000000000002 109.301 157.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.501 ' CD ' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -155.95 173.83 16.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.918 -2.253 . . . . 5.7300000000000004 104.918 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.0 -87.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 106.236 -1.764 . . . . 1.46 106.236 160.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.93 -171.01 43.21 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.84 -1.704 . . . . 1.8799999999999999 108.84 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -120.24 24.81 10.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.292 1.037 . . . . 6.8899999999999997 110.62 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.3 m -138.83 159.73 41.43 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.55 -1.648 . . . . 2.2799999999999998 106.55 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -79.75 55.97 2.17 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.883 0.473 . . . . 4.6200000000000001 110.594 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.8 159.57 29.3 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.331 -0.707 . . . . 1.47 111.331 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -140.41 73.05 1.41 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.781 -1.563 . . . . 1.9399999999999999 106.781 171.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.89 97.03 22.25 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 108.632 -0.877 . . . . 0.81999999999999995 108.632 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.0 118.27 5.12 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 120.462 1.201 . . . . 0.95999999999999996 109.153 172.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -120.88 179.3 4.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 127.571 2.349 . . . . 3.8599999999999999 108.429 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -117.83 148.39 42.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.584 2.354 . . . . 0.98999999999999999 107.729 167.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 7' ' ' LYS . 2.3 p90 -134.32 156.02 49.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.498 -1.667 . . . . 1.27 106.498 166.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -66.77 112.28 4.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.558 -1.645 . . . . 1.51 106.558 159.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -93.08 122.3 35.31 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 123.898 0.749 . . . . 1.76 110.49 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -89.2 -5.25 57.84 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 117.82 -1.086 . . . . 1.8300000000000001 111.938 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -71.19 -48.86 49.06 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.624 -1.621 . . . . 4.6900000000000004 106.624 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.8 p -88.16 -30.81 19.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.695 1.198 . . . . 1.6899999999999999 112.73 174.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.33 26.75 29.7 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.1 0.857 . . . . 0.98999999999999999 111.952 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -142.49 154.32 44.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.189 1.396 . . . . 4.7599999999999998 110.819 -167.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.7 m -68.99 121.27 16.29 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 108.224 -1.028 . . . . 0.64000000000000001 108.224 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.2 m -144.65 145.07 26.93 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 123.512 0.725 . . . . 0.72999999999999998 109.183 -160.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.48 154.44 68.83 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.913 2.409 . . . . 0.72999999999999998 111.723 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -155.66 158.07 37.7 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.652 -1.24 . . . . 0.68000000000000005 107.652 166.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -94.92 118.33 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 N-CA-C 107.48 -1.304 . . . . 1.3600000000000001 107.48 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -91.49 145.17 24.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.881 1.272 . . . . 2.0899999999999999 109.82 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.26 22.61 37.69 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.786 1.184 . . . . 1.6000000000000001 112.734 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.92 -46.34 3.64 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.629 1.214 . . . . 1.4099999999999999 111.99 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.0 155.45 49.96 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.564 1.146 . . . . 2.1400000000000001 110.325 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.07 47.79 35.97 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.285 -0.726 . . . . 2.7799999999999998 111.285 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.96 -153.42 29.31 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.736 0.684 . . . . 1.3600000000000001 111.907 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.501 ' ND2' ' CD ' ' A' ' 8' ' ' LYS . 17.5 p30 -149.36 -171.52 3.91 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.93 -1.878 . . . . 1.8400000000000001 105.93 165.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.51 -35.01 85.94 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.907 0.776 . . . . 0.66000000000000003 112.175 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -76.65 70.76 3.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.572 1.149 . . . . 1.8200000000000001 109.731 -176.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.92 63.48 0.65 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.071 -0.714 . . . . 2.1000000000000001 109.071 -161.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -104.41 146.89 28.2 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 124.722 1.209 . . . . 0.81999999999999995 109.519 -162.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -64.54 -40.01 94.82 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.873 1.669 . . . . 2.8300000000000001 110.58 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -126.03 153.73 43.99 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.998 1.111 . . . . 0.47999999999999998 113.998 -167.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.85 -47.22 42.84 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.557 1.143 . . . . 0.54000000000000004 110.273 159.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -44.16 -53.77 6.2 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.416 0.686 . . . . 2.0800000000000001 110.408 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -64.92 -52.37 56.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 119.534 -0.269 . . . . 2.4500000000000002 110.44 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.0 t -48.25 -52.68 20.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.533 0.682 . . . . 0.70999999999999996 111.436 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.9 ttm-85 -57.0 -62.05 2.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.726 1.211 . . . . 2.79 109.927 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.97 -38.06 64.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.513 0.725 . . . . 0.71999999999999997 111.993 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.4 mt -75.41 -53.53 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 122.91 0.484 . . . . 1.52 110.75 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.9 t -99.47 -37.74 9.07 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.584 0.957 . . . . 1.5700000000000001 113.584 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -111.49 -152.45 0.5 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.551 1.54 . . . . 4.4800000000000004 109.856 -169.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 104.478 -2.416 . . . . 4.8099999999999996 104.478 161.011 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 117.789 -1.1 . . . . 2.7999999999999998 109.221 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -44.61 -38.17 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.632 1.173 . . . . 1.8899999999999999 112.157 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.02 -13.32 1.86 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.89 1.676 . . . . 2.3399999999999999 114.324 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.03 -33.97 70.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.198 -1.038 . . . . 2.6699999999999999 108.198 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -77.98 137.98 61.41 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.44 -0.948 . . . . 3.5099999999999998 108.44 167.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -80.13 -179.68 5.46 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.064 1.842 . . . . 1.46 110.072 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -39.87 139.13 0.68 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 115.496 1.665 . . . . 3.1099999999999999 115.496 149.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -157.36 151.53 24.77 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 129.128 2.971 . . . . 4.96 104.853 168.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.3 t -136.7 -60.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.09 0.471 . . . . 2.0899999999999999 111.961 -160.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.67 65.96 3.09 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 114.679 0.632 . . . . 3.6200000000000001 114.679 -155.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.78 -18.51 5.57 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.49 0.716 . . . . 6.5199999999999996 112.245 164.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.5 m -130.88 160.81 33.35 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 106.845 -1.539 . . . . 1.9099999999999999 106.845 161.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -120.69 52.94 1.14 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.503 1.121 . . . . 4.9900000000000002 109.727 -170.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.16 139.61 15.49 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.316 -1.113 . . . . 1.76 110.316 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -82.64 74.48 9.6 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.078 -0.712 . . . . 1.1599999999999999 109.078 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -101.7 92.44 2.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 118.204 -0.903 . . . . 1.03 109.998 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.21 111.36 2.24 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.977 1.784 . . . . 0.72999999999999998 109.586 174.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HG3' HD21 ' A' ' 42' ' ' ASN . 9.0 mmt85 -120.66 -179.08 3.88 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.897 1.679 . . . . 3.1899999999999999 108.891 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -120.0 146.48 45.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.735 1.614 . . . . 0.40000000000000002 108.538 172.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 6.0 p90 -127.76 152.22 48.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.451 -1.315 . . . . 0.69999999999999996 107.451 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -68.04 101.9 1.21 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.071 -1.825 . . . . 1.3200000000000001 106.071 158.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -73.44 138.06 44.95 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.412 -0.588 . . . . 2.2200000000000002 109.412 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.7 t -108.2 -8.37 15.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.692 1.197 . . . . 1.6399999999999999 111.068 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.64 -50.25 45.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.363 -1.347 . . . . 4.2199999999999998 107.363 168.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.9 p -89.14 -28.23 20.19 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.798 0.839 . . . . 1.27 112.231 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.06 39.7 18.97 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.317 -0.713 . . . . 0.90000000000000002 111.352 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -148.69 148.09 29.64 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.614 1.207 . . . . 4.2599999999999998 110.414 -166.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.8 m -68.7 118.4 11.64 Favored 'General case' 0 CA--C 1.526 0.049 0 N-CA-C 108.572 -0.899 . . . . 0.52000000000000002 108.572 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.2 m -136.71 142.02 37.43 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 124.928 1.291 . . . . 0.56000000000000005 108.718 -164.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.52 154.45 50.15 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.016 2.478 . . . . 0.45000000000000001 111.453 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -159.64 158.24 31.16 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.577 1.151 . . . . 0.76000000000000001 109.176 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.1 mm -86.3 119.87 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 106.64 -1.615 . . . . 1.1799999999999999 106.64 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -80.09 -19.78 46.64 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.018 0.747 . . . . 3.4199999999999999 113.018 -168.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.29 -46.46 3.41 Favored Glycine 0 CA--C 1.527 0.821 0 O-C-N 120.979 -1.076 . . . . 1.1499999999999999 110.45 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.8 -30.94 3.85 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.21 0.909 . . . . 1.79 112.953 165.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.69 159.42 39.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.736 0.814 . . . . 2.4700000000000002 111.607 -169.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.0 5.03 51.32 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.192 0.901 . . . . 3.1499999999999999 112.414 -166.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.17 -149.71 3.5 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.395 0.998 . . . . 1.8300000000000001 110.943 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -151.56 -176.24 5.52 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.709 1.204 . . . . 1.28 108.629 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.38 -5.14 90.22 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.549 -1.14 . . . . 1.1000000000000001 113.152 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -78.15 65.58 3.56 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.961 1.88 . . . . 1.5900000000000001 107.073 170.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.425 HD21 ' HG3' ' A' ' 18' ' ' ARG . 20.6 t-20 -159.0 112.68 2.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.929 -1.137 . . . . 2.4399999999999999 107.929 -165.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -136.24 148.5 48.08 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.549 1.14 . . . . 0.70999999999999996 108.206 -165.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.46 -38.59 84.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.337 0.517 . . . . 2.6000000000000001 109.779 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.5 p -135.66 160.14 39.43 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.873 0.869 . . . . 0.69999999999999996 111.707 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.66 -46.81 58.73 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 123.393 0.677 . . . . 0.62 109.803 161.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -49.32 -49.59 43.29 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.099 -0.334 . . . . 2.6000000000000001 110.099 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -67.22 -50.61 60.11 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.024 -0.362 . . . . 1.9099999999999999 110.024 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.8 t -50.63 -46.15 58.08 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.507 0.67 . . . . 0.60999999999999999 111.184 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -59.15 -59.8 4.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.806 1.242 . . . . 2.75 109.727 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.54 -41.93 54.52 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.359 0.664 . . . . 0.66000000000000003 111.824 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.92 -50.39 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 122.962 0.505 . . . . 1.48 111.236 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.0 t -129.24 -5.63 4.87 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.783 1.401 . . . . 2.0 114.783 -156.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -117.75 -156.82 0.65 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.609 1.564 . . . . 5.6500000000000004 108.591 167.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 104.075 -2.565 . . . . 4.75 104.075 148.005 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 107.347 -1.353 . . . . 3.3199999999999998 107.347 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -50.56 -29.51 6.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 O-C-N 123.888 0.743 . . . . 2.0499999999999998 111.234 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 66.4 m -45.13 -32.95 1.99 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.488 1.515 . . . . 1.3400000000000001 112.093 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.55 7.14 47.25 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.617 0.599 . . . . 2.6899999999999999 112.617 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.16 127.5 92.03 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.56 1.073 . . . . 3.29 109.165 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.11 145.61 49.83 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.797 2.331 . . . . 2.0800000000000001 107.337 170.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -76.07 132.58 40.18 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 117.932 -1.507 . . . . 8.4299999999999997 112.087 -164.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.86 148.1 39.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.789 2.036 . . . . 5.5599999999999996 107.251 168.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -80.87 -87.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.746 -1.575 . . . . 2.2200000000000002 106.746 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.57 55.09 0.03 OUTLIER Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.357 0.503 . . . . 3.48 112.657 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.25 47.55 0.69 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.63 1.972 . . . . 5.29 113.679 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.8 m -96.53 164.25 12.69 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.237 0.615 . . . . 3.7200000000000002 111.343 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -140.33 58.86 1.57 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.425 -1.324 . . . . 6.7000000000000002 107.425 170.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.49 171.97 31.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 108.35 -1.9 . . . . 1.24 108.35 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -125.71 102.36 7.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.78 1.232 . . . . 1.21 108.43 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -131.9 105.15 13.96 Favored Pre-proline 0 C--O 1.233 0.207 0 N-CA-C 106.364 -1.717 . . . . 1.25 106.364 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.67 132.04 21.1 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.92 1.747 . . . . 0.64000000000000001 108.773 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -136.97 178.91 6.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.678 1.591 . . . . 3.5299999999999998 107.356 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -122.27 145.46 48.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.508 1.523 . . . . 0.47999999999999998 109.3 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -130.97 150.56 52.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.063 -1.088 . . . . 0.89000000000000001 108.063 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -72.34 101.42 2.88 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.63 -1.618 . . . . 1.26 106.63 166.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.79 109.57 6.48 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.541 -1.281 . . . . 2.04 107.541 169.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -85.62 -7.07 59.05 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.017 0.927 . . . . 1.3899999999999999 111.971 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -71.01 -55.64 7.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.828 -1.545 . . . . 7.4000000000000004 106.828 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 p -85.37 -19.03 32.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.774 -1.103 . . . . 1.21 111.986 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.22 41.47 69.05 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.129 -1.188 . . . . 1.1499999999999999 110.129 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.08 131.81 45.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.072 0.949 . . . . 5.3499999999999996 109.893 -170.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.535 ' HB2' HD13 ' A' ' 46' ' ' LEU . 56.0 m -67.44 113.01 4.96 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.041 -1.466 . . . . 0.68000000000000005 107.041 159.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.2 m -126.93 137.25 30.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 126.767 2.027 . . . . 0.72999999999999998 107.825 -165.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.55 156.21 58.26 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.633 2.222 . . . . 0.41999999999999998 111.022 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -161.63 165.8 27.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.47 1.508 . . . . 0.62 107.588 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.28 118.72 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 107.62 -1.252 . . . . 0.82999999999999996 107.62 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -77.45 -42.68 35.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.67 0.788 . . . . 2.3500000000000001 110.834 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.7 -16.92 43.15 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.978 -0.901 . . . . 1.75 112.895 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.75 25.17 21.24 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 118.171 0.986 . . . . 1.8999999999999999 113.24 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.86 159.98 9.97 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.323 1.062 . . . . 2.9399999999999999 109.939 -171.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.85 32.9 59.48 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.221 1.391 . . . . 2.3100000000000001 114.575 169.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.43 -163.28 9.76 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 122.263 0.924 . . . . 1.3600000000000001 115.276 -168.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -156.7 -179.75 8.49 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 127.686 2.394 . . . . 1.3799999999999999 106.377 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.99 -40.03 95.09 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 118.237 0.472 . . . . 0.79000000000000004 113.411 -169.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -77.34 57.57 1.52 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.466 1.106 . . . . 1.73 111.25 -167.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.75 76.75 1.02 Allowed 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.251 -0.905 . . . . 2.4199999999999999 110.725 -148.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -122.04 145.24 48.34 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.11 1.364 . . . . 0.83999999999999997 111.802 -152.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -57.12 -39.06 74.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.487 1.115 . . . . 2.77 111.533 -173.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -144.94 161.15 40.06 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.139 0.576 . . . . 0.64000000000000001 110.109 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.535 HD13 ' HB2' ' A' ' 28' ' ' CYS . 1.2 tp -52.12 -48.46 64.82 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 118.514 -0.755 . . . . 0.63 109.012 164.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -43.63 -53.9 5.38 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.477 -0.564 . . . . 2.52 109.477 176.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -69.72 -46.51 65.8 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.835 -0.432 . . . . 1.97 109.835 -171.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.4 t -51.97 -49.35 63.39 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 121.078 0.466 . . . . 0.58999999999999997 110.726 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -60.98 -61.19 2.76 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.223 -1.028 . . . . 5.2800000000000002 108.223 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -43.8 -48.44 8.18 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.473 1.509 . . . . 0.60999999999999999 111.55 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -67.4 -50.85 58.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.655 0.382 . . . . 1.6699999999999999 111.048 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 32.1 m -76.85 -52.81 8.81 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.071 -0.393 . . . . 2.27 112.054 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.432 HH21 ' C ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -138.07 107.87 6.29 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 125.583 1.553 . . . . 8.4600000000000009 109.654 171.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.432 ' C ' HH21 ' A' ' 54' ' ' ARG . . . . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 118.858 -0.591 . . . . 5.9199999999999999 109.975 162.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 118.144 -0.932 . . . . 2.9900000000000002 109.201 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.2 pt -71.73 -5.53 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.082 0.953 . . . . 1.8600000000000001 113.321 -171.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.6 m -56.38 -41.3 76.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.643 -0.661 . . . . 1.48 110.172 160.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.4 -27.47 41.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.592 1.157 . . . . 1.73 111.99 -173.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 50.5 mt-10 -58.32 139.38 84.47 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 106.974 -1.491 . . . . 3.1800000000000002 106.974 166.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -102.56 -175.77 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.836 2.357 . . . . 1.24 110.821 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.0 132.3 37.5 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.114 -0.699 . . . . 2.7599999999999998 109.114 167.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.25 136.6 15.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.487 -2.042 . . . . 4.9199999999999999 105.487 172.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t -74.11 -71.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.131 0.878 . . . . 1.6000000000000001 108.971 -174.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.69 178.34 17.74 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.232 -1.547 . . . . 1.78 109.232 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -79.01 37.28 0.3 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 117.842 0.821 . . . . 5.5499999999999998 110.688 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.8 m -166.34 158.86 14.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 105.513 -2.032 . . . . 1.78 105.513 -166.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -139.6 41.53 2.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.399 0.68 . . . . 6.2000000000000002 110.543 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.81 152.1 49.99 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 109.981 -1.247 . . . . 1.3600000000000001 109.981 173.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -82.4 74.15 9.39 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.721 -0.87 . . . . 1.3500000000000001 109.032 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.58 91.0 3.05 Favored Pre-proline 0 CA--C 1.529 0.169 0 N-CA-C 108.77 -0.826 . . . . 0.79000000000000004 108.77 171.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -62.81 122.63 11.01 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 N-CA-C 108.702 -1.307 . . . . 0.84999999999999998 108.702 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -130.65 176.39 8.22 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.059 1.744 . . . . 3.48 107.984 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -109.01 148.95 29.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.837 1.255 . . . . 0.59999999999999998 108.488 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -131.51 153.58 49.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.323 -1.362 . . . . 0.93000000000000005 107.323 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -82.71 107.01 15.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.171 -1.789 . . . . 1.2 106.171 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.16 112.88 15.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.275 -1.009 . . . . 2.1000000000000001 108.275 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 t -88.5 -0.56 57.35 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 117.966 -1.016 . . . . 1.22 113.106 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -82.63 -48.98 10.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.498 -1.668 . . . . 5.21 106.498 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.4 p -79.63 -30.71 41.47 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.769 1.228 . . . . 1.1000000000000001 110.062 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.39 57.06 5.77 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.056 -1.618 . . . . 0.88 109.056 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.28 160.89 37.55 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.18 0.992 . . . . 4.6200000000000001 110.039 -177.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.0 m -85.99 128.72 34.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.652 0.781 . . . . 0.57999999999999996 109.075 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -144.06 144.91 27.99 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.52 1.128 . . . . 0.5 108.306 -161.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.43 155.2 45.79 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.969 2.446 . . . . 0.48999999999999999 112.265 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.25 169.5 23.09 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.526 1.53 . . . . 0.69999999999999996 108.114 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.18 119.13 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.307 -0.998 . . . . 0.85999999999999999 108.307 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -89.39 143.57 26.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.32 1.848 . . . . 1.97 109.963 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.3 -36.59 91.3 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.412 -0.66 . . . . 1.0900000000000001 113.381 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.86 18.9 28.32 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.125 0.869 . . . . 2.21 112.894 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.4 m -141.95 -159.18 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.559 1.144 . . . . 3.1899999999999999 108.162 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -15.55 -60.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 C-N-CA 128.27 2.843 . . . . 4.4299999999999997 115.664 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.42 -133.79 12.14 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 119.336 -0.702 . . . . 1.3700000000000001 111.545 168.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 168.66 -173.42 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 128.904 2.881 . . . . 1.98 106.851 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.17 -44.94 10.69 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.767 -0.933 . . . . 0.80000000000000004 110.767 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 11.4 t-20 -73.65 67.94 1.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.72 1.208 . . . . 2.9399999999999999 110.057 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -163.15 88.12 0.58 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.736 1.214 . . . . 2.1200000000000001 109.791 -168.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -121.21 148.76 43.81 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.432 1.093 . . . . 1.3200000000000001 111.537 -162.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.45 -38.26 80.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.853 0.461 . . . . 2.9399999999999999 111.022 -174.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.3 p -142.28 165.83 26.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.516 0.726 . . . . 0.56000000000000005 110.561 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -47.76 79.01 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.814 0.846 . . . . 0.55000000000000004 110.675 166.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -48.82 -53.61 18.59 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.316 -0.624 . . . . 2.2999999999999998 109.316 175.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -65.44 -49.98 67.11 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.541 -0.54 . . . . 2.3700000000000001 109.541 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.5 t -50.3 -51.95 40.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.549 0.69 . . . . 0.97999999999999998 110.933 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -65.27 -49.18 70.56 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.466 -0.788 . . . . 3.8500000000000001 109.815 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.87 -44.42 82.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.388 0.675 . . . . 1.21 111.624 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.3 mt -69.95 -51.78 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 122.579 0.352 . . . . 2.1499999999999999 110.667 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.6 t -73.26 -53.59 10.49 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.504 0.557 . . . . 2.4100000000000001 112.504 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 54' ' ' ARG . 7.8 mtp-105 -83.65 166.42 18.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 114.608 1.336 . . . . 5.6600000000000001 114.608 -167.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 104.468 -2.419 . . . . 6.6600000000000001 104.468 139.398 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 108.704 -0.851 . . . . 3.0600000000000001 108.704 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.3 pt -64.31 -15.54 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.393 0.677 . . . . 1.7 111.774 171.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.7 m -77.36 -27.88 52.79 Favored 'General case' 0 C--O 1.222 -0.359 0 O-C-N 121.87 -0.519 . . . . 1.3600000000000001 110.655 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.92 -30.77 19.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.494 -0.928 . . . . 1.75 108.494 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -52.99 139.04 44.51 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 108.006 -1.109 . . . . 2.79 108.006 165.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -98.79 175.74 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.747 2.298 . . . . 1.4199999999999999 111.064 172.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.28 138.88 31.24 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.853 -1.067 . . . . 3.1699999999999999 110.1 160.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 132.4 8.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 128.242 2.617 . . . . 4.5700000000000003 106.378 176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.1 t -75.51 -86.02 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.103 -1.073 . . . . 2.3199999999999998 108.103 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.74 147.57 0.6 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 123.606 0.622 . . . . 2.3199999999999998 113.005 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 65.16 -55.47 0.31 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.871 2.868 . . . . 8.2100000000000009 115.808 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.7 m -140.06 166.57 24.29 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.299 1.04 . . . . 1.8799999999999999 109.73 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -133.28 33.0 3.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.087 0.955 . . . . 6.1900000000000004 110.787 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.75 146.72 42.27 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.071 -1.212 . . . . 1.45 110.071 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -81.79 72.4 8.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.883 0.849 . . . . 1.1399999999999999 108.718 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -101.57 95.95 5.78 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 107.761 -1.2 . . . . 0.81000000000000005 107.761 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.1 131.02 29.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 N-CA-C 108.511 -1.38 . . . . 0.71999999999999997 108.511 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -135.11 174.89 10.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.46 -1.311 . . . . 3.52 107.46 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -111.08 146.65 36.39 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.703 1.201 . . . . 0.46000000000000002 108.311 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -129.75 152.13 49.59 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.634 -1.247 . . . . 0.95999999999999996 107.634 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.47 102.42 5.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 103.892 -2.633 . . . . 1.48 103.892 160.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -72.08 109.98 6.24 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.82 -1.918 . . . . 2.2400000000000002 105.82 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 t -86.27 -14.75 42.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.508 -0.553 . . . . 1.1299999999999999 109.508 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -63.09 -44.43 95.72 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.846 -1.909 . . . . 4.3499999999999996 105.846 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.7 p -91.95 -40.83 10.91 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.952 2.501 . . . . 1.21 111.465 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.03 21.89 24.32 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.926 1.727 . . . . 1.04 112.398 -169.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -120.93 151.16 40.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.936 1.694 . . . . 4.5300000000000002 109.195 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -73.15 136.68 44.82 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 120.664 -1.273 . . . . 0.57999999999999996 108.093 168.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.8 m -155.11 147.24 17.4 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.431 -0.795 . . . . 0.78000000000000003 108.947 -169.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.44 152.18 29.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.285 2.657 . . . . 0.64000000000000001 111.774 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -150.72 158.41 44.12 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 124.831 1.252 . . . . 0.51000000000000001 108.867 172.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.07 118.79 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 105.726 -1.953 . . . . 0.82999999999999996 105.726 168.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.79 -54.06 9.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.408 0.683 . . . . 2.8399999999999999 110.569 -173.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.29 -27.81 7.52 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.208 -0.757 . . . . 1.1399999999999999 111.208 -173.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.64 -45.36 1.4 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.419 1.009 . . . . 1.5 111.364 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 m -106.4 157.73 17.41 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.577 1.151 . . . . 2.6400000000000001 108.745 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 30.83 60.95 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.499 -0.612 . . . . 2.1699999999999999 113.459 166.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.18 157.96 46.12 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 118.442 1.121 . . . . 2.04 111.75 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -117.17 -163.1 0.9 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.557 1.543 . . . . 1.05 108.495 170.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.98 69.39 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.17 -1.172 . . . . 0.87 110.17 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -75.17 58.8 0.94 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.678 1.591 . . . . 2.6899999999999999 111.522 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.29 78.57 1.02 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.935 -0.478 . . . . 2.0499999999999998 110.202 -161.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -109.77 154.57 22.76 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.247 1.019 . . . . 0.71999999999999997 110.983 -164.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -67.01 -44.54 80.05 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.833 -0.542 . . . . 2.4500000000000002 109.564 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 78.3 p -131.28 154.29 48.66 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.958 0.725 . . . . 0.67000000000000004 112.958 -169.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.02 -47.01 22.38 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.5 1.12 . . . . 0.82999999999999996 110.037 159.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.3 -50.72 15.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.241 0.616 . . . . 2.2400000000000002 110.598 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -65.89 -53.62 37.17 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 119.038 -0.506 . . . . 2.6800000000000002 110.842 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 t -47.39 -44.29 24.2 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.555 0.693 . . . . 0.59999999999999998 111.656 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.1 ttm-85 -62.14 -70.41 0.2 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.499 1.12 . . . . 2.7200000000000002 109.576 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.02 -40.81 45.81 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.204 1.402 . . . . 0.54000000000000004 112.939 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mm -63.68 -39.3 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 123.99 0.916 . . . . 1.4199999999999999 110.638 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 17.5 t -107.84 -52.2 2.8 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 113.005 0.742 . . . . 1.73 113.005 -165.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -129.09 -154.83 0.66 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.626 1.57 . . . . 4.3600000000000003 110.18 -160.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 105.919 -1.882 . . . . 5.1100000000000003 105.919 170.502 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 118.44 -0.791 . . . . 4.2699999999999996 109.384 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.1 pt -71.19 -14.31 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 113.098 0.777 . . . . 1.73 113.098 -168.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.9 m -73.37 -32.65 64.63 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.811 0.444 . . . . 1.5900000000000001 111.096 166.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.2 -35.51 31.26 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.908 -0.495 . . . . 1.71 110.134 -177.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -60.01 135.43 90.42 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 117.853 -1.07 . . . . 4.0599999999999996 109.125 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -104.58 177.2 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.994 2.463 . . . . 1.5800000000000001 111.757 170.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -36.54 134.07 0.49 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 126.958 2.103 . . . . 2.6499999999999999 112.911 166.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.07 135.81 9.45 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 113.282 -1.781 . . . . 4.71 109.132 166.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.61 -49.87 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.063 -0.717 . . . . 1.3 109.063 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.95 85.42 0.97 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.705 0.669 . . . . 3.6899999999999999 112.815 165.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 87.9 mtm-85 65.66 -52.52 0.37 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 128.89 2.876 . . . . 8.8000000000000007 115.027 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 m -71.87 169.44 15.8 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.114 0.566 . . . . 2.3500000000000001 109.984 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -129.42 31.03 4.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.012 1.325 . . . . 7.3099999999999996 109.493 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.83 177.67 48.21 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.808 -1.317 . . . . 1.4299999999999999 109.808 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -124.96 87.61 2.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.091 0.956 . . . . 1.8899999999999999 108.73 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -111.57 103.13 54.76 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 108.096 -1.076 . . . . 0.88 108.096 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.6 125.17 14.99 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 N-CA-C 108.874 -1.241 . . . . 0.89000000000000001 108.874 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -134.2 175.71 9.25 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.468 1.507 . . . . 2.5499999999999998 107.886 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -103.64 149.28 25.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.942 1.297 . . . . 0.79000000000000004 108.06 167.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -128.32 157.45 40.93 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.726 -1.583 . . . . 0.79000000000000004 106.726 166.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -78.84 103.0 8.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.056 -1.831 . . . . 1.3300000000000001 106.056 163.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -77.4 111.38 13.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.619 -0.882 . . . . 1.8300000000000001 108.619 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 t -89.3 9.83 24.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.531 0.733 . . . . 1.6699999999999999 111.892 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -86.68 -45.29 11.13 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.16 -1.792 . . . . 4.4900000000000002 106.16 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.1 p -93.76 -31.71 14.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 130.263 3.425 . . . . 1.0700000000000001 111.684 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.35 30.93 12.47 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.436 1.493 . . . . 0.94999999999999996 112.765 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -143.61 148.11 35.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.19 1.396 . . . . 4.3600000000000003 111.502 -161.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 78.8 m -71.31 128.23 35.21 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 120.18 -1.575 . . . . 0.5 109.663 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.1 m -149.4 147.33 22.98 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 117.965 -1.016 . . . . 0.56000000000000005 109.253 -161.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.78 150.0 34.34 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.319 2.679 . . . . 0.53000000000000003 112.219 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -153.42 171.83 18.05 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.17 1.388 . . . . 0.58999999999999997 109.014 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.58 107.86 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.765 -0.828 . . . . 1.3300000000000001 108.765 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -78.47 139.68 38.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.21 1.004 . . . . 2.1699999999999999 108.706 170.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.12 -43.03 49.39 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-O 119.365 -0.686 . . . . 1.3100000000000001 112.385 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.62 -9.03 13.02 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.149 0.88 . . . . 1.6299999999999999 113.448 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.0 m -113.34 -131.11 0.32 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.155 -1.424 . . . . 2.8500000000000001 107.155 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.04 -62.78 0.04 OUTLIER Glycine 0 C--N 1.338 0.694 0 C-N-CA 127.881 2.657 . . . . 3.0 115.193 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.26 -134.16 8.04 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.506 -1.038 . . . . 1.9299999999999999 110.506 -166.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -170.0 177.0 4.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 128.21 2.604 . . . . 1.27 106.139 171.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.17 -25.12 73.49 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.193 -0.763 . . . . 0.68999999999999995 111.193 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -73.7 55.61 0.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.649 1.58 . . . . 2.71 109.908 174.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -147.53 120.57 8.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.521 -1.289 . . . . 2.3999999999999999 107.521 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -138.6 147.72 43.3 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.49 1.116 . . . . 0.69999999999999996 108.898 -165.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -78.68 -25.13 44.77 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.884 -0.51 . . . . 3.1000000000000001 110.92 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -142.42 155.42 45.1 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.512 0.725 . . . . 0.68999999999999995 111.021 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.13 -45.59 53.12 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 109.297 -0.631 . . . . 0.79000000000000004 109.297 160.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -44.77 -53.77 7.03 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.939 0.496 . . . . 2.23 110.543 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -63.97 -54.12 39.47 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 110.161 -0.311 . . . . 1.8100000000000001 110.161 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -48.58 -49.74 35.4 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.31 0.576 . . . . 0.54000000000000004 111.503 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -59.93 -64.43 0.95 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.613 1.165 . . . . 2.54 109.165 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -44.55 -45.64 9.49 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.508 1.123 . . . . 0.77000000000000002 111.699 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.8 mm -71.29 -56.71 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.888 0.875 . . . . 1.6499999999999999 110.739 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 46.5 t -88.09 -44.9 10.6 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.225 0.824 . . . . 1.51 113.225 -168.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.85 82.98 1.63 Allowed 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.633 1.573 . . . . 5.3200000000000003 111.006 176.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 118.275 -0.869 . . . . 5.29 112.335 -176.794 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 107.383 -1.34 . . . . 3.9199999999999999 107.383 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.9 pt -47.11 -32.58 2.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 124.574 1.15 . . . . 2.2400000000000002 112.025 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.8 t -32.23 -41.44 0.05 Allowed 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 126.88 2.072 . . . . 1.8200000000000001 114.708 169.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.72 -22.82 61.57 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.138 -1.392 . . . . 1.8 111.186 -169.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.43 149.76 94.45 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 118.879 0.763 . . . . 3.0600000000000001 109.395 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.68 173.16 13.32 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.137 1.891 . . . . 1.0600000000000001 110.259 170.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -54.32 141.88 28.51 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.782 0.801 . . . . 2.6400000000000001 109.471 160.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -143.94 133.05 22.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.602 -1.629 . . . . 5.8899999999999997 106.602 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.84 -55.19 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.295 0.498 . . . . 1.5700000000000001 110.144 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.64 -157.83 22.53 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 108.39 -1.884 . . . . 2.1800000000000002 108.39 -175.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -24.13 4.59 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.886 0.875 . . . . 6.2300000000000004 112.22 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.42 ' HB2' ' H ' ' A' ' 36' ' ' CYS . 64.9 m -79.12 158.26 27.79 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.539 -0.911 . . . . 2.5 108.539 166.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -106.28 45.84 0.96 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.836 0.855 . . . . 5.21 110.15 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.98 176.15 54.11 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.167 -0.773 . . . . 1.1799999999999999 111.167 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -124.44 81.07 1.9 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.15 1.38 . . . . 1.1899999999999999 107.287 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -105.99 104.67 50.46 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 108.027 -1.101 . . . . 1.1599999999999999 108.027 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -65.07 112.96 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 N-CA-C 108.544 -1.368 . . . . 0.62 108.544 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -121.69 178.34 4.89 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.934 2.094 . . . . 3.6000000000000001 109.211 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -127.32 146.15 50.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.131 1.772 . . . . 0.53000000000000003 108.313 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -135.25 153.29 51.96 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.167 -1.42 . . . . 0.81000000000000005 107.167 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 55' ' ' ALA . 46.9 t80 -65.57 103.16 0.81 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.482 -1.673 . . . . 1.3100000000000001 106.482 161.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -78.54 114.91 17.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.376 -1.713 . . . . 1.95 106.376 169.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 t -86.28 -16.64 36.95 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.404 0.281 . . . . 1.6599999999999999 110.275 -175.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -67.2 -45.52 76.61 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 126.673 1.989 . . . . 3.6699999999999999 106.139 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.7 p -88.16 -35.6 17.31 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.246 1.818 . . . . 1.21 110.981 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.48 44.18 8.82 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.845 -1.302 . . . . 0.91000000000000003 109.845 -171.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.54 141.93 43.4 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.842 1.657 . . . . 5.8399999999999999 110.162 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.5 m -65.61 113.47 4.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.099 -1.074 . . . . 0.81000000000000005 108.099 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.7 m -132.94 144.13 51.54 Favored Pre-proline 0 C--N 1.332 -0.185 0 C-N-CA 125.65 1.58 . . . . 0.55000000000000004 108.613 -163.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.31 156.3 62.21 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.732 2.288 . . . . 0.47999999999999998 111.697 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -155.21 161.76 41.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.839 1.255 . . . . 0.59999999999999998 108.051 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.9 mm -93.67 112.39 26.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 108.136 -1.061 . . . . 1.24 108.136 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -90.19 147.14 23.75 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.691 1.196 . . . . 2.2599999999999998 109.366 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.48 -6.68 89.16 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.252 1.406 . . . . 1.0600000000000001 113.536 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.78 -49.87 1.41 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.915 1.358 . . . . 1.72 111.581 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.42 ' H ' ' HB2' ' A' ' 12' ' ' CYS . 0.6 OUTLIER -127.23 144.74 50.98 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.127 0.971 . . . . 2.3999999999999999 110.379 173.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.51 12.47 41.28 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.669 1.604 . . . . 2.1899999999999999 112.745 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.03 148.88 47.87 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 118.313 1.056 . . . . 2.1699999999999999 113.094 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -91.01 -161.18 0.79 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.411 1.484 . . . . 1.6899999999999999 109.732 171.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.27 -45.67 6.13 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.914 -1.275 . . . . 0.89000000000000001 109.914 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -73.76 72.68 1.52 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.624 0.712 . . . . 1.53 110.158 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -159.95 93.79 1.09 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.745 1.218 . . . . 2.27 108.704 -163.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -131.66 141.63 49.64 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 123.208 0.603 . . . . 1.1200000000000001 111.056 -160.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -54.52 -43.68 72.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.747 0.819 . . . . 2.7000000000000002 110.833 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.7 p -137.01 158.28 44.83 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.172 0.511 . . . . 0.68999999999999995 112.363 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.24 -46.93 62.47 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.167 -0.679 . . . . 0.56999999999999995 109.167 159.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -46.59 -50.67 17.07 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.223 0.465 . . . . 1.8400000000000001 110.437 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -65.08 -53.9 38.38 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.764 0.426 . . . . 2.96 110.215 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.0 t -51.83 -45.06 63.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.868 0.842 . . . . 0.54000000000000004 111.246 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.417 HH21 ' C ' ' A' ' 55' ' ' ALA . 30.9 ttm180 -64.56 -53.76 42.76 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.153 1.381 . . . . 2.98 109.349 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.6 -43.11 56.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.768 0.427 . . . . 0.72999999999999998 111.167 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.4 mt -69.26 -57.05 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.045 0.538 . . . . 1.96 111.719 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -120.97 -24.4 5.61 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.022 1.119 . . . . 1.5800000000000001 114.022 -166.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.275 0.3 OUTLIER 67.56 118.25 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 130.929 3.692 . . . . 6.9400000000000004 110.719 -177.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.417 ' C ' HH21 ' A' ' 50' ' ' ARG . . . . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 127.473 2.309 . . . . 8.9800000000000004 106.448 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 118.68 -0.676 . . . . 4.4500000000000002 110.051 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 pt -55.8 -28.65 24.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 114.37 1.248 . . . . 1.95 114.37 -162.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.3 m -55.61 -35.91 66.36 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.896 -0.502 . . . . 1.55 112.226 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.05 -19.37 20.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.947 0.499 . . . . 1.5700000000000001 111.088 -162.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -72.56 146.21 88.38 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 118.208 0.458 . . . . 4.25 110.323 -161.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.36 166.49 29.14 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.499 2.132 . . . . 1.8400000000000001 113.092 -169.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -57.68 147.27 28.1 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 107.702 -1.221 . . . . 2.6600000000000001 107.702 169.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -154.92 69.74 0.74 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.966 0.888 . . . . 6.0599999999999996 110.791 -156.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.3 t -60.35 -44.67 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.392 -0.596 . . . . 1.8 109.392 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.7 -146.26 18.16 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 107.972 -2.051 . . . . 2.96 107.972 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -154.15 55.11 0.71 Allowed 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.086 -0.709 . . . . 7.6799999999999997 109.086 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.0 m -150.16 150.56 31.81 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.29 1.036 . . . . 2.8500000000000001 108.247 -165.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -77.81 63.87 2.95 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.975 0.51 . . . . 7.1399999999999997 110.351 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -116.2 153.42 17.47 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.733 -1.747 . . . . 1.4399999999999999 108.733 168.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -144.56 81.2 1.65 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.537 -0.912 . . . . 1.6000000000000001 108.537 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.33 100.13 45.21 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 108.148 -1.056 . . . . 1.3700000000000001 108.148 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.71 126.0 17.27 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.32 1.346 . . . . 0.60999999999999999 109.418 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -137.64 176.24 8.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.493 1.517 . . . . 3.5699999999999998 108.305 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -121.2 142.44 49.9 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.556 1.543 . . . . 0.54000000000000004 108.52 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -128.36 152.15 48.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.965 -1.494 . . . . 1.0700000000000001 106.965 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -73.03 104.14 4.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.637 -1.616 . . . . 1.3400000000000001 106.637 168.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.16 105.96 4.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.084 -1.45 . . . . 2.04 107.084 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.2 t -81.17 -6.9 59.36 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.154 -0.927 . . . . 1.4299999999999999 112.831 -173.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -76.09 -49.95 16.03 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.211 -1.403 . . . . 5.2400000000000002 107.211 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.4 p -88.97 -12.64 40.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.708 0.803 . . . . 1.3999999999999999 111.752 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.7 37.17 76.36 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.924 1.249 . . . . 0.81000000000000005 111.119 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -137.96 135.49 36.07 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.316 1.046 . . . . 4.4400000000000004 110.747 -163.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 90.6 m -66.04 124.45 22.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.347 -0.983 . . . . 0.59999999999999998 108.347 170.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.5 m -141.37 138.99 18.15 Favored Pre-proline 0 N--CA 1.451 -0.401 0 C-N-CA 124.701 1.2 . . . . 0.83999999999999997 107.862 -164.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.03 156.89 61.55 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.456 2.104 . . . . 0.65000000000000002 111.06 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.1 157.86 36.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.215 -1.402 . . . . 0.87 107.215 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.63 116.24 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 105.293 -2.114 . . . . 0.88 105.293 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -86.28 131.2 34.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.53 -1.285 . . . . 2.3300000000000001 107.53 173.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.52 18.38 56.33 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.851 -0.416 . . . . 1.6399999999999999 112.408 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.62 -53.83 4.73 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.854 -1.698 . . . . 2.75 108.854 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.6 m -64.3 168.97 5.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.391 1.076 . . . . 2.8500000000000001 108.73 162.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.15 39.77 62.32 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 109.816 -1.314 . . . . 3.3300000000000001 109.816 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.95 57.55 5.04 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.655 -1.497 . . . . 2.6699999999999999 112.686 -171.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -81.68 173.54 12.23 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.146 0.973 . . . . 1.98 108.912 161.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.62 -23.45 72.85 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.519 0.581 . . . . 0.67000000000000004 114.051 -166.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -77.15 74.76 3.72 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.972 0.886 . . . . 1.74 109.724 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -152.17 96.52 2.2 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.071 0.548 . . . . 2.2000000000000002 109.96 -160.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -124.35 148.46 47.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.137 0.575 . . . . 1.25 109.492 -170.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -77.06 -27.55 54.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.971 -0.381 . . . . 4.7300000000000004 109.971 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.9 p -137.0 162.43 33.31 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.819 0.848 . . . . 0.95999999999999996 112.208 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.77 -49.26 39.38 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.254 1.021 . . . . 0.91000000000000003 110.101 159.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -46.8 -50.5 18.22 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.701 0.4 . . . . 2.1899999999999999 110.085 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -66.42 -52.57 45.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 119.235 -0.412 . . . . 3.9700000000000002 111.2 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 t -47.9 -49.74 28.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.606 0.639 . . . . 0.5 111.212 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -56.71 -65.44 0.61 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.49 1.116 . . . . 3.2000000000000002 109.538 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.62 -40.0 71.55 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.05 0.94 . . . . 1.0600000000000001 112.949 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mp -74.19 -52.1 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 119.258 -0.401 . . . . 2.4700000000000002 110.094 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.0 t -79.56 -47.87 14.79 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.097 0.862 . . . . 1.55 112.546 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -125.97 -151.68 0.49 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.6 1.96 . . . . 4.3399999999999999 109.155 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 105.423 -2.066 . . . . 4.7000000000000002 105.423 163.142 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.529 -0.545 . . . . 4.21 109.529 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pp -63.76 -29.39 47.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 113.166 0.802 . . . . 3.48 113.166 -156.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -18.46 60.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.286 0.565 . . . . 1.8899999999999999 111.692 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.81 -44.2 12.67 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.388 1.075 . . . . 1.9299999999999999 110.741 168.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.2 116.15 20.46 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.787 -0.625 . . . . 4.1600000000000001 110.221 -174.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.93 153.53 42.2 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.502 1.468 . . . . 1.3999999999999999 110.791 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.88 143.93 9.3 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 122.123 0.963 . . . . 2.5899999999999999 112.52 163.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.99 128.78 10.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.257 1.823 . . . . 5.2999999999999998 106.274 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.0 t -72.86 -51.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.11 -0.7 . . . . 1.3700000000000001 109.11 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.9 143.87 15.6 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.119 1.342 . . . . 2.46 109.838 -172.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -76.81 67.11 2.82 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.857 -0.79 . . . . 9.8599999999999994 108.893 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 m -107.05 178.57 4.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.414 1.086 . . . . 3.3599999999999999 109.919 -171.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -122.28 68.05 0.94 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.404 -1.332 . . . . 8.2899999999999991 107.404 167.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.14 165.97 35.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.325 -1.51 . . . . 1.51 109.325 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -146.37 99.36 3.21 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.099 1.759 . . . . 1.45 106.283 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -123.64 100.86 37.4 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 107.66 -1.237 . . . . 0.93000000000000005 107.66 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.2 125.73 17.7 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 108.484 -1.391 . . . . 0.54000000000000004 108.484 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.6 mmt-85 -135.66 174.47 10.58 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.388 1.475 . . . . 3.3799999999999999 108.347 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -115.85 140.98 48.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.241 1.417 . . . . 0.40000000000000002 108.154 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.459 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 7.4 p90 -123.6 152.65 41.68 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.331 -1.359 . . . . 0.68000000000000005 107.331 169.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -66.64 105.66 1.6 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.24 -1.763 . . . . 1.05 106.24 155.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 6.5 t70 -72.05 116.87 12.96 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.767 -1.938 . . . . 1.8300000000000001 105.767 168.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.65 -25.11 28.71 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.745 -0.835 . . . . 1.29 108.745 -169.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -63.73 -45.9 87.85 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 128.208 2.603 . . . . 3.8999999999999999 106.636 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.8 p -84.9 -34.24 22.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.101 1.36 . . . . 1.0700000000000001 110.783 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.9 37.01 23.73 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.146 1.355 . . . . 1.22 110.494 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' NZ ' ' OXT' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -146.93 156.75 43.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.779 1.232 . . . . 6.8200000000000003 110.384 -174.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.2 m -67.34 139.03 57.2 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.398 -0.814 . . . . 0.75 109.435 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -156.65 146.15 15.3 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.874 -1.158 . . . . 0.91000000000000003 107.874 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.66 156.49 49.11 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.091 2.528 . . . . 0.39000000000000001 111.695 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -153.69 162.95 40.79 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.414 1.486 . . . . 0.42999999999999999 107.359 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -96.05 113.67 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.862 -1.903 . . . . 0.76000000000000001 105.862 170.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -81.57 139.77 34.87 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.639 -1.245 . . . . 2.1200000000000001 107.639 169.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.26 -11.24 85.53 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 121.725 -0.609 . . . . 1.03 112.653 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.27 -43.88 1.7 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.206 -1.158 . . . . 1.51 110.206 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.9 159.03 15.19 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.131 1.773 . . . . 2.3500000000000001 111.374 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.09 37.59 93.05 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 114.759 0.664 . . . . 2.6899999999999999 114.759 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.61 -153.6 15.81 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.887 0.844 . . . . 1.3100000000000001 112.815 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -160.38 -163.32 1.08 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.381 2.272 . . . . 1.4399999999999999 105.675 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.21 -20.84 68.83 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.566 1.076 . . . . 0.79000000000000004 112.239 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -81.5 63.97 6.02 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 118.502 1.151 . . . . 1.6200000000000001 110.069 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -159.09 78.24 0.74 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.914 -0.584 . . . . 1.74 109.544 -155.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -112.99 154.5 26.36 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.465 0.706 . . . . 0.84999999999999998 110.916 -167.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.24 -39.73 94.56 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.803 -0.814 . . . . 3.04 108.803 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.8 p -130.66 150.59 51.78 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.142 1.164 . . . . 0.53000000000000003 114.142 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.9 -46.11 42.33 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.224 1.41 . . . . 0.70999999999999996 110.242 159.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.42 -49.96 23.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.704 0.802 . . . . 2.0499999999999998 110.488 175.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -64.46 -54.96 24.39 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 119.186 -0.435 . . . . 2.2999999999999998 110.358 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.25 -43.54 42.91 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.294 1.045 . . . . 0.65000000000000002 111.509 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -60.61 -58.77 7.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.864 1.266 . . . . 4.9100000000000001 111.516 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.32 -43.55 67.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.621 0.769 . . . . 0.62 112.298 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.5 -44.17 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.899 0.88 . . . . 1.76 110.331 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 10.7 t -147.94 -54.51 0.21 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.058 0.762 . . . . 1.8899999999999999 113.058 -171.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.15 136.38 52.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.301 1.223 . . . . 7.7400000000000002 114.301 -153.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' OXT' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . 0 N--CA 1.453 -0.298 0 C-N-CA 125.587 1.555 . . . . 6.9699999999999998 107.685 163.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 117.94 -1.028 . . . . 2.8999999999999999 109.3 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.8 pt -45.24 -34.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.168 0.987 . . . . 1.73 111.927 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.2 m -49.1 -27.35 3.33 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.343 1.057 . . . . 1.3500000000000001 112.704 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -33.26 66.13 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.912 -0.492 . . . . 1.3899999999999999 111.038 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.44 119.21 44.6 Favored Pre-proline 0 C--O 1.225 -0.2 0 CA-C-O 118.11 -0.947 . . . . 4.9000000000000004 109.072 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.08 173.51 12.03 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 120.802 1.322 . . . . 1.3400000000000001 111.626 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -45.21 131.56 7.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.115 -1.402 . . . . 2.79 110.52 157.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -159.17 137.01 10.25 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.711 2.004 . . . . 5.1699999999999999 106.722 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.52 -66.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.799 0.727 . . . . 1.3100000000000001 109.782 -172.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.77 -178.82 19.1 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.241 -1.543 . . . . 1.8400000000000001 109.241 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -68.06 -43.36 78.81 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.915 -0.772 . . . . 6.46 108.915 172.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.2 m -71.52 151.97 43.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.269 -1.752 . . . . 2.0299999999999998 106.269 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -138.09 46.95 2.03 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.448 0.699 . . . . 6.4500000000000002 109.134 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.94 153.91 34.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.269 -1.532 . . . . 1.4199999999999999 109.269 170.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -83.1 77.8 9.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.981 -0.717 . . . . 1.1899999999999999 109.523 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -101.31 94.35 3.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.071 -0.715 . . . . 0.78000000000000003 109.071 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.67 122.33 10.39 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 CA-C-N 120.548 1.232 . . . . 0.5 108.935 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -130.7 177.99 6.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 125.578 1.551 . . . . 3.7000000000000002 107.268 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -117.53 142.49 47.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.794 1.638 . . . . 0.38 108.144 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -124.84 150.43 46.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.567 -1.642 . . . . 0.81000000000000005 106.567 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.9 102.34 0.77 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 104.559 -2.386 . . . . 1.3999999999999999 104.559 157.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.39 103.22 3.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.243 -1.762 . . . . 2.0800000000000001 106.243 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 t -74.9 -15.33 60.71 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.258 0.623 . . . . 1.1399999999999999 110.66 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -62.4 -41.66 98.84 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.446 1.098 . . . . 4.3399999999999999 108.107 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.5 p -105.33 -25.66 12.31 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.783 2.833 . . . . 0.83999999999999997 112.911 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.1 30.39 22.97 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.867 2.175 . . . . 0.97999999999999998 113.233 -173.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -136.65 138.2 40.87 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.152 1.476 . . . . 4.4900000000000002 110.96 -161.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 m -70.48 120.17 15.73 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 120.491 -1.38 . . . . 0.56999999999999995 108.952 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.9 m -140.72 145.65 40.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.637 1.175 . . . . 0.51000000000000001 108.868 -163.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.65 151.25 41.16 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.218 2.612 . . . . 0.46000000000000002 111.899 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -154.64 162.99 40.88 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.349 1.46 . . . . 0.51000000000000001 108.27 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.39 113.15 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.02 -1.474 . . . . 0.67000000000000004 107.02 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -80.83 145.19 31.53 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.526 1.13 . . . . 1.98 108.004 168.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.31 -31.3 47.16 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.992 0.806 . . . . 1.04 114.012 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.42 17.35 24.51 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.391 0.996 . . . . 1.75 113.115 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -125.57 -156.93 0.76 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.125 1.37 . . . . 2.8700000000000001 109.403 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.48 67.61 0.26 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.868 1.699 . . . . 2.6099999999999999 110.254 163.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.33 -83.92 0.09 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.135 -1.586 . . . . 2.4199999999999999 109.135 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -177.85 -174.13 0.43 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 127.431 2.292 . . . . 1.1599999999999999 108.061 167.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.55 -20.51 61.81 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.463 0.554 . . . . 0.98999999999999999 112.69 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -80.24 64.89 5.21 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.372 1.086 . . . . 1.7 108.577 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.9 69.39 0.73 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.824 -0.806 . . . . 1.9199999999999999 108.824 -151.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -106.77 163.41 12.95 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.438 1.495 . . . . 0.67000000000000004 111.309 -162.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -30.43 35.29 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.671 -0.643 . . . . 3.3700000000000001 110.59 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.8 p -146.97 162.38 38.88 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.244 0.618 . . . . 0.66000000000000003 110.852 -173.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -46.11 70.31 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 123.432 0.693 . . . . 0.57999999999999996 109.855 163.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -47.82 -51.95 20.8 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.91 -0.404 . . . . 2.3500000000000001 109.91 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -68.96 -49.98 53.17 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.361 -0.237 . . . . 1.99 110.361 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -50.49 -47.65 57.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.509 0.671 . . . . 0.57999999999999996 110.699 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -61.89 -58.86 6.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 123.921 0.889 . . . . 4.4000000000000004 110.097 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.64 -45.61 63.38 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.502 0.721 . . . . 0.60999999999999999 111.584 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.5 mm -65.63 -54.58 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 122.661 0.385 . . . . 1.51 110.014 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.5 t -81.26 -57.03 3.68 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.781 0.66 . . . . 1.75 112.781 -168.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -125.84 67.06 1.18 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.706 2.002 . . . . 4.29 108.695 -166.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 118.14 -0.933 . . . . 5.8300000000000001 110.035 174.579 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 108.151 -1.055 . . . . 3.2599999999999998 108.151 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.4 pt -51.58 -30.93 11.9 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 C-N-CA 123.304 0.642 . . . . 1.78 110.756 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.4 m -47.76 -28.5 2.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.644 0.778 . . . . 1.26 112.302 176.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.34 -17.03 55.34 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.025 -0.988 . . . . 1.8700000000000001 112.419 -172.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.77 148.91 81.58 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 120.511 1.505 . . . . 3.21 111.518 -173.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.2 170.15 20.84 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.665 2.243 . . . . 1.6000000000000001 110.29 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.452 ' HE2' ' CE1' ' A' ' 20' ' ' TYR . 26.7 ttmt -67.99 140.84 56.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.255 -0.646 . . . . 4.2999999999999998 109.255 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.53 149.92 30.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.505 -1.665 . . . . 5.4500000000000002 106.505 176.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.6 t -90.73 -72.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 108.915 -0.772 . . . . 1.48 108.915 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.96 173.48 34.46 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 108.838 -1.705 . . . . 1.77 108.838 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -74.23 -43.17 58.14 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.289 -1.374 . . . . 8.9600000000000009 107.289 168.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.24 144.21 50.14 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.059 -1.83 . . . . 2.3700000000000001 106.059 166.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -59.61 2.64 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 119.041 -0.504 . . . . 6.3099999999999996 109.963 -173.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.19 -178.28 0.62 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.314 1.435 . . . . 1.79 115.839 166.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -147.99 95.26 2.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.402 1.081 . . . . 1.0800000000000001 108.986 170.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.2 107.17 13.54 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 109.121 -0.696 . . . . 0.83999999999999997 109.121 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.81 117.81 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.628 1.552 . . . . 0.71999999999999997 110.208 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -120.22 176.94 5.21 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 126.921 2.088 . . . . 3.2200000000000002 109.238 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -123.63 140.69 52.74 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.779 2.031 . . . . 0.51000000000000001 107.559 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.452 ' CE1' ' HE2' ' A' ' 7' ' ' LYS . 1.3 p90 -122.55 150.65 42.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.852 -1.906 . . . . 1.03 105.852 169.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -68.57 107.74 3.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.381 -2.081 . . . . 1.4399999999999999 105.381 159.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.07 111.98 7.77 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.884 -1.525 . . . . 2.23 106.884 170.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 t -88.06 1.53 54.04 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.004 -0.998 . . . . 1.24 112.945 -171.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -85.0 -50.07 7.77 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.862 -1.533 . . . . 5.7199999999999998 106.862 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.3 p -83.43 -26.07 30.68 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.862 0.865 . . . . 1.3100000000000001 111.357 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.08 31.27 53.39 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.867 1.222 . . . . 1.05 111.126 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.2 131.61 53.55 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 118.751 1.275 . . . . 4.6399999999999997 110.548 -169.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.8 m -62.31 129.02 38.83 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 107.439 -1.319 . . . . 0.47999999999999998 107.439 168.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.408 HG23 ' HD2' ' A' ' 30' ' ' PRO . 11.0 m -156.28 149.62 18.78 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.899 -1.148 . . . . 0.94999999999999996 107.899 -165.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.408 ' HD2' HG23 ' A' ' 29' ' ' THR . 57.3 Cg_endo -73.97 157.88 46.62 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.101 2.534 . . . . 0.54000000000000004 114.528 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -154.07 164.3 38.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.257 1.423 . . . . 0.59999999999999998 108.869 167.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.9 mm -98.93 104.87 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.575 -1.268 . . . . 0.89000000000000001 107.575 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -73.4 152.75 40.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.498 -0.927 . . . . 2.25 108.498 168.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.53 13.27 47.18 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 114.365 0.506 . . . . 1.1799999999999999 114.365 -172.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.76 -48.86 2.8 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 118.645 1.223 . . . . 1.49 110.943 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.52 128.04 38.5 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.712 0.805 . . . . 2.6499999999999999 111.834 174.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.14 52.5 0.24 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.522 2.01 . . . . 2.46 108.548 -170.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.15 164.73 54.35 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.065 -0.814 . . . . 1.97 111.065 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -156.8 -173.2 4.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.206 -1.775 . . . . 1.55 106.206 171.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.09 -47.29 9.37 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.023 -1.231 . . . . 0.79000000000000004 110.023 -172.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.11 65.92 2.19 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.929 0.492 . . . . 1.5600000000000001 110.926 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.0 66.12 0.91 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.343 1.057 . . . . 2.1000000000000001 109.859 -159.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -108.65 140.93 41.35 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.726 0.81 . . . . 0.75 110.994 -160.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.15 -42.29 80.76 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.252 0.933 . . . . 2.52 110.722 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.9 p -138.98 163.5 32.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.615 0.766 . . . . 0.55000000000000004 111.507 -169.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.79 -47.7 67.37 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.207 0.603 . . . . 0.5 109.548 162.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -48.69 -48.68 39.94 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.998 -0.371 . . . . 2.1099999999999999 109.998 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -68.58 -51.54 41.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.517 0.327 . . . . 2.25 110.641 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.5 t -51.13 -48.53 61.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.548 0.69 . . . . 0.54000000000000004 111.092 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -57.49 -60.34 3.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.224 1.01 . . . . 2.7599999999999998 109.129 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.75 -43.6 27.36 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.479 0.712 . . . . 0.73999999999999999 112.204 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.38 -59.35 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.945 0.339 . . . . 1.3600000000000001 110.151 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.3 t -81.38 -47.11 13.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 119.95 -0.7 . . . . 1.6200000000000001 112.522 -164.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -126.26 77.99 1.73 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.299 3.039 . . . . 5.0199999999999996 110.222 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 118.202 -0.904 . . . . 6.3399999999999999 109.786 169.158 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 107.942 -1.132 . . . . 3.5099999999999998 107.942 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.35 -24.84 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.618 0.767 . . . . 2.3199999999999998 111.774 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.3 m -33.12 -45.84 0.15 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.069 1.347 . . . . 1.6799999999999999 111.165 166.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.44 -22.25 61.12 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.589 0.959 . . . . 1.54 113.589 -169.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -65.71 146.16 99.0 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 119.787 1.176 . . . . 3.0899999999999999 111.027 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.32 169.91 21.45 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.949 1.766 . . . . 1.1499999999999999 110.735 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -56.68 143.03 37.82 Favored 'General case' 0 N--CA 1.46 0.051 0 C-N-CA 125.506 1.523 . . . . 2.5099999999999998 111.327 161.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -146.75 99.01 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.038 1.735 . . . . 5.3600000000000003 110.196 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.3 -42.09 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.442 -0.577 . . . . 1.51 109.442 174.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.62 -178.33 42.52 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.67 -0.972 . . . . 1.99 110.67 -172.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.06 55.56 2.53 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.985 -0.715 . . . . 7.6900000000000004 112.105 -170.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.9 m -147.58 165.44 30.36 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.917 1.287 . . . . 1.8500000000000001 107.573 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -139.42 20.55 2.56 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.236 0.615 . . . . 5.9299999999999997 112.103 -177.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.71 145.19 38.14 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.255 -1.138 . . . . 1.5600000000000001 110.255 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -81.95 73.32 9.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.69 0.757 . . . . 1.76 109.097 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -102.42 90.75 2.28 Favored Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 108.03 -1.1 . . . . 0.89000000000000001 108.03 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.56 136.45 46.41 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.207 1.271 . . . . 0.93999999999999995 109.549 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -140.43 179.35 6.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.051 2.141 . . . . 2.7599999999999998 107.62 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -122.95 147.23 46.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.892 2.077 . . . . 0.52000000000000002 108.391 169.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -128.61 155.81 44.37 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.955 -1.869 . . . . 1.0800000000000001 105.955 166.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -75.99 101.93 5.43 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.341 -1.355 . . . . 1.46 107.341 164.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -72.35 98.66 2.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.28 -1.378 . . . . 1.8 107.28 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -72.26 -14.69 61.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.245 -0.883 . . . . 1.24 112.817 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -69.27 -49.05 59.64 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.413 -1.328 . . . . 4.9800000000000004 107.413 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 64.1 p -83.77 -19.54 34.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.937 0.495 . . . . 0.96999999999999997 111.596 174.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.96 34.36 58.92 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.51 1.052 . . . . 0.78000000000000003 110.831 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.73 136.52 52.54 Favored 'General case' 0 CA--C 1.523 -0.059 0 C-N-CA 124.631 1.172 . . . . 5.5199999999999996 110.527 -169.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.8 m -61.99 124.68 21.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.905 -1.146 . . . . 0.63 107.905 156.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.5 m -141.54 137.69 16.67 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 107.299 -1.371 . . . . 0.89000000000000001 107.299 -166.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.03 155.17 65.67 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.405 2.07 . . . . 0.71999999999999997 110.84 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -153.46 157.84 40.47 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.147 -1.057 . . . . 0.70999999999999996 108.147 167.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.6 120.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 105.961 -1.866 . . . . 1.0 105.961 172.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -84.84 -7.53 59.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.071 1.348 . . . . 2.6299999999999999 111.707 -172.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.09 -33.12 1.5 Allowed Glycine 0 CA--C 1.533 1.203 0 O-C-N 119.991 -1.693 . . . . 1.45 113.221 172.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.96 25.73 18.9 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 126.059 1.79 . . . . 2.2599999999999998 110.478 -171.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.87 -160.71 0.72 Allowed 'General case' 0 C--N 1.34 0.195 0 N-CA-C 114.926 1.454 . . . . 2.8500000000000001 114.926 -164.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -31.02 -58.51 0.26 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 127.343 2.401 . . . . 3.3799999999999999 113.42 173.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.04 -161.88 46.89 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.995 -0.442 . . . . 1.29 111.995 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -172.23 -169.8 0.67 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.976 1.71 . . . . 1.1599999999999999 109.776 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.73 -41.9 18.39 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.584 -1.407 . . . . 0.89000000000000001 109.584 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -73.89 67.06 1.2 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.879 0.371 . . . . 1.78 111.179 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -149.58 117.92 6.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.097 1.359 . . . . 2.1400000000000001 108.492 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -138.77 139.84 38.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.766 0.827 . . . . 0.93000000000000005 108.83 -166.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -63.44 -35.98 82.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.878 0.763 . . . . 3.1299999999999999 110.936 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.5 p -131.11 155.05 47.62 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.592 0.757 . . . . 0.46000000000000002 111.314 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.92 -45.57 60.5 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.137 -0.69 . . . . 0.62 109.137 161.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.14 -53.72 7.72 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.821 0.449 . . . . 2.1600000000000001 110.498 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -64.71 -54.2 35.21 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.038 -0.356 . . . . 1.8 110.038 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 t -49.64 -50.22 44.05 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.01 0.433 . . . . 0.46000000000000002 110.93 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -57.81 -60.89 3.01 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.743 1.217 . . . . 3.02 109.111 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.05 -32.55 61.99 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.103 0.961 . . . . 0.68999999999999995 112.851 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.5 mm -88.29 -50.4 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.29 0.636 . . . . 1.8400000000000001 110.82 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.8 t -78.46 -49.1 14.04 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.705 -0.622 . . . . 1.55 111.484 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -104.3 -151.23 0.44 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.025 1.73 . . . . 4.8200000000000003 109.442 171.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 104.847 -2.279 . . . . 4.8399999999999999 104.847 148.761 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 108.707 -0.849 . . . . 3.4900000000000002 108.707 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp -55.41 -24.97 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.662 1.185 . . . . 2.75 110.976 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m -40.73 -36.8 0.66 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.462 1.505 . . . . 1.6799999999999999 111.694 170.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -23.89 60.77 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.594 0.961 . . . . 1.76 113.594 -176.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -72.29 144.66 87.21 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.695 0.68 . . . . 4.0999999999999996 109.893 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -83.54 169.27 12.37 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.252 1.968 . . . . 2.1600000000000001 112.193 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -60.3 140.42 57.1 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.906 1.283 . . . . 2.9199999999999999 107.914 153.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.515 ' HD2' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -158.24 134.47 9.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.529 0.732 . . . . 5.0800000000000001 109.763 176.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.56 -27.27 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.692 0.758 . . . . 2.1600000000000001 110.445 -173.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.4 179.07 9.69 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 121.932 0.74 . . . . 2.1000000000000001 111.77 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -81.25 53.2 1.98 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.605 -0.939 . . . . 7.9699999999999998 109.266 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.6 m -143.47 147.34 34.39 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.299 -1.371 . . . . 1.6799999999999999 107.299 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.71 39.11 3.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.411 0.685 . . . . 4.96 111.953 -171.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.09 141.56 15.66 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.501 -1.04 . . . . 1.55 110.501 174.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -82.05 74.93 9.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.743 -0.836 . . . . 1.3500000000000001 108.743 -176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -102.0 88.55 1.31 Allowed Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.114 0.966 . . . . 0.79000000000000004 109.059 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.34 119.88 6.99 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.57 1.514 . . . . 0.55000000000000004 109.322 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -116.7 178.05 4.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.823 2.049 . . . . 3.3700000000000001 108.919 169.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -116.62 139.69 50.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.989 1.716 . . . . 0.40000000000000002 108.373 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -120.79 148.01 44.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.931 -1.507 . . . . 0.71999999999999997 106.931 165.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -67.47 105.44 1.82 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.546 -1.65 . . . . 0.98999999999999999 106.546 158.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.57 103.57 3.59 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.149 -1.426 . . . . 1.9399999999999999 107.149 168.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 t -76.91 -9.46 58.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.215 -0.898 . . . . 1.1699999999999999 112.593 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.85 -48.85 34.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.522 -1.288 . . . . 4.1900000000000004 107.522 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.8 p -92.0 -13.72 30.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.904 0.882 . . . . 1.1899999999999999 112.589 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.03 33.67 84.4 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.134 0.873 . . . . 0.98999999999999999 111.108 -174.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 133.69 55.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 125.049 1.34 . . . . 5.29 109.844 -170.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.3 m -64.55 124.01 20.74 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.063 -1.088 . . . . 0.51000000000000001 108.063 158.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.8 m -142.71 141.83 21.26 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.724 1.61 . . . . 0.56000000000000005 107.36 -165.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.45 153.9 50.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.45 2.1 . . . . 0.52000000000000002 111.693 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -153.87 159.25 41.72 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.884 1.273 . . . . 0.54000000000000004 108.054 169.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.55 120.5 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 106.734 -1.58 . . . . 0.80000000000000004 106.734 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.0 -23.81 59.49 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.162 0.585 . . . . 2.7400000000000002 112.392 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.14 -49.73 4.17 Favored Glycine 0 CA--C 1.522 0.489 0 O-C-N 121.08 -1.013 . . . . 1.4199999999999999 110.749 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.68 -31.18 2.03 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.396 -0.669 . . . . 1.54 113.062 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.05 176.23 7.17 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.371 1.085 . . . . 2.3300000000000001 108.38 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.23 43.62 25.21 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.922 -1.271 . . . . 2.75 109.922 -172.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.85 147.47 48.43 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.091 -1.203 . . . . 2.1099999999999999 110.091 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' ND2' ' HD2' ' A' ' 8' ' ' LYS . 51.8 p30 -153.65 -174.45 4.96 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 105.758 -1.942 . . . . 1.6200000000000001 105.758 170.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.79 -43.7 65.66 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.906 -1.278 . . . . 1.3 109.906 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -75.17 67.11 1.77 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.471 0.708 . . . . 1.72 111.705 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.05 60.69 0.46 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.726 0.81 . . . . 2.0499999999999998 110.061 -160.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -104.07 142.1 35.05 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 123.622 0.769 . . . . 0.93000000000000005 110.822 -161.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -63.6 -41.91 98.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.549 1.068 . . . . 2.6499999999999999 110.542 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.1 p -118.21 152.24 36.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.751 0.82 . . . . 0.64000000000000001 112.571 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.23 -46.68 54.92 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.55 0.74 . . . . 0.55000000000000004 109.578 160.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.56 -51.8 11.41 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.246 0.618 . . . . 2.0099999999999998 110.586 176.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -65.25 -54.68 25.74 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 110.078 -0.341 . . . . 2.3799999999999999 110.078 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 t -48.28 -48.02 35.92 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.293 0.568 . . . . 0.52000000000000002 111.47 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -57.46 -62.65 1.63 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.908 1.283 . . . . 3.2400000000000002 108.794 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.04 -46.23 43.9 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.873 0.869 . . . . 0.73999999999999999 112.64 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mp -75.64 -57.46 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 118.061 0.392 . . . . 1.6399999999999999 110.272 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 16.0 t -82.94 -58.18 2.98 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.782 0.719 . . . . 1.6299999999999999 111.257 -170.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -81.59 62.71 5.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.838 0.455 . . . . 4.6900000000000004 110.772 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.335 0 O-C-N 124.149 0.906 . . . . 6.2800000000000002 109.438 166.759 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.1 t . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 107.421 -1.326 . . . . 3.52 107.421 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.525 HG22 ' HA3' ' A' ' 40' ' ' GLY . 0.1 OUTLIER -67.2 -13.26 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 114.07 1.137 . . . . 2.7599999999999998 114.07 -165.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.2 m -96.89 -12.61 23.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.792 0.437 . . . . 1.49 111.466 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.22 -37.47 8.9 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.087 0.955 . . . . 1.54 108.754 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -59.2 132.24 87.58 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.54 -1.652 . . . . 4.1100000000000003 106.54 172.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -99.44 175.68 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.597 2.198 . . . . 1.4199999999999999 111.398 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -48.95 140.88 8.33 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.673 1.702 . . . . 2.9300000000000002 112.693 153.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.86 -176.61 5.27 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 102.709 -3.071 . . . . 5.0199999999999996 102.709 165.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 t -120.89 -84.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.82 -1.548 . . . . 2.0299999999999998 106.82 158.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.2 170.6 15.6 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 107.185 -2.366 . . . . 2.7599999999999998 107.185 -173.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -80.38 60.58 3.85 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.287 -1.005 . . . . 6.5099999999999998 108.287 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.5 m -151.68 157.13 41.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.053 -1.091 . . . . 3.0899999999999999 108.053 -161.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.14 81.13 1.84 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.175 0.99 . . . . 5.9199999999999999 108.659 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.86 131.67 6.55 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.61 -1.396 . . . . 1.73 109.61 169.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -83.12 74.35 10.0 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.766 0.827 . . . . 2.1699999999999999 109.398 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -102.83 87.31 1.17 Allowed Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 107.879 -1.156 . . . . 1.28 107.879 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.7 120.93 8.32 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 N-CA-C 108.038 -1.562 . . . . 0.67000000000000004 108.038 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -128.91 177.28 7.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.2 1.4 . . . . 3.8599999999999999 107.774 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -112.63 156.52 22.58 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.276 1.83 . . . . 0.53000000000000003 107.946 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 31' ' ' PHE . 6.3 p90 -148.26 152.09 36.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.924 -1.139 . . . . 1.3500000000000001 107.924 175.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -76.07 100.08 4.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.987 -1.857 . . . . 0.92000000000000004 105.987 169.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 20' ' ' TYR . 11.0 t70 -72.3 109.68 6.2 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.638 -1.245 . . . . 2.48 107.638 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.6 t -87.21 6.76 31.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.593 -0.718 . . . . 1.8100000000000001 111.631 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.5 -45.63 10.31 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 105.987 -1.857 . . . . 4.5 105.987 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.9 p -94.25 -25.98 16.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.581 2.752 . . . . 1.4299999999999999 111.602 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.53 59.9 3.95 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.015 -1.234 . . . . 1.3100000000000001 110.015 -173.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.5 144.96 17.24 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.826 1.313 . . . . 4.0899999999999999 112.938 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.5 m -73.84 119.21 17.75 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.352 -0.842 . . . . 0.52000000000000002 108.75 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.3 m -141.93 147.54 45.23 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 117.956 -1.021 . . . . 0.57999999999999996 109.205 -161.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.38 145.22 21.02 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.333 2.689 . . . . 0.63 112.702 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -147.7 161.07 41.95 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.602 1.561 . . . . 0.65000000000000002 108.268 173.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.87 118.57 37.57 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 105.57 -2.011 . . . . 0.98999999999999999 105.57 170.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -72.77 -41.43 65.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.73 0.412 . . . . 2.9700000000000002 111.52 -171.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.15 -15.33 61.59 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 118.37 0.532 . . . . 1.1799999999999999 112.206 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.87 -51.72 4.61 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.626 1.213 . . . . 1.6200000000000001 110.145 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -178.9 4.77 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.036 1.334 . . . . 2.9900000000000002 109.928 170.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.99 49.74 65.42 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.604 -0.598 . . . . 2.5099999999999998 111.604 164.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.61 148.91 44.28 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.584 -0.95 . . . . 1.8700000000000001 112.6 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -143.62 178.99 7.41 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 104.782 -2.303 . . . . 1.0800000000000001 104.782 157.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 2' ' ' ILE . . . -75.05 -25.66 68.46 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.253 -0.739 . . . . 0.82999999999999996 111.253 -175.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -72.91 65.84 0.75 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.138 1.375 . . . . 2.52 110.471 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -162.07 97.16 1.02 Allowed 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.873 -0.517 . . . . 2.0699999999999998 110.466 -169.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.46 140.75 52.66 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.415 1.486 . . . . 0.81000000000000005 110.282 -165.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.68 -32.39 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.603 1.092 . . . . 2.8700000000000001 111.501 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.9 p -143.76 156.6 44.56 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.277 0.631 . . . . 0.46999999999999997 111.809 -169.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -45.08 64.71 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 108.869 -0.789 . . . . 0.5 108.869 160.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -43.9 -53.44 6.1 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.476 0.31 . . . . 2.1600000000000001 110.757 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -63.66 -57.04 11.29 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 117.951 0.341 . . . . 1.9399999999999999 110.136 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.9 t -49.12 -42.1 38.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.086 0.469 . . . . 0.64000000000000001 111.963 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -66.82 -54.78 19.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.161 1.384 . . . . 3.1699999999999999 109.684 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.73 -40.94 30.4 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.932 0.493 . . . . 0.67000000000000004 111.955 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.18 -63.78 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.003 0.521 . . . . 1.8200000000000001 110.961 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 70.9 m -97.29 -25.83 15.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.971 0.908 . . . . 2.1899999999999999 113.355 -166.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.99 118.42 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.31 2.644 . . . . 6.5700000000000003 108.955 -171.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 105.029 -2.211 . . . . 9.3399999999999999 105.029 158.601 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 107.692 -1.225 . . . . 3.3500000000000001 107.692 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.2 pt -49.63 -34.02 8.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 118.422 0.556 . . . . 1.6799999999999999 110.451 169.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.0 m -51.05 -24.93 4.25 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.27 0.628 . . . . 1.3999999999999999 112.685 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.59 -35.66 67.97 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.216 0.462 . . . . 1.47 110.336 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 110.02 3.58 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.206 1.003 . . . . 4.2699999999999996 111.873 -164.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.95 146.0 69.94 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 CA-C-N 120.912 1.361 . . . . 1.45 110.83 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -34.05 133.67 0.21 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 128.589 2.755 . . . . 3.6600000000000001 112.62 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -138.73 149.01 44.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.162 2.585 . . . . 5.3600000000000003 108.118 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.5 t -117.82 -22.63 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.365 1.066 . . . . 1.9399999999999999 111.759 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.17 150.64 0.77 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-O 122.391 0.995 . . . . 2.1600000000000001 112.612 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.29 50.23 0.9 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.587 -0.949 . . . . 7.8799999999999999 111.721 -178.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.1 m -126.3 142.71 51.42 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.37 0.668 . . . . 2.0099999999999998 111.098 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 78.33 8.71 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.27 -1.011 . . . . 7.7999999999999998 108.27 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.97 -179.77 22.43 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.02 -1.232 . . . . 1.51 110.02 168.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -146.53 117.86 7.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.899 1.28 . . . . 1.6699999999999999 107.793 -176.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -145.1 119.03 5.55 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 106.847 -1.538 . . . . 0.93000000000000005 106.847 175.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.9 134.37 23.5 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.643 1.562 . . . . 1.1499999999999999 109.055 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.2 mmt-85 -140.82 176.26 8.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.506 1.122 . . . . 2.98 108.519 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -125.28 136.97 54.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.068 1.747 . . . . 0.60999999999999999 107.634 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -118.93 150.97 39.01 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.338 -1.356 . . . . 0.92000000000000004 107.338 171.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.24 100.33 2.08 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.215 -2.142 . . . . 1.6499999999999999 105.215 161.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.39 104.02 3.63 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.844 -1.539 . . . . 2.0600000000000001 106.844 171.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 t -82.62 -0.14 45.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.394 -0.812 . . . . 1.29 112.564 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.98 -47.55 12.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.947 -1.501 . . . . 3.7000000000000002 106.947 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.5 p -79.48 -30.15 41.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.719 1.208 . . . . 0.95999999999999996 111.167 170.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.23 29.78 44.17 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.83 1.205 . . . . 0.80000000000000004 111.309 -172.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -129.19 147.35 51.03 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 118.858 1.329 . . . . 4.5499999999999998 110.131 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 57.8 m -69.86 135.09 49.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.152 -1.425 . . . . 0.73999999999999999 107.152 166.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 m -151.72 139.42 12.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.06 -1.089 . . . . 0.55000000000000004 108.06 -169.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.17 159.1 53.12 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.842 2.361 . . . . 0.5 111.101 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -158.47 163.53 37.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.952 1.301 . . . . 0.68000000000000005 108.158 171.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.7 mm -93.11 115.35 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.545 -1.65 . . . . 1.27 106.545 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.03 -19.34 61.21 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.789 0.836 . . . . 2.6099999999999999 111.678 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.47 -45.78 3.31 Favored Glycine 0 CA--C 1.525 0.681 0 O-C-N 121.303 -0.873 . . . . 1.5800000000000001 110.951 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.32 -24.43 3.38 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 124.074 0.845 . . . . 1.28 111.86 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -145.04 176.55 9.42 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.545 1.138 . . . . 2.2000000000000002 109.426 -172.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 41.52 44.61 4.19 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.262 1.411 . . . . 3.3999999999999999 114.245 171.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.95 -133.66 7.31 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.602 -1.399 . . . . 2.0299999999999998 109.602 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -152.94 -168.51 3.06 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.337 1.855 . . . . 1.3899999999999999 107.028 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.27 -12.07 65.94 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.928 0.775 . . . . 0.83999999999999997 113.035 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -79.15 63.76 3.88 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 118.5 1.15 . . . . 1.8999999999999999 107.913 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -159.44 87.91 0.84 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.818 -0.808 . . . . 1.9199999999999999 108.818 -146.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -126.41 150.64 48.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.751 0.82 . . . . 0.62 110.497 -159.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.86 -42.81 98.62 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.474 0.709 . . . . 2.6699999999999999 109.917 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.6 p -135.37 159.35 41.86 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.26 0.624 . . . . 0.58999999999999997 112.091 -170.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.01 -47.4 61.62 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.67 0.788 . . . . 0.71999999999999997 110.041 160.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -48.15 -49.96 30.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.485 0.314 . . . . 2.6400000000000001 110.179 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -67.67 -52.47 37.6 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 110.198 -0.297 . . . . 2.1099999999999999 110.198 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.0 t -49.88 -46.28 51.52 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.387 0.675 . . . . 0.47999999999999998 111.207 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -59.52 -73.24 0.09 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.752 -1.203 . . . . 2.7400000000000002 107.752 172.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -42.3 -43.55 3.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.589 1.156 . . . . 0.83999999999999997 113.577 -172.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.26 -40.74 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 122.855 0.462 . . . . 1.3999999999999999 111.875 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.0 t -100.53 -44.64 5.8 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.979 1.103 . . . . 1.6599999999999999 113.979 -170.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.32 149.48 28.71 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.803 1.641 . . . . 5.0099999999999998 108.368 -160.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.235 0 O-C-N 122.296 -0.252 . . . . 5.2999999999999998 110.449 173.265 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 117.809 -1.091 . . . . 3.4500000000000002 109.347 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.8 pt -43.89 -31.56 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.497 1.519 . . . . 2.4199999999999999 113.702 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 t -31.85 -45.3 0.1 Allowed 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.279 1.832 . . . . 1.9099999999999999 113.738 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.16 -21.0 61.51 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 125.32 1.638 . . . . 2.0899999999999999 111.723 -164.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -62.84 157.85 56.88 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.361 0.982 . . . . 3.2200000000000002 109.489 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -88.33 166.65 6.58 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.588 2.192 . . . . 1.1200000000000001 111.132 173.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -44.63 132.02 6.51 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.013 0.925 . . . . 2.6499999999999999 108.67 157.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.0 tttm -158.57 99.03 1.56 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 104.807 -2.294 . . . . 5.1699999999999999 104.807 -169.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.78 -43.04 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.521 0.728 . . . . 1.3100000000000001 111.809 -168.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.84 151.11 27.76 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.682 -1.367 . . . . 1.8999999999999999 109.682 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -80.75 50.66 1.38 Allowed 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.967 -0.725 . . . . 5.6100000000000003 112.872 -166.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.47 142.01 39.43 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 107.578 -1.267 . . . . 1.6899999999999999 107.578 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -85.32 54.72 3.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.208 0.603 . . . . 5.6200000000000001 109.617 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.53 173.15 25.74 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.618 -0.593 . . . . 1.6699999999999999 111.618 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -137.65 79.58 1.75 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.992 1.317 . . . . 1.1000000000000001 107.814 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -116.1 107.25 48.05 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 106.96 -1.496 . . . . 1.01 106.96 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.21 133.99 40.37 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 CA-C-N 120.637 1.263 . . . . 0.78000000000000003 109.097 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -131.55 172.3 12.39 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.836 -1.172 . . . . 3.0600000000000001 107.836 170.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.06 144.67 36.77 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.682 1.593 . . . . 0.5 107.501 170.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.46 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 1.8 p90 -131.22 161.19 32.79 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.568 -0.901 . . . . 0.71999999999999997 108.568 169.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -73.16 105.39 4.57 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.64 -1.985 . . . . 1.3700000000000001 105.64 156.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 6.4 t70 -73.45 118.52 16.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.895 -1.52 . . . . 2.29 106.895 169.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 t -86.26 -25.44 25.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.186 0.994 . . . . 1.72 108.799 -174.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -61.94 -43.79 98.11 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 127.178 2.191 . . . . 4.2400000000000002 107.082 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.1 p -96.24 -36.57 10.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.825 2.05 . . . . 1.1699999999999999 110.759 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.64 48.82 4.83 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.208 1.385 . . . . 0.88 110.506 -173.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.04 147.04 31.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 128.29 2.636 . . . . 4.1699999999999999 111.92 -172.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 99.9 m -69.75 123.14 20.64 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.802 -0.814 . . . . 0.64000000000000001 108.802 171.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.4 m -147.33 148.86 32.95 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 124.353 1.061 . . . . 0.62 108.457 -161.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.75 151.58 36.4 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.969 2.446 . . . . 0.48999999999999999 112.148 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -149.91 163.2 38.69 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.537 1.535 . . . . 0.5 107.743 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.56 120.24 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 107.958 -1.127 . . . . 0.84999999999999998 107.958 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -95.79 143.96 26.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.535 1.934 . . . . 2.2200000000000002 107.427 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.33 0.77 88.67 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.509 -0.606 . . . . 1.0800000000000001 113.068 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.94 6.16 77.82 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.796 1.298 . . . . 1.72 112.125 -172.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.98 -156.06 0.31 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.291 1.037 . . . . 3.0099999999999998 111.393 -174.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -38.81 -41.96 1.37 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.429 1.49 . . . . 3.79 114.173 169.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.95 -141.01 46.11 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.698 -1.361 . . . . 1.47 109.698 -177.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -179.95 -160.53 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.786 2.034 . . . . 1.0600000000000001 108.634 174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.62 -44.14 16.77 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 118.685 0.675 . . . . 0.78000000000000003 111.447 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -73.87 64.94 1.01 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.92 1.288 . . . . 3.0499999999999998 109.314 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -159.14 74.31 0.63 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.082 0.953 . . . . 2.0699999999999998 109.375 -168.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -103.34 153.59 20.28 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 124.049 0.939 . . . . 0.77000000000000002 110.371 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.25 -48.63 79.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.325 -0.62 . . . . 2.6600000000000001 109.325 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.1 p -130.87 161.06 32.67 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.243 0.831 . . . . 0.83999999999999997 113.243 -164.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.45 -49.46 61.69 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.713 -0.847 . . . . 0.84999999999999998 108.713 159.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -42.54 -51.88 4.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.427 0.558 . . . . 2.1299999999999999 110.504 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -61.31 -56.54 19.37 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.07 -0.49 . . . . 1.95 111.044 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.9 t -52.75 -41.15 63.77 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.924 0.868 . . . . 0.91000000000000003 112.368 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -60.74 3.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.973 2.109 . . . . 2.8799999999999999 109.165 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.72 -44.29 93.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.77 0.828 . . . . 0.81000000000000005 111.347 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.49 -40.75 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.259 1.023 . . . . 1.5700000000000001 110.991 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.9 t -144.49 -70.2 0.29 Allowed 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 112.551 0.574 . . . . 1.7 112.551 -166.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -82.99 65.84 8.31 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.28 -1.378 . . . . 4.6600000000000001 107.28 -169.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 117.619 -1.182 . . . . 4.5700000000000003 111.265 -177.769 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 CA--C 1.504 -0.822 0 CA-C-O 118.026 -0.988 . . . . 4.8899999999999997 108.87 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp -31.75 -34.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 127.768 2.427 . . . . 2.4399999999999999 116.934 -147.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.9 m -72.55 -12.77 61.21 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.674 -0.641 . . . . 1.8600000000000001 111.835 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -52.5 10.75 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.192 -1.04 . . . . 1.79 108.192 165.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.14 108.08 1.46 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.347 1.459 . . . . 4.5300000000000002 111.544 -174.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.06 175.43 10.91 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 CA-C-N 120.698 1.285 . . . . 1.7 112.031 -173.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -40.96 133.65 2.12 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 126.189 1.795 . . . . 3.0899999999999999 111.206 167.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -156.6 130.92 8.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.842 2.057 . . . . 5.0 105.922 170.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.68 -52.37 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 N-CA-C 109.547 -0.538 . . . . 1.5 109.547 -170.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.0 28.86 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.465 -1.854 . . . . 2.1899999999999999 108.465 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -94.59 14.38 21.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.007 0.523 . . . . 5.9000000000000004 111.128 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 60.0 m -145.36 160.07 42.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 105.877 -1.897 . . . . 2.1699999999999999 105.877 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -74.09 -73.11 0.24 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.918 0.326 . . . . 5.4800000000000004 110.273 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.51 -179.91 0.53 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.56 1.076 . . . . 1.7 113.571 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -148.12 76.0 1.36 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.7 0.8 . . . . 1.52 109.73 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -114.64 100.36 53.09 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.851 -0.796 . . . . 0.94999999999999996 108.851 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.59 118.5 5.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.49 1.46 . . . . 0.62 109.771 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -125.19 -179.61 4.66 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 127.24 2.216 . . . . 3.4500000000000002 109.292 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -123.29 143.86 49.8 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.288 2.235 . . . . 0.44 107.661 171.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -126.28 154.15 43.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.133 -1.432 . . . . 0.67000000000000004 107.133 170.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.14 104.45 5.72 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.726 -1.583 . . . . 0.95999999999999996 106.726 160.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.03 117.01 17.3 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.118 1.367 . . . . 1.97 107.769 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 t -86.47 -20.79 27.59 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 122.191 -0.318 . . . . 1.0700000000000001 110.37 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -65.56 -46.4 79.62 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 126.859 2.064 . . . . 4.1600000000000001 106.75 -173.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.4 p -88.71 -29.85 19.54 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.374 1.869 . . . . 0.84999999999999998 110.413 170.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.73 54.45 7.36 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.348 -1.501 . . . . 0.84999999999999998 109.348 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -146.1 157.21 43.84 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 126.813 2.045 . . . . 4.7199999999999998 108.129 -172.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 95.7 m -80.48 142.43 34.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.321 -1.362 . . . . 0.72999999999999998 107.321 161.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.9 m -154.32 141.39 13.42 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.327 -0.99 . . . . 0.5 108.327 -169.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.76 154.83 59.01 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.954 2.436 . . . . 0.44 111.177 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -158.03 160.89 37.93 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.083 0.953 . . . . 0.46999999999999997 109.179 172.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -89.65 115.01 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 107.309 -1.367 . . . . 0.83999999999999997 107.309 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -85.37 149.77 25.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.612 1.565 . . . . 2.27 107.581 167.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.81 13.64 34.91 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.601 1.096 . . . . 1.3799999999999999 113.273 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.4 -52.29 4.71 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.891 1.234 . . . . 1.6599999999999999 110.237 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.42 122.37 40.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.093 0.949 . . . . 2.1800000000000002 111.268 -165.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.94 -66.25 3.8 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.613 1.101 . . . . 2.73 110.836 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 36.58 -118.38 0.47 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.03 1.3 . . . . 2.29 112.366 -172.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -172.46 179.9 2.38 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 127.984 2.513 . . . . 1.3200000000000001 107.272 165.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.09 -32.24 72.78 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 112.176 -0.37 . . . . 1.1100000000000001 112.176 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -75.45 70.56 2.33 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.889 0.875 . . . . 1.6799999999999999 109.831 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -158.62 78.61 0.79 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.897 1.279 . . . . 1.77 108.069 -157.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -115.71 144.45 43.93 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.316 1.446 . . . . 0.78000000000000003 110.433 -162.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.89 -38.3 90.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.294 0.952 . . . . 3.1699999999999999 111.579 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -133.49 161.69 33.9 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.277 0.631 . . . . 0.48999999999999999 111.987 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 tp -51.8 -49.69 62.24 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.638 -0.875 . . . . 1.0600000000000001 108.638 159.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -45.93 -48.58 16.24 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.183 0.901 . . . . 2.3599999999999999 110.38 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -66.03 -54.42 26.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.375 -0.232 . . . . 2.1600000000000001 110.375 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.3 t -53.62 -48.41 69.34 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.437 0.637 . . . . 0.5 111.895 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -54.19 -55.18 30.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.876 2.47 . . . . 2.5899999999999999 110.055 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.23 -43.46 78.64 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.666 0.386 . . . . 0.68000000000000005 110.957 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.4 mm -68.25 -45.13 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 118.916 -0.564 . . . . 1.8799999999999999 111.126 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.7 m -128.76 -97.33 0.38 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.833 0.742 . . . . 2.5099999999999998 110.991 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.89 155.29 6.78 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.843 0.747 . . . . 6.1600000000000001 111.608 -163.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.304 0 C-N-CA 127.647 2.379 . . . . 9.4600000000000009 113.57 169.074 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 117.826 -1.083 . . . . 3.6699999999999999 109.357 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 pt -52.06 -41.31 31.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-N 118.967 0.803 . . . . 1.8700000000000001 110.8 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.9 m -57.71 -18.35 20.42 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.536 0.734 . . . . 1.9299999999999999 112.617 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.01 -25.23 32.4 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.256 0.935 . . . . 1.3300000000000001 110.792 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -64.41 144.36 98.53 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 118.787 0.721 . . . . 4.5899999999999999 110.699 -174.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.81 -173.63 1.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.038 2.492 . . . . 1.27 110.702 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -77.83 141.73 38.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.08 1.352 . . . . 3.3999999999999999 111.411 161.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.62 ' HD2' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -159.16 139.9 12.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.116 -2.55 . . . . 5.2999999999999998 104.116 -176.666 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.7 t -63.15 -44.89 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 120.144 1.338 . . . . 1.6200000000000001 109.506 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.52 144.69 15.74 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.823 -1.711 . . . . 2.2799999999999998 108.823 -171.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -80.66 59.32 3.57 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.13 -0.629 . . . . 5.8600000000000003 112.682 -165.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.4 m -143.35 144.03 31.91 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 108.837 -0.801 . . . . 2.3700000000000001 108.837 167.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -90.08 72.04 7.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.682 0.793 . . . . 4.9100000000000001 109.457 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.07 -174.96 13.79 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.636 -0.985 . . . . 1.27 110.636 172.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -142.05 93.89 2.6 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.323 1.449 . . . . 1.48 107.354 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -124.75 105.74 29.73 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 108.486 -0.931 . . . . 0.92000000000000004 108.486 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.4 100.18 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.572 1.514 . . . . 1.22 109.477 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.444 ' HG3' HD21 ' A' ' 42' ' ' ASN . 8.6 mmt85 -106.81 179.84 4.15 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.512 1.525 . . . . 3.3900000000000001 108.345 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -119.53 145.09 46.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.253 1.421 . . . . 0.40999999999999998 108.333 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -124.02 150.42 44.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.144 -1.428 . . . . 0.75 107.144 167.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -75.56 102.0 5.11 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.307 -1.738 . . . . 1.21 106.307 162.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.44 104.95 4.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.619 -1.252 . . . . 2.21 107.619 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.2 t -84.0 -1.63 55.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.048 -0.977 . . . . 1.6499999999999999 112.824 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.29 -48.12 10.77 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.936 -1.505 . . . . 5.25 106.936 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 64.7 p -82.32 -32.14 29.58 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.431 1.092 . . . . 1.1299999999999999 110.603 175.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.92 4.84 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.008 -1.237 . . . . 0.95999999999999996 110.008 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.51 135.61 22.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.904 0.882 . . . . 5.9100000000000001 111.809 -169.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.3 m -69.5 126.45 29.79 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.215 -1.402 . . . . 0.45000000000000001 107.215 163.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.2 m -147.68 138.41 12.99 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.321 -0.992 . . . . 0.51000000000000001 108.321 -163.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 157.47 57.66 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.516 2.144 . . . . 0.38 111.015 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -158.17 155.65 29.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.343 1.057 . . . . 0.53000000000000003 109.401 170.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.4 mm -84.51 109.2 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.871 -1.159 . . . . 1.1100000000000001 107.871 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -87.12 146.15 26.16 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.693 1.197 . . . . 2.2999999999999998 109.616 174.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.08 -28.78 53.2 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.585 1.564 . . . . 1.1499999999999999 112.488 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.59 -40.89 1.71 Allowed Glycine 0 C--N 1.339 0.706 0 CA-C-N 117.738 0.769 . . . . 1.9099999999999999 111.294 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -154.29 165.2 37.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.6 -0.889 . . . . 3.3500000000000001 108.6 -174.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.24 49.14 81.75 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.962 0.791 . . . . 2.98 111.9 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.0 -121.37 4.16 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.115 -1.194 . . . . 1.78 110.115 174.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.62 ' ND2' ' HD2' ' A' ' 8' ' ' LYS . 29.4 p30 -157.03 -179.73 8.49 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.965 1.306 . . . . 1.27 107.559 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.58 -21.67 74.73 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.347 -0.696 . . . . 0.85999999999999999 113.821 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -78.26 70.65 4.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.092 1.446 . . . . 1.53 108.065 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.444 HD21 ' HG3' ' A' ' 18' ' ' ARG . 14.5 t-20 -158.84 85.35 0.82 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.017 1.727 . . . . 2.1099999999999999 108.046 -169.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -114.29 147.15 39.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.502 1.121 . . . . 0.78000000000000003 109.587 -164.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.14 -39.2 93.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.937 0.399 . . . . 2.6200000000000001 110.475 -174.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.6 p -141.33 163.04 34.02 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.689 0.795 . . . . 0.54000000000000004 110.735 -169.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.61 -45.97 66.82 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 109.402 -0.592 . . . . 0.48999999999999999 109.402 162.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -47.56 -51.11 22.06 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.973 0.352 . . . . 2.0 110.509 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -69.56 -49.4 54.6 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.264 -0.273 . . . . 2.21 110.264 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 t -50.66 -44.02 57.51 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.381 0.61 . . . . 0.55000000000000004 111.143 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -62.94 -58.39 7.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.46 1.104 . . . . 3.8199999999999998 109.603 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.11 -41.38 17.2 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.782 0.676 . . . . 0.82999999999999996 111.429 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.03 -53.3 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.767 0.427 . . . . 1.5800000000000001 112.028 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 78.7 m -110.61 -21.63 12.02 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.392 1.256 . . . . 2.8399999999999999 114.392 -163.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -117.44 62.5 0.74 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.893 1.677 . . . . 5.5800000000000001 110.432 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 105.18 -2.155 . . . . 6.8899999999999997 105.18 173.277 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 117.577 -1.202 . . . . 3.3999999999999999 108.855 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.8 pt -47.07 -31.4 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 124.086 0.866 . . . . 1.6499999999999999 111.905 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.5 m -49.87 -26.29 3.93 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.493 1.117 . . . . 1.26 112.743 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.27 -26.51 62.02 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.289 0.495 . . . . 1.3500000000000001 110.433 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -61.06 137.87 94.14 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 108.597 -0.89 . . . . 3.52 108.597 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.16 170.2 20.52 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.864 1.709 . . . . 1.23 111.769 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 20' ' ' TYR . 1.6 ttpm? -51.76 140.69 18.6 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.164 0.983 . . . . 2.6600000000000001 110.697 156.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 132.54 8.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 113.756 -1.565 . . . . 5.6699999999999999 106.943 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -67.48 -39.95 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.479 -0.934 . . . . 1.3899999999999999 108.479 172.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.48 33.38 8.63 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.836 0.732 . . . . 3.2400000000000002 111.655 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 48.71 60.55 3.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.254 1.821 . . . . 8.3900000000000006 113.391 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -153.89 152.15 30.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.774 -0.825 . . . . 1.78 108.774 168.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -82.82 70.36 9.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.853 -1.166 . . . . 4.8399999999999999 107.853 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.23 149.85 16.97 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 109.39 -1.484 . . . . 1.29 109.39 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -120.14 72.6 0.94 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.923 -1.51 . . . . 1.22 106.923 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -102.73 96.01 7.05 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 107.092 -1.447 . . . . 0.73999999999999999 107.092 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -60.97 127.15 21.45 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 N-CA-C 108.879 -1.239 . . . . 0.56000000000000005 108.879 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -135.49 179.98 6.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.71 1.604 . . . . 2.6000000000000001 107.642 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -119.8 149.17 42.48 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.101 1.76 . . . . 0.46999999999999997 107.949 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.492 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 2.2 p90 -134.03 157.26 46.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.866 -1.902 . . . . 0.66000000000000003 105.866 170.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -71.34 105.89 3.67 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.377 -1.712 . . . . 0.94999999999999996 106.377 159.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.492 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 7.5 t0 -71.65 115.31 10.69 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.855 -1.535 . . . . 2.25 106.855 172.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 t -94.46 -9.25 36.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 123.8 0.688 . . . . 1.3300000000000001 109.674 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.45 -43.68 72.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.451 -2.055 . . . . 4.2999999999999998 105.451 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.8 p -98.89 -40.08 8.27 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.564 2.346 . . . . 1.0900000000000001 112.846 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 60.9 1.26 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.94 -1.264 . . . . 1.05 109.94 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -157.63 138.36 13.1 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 124.16 0.984 . . . . 5.1500000000000004 109.556 -163.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.6 m -72.85 122.38 21.5 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 120.617 -1.302 . . . . 0.56000000000000005 107.594 165.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.4 m -143.06 145.34 32.51 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 108.507 -0.923 . . . . 0.62 108.507 -162.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.51 153.21 65.64 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.789 2.326 . . . . 0.51000000000000001 111.188 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -155.76 163.21 40.14 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.195 -1.409 . . . . 0.68000000000000005 107.195 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.11 126.47 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 N-CA-C 108.01 -1.107 . . . . 0.90000000000000002 108.01 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -105.91 148.66 27.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.515 1.126 . . . . 2.2999999999999998 108.384 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.83 -9.57 62.42 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.711 1.148 . . . . 1.1399999999999999 113.028 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.52 14.05 80.65 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.155 0.977 . . . . 1.6399999999999999 112.395 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.5 m -145.96 178.48 8.16 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 107.016 -1.476 . . . . 2.1600000000000001 107.016 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.64 -69.17 2.1 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.383 1.944 . . . . 3.0699999999999998 110.674 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.67 -163.98 3.52 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.326 1.917 . . . . 1.4299999999999999 113.578 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.5 p30 170.46 -160.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.256 3.822 . . . . 1.6000000000000001 104.759 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.38 -44.52 7.93 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.76 1.164 . . . . 0.98999999999999999 110.287 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -74.88 78.26 2.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.105 0.955 . . . . 1.5600000000000001 112.134 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -156.55 115.38 3.39 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.763 1.625 . . . . 2.23 108.002 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -133.95 155.65 49.56 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 124.762 1.225 . . . . 0.64000000000000001 108.73 -168.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -80.2 -31.22 38.75 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.463 -0.773 . . . . 2.9700000000000002 111.633 -174.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.1 p -145.73 165.01 30.03 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.761 0.824 . . . . 0.68999999999999995 110.08 -173.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.57 -46.55 70.32 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 109.558 -0.534 . . . . 0.57999999999999996 109.558 163.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -47.03 -52.19 15.53 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 110.039 -0.356 . . . . 2.1000000000000001 110.039 175.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 tp-100 -66.94 -51.73 51.72 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.283 -0.265 . . . . 3.96 110.283 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.7 t -51.84 -48.59 63.89 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 122.911 0.484 . . . . 0.58999999999999997 110.882 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.4 -58.13 9.82 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.943 0.897 . . . . 2.48 109.273 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.19 -41.64 62.82 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.514 0.725 . . . . 0.73999999999999999 111.763 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.3 mm -70.43 -51.66 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.39 0.276 . . . . 1.5 110.522 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.7 t -81.86 -44.53 16.74 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.044 0.757 . . . . 1.49 113.044 -164.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.4 mtp85 -134.01 -159.76 0.99 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.893 2.077 . . . . 5.3300000000000001 110.85 -169.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 104.57 -2.382 . . . . 4.9100000000000001 104.57 117.858 . . . . . . . . 0 0 . 1 stop_ save_